1 00:00:05,080 --> 00:00:09,760 >> I WOULD LIKE TO 2 00:00:09,760 --> 00:00:13,600 CALL TO ORDER THE 85th MEETING 3 00:00:13,600 --> 00:00:15,400 OF THE NATIONAL ADVISORY COUNCIL 4 00:00:15,400 --> 00:00:16,880 FOR COMPLEMENTARY AND 5 00:00:16,880 --> 00:00:17,320 INTEGRATIVE HEALTH. 6 00:00:17,320 --> 00:00:20,840 I'M MARTINA SCHMIDT AND SERVE AS 7 00:00:20,840 --> 00:00:24,240 THE EXECUTIVE SECRETARY FOR THE 8 00:00:24,240 --> 00:00:24,880 NCCIH ADVISORY COUNCIL. 9 00:00:24,880 --> 00:00:27,360 THIS MEETING IS BEING HELD AS A 10 00:00:27,360 --> 00:00:28,000 HYBRID MEETING. 11 00:00:28,000 --> 00:00:31,080 THIS MEANS I DON'T HAVE MANY OF 12 00:00:31,080 --> 00:00:32,680 THE COUNCIL MEMBERS AND STAFF 13 00:00:32,680 --> 00:00:36,840 WITH ME IN THE ROOM WHILE THOSE 14 00:00:36,840 --> 00:00:39,200 WHO CAN'T BE WITH US IN PERSON 15 00:00:39,200 --> 00:00:41,240 INCLUDING THE PUBLIC MUST ATTEND 16 00:00:41,240 --> 00:00:41,520 VIRTUALLY. 17 00:00:41,520 --> 00:00:46,600 I WOULD LIKE TO POINT OUT THIS 18 00:00:46,600 --> 00:00:49,600 IS NOT A SECOND TIME THE SECOND 19 00:00:49,600 --> 00:00:51,240 TIME WE HAVE AN IN-PERSON 20 00:00:51,240 --> 00:00:52,080 COMPONENT AND WE'RE EXCITE ABOUT 21 00:00:52,080 --> 00:00:52,480 THIS. 22 00:00:52,480 --> 00:00:54,120 THIS MEETING IS RECORDED AND 23 00:00:54,120 --> 00:01:00,640 BROADCAST TO THE PUBLIC. 24 00:01:00,640 --> 00:01:07,160 WE'LL BE ABLE TO FINISH BY 4:00 25 00:01:07,160 --> 00:01:09,520 P.M. AND THIS IS OPEN TO THE 26 00:01:09,520 --> 00:01:14,120 PUBLIC VIA LIVE NIH VIDEO CAST. 27 00:01:14,120 --> 00:01:18,360 THE COUNCIL IS CONVENED BY THE 28 00:01:18,360 --> 00:01:19,800 TITLE 42 THAT GOVERN THE NIH IN 29 00:01:19,800 --> 00:01:24,280 GENERAL AND IN ACCORDANCE WITH 30 00:01:24,280 --> 00:01:26,200 THE FEDERAL ADVISORY COMMITTEE 31 00:01:26,200 --> 00:01:30,960 ACT AND CLOSED SESSION WAS HELD 32 00:01:30,960 --> 00:01:33,720 HELD THIS MORNING AND CLOSED IN 33 00:01:33,720 --> 00:01:36,760 ACCORDANCE WITH THE SUNSHINE 34 00:01:36,760 --> 00:01:36,920 ACT. 35 00:01:36,920 --> 00:01:38,920 THIS WILL INCLUDE THE OPENING 36 00:01:38,920 --> 00:01:43,240 PROCEDURAL REMARKS FOLLOWED BY 37 00:01:43,240 --> 00:01:44,880 THE NCCIH DIRECTOR REPORT. 38 00:01:44,880 --> 00:01:47,680 AT NOON WE'LL BREAK FOR LUNCH. 39 00:01:47,680 --> 00:01:50,400 AFTER LUNCH THERE'LL BE AN 40 00:01:50,400 --> 00:01:51,760 UPDATE ON THE RESEARCH PROGRAM 41 00:01:51,760 --> 00:02:00,400 PRESENT THE DEPUTY DIRECTOR 42 00:02:00,400 --> 00:02:02,120 DR. SHURTLEFF AND THEN WE'LL 43 00:02:02,120 --> 00:02:04,160 TALK WITH ENHANCING THE FAIRNESS 44 00:02:04,160 --> 00:02:06,000 AND EFFECTIVENESS OF PEER 45 00:02:06,000 --> 00:02:06,480 REVIEW. 46 00:02:06,480 --> 00:02:09,080 WE'LL FINISH OUR PRESENTATIONS 47 00:02:09,080 --> 00:02:10,840 BY PRESENTING TWO CONCEPTS TO 48 00:02:10,840 --> 00:02:12,400 COUNCIL FOR REVIEW AND CLEARANCE 49 00:02:12,400 --> 00:02:15,920 BY COUNCIL. 50 00:02:15,920 --> 00:02:17,320 OUR FIRST ORDER OF BUSINESS 51 00:02:17,320 --> 00:02:20,800 TODAY WILL BE TO APPROVE THE MAY 52 00:02:20,800 --> 00:02:22,600 2023 COUNCIL MINUTES WHICH WAS 53 00:02:22,600 --> 00:02:25,280 PROVIDED TO OUR COUNCIL MEMBERS 54 00:02:25,280 --> 00:02:26,920 VIA THE ELECTRONIC COUNCIL BOOK 55 00:02:26,920 --> 00:02:29,680 AND A COPY I BELIEVE IS 56 00:02:29,680 --> 00:02:30,480 CURRENTLY PLACED ON THE SCREEN. 57 00:02:30,480 --> 00:02:33,320 AT THIS TIME, I WOULD LIKE TO 58 00:02:33,320 --> 00:02:34,240 FINALIZE THE MINUTES. 59 00:02:34,240 --> 00:02:36,400 ARE THERE ANY CORRECTIONS TO THE 60 00:02:36,400 --> 00:02:43,720 COUNCIL MEETING MINUTES? 61 00:02:43,720 --> 00:02:43,880 NO? 62 00:02:43,880 --> 00:02:44,080 OKAY. 63 00:02:44,080 --> 00:02:46,880 IF NOT, MAY I HAVE A MOTION TO 64 00:02:46,880 --> 00:02:49,280 APPROVE THE MEETING MINUTES FOR 65 00:02:49,280 --> 00:02:59,760 THE MAY 2023 COUNCIL MEETING. 66 00:03:01,760 --> 00:03:04,040 ALL IN FAVOR RAISE YOUR HAND AND 67 00:03:04,040 --> 00:03:06,280 FOR THOSE IN THE ROOM AS WELL AS 68 00:03:06,280 --> 00:03:07,280 ELECTRONICALLY FOR THOSE WHO 69 00:03:07,280 --> 00:03:11,640 ATTEND VIRTUALLY. 70 00:03:11,640 --> 00:03:13,440 ANY OPPOSED? 71 00:03:13,440 --> 00:03:13,760 OKAY. 72 00:03:13,760 --> 00:03:14,040 THANK YOU. 73 00:03:14,040 --> 00:03:22,520 THE MOTION HAS BEEN APPROVED. 74 00:03:22,520 --> 00:03:25,360 THAT'S IT AND I'LL HAND IT OVER 75 00:03:25,360 --> 00:03:26,360 TO DIRECTOR LANGEVIN FOR HER 76 00:03:26,360 --> 00:03:27,000 COMMENTS. 77 00:03:27,000 --> 00:03:30,200 >>IT'S MY PLEASURE TO PRESENT MY 78 00:03:30,200 --> 00:03:32,720 DIRECTOR'S REPORT TO COUNCIL. 79 00:03:32,720 --> 00:03:34,960 IT'S BEEN BUSY SINCE WE LAST MET 80 00:03:34,960 --> 00:03:40,400 IN MAY AND I'LL START WITH 81 00:03:40,400 --> 00:03:44,000 GENERAL NIH WIDE NEWS AND AN A 82 00:03:44,000 --> 00:03:54,520 VERY IMPORTANT PIECE OF NEWS. 83 00:04:12,280 --> 00:04:22,040 THE FIRST IS DR. BERTAGNOLLI HAS 84 00:04:22,040 --> 00:04:24,200 BEEN NOMINATED BY PRESIDENT 85 00:04:24,200 --> 00:04:25,880 BIDEN AND IS NOT CONFIRMED YET. 86 00:04:25,880 --> 00:04:30,640 SHE'S CURRENTLY THE OF THE 87 00:04:30,640 --> 00:04:31,400 NATIONAL CANCER INSTITUTE. 88 00:04:31,400 --> 00:04:32,920 THE NEXT STEP IS SHE'LL BE 89 00:04:32,920 --> 00:04:34,640 MEETING WITH INDIVIDUAL MEMBERS 90 00:04:34,640 --> 00:04:37,080 OF CONGRESS AND THERE'LL BE A 91 00:04:37,080 --> 00:04:40,480 HEARING AND THEN SENATE AND THEN 92 00:04:40,480 --> 00:04:42,880 IF SHE'S CONFIRMED AT THAT POINT 93 00:04:42,880 --> 00:04:44,760 SHE'LL BECOME THE NIH DIRECTOR. 94 00:04:44,760 --> 00:04:46,920 WE'RE VERY INTERESTED IN 95 00:04:46,920 --> 00:04:48,120 FOLLOWING THIS ALONG. 96 00:04:48,120 --> 00:04:50,280 UNTIL HER NOMINATE IS CONFIRMED, 97 00:04:50,280 --> 00:04:53,640 DR. LARRY TABAK WILL CONTINUE AS 98 00:04:53,640 --> 00:04:55,920 ACTING DIRECTOR AT NIH. 99 00:04:55,920 --> 00:04:59,240 AND DR. BERTAGNOLLI WILL REMAIN 100 00:04:59,240 --> 00:05:00,160 NCI DIRECTOR. 101 00:05:00,160 --> 00:05:07,200 WE ALSO HAD QUITE A FEW NEW 102 00:05:07,200 --> 00:05:15,600 ARRIVALS AT NIH. 103 00:05:15,600 --> 00:05:17,720 WE HAVE A NEW DIRECTOR OF THE 104 00:05:17,720 --> 00:05:28,240 OFFICE OF DIETARY SUPPLEMENTS. 105 00:05:28,680 --> 00:05:36,240 HE WAS IN THE DIVISION OF 106 00:05:36,240 --> 00:05:37,840 MILITARY PERFORMANCE AT THE 107 00:05:37,840 --> 00:05:39,200 UNITED STATES ARMY RESEARCH 108 00:05:39,200 --> 00:05:41,720 INSTITUTE OF ENVIRONMENTAL 109 00:05:41,720 --> 00:05:42,000 MEDICINE. 110 00:05:42,000 --> 00:05:49,400 DR. PASIAKOS LED A PROGRAM TO 111 00:05:49,400 --> 00:05:52,000 REFINE DIETARY PROTEIN 112 00:05:52,000 --> 00:05:54,200 REQUIREMENTS FOR SOLDIERS AND 113 00:05:54,200 --> 00:05:57,200 DEVELOPED TARGETED DIETARY 114 00:05:57,200 --> 00:06:00,520 SUPPLEMENTS TO RETAIN MUSCLE 115 00:06:00,520 --> 00:06:04,480 MASS-HIS INTEREST MUSCLE 116 00:06:04,480 --> 00:06:07,080 PHYSIOLOGY, BIO ENERGETICS OF 117 00:06:07,080 --> 00:06:09,200 EXERCISE AND METABOLISM AND 118 00:06:09,200 --> 00:06:12,600 EXCITED TO WORK WITH HIM AS YOU 119 00:06:12,600 --> 00:06:14,920 KNOW THE RELATIONSHIP BETWEEN 120 00:06:14,920 --> 00:06:17,880 NCCIH AND THE OFFICE OF DIETARY 121 00:06:17,880 --> 00:06:20,960 SUPPLEMENTS IS A STRONG ONE BY, 122 00:06:20,960 --> 00:06:22,960 FOR EXAMPLE, A PROGRAM WHICH 123 00:06:22,960 --> 00:06:31,960 YOU'LL BE HEARING MORE ABOUT. 124 00:06:31,960 --> 00:06:34,080 WE HAVE OUR NEW DIRECTOR OF THE 125 00:06:34,080 --> 00:06:37,080 INSTITUTE OF ALLERGY AND 126 00:06:37,080 --> 00:06:40,800 INFECTIOUS DISEASES, A SUCCESSOR 127 00:06:40,800 --> 00:06:46,520 TO DR. TONY FAUCI. 128 00:06:46,520 --> 00:06:51,000 DR. MARRAZZO COMES FROM THE 129 00:06:51,000 --> 00:06:53,280 UNIVERSITY OF BIRMINGHAM. 130 00:06:53,280 --> 00:06:55,480 HER RESEARCH IN DISCOVERY AND 131 00:06:55,480 --> 00:06:56,480 IMPLEMENTATION SCIENCE FOCUSSED 132 00:06:56,480 --> 00:06:59,000 ON THE HUMAN MICROBIOME 133 00:06:59,000 --> 00:07:04,880 SPECIFICALLY AS IT RELATES TO 134 00:07:04,880 --> 00:07:12,400 FEMALE TRACT INFECTION AND USING 135 00:07:12,400 --> 00:07:14,720 PRPE AND MICROBECYTES AND THE 136 00:07:14,720 --> 00:07:15,840 MANAGEMENT OF SEXUALLY 137 00:07:15,840 --> 00:07:16,800 TRANSMITTED DISEASES. 138 00:07:16,800 --> 00:07:18,280 WE'RE SO THRILLED TO WELCOME 139 00:07:18,280 --> 00:07:27,400 DR. MARRAZZO. 140 00:07:27,400 --> 00:07:30,840 AND WE HAVE A NEW DIRECTOR OF 141 00:07:30,840 --> 00:07:35,160 THE OFFICE OF OB SR AND 142 00:07:35,160 --> 00:07:37,840 ASSOCIATE DIRECTOR OF SOCIAL 143 00:07:37,840 --> 00:07:38,280 SCIENCES RESEARCH. 144 00:07:38,280 --> 00:07:39,200 ANOTHER VERY IMPORTANT PARTNER 145 00:07:39,200 --> 00:07:43,920 AT THE OFFICE OF THE DIRECTOR. 146 00:07:43,920 --> 00:07:48,960 DR. SIMONI JOINS US FROM 147 00:07:48,960 --> 00:07:50,280 WASHINGTON, SEATTLE AND WAS A 148 00:07:50,280 --> 00:07:52,400 PROFESSOR IN THE DEPARTMENT OF 149 00:07:52,400 --> 00:07:52,720 PSYCHOLOGY. 150 00:07:52,720 --> 00:07:54,320 SHE'S A CLINICAL PSYCHOLOGIST 151 00:07:54,320 --> 00:07:55,920 WITH MORE THAN 25 YEARS IN 152 00:07:55,920 --> 00:07:57,400 EXPERIENCE IN RESEARCH FOCUSSED 153 00:07:57,400 --> 00:07:59,160 ON HEALTH DISPARITIES AND 154 00:07:59,160 --> 00:07:59,880 RESEARCH ON POPULATIONS SOCIALLY 155 00:07:59,880 --> 00:08:02,680 MARGINALIZED. 156 00:08:02,680 --> 00:08:08,440 HER INTERVENTION RESEARCH HAS 157 00:08:08,440 --> 00:08:10,200 EXAMINED CHRONIC ILLNESS USING 158 00:08:10,200 --> 00:08:12,240 MIXED METHODS AND CLINICAL 159 00:08:12,240 --> 00:08:13,840 TRIALS AND PEER SUPPORT AND 160 00:08:13,840 --> 00:08:14,840 PROVIDER TRAINING AND COUNSELING 161 00:08:14,840 --> 00:08:16,440 AND M-HEALTH. 162 00:08:16,440 --> 00:08:19,800 WE'RE LOOKING FORWARD TO WORKING 163 00:08:19,800 --> 00:08:25,720 WITH DR. SIMONI ON OUR JOINT 164 00:08:25,720 --> 00:08:26,000 INTERESTS. 165 00:08:26,000 --> 00:08:30,080 IT'S BITTER SWEET TO ANNOUNCE 166 00:08:30,080 --> 00:08:31,520 THE RETIREMENT OF DR. PATTI 167 00:08:31,520 --> 00:08:34,000 BRENNAN WHO HAS BEEN A FANTASTIC 168 00:08:34,000 --> 00:08:34,840 COLLEGIATE NIH. 169 00:08:34,840 --> 00:08:36,480 SHE'S GOING TO BE RETIRING AT 170 00:08:36,480 --> 00:08:38,160 THE END OF THE MONTH AS DIRECTOR 171 00:08:38,160 --> 00:08:41,360 OF THE NATIONAL LIBRARY OF 172 00:08:41,360 --> 00:08:41,600 MEDICINE. 173 00:08:41,600 --> 00:08:44,880 DR. BRENNAN HAS BEEN A CHAMPION 174 00:08:44,880 --> 00:08:51,920 OF BIO TECHNOLOGY DEVELOPING 175 00:08:51,920 --> 00:08:53,800 NIH'S INFORMATICS AND 176 00:08:53,800 --> 00:08:54,840 INFRASTRUCTURE IN THIS AREA. 177 00:08:54,840 --> 00:08:59,760 SHE'LL BE GREATLY MISSED AND WE 178 00:08:59,760 --> 00:09:06,720 WISH HER WELL ON HER RETIREMENT. 179 00:09:06,720 --> 00:09:09,360 THERE HAS BEEN AN RFI, REQUEST 180 00:09:09,360 --> 00:09:11,120 FOR INFORMATION THAT IS STILL 181 00:09:11,120 --> 00:09:13,400 ACTIVE IN WRITING COMMENTS AND 182 00:09:13,400 --> 00:09:16,720 SUGGESTIONS ON UPDATING THE NIH 183 00:09:16,720 --> 00:09:17,160 MISSION STATEMENT. 184 00:09:17,160 --> 00:09:19,440 THE MISSION STATEMENT FOR THE 185 00:09:19,440 --> 00:09:21,000 ENTIRE NIH. 186 00:09:21,000 --> 00:09:23,560 YOU CAN SEE HERE ON THE SLIDE 187 00:09:23,560 --> 00:09:26,160 THAT THE PROPOSED REVISION OF 188 00:09:26,160 --> 00:09:28,200 THE MISSION STATEMENT WOULD BE 189 00:09:28,200 --> 00:09:29,240 TO SEEK FUNDAMENTAL KNOWLEDGE 190 00:09:29,240 --> 00:09:31,240 ABOUT THE NATURE AND BEHAVIOR OF 191 00:09:31,240 --> 00:09:33,760 LIVING SYSTEMS AND TO APPLY THAT 192 00:09:33,760 --> 00:09:36,520 KNOWLEDGE TO OPTIMIZE HEALTH AND 193 00:09:36,520 --> 00:09:38,960 PREVENT OR REDUCE ILLNESS FOR 194 00:09:38,960 --> 00:09:39,480 ALL PEOPLE. 195 00:09:39,480 --> 00:09:42,160 CAN SEE THE WORD PREVENTION IS 196 00:09:42,160 --> 00:09:43,240 NOT NEW AND WE'RE VERY EXCITED 197 00:09:43,240 --> 00:09:47,000 ABOUT THAT. 198 00:09:47,000 --> 00:09:49,120 INPUT IS SOUGHT ABOUT THE 199 00:09:49,120 --> 00:09:51,920 PROPOSED REVISED MISSION 200 00:09:51,920 --> 00:09:53,120 STATEMENT AND YOU'RE WELCOME OR 201 00:09:53,120 --> 00:09:53,720 EVERYONE IS WELCOME TO SUBMIT 202 00:09:53,720 --> 00:10:03,880 COMMENTS. 203 00:10:08,960 --> 00:10:12,800 WE RELEASED LAST MARCH THE NIH 204 00:10:12,800 --> 00:10:13,960 WIDE PLAN UPON DIVERSITY, EQUITY 205 00:10:13,960 --> 00:10:14,320 AND INCLUSION. 206 00:10:14,320 --> 00:10:16,160 THIS PROVIDES A FRAMEWORK FOR 207 00:10:16,160 --> 00:10:17,360 ADVANCING EFFORTS IN A 208 00:10:17,360 --> 00:10:18,280 TRANSPARENT AND ACCOUNTABLE 209 00:10:18,280 --> 00:10:19,080 MANNER OFFER THE NEXT FIVE 210 00:10:19,080 --> 00:10:20,720 YEARS. 211 00:10:20,720 --> 00:10:23,120 OUR STRENGTH AS AN AGENCY IS 212 00:10:23,120 --> 00:10:25,360 DERIVED IN LARGE PART FROM OUR 213 00:10:25,360 --> 00:10:27,400 DIVERSITY AND BROAD RANGE OF 214 00:10:27,400 --> 00:10:27,720 PERSPECTIVES. 215 00:10:27,720 --> 00:10:30,880 SO THIS IS SO IMPORTANT AS WE 216 00:10:30,880 --> 00:10:32,640 PLAY A ROLE IN FOSTERING A 217 00:10:32,640 --> 00:10:33,720 CULTURE WHERE WE ALL FEEL 218 00:10:33,720 --> 00:10:34,200 WELCOME. 219 00:10:34,200 --> 00:10:35,720 THIS IS A VERY IMPORTANT 220 00:10:35,720 --> 00:10:41,960 DOCUMENT WE'LL ALL BE ABIDING BY 221 00:10:41,960 --> 00:10:46,760 VERY CLOSELY. 222 00:10:46,760 --> 00:10:50,160 THERE ALSO HAS BEEN A 223 00:10:50,160 --> 00:10:55,120 RECOMMENDATION ON RESPONSIBLE 224 00:10:55,120 --> 00:10:57,040 STEWARDSHIP ON PERSONAL HEALTH 225 00:10:57,040 --> 00:10:58,320 DATA AND THESE ARE IMPORTANT 226 00:10:58,320 --> 00:11:00,600 RECOMMENDATION COME FROM THE 227 00:11:00,600 --> 00:11:04,560 RESEARCH ADVISORY COMMITTEE 228 00:11:04,560 --> 00:11:06,200 WHICH NEXTRAC PROVIDING 229 00:11:06,200 --> 00:11:06,920 INFORMATION TO THE NIH DIRECTOR 230 00:11:06,920 --> 00:11:09,680 IN THE PUBLIC FORUM FOR THE 231 00:11:09,680 --> 00:11:11,240 DISCUSSION OF SAFETY, SCIENTIFIC 232 00:11:11,240 --> 00:11:12,720 SAFETY AND ETHICAL ISSUES 233 00:11:12,720 --> 00:11:14,200 ASSOCIATED SPECIFICALLY WITH 234 00:11:14,200 --> 00:11:24,600 EMERGING BIO TECHNOLOGY. 235 00:11:26,680 --> 00:11:29,520 ENGAGING WITH PARTICIPANTS AND 236 00:11:29,520 --> 00:11:31,120 COMMUNITIES EARLY AND OFTEN 237 00:11:31,120 --> 00:11:32,920 ESPECIALLY WHEN THE USE OF 238 00:11:32,920 --> 00:11:33,560 PERSONAL HEALTH DATA IS 239 00:11:33,560 --> 00:11:36,840 CONTEMPLATED. 240 00:11:36,840 --> 00:11:38,240 IMPROVING HOW RESEARCHERS INFORM 241 00:11:38,240 --> 00:11:39,840 AND GAIN CONSENT FROM 242 00:11:39,840 --> 00:11:41,360 PARTICIPANTS ON THE USE AND 243 00:11:41,360 --> 00:11:43,760 SHARING OF THEIR HEALTH DATA 244 00:11:43,760 --> 00:11:45,920 ESPECIALLY IN THE LONG TERM. 245 00:11:45,920 --> 00:11:47,880 ENSURING THAT BIOETHICS IS 246 00:11:47,880 --> 00:11:49,560 INTEGRATED INTO RESEARCH TO 247 00:11:49,560 --> 00:11:51,680 INFORM THE RETURN OF THE VALUE 248 00:11:51,680 --> 00:11:54,040 FROM THE STUDIES INCLUDING A 249 00:11:54,040 --> 00:11:56,520 RESEARCH RESULT TO PARTICIPANTS 250 00:11:56,520 --> 00:11:58,200 AND COMMUNITIES. 251 00:11:58,200 --> 00:12:01,080 EXTREMELY IMPORTANT ASPECT OF 252 00:12:01,080 --> 00:12:11,240 RESEARCH. 253 00:12:13,160 --> 00:12:18,720 ARPA-H HAS CREATED A PROGRAM TO 254 00:12:18,720 --> 00:12:21,520 DEVELOPMENT OF TOOLS FOR TISSUE 255 00:12:21,520 --> 00:12:24,000 REGENERATION IN OSTEOARTHRITIS. 256 00:12:24,000 --> 00:12:26,720 IT'S REGENERATIVE MEDICINE AND 257 00:12:26,720 --> 00:12:32,800 WE'RE VERY EXCITED TO SEE HOW 258 00:12:32,800 --> 00:12:39,000 THE ARPA-H PROGRAM ARE GETTING 259 00:12:39,000 --> 00:12:42,200 LAUNCHED AND FOR ALL LISTENING, 260 00:12:42,200 --> 00:12:44,240 ARPA-H IS CURRENTLY HIRING 261 00:12:44,240 --> 00:12:45,440 PROGRAM MANAGERS. 262 00:12:45,440 --> 00:12:46,880 THEY'RE VERY IMPORTANT. 263 00:12:46,880 --> 00:12:49,360 IS THIS HOW ARPA-H WORKS. 264 00:12:49,360 --> 00:12:52,200 THEY HIRE PEOPLE THAT ARE FROM 265 00:12:52,200 --> 00:12:54,200 THE COMMUNITY TO COME AND WORK 266 00:12:54,200 --> 00:12:56,640 AT ARPA-H FOR THREE YEARS. 267 00:12:56,640 --> 00:12:58,840 AND THESE PROGRAM MANAGERS ARE 268 00:12:58,840 --> 00:13:00,440 HIRED IN ORDER TO ESSENTIALLY 269 00:13:00,440 --> 00:13:01,760 MAKE SOMETHING HAPPEN. 270 00:13:01,760 --> 00:13:03,840 SO THIS IS A VERY INTERESTING 271 00:13:03,840 --> 00:13:06,840 MODEL THAT THEY ARE PURSUING. 272 00:13:06,840 --> 00:13:10,520 THE AREAS OF FOCUS THAT THEY'RE 273 00:13:10,520 --> 00:13:13,200 LOOKING FOR INCLUDE HEALTH 274 00:13:13,200 --> 00:13:17,600 SCIENCES FUTURES, EXPANDING 275 00:13:17,600 --> 00:13:18,240 WHAT'S TECHNICALLY POSSIBLE, 276 00:13:18,240 --> 00:13:20,680 SCALING SOLUTIONS, PROACTIVE 277 00:13:20,680 --> 00:13:23,200 HEALTH, KEEPING PEOPLE FROM 278 00:13:23,200 --> 00:13:24,880 BEING PATIENTS AND RESILIENT 279 00:13:24,880 --> 00:13:26,800 SYSTEMS BUILDING INTEGRITIED 280 00:13:26,800 --> 00:13:27,920 HEALTH CARE SYSTEMS. 281 00:13:27,920 --> 00:13:30,200 YOU CAN SEE A LOT OF THE THEMES 282 00:13:30,200 --> 00:13:32,640 ARPA-H ARE INTERESTED IN ARE 283 00:13:32,640 --> 00:13:36,120 VERY MUCH IN LINE WITH HOW WE 284 00:13:36,120 --> 00:13:38,000 THINK ABOUT OUR FULL PERSON 285 00:13:38,000 --> 00:13:39,960 HEALTH, RESILIENCE AND 286 00:13:39,960 --> 00:13:42,200 PREVENTION. 287 00:13:42,200 --> 00:13:52,400 KEEPING PEOPLE FROM BEING SICK. 288 00:13:52,400 --> 00:13:53,760 IF ANYONE IS INTERESTED YOU 289 00:13:53,760 --> 00:13:55,160 SHOULD CONTACT THE LINK ON THE 290 00:13:55,160 --> 00:13:56,160 SLIDE. 291 00:13:56,160 --> 00:13:57,880 WE'RE EXCITED NIH HAS 292 00:13:57,880 --> 00:14:00,760 ESTABLISHED MATERNAL HEALTH 293 00:14:00,760 --> 00:14:04,400 RESEARCH CENTERS OF EXCELLENCE 294 00:14:04,400 --> 00:14:05,520 FOR MATERNAL HEALTH. 295 00:14:05,520 --> 00:14:07,680 NCCIH IS PART OF THIS EFFORT 296 00:14:07,680 --> 00:14:09,760 CALLED IMPROVE. 297 00:14:09,760 --> 00:14:13,200 $24 MILLION HAS BEEN AWARDED SO 298 00:14:13,200 --> 00:14:15,760 FAR TO ESTABLISH THE CENTERS FOR 299 00:14:15,760 --> 00:14:17,200 EXCELLENCE. 300 00:14:17,200 --> 00:14:21,240 WE'VE NOT YET HAD CO-FUNDED S 301 00:14:21,240 --> 00:14:23,240 BUT WE'RE KEEPING A CLOSE EYE ON 302 00:14:23,240 --> 00:14:25,840 THIS BECAUSE IT'S POSSIBLE WE'LL 303 00:14:25,840 --> 00:14:28,000 BE ABLE TO GO FUND SOME 304 00:14:28,000 --> 00:14:29,120 APPLICATIONS AND TAKE ADVANTAGE 305 00:14:29,120 --> 00:14:39,480 OF THE OPPORTUNITY. 306 00:14:46,240 --> 00:14:48,960 NIH LAUNCHED TRIALS FOR 307 00:14:48,960 --> 00:14:50,720 POST-ACUTE COVID SYNDROME. 308 00:14:50,720 --> 00:14:55,320 ONE IS RECOVERED VITAL TESTING A 309 00:14:55,320 --> 00:14:58,760 LONGER COURSE OF PAXLOVID TO SEE 310 00:14:58,760 --> 00:15:02,000 IF IT'S HELPFUL TO HELP PEOPLE 311 00:15:02,000 --> 00:15:03,080 RECOVER FROM LONG-TERM SYSTEMS 312 00:15:03,080 --> 00:15:05,520 AS WELL AS RECOVER-NEURO WHICH 313 00:15:05,520 --> 00:15:07,800 IS TRAINING AND SIMULATION 314 00:15:07,800 --> 00:15:09,480 INTERVENTIONS FOR BRAIN FOG THAT 315 00:15:09,480 --> 00:15:11,320 A LOT OF PEOPLE COMPLAIN THAT IS 316 00:15:11,320 --> 00:15:18,560 PERSISTENT AFTER HAVING COVID. 317 00:15:18,560 --> 00:15:20,400 THERE'S TWO ADDITIONAL PROTOCOLS 318 00:15:20,400 --> 00:15:22,200 RECOVERY SLEEP LOOKING FOR 319 00:15:22,200 --> 00:15:26,200 CHANGES IN SLEEP PATTERNS WHEN 320 00:15:26,200 --> 00:15:28,440 PEOPLE HAVE DIFFICULTIES WITH 321 00:15:28,440 --> 00:15:31,840 LONG COVID AND AUTONOMIC RELATED 322 00:15:31,840 --> 00:15:35,960 TO SYMPTOMS OF REGULATION OF 323 00:15:35,960 --> 00:15:38,040 HEART RATE AND WE GET 324 00:15:38,040 --> 00:15:41,600 HYPOTENSION PROBLEMS AND 325 00:15:41,600 --> 00:15:42,120 BREATHING AND DIGESTION. 326 00:15:42,120 --> 00:15:44,320 MORE COMING SOON FOR THAT. 327 00:15:44,320 --> 00:15:50,280 THERE'S ALSO A VERY EXCITING NIH 328 00:15:50,280 --> 00:15:53,960 COMMON FUND HUMAN VIROME PROGRAM 329 00:15:53,960 --> 00:16:02,640 AND NCCIH IS LEADING ONE OF THE 330 00:16:02,640 --> 00:16:04,440 PROGRAMS THE CHARACTERIZATION OF 331 00:16:04,440 --> 00:16:06,440 FUNCTIONAL INTERACTIONS BETWEEN 332 00:16:06,440 --> 00:16:09,040 VIRUSES AND THE HUMAN MICROBIAL 333 00:16:09,040 --> 00:16:09,640 HOSTS. 334 00:16:09,640 --> 00:16:15,240 THIS IS IMPORTANT TO UNDERSTAND 335 00:16:15,240 --> 00:16:17,720 THE INHABITANTS WITHIN US LIKE 336 00:16:17,720 --> 00:16:19,080 THE MICROBIOME AND IT'S A 337 00:16:19,080 --> 00:16:20,080 DIFFERENT FRONTIER WHEN YOU 338 00:16:20,080 --> 00:16:21,320 THINK OF VIRUSES. 339 00:16:21,320 --> 00:16:23,440 NOTICES TO INTEND TO PUBLISHING 340 00:16:23,440 --> 00:16:27,080 WERE RELEASED JUNE AND THERE 341 00:16:27,080 --> 00:16:28,080 WILL BE FUNDING OPPORTUNITIES 342 00:16:28,080 --> 00:16:36,560 EXPECTED IN THE FALL ON THIS. 343 00:16:36,560 --> 00:16:40,160 THE SMART HEALTH AND ARTIFICIAL 344 00:16:40,160 --> 00:16:41,000 INTELLIGENCE AND ADVANCED DATA 345 00:16:41,000 --> 00:16:44,960 SCIENCE IS A CO-FUNDING 346 00:16:44,960 --> 00:16:47,520 OPPORTUNITY BETWEEN NIH AND NSF 347 00:16:47,520 --> 00:16:51,280 CONTRIBUTING TO THIS. 348 00:16:51,280 --> 00:16:52,880 THE PROPOSAL DEADLINE THE NEXT 349 00:16:52,880 --> 00:16:54,560 IS GOING TO BE NOVEMBER 9. 350 00:16:54,560 --> 00:16:56,200 THE PURPOSE OF THIS IS TO 351 00:16:56,200 --> 00:16:59,920 SUPPORT THE DEVELOPMENT OF 352 00:16:59,920 --> 00:17:02,200 TRANSFORMATIVE HIGH-RISK, 353 00:17:02,200 --> 00:17:03,880 HIGH-REWARD ADVANCES IN AND 354 00:17:03,880 --> 00:17:05,400 SCIENCE AND ENGINEERING, 355 00:17:05,400 --> 00:17:08,520 MATHEMATICS, STATISTICS AND 356 00:17:08,520 --> 00:17:10,040 BEHAVIORAL AND/OR COGNITIVE 357 00:17:10,040 --> 00:17:11,800 RESEARCH TO ADDRESS PRESSING 358 00:17:11,800 --> 00:17:14,720 QUESTIONS IN THE MEDICAL AND BIO 359 00:17:14,720 --> 00:17:17,160 MEDICAL COMMUNITIES. 360 00:17:17,160 --> 00:17:19,360 FINALLY, THERE IS AN NIH VIRTUAL 361 00:17:19,360 --> 00:17:21,160 TOUR THAT HAS BEEN NOW POSTED ON 362 00:17:21,160 --> 00:17:23,320 OUR WEBSITE AND THIS IS 363 00:17:23,320 --> 00:17:25,120 SOMETHING THAT I INVITE YOU ALL 364 00:17:25,120 --> 00:17:26,360 TO TAKE A LOOK. 365 00:17:26,360 --> 00:17:28,720 YOU CAN ACTUALLY NAVIGATE 366 00:17:28,720 --> 00:17:29,560 THROUGH THE NIH CAMPUS. 367 00:17:29,560 --> 00:17:31,760 IT'S ACTUALLY PRETTY FUN TO DO 368 00:17:31,760 --> 00:17:34,320 SO PEOPLE CAN REALIZE ALL THE 369 00:17:34,320 --> 00:17:37,000 ACTIVITIES GOING ON ON CAMPUS 370 00:17:37,000 --> 00:17:38,560 WHICH HAS BEEN GOING ON 371 00:17:38,560 --> 00:17:40,640 THROUGHOUT THE PANDEMIC, REALLY. 372 00:17:40,640 --> 00:17:41,640 I INVITE YOU TO TAKE A LOOK AT 373 00:17:41,640 --> 00:17:48,280 THIS. 374 00:17:48,280 --> 00:17:49,640 NOW FOR SOME NCCIH STAFF 375 00:17:49,640 --> 00:17:49,880 UPDATES. 376 00:17:49,880 --> 00:17:56,560 WE'RE HAPPY TO WELCOME DR. HALL 377 00:17:56,560 --> 00:17:58,320 AS A NEW SCIENTIFIC REVIEW 378 00:17:58,320 --> 00:17:59,360 OFFICER. 379 00:17:59,360 --> 00:18:05,400 DR. HALL RESOURCE RECEIVED HER 380 00:18:05,400 --> 00:18:09,120 Ph.D. FROM CORNELL MEDICINE 381 00:18:09,120 --> 00:18:12,000 STUDYING THE FUNCTION IN SOCIAL 382 00:18:12,000 --> 00:18:12,880 HIERARCHY AND BEHAVIORS TO 383 00:18:12,880 --> 00:18:15,640 CHRONIC SOCIAL STRESS. 384 00:18:15,640 --> 00:18:17,960 A FUN FACT IS THAT SHE'S A 385 00:18:17,960 --> 00:18:19,120 HARPIST AND USED TO PLAY MUSIC 386 00:18:19,120 --> 00:18:25,800 FOR PATIENTS IN THE HOSPITAL. 387 00:18:25,800 --> 00:18:30,160 WE ALSO HAVE SEVERAL NEW STAFF 388 00:18:30,160 --> 00:18:35,680 MEMBERS ARRIVING IN THE OFF THES 389 00:18:35,680 --> 00:18:42,560 DIRECTOR AND OF PEOPLE LEAVING 390 00:18:42,560 --> 00:18:43,840 THE DIVISION OF EXTRAMURAL 391 00:18:43,840 --> 00:18:44,120 RESEARCH. 392 00:18:44,120 --> 00:18:48,640 I'M ALSO LISTED HERE OUR NEW 393 00:18:48,640 --> 00:18:51,160 DIRR STAFF CONTINUE TO HAVE A 394 00:18:51,160 --> 00:18:52,720 HOST OF WONDERFUL TRAINEES THAT 395 00:18:52,720 --> 00:19:02,880 COME AND SPENT TIME AT THE POST 396 00:19:02,880 --> 00:19:03,560 BACCALAUREATE LEVEL AND POSTDOC 397 00:19:03,560 --> 00:19:07,760 LEVEL. 398 00:19:07,760 --> 00:19:10,840 FINALLY SOME BUDGET UPDATES. 399 00:19:10,840 --> 00:19:14,120 SO, AS YOU CAN SEE ON THIS 400 00:19:14,120 --> 00:19:19,080 BUDGET TABLE THE GOOD NEWS IS 401 00:19:19,080 --> 00:19:22,440 THAT WE DID QUITE WELL IN FY23. 402 00:19:22,440 --> 00:19:28,600 WE WERE PROJECTED TO AWARD 16% 403 00:19:28,600 --> 00:19:30,120 MORE RESEARCH PROJECT GRANTS IN 404 00:19:30,120 --> 00:19:31,080 COMPETITIVE GRANT FUNDS MORE 405 00:19:31,080 --> 00:19:34,160 THAN LAST YEAR. 406 00:19:34,160 --> 00:19:34,960 EQUATING TO APPROXIMATELY 10 407 00:19:34,960 --> 00:19:37,640 MORE AWARDS THAN LAST YEAR. 408 00:19:37,640 --> 00:19:39,960 SO WE'RE HAPPY ABOUT THAT. 409 00:19:39,960 --> 00:19:43,000 PART OF THIS WAS IN THANKS TO 410 00:19:43,000 --> 00:19:45,360 THE ADDITIONAL $5 MILLION WE 411 00:19:45,360 --> 00:19:49,600 RECEIVED THAT WAS APPROPRIATED 412 00:19:49,600 --> 00:19:52,000 SPECIFICALLY TO NCCIH AND 413 00:19:52,000 --> 00:19:54,200 EARMARKED FOR PAIN-RELATED 414 00:19:54,200 --> 00:19:55,240 RESEARCH ACKNOWLEDGING THE 415 00:19:55,240 --> 00:19:55,880 IMPORTANT WORK WE'VE BEEN DOING 416 00:19:55,880 --> 00:20:02,080 IN THIS AREA. 417 00:20:02,080 --> 00:20:08,200 SO THE PERHAPS LESS GOOD NEWS IS 418 00:20:08,200 --> 00:20:11,160 THAT WE ARE GETTING A LOT OF 419 00:20:11,160 --> 00:20:12,600 SIGNALS FROM CONGRESS WE MAY 420 00:20:12,600 --> 00:20:13,960 LOOK AT TIGHT BUDGETS GOING 421 00:20:13,960 --> 00:20:14,160 AHEAD. 422 00:20:14,160 --> 00:20:17,880 WE WILL GET MORE DETAILS ON THIS 423 00:20:17,880 --> 00:20:20,000 IN THE NEXT COUNCIL ROUND. 424 00:20:20,000 --> 00:20:23,400 WE HAVE BEEN WANTED TO MAKE SURE 425 00:20:23,400 --> 00:20:29,000 WE SEND A SIGNAL TO THE RESEARCH 426 00:20:29,000 --> 00:20:31,840 COMMUNITY TO GET READY FOR SOME 427 00:20:31,840 --> 00:20:34,200 POSSIBLE TIGHTENING OF BUDGETS 428 00:20:34,200 --> 00:20:36,280 COMING UP. 429 00:20:36,280 --> 00:20:40,280 I WANT TO MENTION WE'VE BEEN 430 00:20:40,280 --> 00:20:41,160 ABLE TO CONTRIBUTE TO OUR 431 00:20:41,160 --> 00:20:43,320 CONTINUING COMMITMENT TO THE 432 00:20:43,320 --> 00:20:44,960 NATIONAL HEALTH INTERVIEW 433 00:20:44,960 --> 00:20:45,240 SURVEY. 434 00:20:45,240 --> 00:20:46,680 IT'S BEEN CONDUCTED FOR THE 435 00:20:46,680 --> 00:20:50,080 CENTER FOR DISEASE CONTROL, CDC 436 00:20:50,080 --> 00:20:53,960 AND RUNS PERIODIC SURVEYS THAT 437 00:20:53,960 --> 00:20:56,160 INCLUDE QUESTIONS ABOUT THE USE 438 00:20:56,160 --> 00:21:00,880 OF COMPLEMENTARY AND INTEGRATIVE 439 00:21:00,880 --> 00:21:01,320 APPROACHES. 440 00:21:01,320 --> 00:21:03,360 WE'VE BEEN FORTUNATE DR. MAYHAN 441 00:21:03,360 --> 00:21:05,960 HAS BEEN WORKING WITH US OUR 442 00:21:05,960 --> 00:21:07,360 IMMUNOLOGIST AND GOT VALUABLE 443 00:21:07,360 --> 00:21:08,880 INFORMATION FROM THE SURVEY AND 444 00:21:08,880 --> 00:21:10,240 WE ARE NOW PLANNING TO INCLUDE 445 00:21:10,240 --> 00:21:14,200 SOME ADDITIONAL QUESTIONS 446 00:21:14,200 --> 00:21:14,800 PERTAINING TO WHOLE PERSON 447 00:21:14,800 --> 00:21:15,360 HEALTH IN THE SURVEY. 448 00:21:15,360 --> 00:21:22,960 WE'RE LOOKING FORWARD TO THAT. 449 00:21:22,960 --> 00:21:26,200 NOW SOME PROGRAM NEWS, I'M 450 00:21:26,200 --> 00:21:28,400 DELIGHTED TO ANNOUNCE THAT THE 451 00:21:28,400 --> 00:21:31,080 RESEARCH RESOURCE CENTER TO 452 00:21:31,080 --> 00:21:33,560 BUILD AN OPEN ACCESS REPOSITORY 453 00:21:33,560 --> 00:21:40,560 AND DATABASE FOR ANATOMICAL AND 454 00:21:40,560 --> 00:21:47,240 PHYSIOLOGICAL CORRELATES OF ACU 455 00:21:47,240 --> 00:21:56,120 POINTS HAS BEEN MADE TO DOCTORS 456 00:21:56,120 --> 00:21:57,760 NAPADOW AND HIMER. 457 00:21:57,760 --> 00:22:02,320 THE ROLE IS TO CREATE A ROSETTA 458 00:22:02,320 --> 00:22:04,880 STONE TO CONNECT CLASSICAL 459 00:22:04,880 --> 00:22:07,240 KNOWLEDGE OF ACU POINT LOCATIONS 460 00:22:07,240 --> 00:22:14,240 TO CURRENT AND EVOLVING 461 00:22:14,240 --> 00:22:15,280 PHYSIOLOGICAL DATABASES. 462 00:22:15,280 --> 00:22:19,320 SO THIS PROJECT WILL BE VERY 463 00:22:19,320 --> 00:22:21,720 EXTENSIVE AND CONTAIN FOUR 464 00:22:21,720 --> 00:22:24,400 DIFFERENT CORES. 465 00:22:24,400 --> 00:22:30,680 THERE'S GOING TO BE ADDITIONAL 466 00:22:30,680 --> 00:22:32,240 EAST MEDICINE CORE TO COORDINATE 467 00:22:32,240 --> 00:22:34,200 KNOWLEDGE ABOUT THE LOCATION AND 468 00:22:34,200 --> 00:22:36,800 USAGE OF ACU POINTS FROM 469 00:22:36,800 --> 00:22:39,160 CLINICIANS AND ACUPUNCTURE 470 00:22:39,160 --> 00:22:41,240 RESEARCHERS AND HAVE BROAD 471 00:22:41,240 --> 00:22:43,040 IMPLEMENTATION OF THE PROJECT 472 00:22:43,040 --> 00:22:48,080 WITHIN THE WORLDWIDE ACUPUNCTURE 473 00:22:48,080 --> 00:22:48,840 COMMUNITY. 474 00:22:48,840 --> 00:22:59,320 AND THE CORE AUCKLAND WILL 475 00:23:00,400 --> 00:23:02,560 CONDUCT INFORMATION BASED ON 476 00:23:02,560 --> 00:23:07,040 RECONSTRUCTED MRI IMAGES. 477 00:23:07,040 --> 00:23:09,640 DATA CORPS WILL BUILD THE ACU 478 00:23:09,640 --> 00:23:11,000 POINT DATABASE FROM THE 479 00:23:11,000 --> 00:23:12,800 ANATOMICAL MAPPING DATA AND 480 00:23:12,800 --> 00:23:14,200 INTEGRATE THE ANATOMICAL DATA 481 00:23:14,200 --> 00:23:18,840 WITH EXISTING PHYSIOLOGICAL 482 00:23:18,840 --> 00:23:20,400 DATABASES SUCH AS THE SPARK 483 00:23:20,400 --> 00:23:22,640 DATABASE WHICH MAPS THE 484 00:23:22,640 --> 00:23:24,480 PERIPHERAL ACTIVITY THROUGHOUT 485 00:23:24,480 --> 00:23:27,880 THE AUTONOMIC SYSTEM AND THE 486 00:23:27,880 --> 00:23:31,120 ATLAS PROGRAM OR HUB MAP AND 487 00:23:31,120 --> 00:23:31,920 OPEN NEURO. 488 00:23:31,920 --> 00:23:37,680 THIS SAY -- IS A HUGE 489 00:23:37,680 --> 00:23:39,440 UNDERTAKING AND IT WILL BE 490 00:23:39,440 --> 00:23:41,160 IMPORTANT TO LOOK AT WHAT 491 00:23:41,160 --> 00:23:43,400 HAPPENS AT THESE POINTS IN THE 492 00:23:43,400 --> 00:23:47,480 BODY WHEN YOU STIMULATE THEM AND 493 00:23:47,480 --> 00:23:51,160 A CORPS WILL BUILD ACU POINT 494 00:23:51,160 --> 00:23:55,040 THAT DEFINE NOMENCLATURE SYSTEMS 495 00:23:55,040 --> 00:23:57,080 INCORPORATING THE TRA ADDITIONAL 496 00:23:57,080 --> 00:23:59,360 EAST-ASIAN MEDICINE AND BIO 497 00:23:59,360 --> 00:24:00,640 MEDICAL ANATOMY SYSTEM. 498 00:24:00,640 --> 00:24:03,480 WE'RE LOOKING FORWARD TO SEEING 499 00:24:03,480 --> 00:24:04,840 WHAT HAPPENS WITH THIS PROJECT 500 00:24:04,840 --> 00:24:10,360 THAT SO IS GOING TO FILL A HUGE 501 00:24:10,360 --> 00:24:14,320 GAP IN THE SCIENCE OF 502 00:24:14,320 --> 00:24:14,600 ACUPUNCTURE. 503 00:24:14,600 --> 00:24:18,280 WE'RE ALSO EXCITED TO ANNOUNCE 504 00:24:18,280 --> 00:24:24,040 THE FUNDING OF THE RESEARCH 505 00:24:24,040 --> 00:24:26,600 ACROSS NATIONAL CENTER FOR 506 00:24:26,600 --> 00:24:27,200 COMPLEMENTARY AND INTEGRATIVE 507 00:24:27,200 --> 00:24:27,720 HEALTH RESOURCE CENTERS. 508 00:24:27,720 --> 00:24:28,600 THIS IS WHAT WE HAVE BEEN 509 00:24:28,600 --> 00:24:29,920 TALKING AT THIS COUNCIL ABOUT 510 00:24:29,920 --> 00:24:31,080 FOR YEARS. 511 00:24:31,080 --> 00:24:34,520 FINALLY WE'RE FUNDING THESE 512 00:24:34,520 --> 00:24:34,760 CENTERS. 513 00:24:34,760 --> 00:24:35,720 THESE ARE SO IMPORTANT BECAUSE 514 00:24:35,720 --> 00:24:42,680 THE GOAL IS TO CREATE A VIRTUAL 515 00:24:42,680 --> 00:24:46,000 RESOURCE CENTER INSTITUTION 516 00:24:46,000 --> 00:24:46,600 PARTICULARLY SCHOOLS OF 517 00:24:46,600 --> 00:24:49,040 COMPLIMENTARY AND INTEGRATIVE 518 00:24:49,040 --> 00:24:51,000 HEALTH PRACTICES. 519 00:24:51,000 --> 00:24:56,800 WITH THE GOAL OF INCREASING THE 520 00:24:56,800 --> 00:24:58,200 COMPETITIVENESS AND THE SUCCESS 521 00:24:58,200 --> 00:25:02,200 OF GRANT APPLICATIONS TO 522 00:25:02,200 --> 00:25:05,320 PROPOSALS IN THE AREAS TO 523 00:25:05,320 --> 00:25:08,320 INCREASE THE ABILITY TO DESIGN 524 00:25:08,320 --> 00:25:11,400 PROJECTS, TO TAKE PROJECTS TO 525 00:25:11,400 --> 00:25:13,240 THE POINT OF VIEW OF COMPETITIVE 526 00:25:13,240 --> 00:25:16,160 GRANT APPLICATIONS, STUDY 527 00:25:16,160 --> 00:25:17,840 DESIGN, IN TERMS OF EVEN 528 00:25:17,840 --> 00:25:19,280 ADMINISTRATIVE SUPPORT, REALLY 529 00:25:19,280 --> 00:25:21,840 HELPING IDENTIFY FUNDING 530 00:25:21,840 --> 00:25:22,440 OPPORTUNITIES AND RESPOND TO 531 00:25:22,440 --> 00:25:26,800 THEM. 532 00:25:26,800 --> 00:25:29,320 THIS CENTER IS GOING TO BE 533 00:25:29,320 --> 00:25:33,400 AWARDED TO DR. PATRICIA HERMAN 534 00:25:33,400 --> 00:25:35,480 AND IAN COULTER AT THE RAN 535 00:25:35,480 --> 00:25:36,960 CORPORATION AND WILL TAKE 536 00:25:36,960 --> 00:25:39,320 ADVANTAGE AND BUILD UPON THE 537 00:25:39,320 --> 00:25:40,680 SUCCESSFUL PREVIOUS CENTERS RAND 538 00:25:40,680 --> 00:25:43,160 DONE IN THE AREA IN THE DOMAIN 539 00:25:43,160 --> 00:25:44,840 OF HEALTH POLICY. 540 00:25:44,840 --> 00:25:48,840 NOW WE'LL APPLY THE MODEL TO 541 00:25:48,840 --> 00:25:49,280 CLINICAL RESEARCH. 542 00:25:49,280 --> 00:25:58,200 WE'RE VERY EXCITED ABOUT THAT. 543 00:25:58,200 --> 00:26:01,600 AND WE BOARDED NEW STUDIES TO 544 00:26:01,600 --> 00:26:05,360 THE COLLABORATORY PROGRAM A NEW 545 00:26:05,360 --> 00:26:07,440 REQUEST FOR APPLICATION FOR NEW 546 00:26:07,440 --> 00:26:10,880 STUDIES HAVE BEEN FUNDED 547 00:26:10,880 --> 00:26:13,840 INCLUDING ONE THAT NCIIH IS 548 00:26:13,840 --> 00:26:17,760 FUNDING THE REMOTE TAI CHI FOR 549 00:26:17,760 --> 00:26:19,840 OSTEOARTHRITIS AND PRAGMATIC 550 00:26:19,840 --> 00:26:20,280 TRIAL. 551 00:26:20,280 --> 00:26:26,120 DR. WONG IS LEADING THIS EFFORT 552 00:26:26,120 --> 00:26:32,400 AS WELL AS DR. LAVRETSKY AND BOB 553 00:26:32,400 --> 00:26:32,600 SAFER. 554 00:26:32,600 --> 00:26:34,200 AND THERE ARE THREE OTHER 555 00:26:34,200 --> 00:26:36,560 PROJECTS FUNDED FOR PRAGMATIC 556 00:26:36,560 --> 00:26:37,840 TRIALS. 557 00:26:37,840 --> 00:26:41,880 ONE FUNDED BY NCCIH ON 558 00:26:41,880 --> 00:26:42,720 BEHAVIORAL ECONOMICS AND 559 00:26:42,720 --> 00:26:43,880 STAFFING STRATEGIES TO INCREASE 560 00:26:43,880 --> 00:26:47,680 THE ADOPTION OF THE ABCDE BUNDLE 561 00:26:47,680 --> 00:26:50,160 IN THE ICU. 562 00:26:50,160 --> 00:26:53,320 ONE ON HEAR HEALTH FUNDED BY 563 00:26:53,320 --> 00:26:56,720 NHLBI AND ONE ON SURGICAL ACP OR 564 00:26:56,720 --> 00:26:58,160 INCLUDING COMPLETION, ACCURACY 565 00:26:58,160 --> 00:27:00,000 AND DISSEMINATION OF ADVANCED 566 00:27:00,000 --> 00:27:02,400 CARE PLANNING. 567 00:27:02,400 --> 00:27:05,440 THESE ARE NOT ALL PROJECTS THAT 568 00:27:05,440 --> 00:27:08,440 NICHD IS FUNDING BUT CO-LEADING 569 00:27:08,440 --> 00:27:10,640 THE PRAGMATIC TRIALS 570 00:27:10,640 --> 00:27:11,640 COLLABORATIVE WITH THE NATIONAL 571 00:27:11,640 --> 00:27:12,520 INSTITUTE ON AGING. 572 00:27:12,520 --> 00:27:14,520 WE'RE HAPPY THIS IS CONTINUING 573 00:27:14,520 --> 00:27:16,680 AS THIS HAS TRANSITIONED FROM 574 00:27:16,680 --> 00:27:18,640 THE COMMON FUND THIS USED TO BE 575 00:27:18,640 --> 00:27:22,760 A COMMON FUND PROGRAM AND IT'S 576 00:27:22,760 --> 00:27:26,120 ENTIRELY A TRANS-NIH PROGRAM 577 00:27:26,120 --> 00:27:27,880 NCCIH IS CO-LEADING. 578 00:27:27,880 --> 00:27:28,840 IT'S VERY IMPORTANT INITIATIVE 579 00:27:28,840 --> 00:27:29,360 THAT WE ARE CONTINUING TO 580 00:27:29,360 --> 00:27:35,080 PURSUE. 581 00:27:35,080 --> 00:27:37,080 ALSO WE HAVE FUNDED NEW STUDIES 582 00:27:37,080 --> 00:27:40,160 ON FOSTERING MENTAL, EMOTIONAL 583 00:27:40,160 --> 00:27:41,640 AND BEHAVIORAL HEALTH AMONG 584 00:27:41,640 --> 00:27:44,560 CHILDREN IN SCHOOL AGED 585 00:27:44,560 --> 00:27:45,080 SETTINGS. 586 00:27:45,080 --> 00:27:47,280 TWO STUDIES. 587 00:27:47,280 --> 00:27:50,840 ONE ON YOUTH CIVIC LEADERSHIP, 588 00:27:50,840 --> 00:27:52,480 ENGAGEMENT AND MINDFULNESS TO 589 00:27:52,480 --> 00:27:54,200 SUPPORT FUNCTIONING AND WELL 590 00:27:54,200 --> 00:27:58,280 BEING OF YOUTH OF COLOR AND ONE 591 00:27:58,280 --> 00:28:00,920 ON TALKING CIRCLE FOR NATIVE 592 00:28:00,920 --> 00:28:03,200 AMERICAN YOUTH AND ONE ON FOOD, 593 00:28:03,200 --> 00:28:05,160 BODY AND MIND INTERVENTIONS. 594 00:28:05,160 --> 00:28:06,880 SO BOSTON UNIVERSITY, UNIVERSITY 595 00:28:06,880 --> 00:28:08,360 OF TEXAS AND MICHIGAN STATE 596 00:28:08,360 --> 00:28:10,200 UNIVERSITY. 597 00:28:10,200 --> 00:28:12,000 . 598 00:28:12,000 --> 00:28:15,040 THE NEXT THING I WANT TO TALK 599 00:28:15,040 --> 00:28:19,240 ABOUT IS RESEARCH NETWORKS TO 600 00:28:19,240 --> 00:28:20,880 PROMOTE MULTIDISCIPLINELY 601 00:28:20,880 --> 00:28:25,200 MECHANISTIC STUDIES FOR PAIN AND 602 00:28:25,200 --> 00:28:25,840 ALZHEIMER'S DISEASE. 603 00:28:25,840 --> 00:28:27,320 IT'S A COLLABORATIVE WITH 604 00:28:27,320 --> 00:28:29,720 NATIONAL INSTITUTE ON AGING. 605 00:28:29,720 --> 00:28:31,480 NCCIH IS FUNDING THE 606 00:28:31,480 --> 00:28:32,680 PAIN-FOCUSSED INTERVENTIONS 607 00:28:32,680 --> 00:28:36,960 INCLUDING MUSIC MECHANISMS AND 608 00:28:36,960 --> 00:28:38,840 TECHNOLOGIES NETWORKS AND WE ARE 609 00:28:38,840 --> 00:28:42,880 LOOKING FORWARD TO DEVELOPING 610 00:28:42,880 --> 00:28:44,160 THIS VERY IMPORTANT AREA OF WORK 611 00:28:44,160 --> 00:28:46,000 AROUND MUSIC AND HOW MUSIC CAN 612 00:28:46,000 --> 00:28:56,000 HELP WITH PAIN MANAGEMENT. 613 00:28:56,000 --> 00:29:00,040 NOW MORE SPECIFIC NCCIH FUNDING 614 00:29:00,040 --> 00:29:01,520 OPPORTUNITIES STILL OPEN. 615 00:29:01,520 --> 00:29:07,120 ONE IS A NOSI FOR THE BRAIN 616 00:29:07,120 --> 00:29:10,360 INITIATIVE SUPPORT FOR RESEARCH 617 00:29:10,360 --> 00:29:17,080 ON INTEROCEPTION CIRCUITS HOW 618 00:29:17,080 --> 00:29:18,920 THE BODY SENSES THE INTERNAL 619 00:29:18,920 --> 00:29:22,920 STATE AND THIS SPECIAL INTEREST 620 00:29:22,920 --> 00:29:24,320 IS FOR FUNDAMENTAL MECHANISMS 621 00:29:24,320 --> 00:29:26,080 AND THE DEVELOPMENT OF TOOLS AND 622 00:29:26,080 --> 00:29:30,240 METHODS AND TECHNOLOGIES TO 623 00:29:30,240 --> 00:29:34,560 ASSESS INTERO CEPTION PROCESSES. 624 00:29:34,560 --> 00:29:40,320 THE DEADLINE IS UP SOON 625 00:29:40,320 --> 00:29:43,160 SEPTEMBER 15. 626 00:29:43,160 --> 00:29:46,240 THIS NOTICE OF SPECIAL INTEREST 627 00:29:46,240 --> 00:29:50,200 IS FROM THE FOGARTY 628 00:29:50,200 --> 00:29:53,200 INTERNATIONAL CENTER FOR GLOBAL 629 00:29:53,200 --> 00:29:54,600 BRAIN AND NERVOUS SYSTEMS 630 00:29:54,600 --> 00:29:55,240 DISORDERS RESEARCH ACROSS THE 631 00:29:55,240 --> 00:29:56,160 LIFE SPAN. 632 00:29:56,160 --> 00:30:01,120 THIS IS A NOTICE OF SPECIAL 633 00:30:01,120 --> 00:30:04,920 INTEREST NCCIH IS ISSUING 634 00:30:04,920 --> 00:30:06,560 REGARDING THE FOGARTY PROGRAM TO 635 00:30:06,560 --> 00:30:08,040 POINT PEOPLE IN THAT DIRECTION. 636 00:30:08,040 --> 00:30:12,280 THIS IS TO DO RESEARCH ON NEW 637 00:30:12,280 --> 00:30:13,320 SOURCES OF NATIONAL PRODUCTS 638 00:30:13,320 --> 00:30:15,400 WITH ACTIVITIES IN THE BRAIN 639 00:30:15,400 --> 00:30:18,720 WITH REGARDS TO PAIN. 640 00:30:18,720 --> 00:30:20,520 AGAIN THE APPLICATION DEADLINE 641 00:30:20,520 --> 00:30:22,400 IS COMING UP SOON NOVEMBER 15. 642 00:30:22,400 --> 00:30:25,160 THE PROGRAM CONTACT FOR THIS IS 643 00:30:25,160 --> 00:30:30,120 DR. PATRICK STILL. 644 00:30:30,120 --> 00:30:35,040 THE NIH PAIN MANAGEMENT 645 00:30:35,040 --> 00:30:35,760 COLLABORATORY IS AS ISSUED AND 646 00:30:35,760 --> 00:30:37,120 ANOTHER ONE WHERE THE 647 00:30:37,120 --> 00:30:38,280 APPLICATION DEADLINE IS VERY 648 00:30:38,280 --> 00:30:41,120 SOON, SEPTEMBER 13. 649 00:30:41,120 --> 00:30:42,520 THIS IS FOR DEMONSTRATION 650 00:30:42,520 --> 00:30:44,720 PROJECTS ON NON-PHARMACOLOGIC 651 00:30:44,720 --> 00:30:46,320 APPROACHES TO PAIN MANAGEMENT 652 00:30:46,320 --> 00:30:51,480 AND OTHER COMORBID CONDITIONS IN 653 00:30:51,480 --> 00:30:52,440 U.S. VETERANS, MILITARY 654 00:30:52,440 --> 00:30:54,520 PERSONNEL AND THEIR FAMILIES. 655 00:30:54,520 --> 00:30:59,960 THIS IS AGAIN A CONTINUATION OF 656 00:30:59,960 --> 00:31:03,360 THE NOW LONG STANDING 657 00:31:03,360 --> 00:31:05,240 COLLABORATION WE'VE HAD AND VERY 658 00:31:05,240 --> 00:31:07,120 SUCCESSFUL WITH THE DEPARTMENT 659 00:31:07,120 --> 00:31:08,840 OF DEFENSE AND VETERANS 660 00:31:08,840 --> 00:31:09,760 ADMINISTRATION AND DR. PETE 661 00:31:09,760 --> 00:31:14,720 MURRAY IS THE CONTACT ON THIS. 662 00:31:14,720 --> 00:31:16,520 AGAIN, THE MORE MUSIC BASED 663 00:31:16,520 --> 00:31:18,000 INTERVENTION FOR BRAIN DISORDERS 664 00:31:18,000 --> 00:31:18,680 OF AGING. 665 00:31:18,680 --> 00:31:23,520 THIS IS A NOTICE TO SUPPORT 666 00:31:23,520 --> 00:31:25,160 PROOF OF CONCEPT TRIALS. 667 00:31:25,160 --> 00:31:27,520 GUIDED BY THE NIH MUSIC-BASED 668 00:31:27,520 --> 00:31:28,960 INTERVENTION TOOL KIT FOR 669 00:31:28,960 --> 00:31:30,720 RESEARCH ON BRAIN DISORDERS OF 670 00:31:30,720 --> 00:31:31,440 AGING. 671 00:31:31,440 --> 00:31:36,640 DEADLINE IS OCTOBER 20 AND THE 672 00:31:36,640 --> 00:31:40,240 P.I. CONTACT IS DR. CHIDEYA. 673 00:31:40,240 --> 00:31:41,840 NOTICE OF INCLUSION OF WELLNESS 674 00:31:41,840 --> 00:31:43,280 ORIENTED PROGRAMMING AND 675 00:31:43,280 --> 00:31:46,240 ACTIVITIES AT CONFERENCES. 676 00:31:46,240 --> 00:31:47,200 THIS IS SOMETHING THAT PEOPLE 677 00:31:47,200 --> 00:31:49,320 HAVE BEEN DOING FOR A LONG TIME 678 00:31:49,320 --> 00:31:53,440 INCLUDING FOR EXAMPLE YOGA 679 00:31:53,440 --> 00:31:54,560 SESSIONS OR DIFFERENT TYPES OF 680 00:31:54,560 --> 00:31:55,960 WELLNESS ACTIVITIES AT 681 00:31:55,960 --> 00:31:56,440 CONFERENCES. 682 00:31:56,440 --> 00:32:01,120 I INVITE YOU IF YOU'RE THINKING 683 00:32:01,120 --> 00:32:03,200 OF WRITING AN R13 APPLICATION 684 00:32:03,200 --> 00:32:04,720 CHECK THIS OUT. 685 00:32:04,720 --> 00:32:09,640 NOW, SOME SIGN-ON OPPORTUNITIES 686 00:32:09,640 --> 00:32:14,240 ON OTHER TYPES OF FUNDING 687 00:32:14,240 --> 00:32:14,600 OPPORTUNITIES. 688 00:32:14,600 --> 00:32:17,880 FOR EXAMPLE, THIS IS AN 689 00:32:17,880 --> 00:32:19,080 ADMINISTRATIVE SUPPLEMENT 690 00:32:19,080 --> 00:32:19,720 PROGRAM FOR ALZHEIMER'S FOCUSSED 691 00:32:19,720 --> 00:32:22,160 NIH GRANTS. 692 00:32:22,160 --> 00:32:23,440 THIS HAS BEEN SUCCESSFUL WE'VE 693 00:32:23,440 --> 00:32:25,520 PARTICIPATED IN A FEW YEARS. 694 00:32:25,520 --> 00:32:27,280 IT'S AN ADMINISTRATIVE 695 00:32:27,280 --> 00:32:28,360 SUPPLEMENT TO EXPAND EXISTING 696 00:32:28,360 --> 00:32:31,680 AWARDS THAT ARE NOT CURRENTLY 697 00:32:31,680 --> 00:32:33,360 FOCUSSED ON ALZHEIMER'S DISEASE 698 00:32:33,360 --> 00:32:35,400 AND RELATED DEMENTIAS BUT 699 00:32:35,400 --> 00:32:37,080 ALLOWING INVESTIGATORS TO 700 00:32:37,080 --> 00:32:38,360 DEVELOP A NEW FOCUS OF 701 00:32:38,360 --> 00:32:39,760 ALZHEIMER'S DISEASES RELATED TO 702 00:32:39,760 --> 00:32:42,240 THE PROJECT THEY ALREADY HAVE 703 00:32:42,240 --> 00:32:45,160 FOCUSSED. 704 00:32:45,160 --> 00:32:48,560 THE PROGRAM CONTACT IS DR 705 00:32:48,560 --> 00:32:52,440 DR. HORGUSLUOGLU AND THE OTHER 706 00:32:52,440 --> 00:32:55,120 IS FOR EMPHATIC SYSTEM IN HEALTH 707 00:32:55,120 --> 00:32:55,520 AND DISEASE. 708 00:32:55,520 --> 00:32:58,520 THIS IS AT NIH THERE'S AN 709 00:32:58,520 --> 00:32:59,560 INCREASING EFFORTS TO UNDERSTAND 710 00:32:59,560 --> 00:33:01,720 THE LYMPHATIC SYSTEM WHICH IS 711 00:33:01,720 --> 00:33:06,360 REALLY A SYSTEM THAT HAS HAD 712 00:33:06,360 --> 00:33:07,960 GAPS IN KNOWLEDGE IN OUR 713 00:33:07,960 --> 00:33:10,520 UNDERSTANDING OF THE BASIC 714 00:33:10,520 --> 00:33:12,760 NORMAL BIOLOGY AND FACTORS THAT 715 00:33:12,760 --> 00:33:15,120 ACCOUNT FOR THE ROLE OF THE 716 00:33:15,120 --> 00:33:18,120 LYMPHATIC SYSTEM IN HEALTH AND 717 00:33:18,120 --> 00:33:19,160 DISEASE AND ALSO POTENTIAL 718 00:33:19,160 --> 00:33:22,200 THERAPEUTIC INTERVENTIONS THAT 719 00:33:22,200 --> 00:33:25,120 CAN PROMOTE GREATER LYMPHATIC 720 00:33:25,120 --> 00:33:26,800 SYSTEM FUNCTION. 721 00:33:26,800 --> 00:33:29,400 NCCIH IS PARTICULARLY INTERESTED 722 00:33:29,400 --> 00:33:35,360 IN ACCEPTING APPLICATIONS AND 723 00:33:35,360 --> 00:33:38,520 INVESTIGATING HOW COMPLEMENTARY 724 00:33:38,520 --> 00:33:40,760 AND INTEGRATIVE SYSTEMS HELP FOR 725 00:33:40,760 --> 00:33:43,200 PAIN RELIEF AND IMPROVE OF OTHER 726 00:33:43,200 --> 00:33:46,720 SYSTEMS SUCH AS ANXIETY, STRESS, 727 00:33:46,720 --> 00:33:52,840 SLEEP DISTURBANCES AND FOR 728 00:33:52,840 --> 00:33:55,800 RESILIENT AND WHOLE PERSON 729 00:33:55,800 --> 00:33:56,240 HEALTH. 730 00:33:56,240 --> 00:33:59,040 NEXT, HEAL UPDATE. 731 00:33:59,040 --> 00:34:00,320 SO, A LOT OF STUFF GOING ON WITH 732 00:34:00,320 --> 00:34:04,600 THE HEAL INITIATIVE. 733 00:34:04,600 --> 00:34:07,560 FIRST, IS WE HAD OUR FIRST 734 00:34:07,560 --> 00:34:09,480 ANNUAL PURPOSE MEETING WHICH IS 735 00:34:09,480 --> 00:34:10,800 VERY IMPORTANT INITIATIVE OF THE 736 00:34:10,800 --> 00:34:12,520 HEAL INITIATIVE. 737 00:34:12,520 --> 00:34:13,200 AS YOU KNOW THE HEAL INITIATIVE 738 00:34:13,200 --> 00:34:15,200 WE TALK ABOUT IT ALL THE TIME IS 739 00:34:15,200 --> 00:34:18,200 A TRANS-NIH EFFORT TO HELP END 740 00:34:18,200 --> 00:34:20,280 ADDICTION LONG TERM. 741 00:34:20,280 --> 00:34:24,440 SO IT'S BASED ON OPIATE USE 742 00:34:24,440 --> 00:34:25,560 DISORDERS AND PAIN. 743 00:34:25,560 --> 00:34:30,200 THIS IS AN EFFORT TO CONNECT 744 00:34:30,200 --> 00:34:31,800 HEALING INVESTIGATORS ACROSS THE 745 00:34:31,800 --> 00:34:35,840 COMMUNITY AND CONNECT THEM WITH 746 00:34:35,840 --> 00:34:38,280 NIH-FUNDED MENTORS SIDE OF THEIR 747 00:34:38,280 --> 00:34:39,880 WHOLE INSTITUTIONS. 748 00:34:39,880 --> 00:34:41,280 THERE WAS A VERY SUCCESSFUL 749 00:34:41,280 --> 00:34:42,440 MEETING THIS PAST MAY. 750 00:34:42,440 --> 00:34:46,200 WE ALSO HAD A WONDERFUL WORKSHOP 751 00:34:46,200 --> 00:34:49,640 ON UNDERSTANDING AND RESTORING 752 00:34:49,640 --> 00:34:50,200 WHOLE JOINT HEALTH IN PAIN 753 00:34:50,200 --> 00:34:53,000 MANAGEMENT. 754 00:34:53,000 --> 00:34:56,960 THIS WORKSHOP WAS VIDEO TAPED 755 00:34:56,960 --> 00:34:58,440 AND I ENCOURAGE YOU TO CHECK OUT 756 00:34:58,440 --> 00:34:59,480 THE RECORDINGS THAT ARE 757 00:34:59,480 --> 00:35:04,480 AVAILABLE ON OUR WEBSITE. 758 00:35:04,480 --> 00:35:08,520 THIS WORKSHOP CENTERED AROUND 759 00:35:08,520 --> 00:35:09,760 UNDERSTANDING OF THE WHOLE JOINT 760 00:35:09,760 --> 00:35:11,800 AND WE TALKED ABOUT JOINT HEALTH 761 00:35:11,800 --> 00:35:13,520 AT PREVIOUS COUNCIL MEETINGS AND 762 00:35:13,520 --> 00:35:15,480 UNDERSTANDING THE JOINT AS A 763 00:35:15,480 --> 00:35:16,960 WHOLE AND HOW TO IMPACT THE 764 00:35:16,960 --> 00:35:18,000 HEALTH AND RESTORE THE HEALTH OF 765 00:35:18,000 --> 00:35:20,200 THE JOINT. 766 00:35:20,200 --> 00:35:22,160 WE ALSO ARE VERY HAPPY THAT 767 00:35:22,160 --> 00:35:27,440 WE'VE BEEN ABLE TO REISSUE OUR 768 00:35:27,440 --> 00:35:30,240 MYOFASCIAL PAIN INITIATIVE 769 00:35:30,240 --> 00:35:31,440 WITHIN THE HEAL INITIATIVE. 770 00:35:31,440 --> 00:35:35,760 SO THERE IS ANOTHER FUNDING 771 00:35:35,760 --> 00:35:38,960 OPPORTUNITY FOR MYOFASCIAL PAIN 772 00:35:38,960 --> 00:35:43,120 DEVELOPING QUANTITATIVE IMAGING 773 00:35:43,120 --> 00:35:45,520 AND OTHER BIOMARKERS OF TISSUES 774 00:35:45,520 --> 00:35:47,280 WITH PAIN MANAGEMENT AND ALL 775 00:35:47,280 --> 00:35:48,800 FUNDED BY THE HEAL INITIATIVE. 776 00:35:48,800 --> 00:35:50,240 WE'LL HAVE ANOTHER OPPORTUNITY 777 00:35:50,240 --> 00:35:53,840 PEOPLE HAVE TO SUBMIT MORE 778 00:35:53,840 --> 00:35:54,200 APPLICATIONS. 779 00:35:54,200 --> 00:35:58,800 THE RECEIPT DATE, DEADLINE IS 780 00:35:58,800 --> 00:35:59,640 OCTOBER 18. 781 00:35:59,640 --> 00:36:07,880 DR. ALEX TUTTLE IS WITH THE 782 00:36:07,880 --> 00:36:12,720 INSTITUTE OF NIBIB. 783 00:36:12,720 --> 00:36:14,120 THERE WAS ALSO A TECHNICAL 784 00:36:14,120 --> 00:36:16,520 ASSISTANCE WEBINAR FOR THOSE 785 00:36:16,520 --> 00:36:18,160 INTERESTED IN THIS THAT OCCURRED 786 00:36:18,160 --> 00:36:20,760 IN AUGUST AND WAS VIDEO TAPED. 787 00:36:20,760 --> 00:36:22,240 YOU CAN LOOK AT IT IF YOU'RE 788 00:36:22,240 --> 00:36:23,800 INTERESTED IN SUBMITTING ONE OF 789 00:36:23,800 --> 00:36:25,680 THESE APPLICATIONS. 790 00:36:25,680 --> 00:36:27,920 AND WE ENCOURAGE PEOPLE TO FORM 791 00:36:27,920 --> 00:36:31,520 TEAMS BETWEEN THE CLINICAL 792 00:36:31,520 --> 00:36:34,080 INVESTIGATORS AND ENGINEERS AND 793 00:36:34,080 --> 00:36:35,280 PEOPLE WHO GET TOGETHER TO 794 00:36:35,280 --> 00:36:43,360 SUBMIT THESE APPLICATIONS. 795 00:36:43,360 --> 00:36:46,880 HERE'S ANOTHER PAST EVENT, NOVEL 796 00:36:46,880 --> 00:36:47,840 TARGETS FOR OPIATE USE DISORDERS 797 00:36:47,840 --> 00:36:48,640 AND OVERDOSE. 798 00:36:48,640 --> 00:36:50,720 THIS IS FOCUSSING ON THE 799 00:36:50,720 --> 00:36:52,120 IDENTIFICATION OF NOVEL TARGETS 800 00:36:52,120 --> 00:36:54,560 IN PRE-CLINICAL VALIDATION OF 801 00:36:54,560 --> 00:36:55,760 SMALL MOLECULES. 802 00:36:55,760 --> 00:36:58,200 NCCIH IS PARTICULARLY INTERESTED 803 00:36:58,200 --> 00:37:00,280 IN MICROBIAL-BASED THERAPIES 804 00:37:00,280 --> 00:37:10,840 SUCH AS PROBIOTICS IN THIS AND 805 00:37:11,560 --> 00:37:13,560 HYE-SOOK KIM IS THE CONTACT. 806 00:37:13,560 --> 00:37:15,720 THE NEXT IS A NOVEL TARGET FOR 807 00:37:15,720 --> 00:37:17,200 OPIOID USE DISORDERS AND OPIOID 808 00:37:17,200 --> 00:37:21,040 OVERDOSE AND THIS IS USING THE 809 00:37:21,040 --> 00:37:23,440 T90, H90 MECHANISM. 810 00:37:23,440 --> 00:37:27,840 THIS IS TO BUILD COHORTS OF 811 00:37:27,840 --> 00:37:29,680 INVESTIGATORS AND 812 00:37:29,680 --> 00:37:31,120 INTERDISCIPLINARY POST-DOCTORAL 813 00:37:31,120 --> 00:37:33,640 TRAINING TO DEVELOP THE NEXT 814 00:37:33,640 --> 00:37:34,800 GENERATION OF INDEPENDENT 815 00:37:34,800 --> 00:37:37,120 CLINICAL PAIN RESEARCHERS. 816 00:37:37,120 --> 00:37:43,920 IT'S VERY IMPORTANT. 817 00:37:43,920 --> 00:37:47,680 IS THE HEAL INITIATIVE IS GOING 818 00:37:47,680 --> 00:37:51,560 TO BE HAVING A -- THIS IS 819 00:37:51,560 --> 00:37:54,360 UPCOMING, FEBRUARY, INITIATIVE 820 00:37:54,360 --> 00:37:55,120 IN INVESTIGATOR MEETING IN 821 00:37:55,120 --> 00:38:05,320 FEBRUARY. 822 00:38:07,000 --> 00:38:08,280 IT WILL BE HYBRID AND SOME ARE 823 00:38:08,280 --> 00:38:09,560 CLOSED AND SOME ARE OPEN. 824 00:38:09,560 --> 00:38:12,280 SOME HAVE OPEN SESSIONS THAT ARE 825 00:38:12,280 --> 00:38:12,560 VIDEOCAST. 826 00:38:12,560 --> 00:38:13,280 THIS PARTICULAR ONE WILL BE. 827 00:38:13,280 --> 00:38:23,720 YOU SHOULD CHECK THIS OUT. 828 00:38:24,160 --> 00:38:26,480 NOW, PAST ACTIVITIES. 829 00:38:26,480 --> 00:38:31,640 THERE WAS A VARIETY OF 830 00:38:31,640 --> 00:38:33,200 INVESTIGATOR MEETINGS THOSE ON 831 00:38:33,200 --> 00:38:39,000 THE SLIDE WERE ALL CLOSED BUT 832 00:38:39,000 --> 00:38:43,440 IT'S IMPORTANT TO LET YOU KNOW 833 00:38:43,440 --> 00:38:46,520 THAT FOR EXAMPLE, PAIN, CARBON, 834 00:38:46,520 --> 00:38:48,040 ETCETERA, WE KEEP CLOSE TOUCH 835 00:38:48,040 --> 00:38:48,920 WITH THE INVESTIGATORS AND IT'S 836 00:38:48,920 --> 00:38:54,040 IMPORTANT FOR THE INVESTIGATORS 837 00:38:54,040 --> 00:38:59,280 TO KNOW EACH OTHER ACROSS THE 838 00:38:59,280 --> 00:39:00,880 PROGRAMS AND WE PAY ATTENTION TO 839 00:39:00,880 --> 00:39:01,760 THAT TO DEVELOP THE GROUP 840 00:39:01,760 --> 00:39:03,480 LEARNING FROM EACH OTHER ACROSS 841 00:39:03,480 --> 00:39:05,440 THE PROGRAMS. 842 00:39:05,440 --> 00:39:07,360 THESE ARE VERY IMPORTANT. 843 00:39:07,360 --> 00:39:10,520 THIS ONE WE'RE HIGHLIGHTING THE 844 00:39:10,520 --> 00:39:11,560 FORCED MANIPULATION THAT 845 00:39:11,560 --> 00:39:14,920 OCCURRED IN JUNE HAD A WONDERFUL 846 00:39:14,920 --> 00:39:21,160 KETO PRESENTATION THAT WAS 847 00:39:21,160 --> 00:39:22,120 RECORDED I ENCOURAGE ANYONE 848 00:39:22,120 --> 00:39:23,960 INTERESTED TO CHECK IT OUT ON 849 00:39:23,960 --> 00:39:26,320 OUR VIDEOCAST. 850 00:39:26,320 --> 00:39:27,520 THE BRAIN INITIATIVE MEETING HAD 851 00:39:27,520 --> 00:39:33,280 THE INVESTIGATOR MEETING IN 852 00:39:33,280 --> 00:39:37,640 JUNE. 853 00:39:37,640 --> 00:39:39,320 IT WAS A NICE ARCHIVED 854 00:39:39,320 --> 00:39:39,880 PRESENTATION IF YOU'RE 855 00:39:39,880 --> 00:39:42,120 INTERESTED IN LOOKING AT THAT. 856 00:39:42,120 --> 00:39:44,600 THE NIH PAIN CONSORTIUM WHICH IS 857 00:39:44,600 --> 00:39:49,920 AN IMPORTANT NIH-WIDE GROUP THAT 858 00:39:49,920 --> 00:39:51,560 COORDINATED PAIN RESEARCH ACROSS 859 00:39:51,560 --> 00:39:57,440 NIH HAD ITS MEETING AND THIS 860 00:39:57,440 --> 00:40:04,360 YEAR WAS THEMED RESILIENCE AND 861 00:40:04,360 --> 00:40:06,640 PATHWAYS TO RECOVERY. 862 00:40:06,640 --> 00:40:07,720 PEOPLE ARE BECOMING INTERESTED 863 00:40:07,720 --> 00:40:09,120 IN NOT JUST TREATMENTS FOR 864 00:40:09,120 --> 00:40:11,440 REDUCING PAIN, WHICH ARE 865 00:40:11,440 --> 00:40:12,160 IMPORTANT BUT IT'S ALSO 866 00:40:12,160 --> 00:40:13,960 IMPORTANT TO LOOK AT RESEARCH 867 00:40:13,960 --> 00:40:20,720 THAT PROMOTES THE RECOVERY FROM 868 00:40:20,720 --> 00:40:21,120 PAIN. 869 00:40:21,120 --> 00:40:31,400 THIS WAS A THEME. 870 00:40:31,400 --> 00:40:34,200 GETTING THE RIGHT EVIDENCE TO 871 00:40:34,200 --> 00:40:38,880 DECISION MAKERS FASTER. 872 00:40:38,880 --> 00:40:45,000 THIS WAS A WORKSHOP THAT WAS 873 00:40:45,000 --> 00:40:55,280 ALSO VIDEOCAST. 874 00:40:58,800 --> 00:40:59,560 WE'RE CREATING LEARNING HEALTH 875 00:40:59,560 --> 00:41:02,400 CARE SYSTEMS THAT BENEFIT FROM 876 00:41:02,400 --> 00:41:02,640 RESEARCH. 877 00:41:02,640 --> 00:41:04,120 I WANT TO HIGHLIGHT TWO WHAT WE 878 00:41:04,120 --> 00:41:06,600 CALL OUR INTEGRATIVE MEDICINE 879 00:41:06,600 --> 00:41:10,080 LECTURE SERIES OR IMLS ONE BY 880 00:41:10,080 --> 00:41:14,040 DR. MARGARET CLINSKI UNLEASHING 881 00:41:14,040 --> 00:41:17,120 THE POWER OF PREVENTION TO 882 00:41:17,120 --> 00:41:18,200 ENHANCE WELL-BEING ACROSS THE 883 00:41:18,200 --> 00:41:25,640 LIFE SPAN AND INSIGHTS INTO 884 00:41:25,640 --> 00:41:30,760 PREVENTION AND MANAGEMENT OF 885 00:41:30,760 --> 00:41:40,680 PAIN IN CHILDREN. 886 00:41:40,680 --> 00:41:43,640 ALSO WE'RE VERY FOCUSSED TO 887 00:41:43,640 --> 00:41:52,000 HEALTH DISPARITIES RESEARCH. 888 00:41:52,000 --> 00:41:56,480 WE HAD SEVERAL INVESTIGATORS 889 00:41:56,480 --> 00:41:57,960 EARLY CAREER INVESTIGATORS 890 00:41:57,960 --> 00:42:00,000 ENGAGED IN HEALTH DISPARITIES 891 00:42:00,000 --> 00:42:01,320 RESEARCH FOCUSSED ON HIV 892 00:42:01,320 --> 00:42:01,760 POPULATION. 893 00:42:01,760 --> 00:42:03,120 WE HAD A WONDERFUL DISCUSSION 894 00:42:03,120 --> 00:42:08,760 THERE WE CAN LOOK AT. 895 00:42:08,760 --> 00:42:11,240 AT THE SOCIETY TI OF ACUPUNCTURE 896 00:42:11,240 --> 00:42:12,880 RESEARCH IN MAY. 897 00:42:12,880 --> 00:42:19,120 I ADDRESSED AND ANNOUNCE THE 898 00:42:19,120 --> 00:42:24,440 FUND 899 00:42:24,440 --> 00:42:25,320 FUNDING AND THERE WAS A 900 00:42:25,320 --> 00:42:35,600 PRESENTATION BY DR. BELLFOR. 901 00:42:35,600 --> 00:42:39,080 ANOTHER NACCIH PARTICIPATES IN 902 00:42:39,080 --> 00:42:41,440 THESE MEETINGS AND AREAS. 903 00:42:41,440 --> 00:42:44,040 THIS IS THE INTERNATIONAL 904 00:42:44,040 --> 00:42:47,200 CANNABINOID RESEARCH SYMPOSIUM 905 00:42:47,200 --> 00:42:47,880 BACK IN JUNE. 906 00:42:47,880 --> 00:42:53,040 A SPEAKER WAS DR. SHURTLEFF 907 00:42:53,040 --> 00:42:57,320 LOOKING BEYOND DELTA 9-THY AND 908 00:42:57,320 --> 00:42:59,720 LOOKING AT THE PERSPECTIVE OF 909 00:42:59,720 --> 00:43:03,480 ANALGESIC PROPERTIES OF 910 00:43:03,480 --> 00:43:05,200 CANNABINOIDS AT THE ASSOCIATION 911 00:43:05,200 --> 00:43:07,160 FOR PSYCHOLOGICAL SCIENCES 912 00:43:07,160 --> 00:43:10,200 SYMPOSIUM AND MEASURING AND 913 00:43:10,200 --> 00:43:14,120 MODULATING. 914 00:43:14,120 --> 00:43:17,880 AGAIN, THIS WAS ALSO ORGANIZED 915 00:43:17,880 --> 00:43:19,240 BY DR. NCCIH AND MODERATED BY 916 00:43:19,240 --> 00:43:26,480 DR. EDWARDS. 917 00:43:26,480 --> 00:43:32,720 A POST-CONFERENCE WORKSHOP WAS 918 00:43:32,720 --> 00:43:38,200 HELD BY DR. WENDY WEBER ON 919 00:43:38,200 --> 00:43:41,000 PRAGMATIC TRIALS COLLABORATORY 920 00:43:41,000 --> 00:43:41,600 PRE-CONFERENCE WORKSHOP ALL 921 00:43:41,600 --> 00:43:44,400 ABOUT LEARNING HOW TO DO 922 00:43:44,400 --> 00:43:45,520 PRAGMATIC TRIALS RESEARCH AND WE 923 00:43:45,520 --> 00:43:46,360 DISSEMINATED THIS INFORMATION 924 00:43:46,360 --> 00:43:49,120 FROM THE PRAGMATIC TRIALS 925 00:43:49,120 --> 00:43:54,440 COLLABORATORY. 926 00:43:54,440 --> 00:43:56,000 THIS WAS THE MULTISCALE 927 00:43:56,000 --> 00:44:00,960 MODELLING CONSORTIUM MEETING 928 00:44:00,960 --> 00:44:03,720 THAT OCCURRED RECENTLY ON THE 929 00:44:03,720 --> 00:44:04,800 FUTURE OF MULTISCALE MODELLING 930 00:44:04,800 --> 00:44:05,400 IMPORTANT TO OUR WHOLE PERSON 931 00:44:05,400 --> 00:44:13,440 RESEARCH. 932 00:44:13,440 --> 00:44:15,800 AND THIS WAS HELD AT THE 933 00:44:15,800 --> 00:44:24,360 WORKSHOP AT THE FOUNDATION FOR 934 00:44:24,360 --> 00:44:25,600 SICKLE CELL DISEASE MEETING AND 935 00:44:25,600 --> 00:44:29,600 THERE WAS A TECHNICAL MEETING TO 936 00:44:29,600 --> 00:44:31,800 PROMOTE MULTIDISCIPLINARY 937 00:44:31,800 --> 00:44:37,000 MECHANISMS ON TRANSLATIONAL 938 00:44:37,000 --> 00:44:38,360 STUDIES FOR SICKLE CELL. 939 00:44:38,360 --> 00:44:40,360 AND A DIVERSITY SUPPLEMENT AND 940 00:44:40,360 --> 00:44:44,160 NETWORKING WORKSHOP. 941 00:44:44,160 --> 00:44:48,080 THIS IS FOR AWARDEES AND MENTORS 942 00:44:48,080 --> 00:44:49,120 THAT OCCURRED IN AUGUST 29 AND 943 00:44:49,120 --> 00:44:59,200 30. 944 00:45:09,080 --> 00:45:12,240 WE'RE HAVING A BIG SECOND ANNUAL 945 00:45:12,240 --> 00:45:14,560 NIH MEETING FOR INTERO CEPTION 946 00:45:14,560 --> 00:45:14,840 RESEARCH. 947 00:45:14,840 --> 00:45:22,200 I THINK WE HAD 1,000 THAT 948 00:45:22,200 --> 00:45:29,240 REGISTERED. 949 00:45:29,240 --> 00:45:31,080 THIS WILL BE OFF CAMPUS IN 950 00:45:31,080 --> 00:45:36,960 BETHESDA BECAUSE WE BUSTED THE 951 00:45:36,960 --> 00:45:37,240 CAPACITY. 952 00:45:37,240 --> 00:45:39,040 THE DEADLINE TO REGISTER IS 953 00:45:39,040 --> 00:45:39,640 OCTOBER 11. 954 00:45:39,640 --> 00:45:40,520 IT'S GOING TO BE A FANTASTIC 955 00:45:40,520 --> 00:45:45,320 MEETING. 956 00:45:45,320 --> 00:45:47,040 THIS IS AMERICAN PUBLIC HEALTH 957 00:45:47,040 --> 00:45:48,720 ASSOCIATION OR APHA. 958 00:45:48,720 --> 00:45:50,520 USING COMPLIMENTARY AND 959 00:45:50,520 --> 00:45:52,960 INTEGRATIVE APPROACHES TO 960 00:45:52,960 --> 00:45:55,600 ADDRESS HIV-RELATED 961 00:45:55,600 --> 00:45:55,920 COMORBIDITIES. 962 00:45:55,920 --> 00:45:58,200 THIS IS GOING TO BE AN 963 00:45:58,200 --> 00:46:01,160 INTERACTIVE PANEL TO LOOK AT 964 00:46:01,160 --> 00:46:05,480 GAPS THAT COULD BE ADDRESSED BY 965 00:46:05,480 --> 00:46:06,200 COMPLEMENTARY AND INTEGRATIVE 966 00:46:06,200 --> 00:46:10,360 APPROACHES. 967 00:46:10,360 --> 00:46:12,480 SOCIETIES FOR NEUROSCIENCE 968 00:46:12,480 --> 00:46:18,200 SYMPOSIUM, MECHANISMS AND 969 00:46:18,200 --> 00:46:19,120 MODULATION OF THE BRAIN 970 00:46:19,120 --> 00:46:20,080 LYMPHATIC SYSTEM. 971 00:46:20,080 --> 00:46:23,160 THIS IS GOING TO BE ON THE 972 00:46:23,160 --> 00:46:25,160 IMPORTANCE OF THE LYMPHATIC 973 00:46:25,160 --> 00:46:30,120 SYSTEMS OF BRAIN HEALTH. 974 00:46:30,120 --> 00:46:31,520 NEXT, MUSIC IS MEDICINE. 975 00:46:31,520 --> 00:46:37,080 SCIENCE AND CLINICAL PRACTICES 976 00:46:37,080 --> 00:46:39,920 DECEMBER 14th AND 15th. 977 00:46:39,920 --> 00:46:41,280 FINALLY THE 2024 INTERNATIONAL 978 00:46:41,280 --> 00:46:43,560 CONFERENCE ON INTEGRATIVE 979 00:46:43,560 --> 00:46:45,440 MEDICINE AND HEALTH. 980 00:46:45,440 --> 00:46:55,880 APRIL 9 TO 13 WE HAVE TEN 981 00:47:11,840 --> 00:47:13,160 SYMPOSIA WE'VE BEEN VERY BUSY 982 00:47:13,160 --> 00:47:15,240 AND I WELCOME ANY COMMENTS, 983 00:47:15,240 --> 00:47:25,640 QUESTIONS YOU MAY HAVE. 984 00:47:26,440 --> 00:47:28,640 >> SPREAD THE FUNDING WITH THIS 985 00:47:28,640 --> 00:47:38,160 MANY INITIATIVES. 986 00:47:38,160 --> 00:47:40,520 A LOT OF TIMES WHAT WE DO IS A 987 00:47:40,520 --> 00:47:44,840 LOT OF THESE WE CO-FUND. 988 00:47:44,840 --> 00:47:46,680 THE WHOLE POINT IS TO BE ABLE TO 989 00:47:46,680 --> 00:47:50,760 SPREAD OUR RESEARCH DOLLARS TO 990 00:47:50,760 --> 00:47:53,640 BE ABLE TO TAKE ADVANTAGE OF THE 991 00:47:53,640 --> 00:47:55,120 PROGRAMS ALREADY OUT THERE WITH 992 00:47:55,120 --> 00:47:59,480 HEAL INITIATIVE, FOR EXAMPLE, 993 00:47:59,480 --> 00:48:02,280 FOR AGING, ALZHEIMER'S WORK, 994 00:48:02,280 --> 00:48:06,560 BRAIN INITIATIVE, ALL THIS WE 995 00:48:06,560 --> 00:48:08,120 CAN LEVERAGE THE PROGRAMS. 996 00:48:08,120 --> 00:48:12,800 A LOT OF TIMES WHAT WE DO IS IF 997 00:48:12,800 --> 00:48:13,720 THERE'S AWARDS WHERE WE CAN FUND 998 00:48:13,720 --> 00:48:16,240 A PORTION OF AN AWARD OR GET 999 00:48:16,240 --> 00:48:18,440 OTHER INSTITUTES AND CENTERS TO 1000 00:48:18,440 --> 00:48:19,000 CO-FUND OURS. 1001 00:48:19,000 --> 00:48:23,400 IT'S JUST A WAY TO SPREAD OUR 1002 00:48:23,400 --> 00:48:30,200 BUDGETS AND BE ABLE TO FUND MORE 1003 00:48:30,200 --> 00:48:39,640 RESEARCH. 1004 00:48:39,640 --> 00:48:40,120 THANK YOU VERY MUCH. 1005 00:48:40,120 --> 00:48:41,280 I THINK WE'RE GOING STO BREAK 1006 00:48:41,280 --> 00:48:43,240 FOR LUNCH NOW AND WE'LL COME 1007 00:48:43,240 --> 00:48:50,040 BACK AFTER LUNCH. 1008 00:48:50,040 --> 00:48:53,840 LET'S RECONVENE AND WE'RE 1009 00:48:53,840 --> 00:48:55,120 STARTING WITH DR. SHURTLEFF. 1010 00:48:55,120 --> 00:48:59,320 THANK YOU. 1011 00:48:59,320 --> 00:48:59,920 >> OKAY. 1012 00:48:59,920 --> 00:49:02,240 THANK YOU, MARTINA. 1013 00:49:02,240 --> 00:49:05,680 AS IS TRADITION EVERY YEAR THE 1014 00:49:05,680 --> 00:49:08,520 DIVISION OF INTRAMURAL RESEARCH 1015 00:49:08,520 --> 00:49:09,520 GIVES AN UPDATE ON OUR RESEARCH 1016 00:49:09,520 --> 00:49:12,400 PROGRAM AND OUR TIME TO DO THIS 1017 00:49:12,400 --> 00:49:15,200 FOR 2023 I'LL TALK ABOUT THE 1018 00:49:15,200 --> 00:49:17,560 DIVISION OF INTRAMURAL BROADLY 1019 00:49:17,560 --> 00:49:18,440 AND THEN PRESENT SPECIFICALLY ON 1020 00:49:18,440 --> 00:49:20,880 THE NEWLY FORMED PAIN RESEARCH 1021 00:49:20,880 --> 00:49:22,680 CENTER WITHIN OUR INTRAMURAL 1022 00:49:22,680 --> 00:49:23,000 PROGRAM. 1023 00:49:23,000 --> 00:49:25,480 JUST TO PUT IT IN PERSPECTIVE, 1024 00:49:25,480 --> 00:49:27,600 WE'RE A RELATIVELY NASCENT 1025 00:49:27,600 --> 00:49:28,000 PROGRAM. 1026 00:49:28,000 --> 00:49:29,280 WE'VE BEEN AN INTRAMURAL 1027 00:49:29,280 --> 00:49:31,480 RESEARCH PROGRAM FOR 11 YEARS 1028 00:49:31,480 --> 00:49:33,160 WHICH RELATIVELY SPEAKING IS A 1029 00:49:33,160 --> 00:49:34,120 RELATIVELY SHORT TIME COMPARED 1030 00:49:34,120 --> 00:49:36,320 TO THE OTHER INSTITUTES AT THE 1031 00:49:36,320 --> 00:49:36,840 NIH. 1032 00:49:36,840 --> 00:49:39,320 IN THAT SHORT TIME WE'VE 1033 00:49:39,320 --> 00:49:41,920 ACCOMPLISHED QUITE A BIT AND 1034 00:49:41,920 --> 00:49:42,520 I'LL OVER THOSE DETAILS WITH 1035 00:49:42,520 --> 00:49:50,800 YOU. 1036 00:49:50,800 --> 00:49:51,880 OUR INTRAMURAL PROGRAM IS SOLELY 1037 00:49:51,880 --> 00:49:53,080 FOCUSSED ON THE STUDY OF PAIN 1038 00:49:53,080 --> 00:49:54,360 AND WE THINK THIS IS AN 1039 00:49:54,360 --> 00:49:57,360 IMPORTANT TOPIC FOR THE REASONS 1040 00:49:57,360 --> 00:50:00,080 ON THE SLIDE MORE PEOPLE LIVE 1041 00:50:00,080 --> 00:50:03,080 WITH CHRONIC PAIN OTHER THAN 1042 00:50:03,080 --> 00:50:05,120 CANCER, DIABETES AND HEART 1043 00:50:05,120 --> 00:50:06,240 DISEASE. 1044 00:50:06,240 --> 00:50:07,960 AMERICANS LIVE WITH SOME FORM OF 1045 00:50:07,960 --> 00:50:13,520 CHRONIC PAIN AND FEEL IT'S AN 1046 00:50:13,520 --> 00:50:19,320 IMPORTANT MISSION TO COVER. 1047 00:50:19,320 --> 00:50:21,680 WE CONDUCT RESEARCH ON THE 1048 00:50:21,680 --> 00:50:23,280 NERVOUS SYSTEM AND OTHER 1049 00:50:23,280 --> 00:50:23,880 PHYSIOLOGICAL SYSTEMS. 1050 00:50:23,880 --> 00:50:31,480 WE THINK OF IT AS PAIN AS A 1051 00:50:31,480 --> 00:50:32,400 BIO/PSYCHOSOCIAL PROBLEM AND 1052 00:50:32,400 --> 00:50:39,120 ACROSS THE NIH A MAJOR FOCUS IS 1053 00:50:39,120 --> 00:50:41,320 IS TRAINING THE NEXT GENERATION 1054 00:50:41,320 --> 00:50:44,200 OF RESEARCHERS DEVELOPING 1055 00:50:44,200 --> 00:50:46,360 CLINICAL AND RESEARCH. 1056 00:50:46,360 --> 00:50:48,680 AND WE STRIVE FOR 1057 00:50:48,680 --> 00:50:49,640 MULTI-DISCIPLINARY COLLABORATIVE 1058 00:50:49,640 --> 00:50:51,240 RESEARCHERS IS UNIQUE TO THE NIH 1059 00:50:51,240 --> 00:50:52,880 SOMETHING WE DO AND THINK ABOUT 1060 00:50:52,880 --> 00:50:55,000 A LOT AND CAPABLE OF DOING 1061 00:50:55,000 --> 00:51:00,040 ACROSS VARIOUS INSTITUTES 1062 00:51:00,040 --> 00:51:01,280 FOCUSSING ON ACUTE AND CHRONIC 1063 00:51:01,280 --> 00:51:03,440 PAIN AND LOOK AT MOLECULE TO 1064 00:51:03,440 --> 00:51:04,160 CIRCUITS TO HUMANS AND COVER 1065 00:51:04,160 --> 00:51:05,520 THAT CURRENTLY. 1066 00:51:05,520 --> 00:51:07,520 WE WANT ROBUST AND DIVERSE 1067 00:51:07,520 --> 00:51:09,920 ENVIRONMENT THAT TRAINS AND 1068 00:51:09,920 --> 00:51:10,680 SUPPORTS THE NEXT GENERATION OF 1069 00:51:10,680 --> 00:51:10,960 SCIENTISTS. 1070 00:51:10,960 --> 00:51:13,080 WE'RE COMMITTING TO EXPANDING 1071 00:51:13,080 --> 00:51:15,200 THE PRESENCE OF PAIN AT NIH. 1072 00:51:15,200 --> 00:51:17,520 AS YOU KNOW, THERE'S NO NIH PAIN 1073 00:51:17,520 --> 00:51:18,800 RESEARCH INSTITUTE SO WE FEEL 1074 00:51:18,800 --> 00:51:21,160 IT'S OUR RESPONSIBILITY TO MAKE 1075 00:51:21,160 --> 00:51:23,040 SURE THIS TOPIC IS WELL 1076 00:51:23,040 --> 00:51:25,600 REPRESENTED TO A VARIETY OF 1077 00:51:25,600 --> 00:51:27,680 ACTIVITIES THAT I'LL GO INTO 1078 00:51:27,680 --> 00:51:29,040 WITH THE PAIN RESEARCH CENTER TO 1079 00:51:29,040 --> 00:51:32,280 ENHANCE AND CONTINUE TO GROW THE 1080 00:51:32,280 --> 00:51:34,720 PAIN RESEARCH ON THE NIH CAMPUS. 1081 00:51:34,720 --> 00:51:35,840 WITH A STRONG COMMITMENT TO 1082 00:51:35,840 --> 00:51:36,960 EQUITY AND DIVERSITY AND ALL WE 1083 00:51:36,960 --> 00:51:38,880 DO AND ULTIMATELY WE WANT TO 1084 00:51:38,880 --> 00:51:40,400 SERVE THE PATIENTS THAT COME TO 1085 00:51:40,400 --> 00:51:42,560 THE CLINICAL CENTER WHO ARE 1086 00:51:42,560 --> 00:51:45,320 AFFECTED BY PAIN. 1087 00:51:45,320 --> 00:51:46,760 PRIMARILY AS A COMORBID 1088 00:51:46,760 --> 00:51:49,280 CONDITION OF OTHER DISEASES. 1089 00:51:49,280 --> 00:51:59,840 TO ACCOMPLISH THIS MISSION, WE 1090 00:51:59,840 --> 00:52:01,600 HAVE A SUPERVISORY CLINICIAN 1091 00:52:01,600 --> 00:52:06,240 HIRED IN 2020 AND WE HAD MARILYN 1092 00:52:06,240 --> 00:52:07,080 POWE AT THE NATIONAL INSTITUTE 1093 00:52:07,080 --> 00:52:09,320 OF MENTAL HEALTH AND SERVED IN 1094 00:52:09,320 --> 00:52:11,880 THAT ROLE TWO PLUS YEARS. 1095 00:52:11,880 --> 00:52:13,760 UNFORTUNATELY, GIVEN HER 1096 00:52:13,760 --> 00:52:15,080 COMMITMENT TO THE NIH SHE WAS 1097 00:52:15,080 --> 00:52:19,320 UNABLE TO CONTINUE AND ASKED 1098 00:52:19,320 --> 00:52:23,920 DR. BACKONJA TO BE ACTING 1099 00:52:23,920 --> 00:52:25,800 DIRECTOR AS WE CONTINUE THE 1100 00:52:25,800 --> 00:52:27,960 SEARCH. 1101 00:52:27,960 --> 00:52:29,200 WE CAME FROM PAIN MEDICINE 1102 00:52:29,200 --> 00:52:30,840 BEFORE HE WAS AT THE UNIVERSITY 1103 00:52:30,840 --> 00:52:32,600 OF WASHINGTON HE WAS A PROFESSOR 1104 00:52:32,600 --> 00:52:33,800 OF NEUROLOGY AT THE UNIVERSITY 1105 00:52:33,800 --> 00:52:41,400 OF WISCONSIN SCHOOL OF MEDICINE 1106 00:52:41,400 --> 00:52:43,440 PUBLIC HEALTH. 1107 00:52:43,440 --> 00:52:46,400 A BROAD EXPERIENCED CLINICAL 1108 00:52:46,400 --> 00:52:47,720 RESEARCH AND EXPERIENCED PAIN 1109 00:52:47,720 --> 00:52:49,200 MEDICINE DOCTOR. 1110 00:52:49,200 --> 00:52:51,720 WE'RE FORTUNATE TO HAVE HIM 1111 00:52:51,720 --> 00:52:53,760 SERVING IN THE ROLE OF ACTING 1112 00:52:53,760 --> 00:52:54,840 CLINICAL DIRECTOR. 1113 00:52:54,840 --> 00:53:00,760 IN ADDITION, WE HAVE THREE VERY 1114 00:53:00,760 --> 00:53:02,200 TALENTED PRINCIPAL 1115 00:53:02,200 --> 00:53:06,600 INVESTIGATORS. 1116 00:53:06,600 --> 00:53:08,800 I'LL GO INTO WHAT THEIR LABS DO 1117 00:53:08,800 --> 00:53:10,920 IN THE NEXT SLIDE. 1118 00:53:10,920 --> 00:53:18,200 I'LL START WITH DR. CARRAQUILLO 1119 00:53:18,200 --> 00:53:21,680 IDENTIFIES THE MECHANISMS 1120 00:53:21,680 --> 00:53:26,000 UNDERLYING PATHOLOGICAL PAIN 1121 00:53:26,000 --> 00:53:29,320 STATE LOOKING AT THE AMYGDALA 1122 00:53:29,320 --> 00:53:31,320 AND HAS ACTUALLY SHOWN THIS AREA 1123 00:53:31,320 --> 00:53:35,040 OF THE BRAIN CAN MODULATE 1124 00:53:35,040 --> 00:53:38,200 TACTILE SENSITIVITY AND 1125 00:53:38,200 --> 00:53:40,080 DIVERSIVE LEARNING AND 1126 00:53:40,080 --> 00:53:42,560 PAIN-REDUCING BEHAVIORS AND 1127 00:53:42,560 --> 00:53:44,840 FOCUSSED ON THE AMYGDALA BUT A 1128 00:53:44,840 --> 00:53:48,000 SPECIFIC PART, THE CENTRAL PART 1129 00:53:48,000 --> 00:53:55,720 OF THE AMYGDALA AND WITH C 1130 00:53:55,720 --> 00:53:56,920 ELEGANS HAS LOOKED AT THE PAIN 1131 00:53:56,920 --> 00:53:59,960 ENVIRONMENT AND THE GOAL IS TO 1132 00:53:59,960 --> 00:54:01,760 EXPAND THAT RESEARCH TO LOOK AT 1133 00:54:01,760 --> 00:54:05,200 WHERE THOSE CONNECTIONS OCCUR 1134 00:54:05,200 --> 00:54:09,040 ACROSS THE BRAIN TO DEVELOP 1135 00:54:09,040 --> 00:54:10,680 REALLY A CIRCUIT MAP OF PAIN IN 1136 00:54:10,680 --> 00:54:13,520 THE BRAIN AND IT'S BEEN EXCITING 1137 00:54:13,520 --> 00:54:14,880 TO SEE WHAT'S DEVELOPED IN THE 1138 00:54:14,880 --> 00:54:17,320 LAST DECADE NOW. 1139 00:54:17,320 --> 00:54:18,960 IMPORTANTLY, SHE'S INCORPORATING 1140 00:54:18,960 --> 00:54:21,200 SEX AS A BIOLOGICAL VARIABLE TO 1141 00:54:21,200 --> 00:54:22,480 UNDERSTAND SEX DIFFERENCES IN 1142 00:54:22,480 --> 00:54:24,080 PAIN PERCEPTION. 1143 00:54:24,080 --> 00:54:29,280 SOME RECENT FINDINGS FROM HER 1144 00:54:29,280 --> 00:54:34,280 LAB JUST PUBLISHED RECENTLY 1145 00:54:34,280 --> 00:54:36,640 SHE'S SHOWN THERE'S AN 1146 00:54:36,640 --> 00:54:39,760 INTERCONNECTION BETWEEN THE SUB 1147 00:54:39,760 --> 00:54:42,000 NUCLEUS OF THE THALAMUS REGION 1148 00:54:42,000 --> 00:54:48,440 AND AMYGDALA AND IT WORKS 1149 00:54:48,440 --> 00:54:50,400 BIDIRECTIONALLY AND IF YOU 1150 00:54:50,400 --> 00:54:55,360 PREVENT THAT INHIBITION IT'S 1151 00:54:55,360 --> 00:54:57,440 ABLE TO INHIBIT PAIN. 1152 00:54:57,440 --> 00:54:59,520 INTERESTING AFFECT AND LOOKING 1153 00:54:59,520 --> 00:55:02,360 WELL BEYOND THE AMYGDALA TO 1154 00:55:02,360 --> 00:55:04,360 OTHER BRAIN REGIONS AS WELL. 1155 00:55:04,360 --> 00:55:06,000 SHE'S VERY INTERESTED IN SEX 1156 00:55:06,000 --> 00:55:12,000 DIFFERENCES AND JUST PUBLISHED A 1157 00:55:12,000 --> 00:55:16,320 PAPER LOOKING AT COLITIS AND SAW 1158 00:55:16,320 --> 00:55:18,360 SEX-DEPENDENT DIFFERENCES AND 1159 00:55:18,360 --> 00:55:20,280 MALES EXHIBIT WORSE PAIN 1160 00:55:20,280 --> 00:55:21,560 PROGRESSION WITH WORSE 1161 00:55:21,560 --> 00:55:22,920 APPEARANCE IN HIGHER WEIGHT LOSS 1162 00:55:22,920 --> 00:55:25,480 THAN IN FEMALES. 1163 00:55:25,480 --> 00:55:27,880 AGAIN, YET ANOTHER EXCITING AND 1164 00:55:27,880 --> 00:55:31,080 IMPORTANT AREA WHEN WE THINK OF 1165 00:55:31,080 --> 00:55:31,800 TREATING PATIENTS. 1166 00:55:31,800 --> 00:55:33,480 SEX IS A VERY IMPORTANT FACTOR. 1167 00:55:33,480 --> 00:55:36,680 NEXT SLIDE TO GIVE YOU AN UPDATE 1168 00:55:36,680 --> 00:55:40,320 ON DR. CHESSLER'S LAB HEADING 1169 00:55:40,320 --> 00:55:42,960 THE SENSORY, CELLS AND CIRCUITS 1170 00:55:42,960 --> 00:55:45,200 AND INTERESTED IN THE CIRCUITS 1171 00:55:45,200 --> 00:55:48,160 OF THE SOMATO SENSORY SYSTEM. 1172 00:55:48,160 --> 00:55:50,360 HIS RESEARCH DISCOVERS NEW 1173 00:55:50,360 --> 00:55:54,200 MOLECULES IN THE TRANSDUCTION OF 1174 00:55:54,200 --> 00:55:57,600 SOMATO SENSATION STIMULI AND ONE 1175 00:55:57,600 --> 00:55:59,240 KEY RESEARCH TOPIC THAT'S 1176 00:55:59,240 --> 00:55:59,880 GETTING A LOT OF INTEREST IS 1177 00:55:59,880 --> 00:56:04,000 HE'S BEEN ABLE TO CHARACTERIZE 1178 00:56:04,000 --> 00:56:06,880 THE PEISO ION CHANNEL IN 1179 00:56:06,880 --> 00:56:11,720 PERIPHERAL NERVES. 1180 00:56:11,720 --> 00:56:18,280 IT'S A COMPONENT TO A PIEZO2 AND 1181 00:56:18,280 --> 00:56:19,200 LOSS OF THE GENE EXPRESSION OF 1182 00:56:19,200 --> 00:56:24,240 THIS RESULTS IN FASCINATING 1183 00:56:24,240 --> 00:56:24,480 EFFECTS. 1184 00:56:24,480 --> 00:56:28,120 LOSS OF PROPRIOCEPTION AND 1185 00:56:28,120 --> 00:56:30,520 SEVERAL SKELETAL ABNORMALITIES 1186 00:56:30,520 --> 00:56:34,480 AND AFFECTS GUT MECHANO 1187 00:56:34,480 --> 00:56:39,680 SENSATION AND REPRODUCTION IN 1188 00:56:39,680 --> 00:56:41,920 MICE AND HE'S BEEN ABLE TO BRING 1189 00:56:41,920 --> 00:56:43,880 IN PEOPLE WITH MUTATION OF THIS 1190 00:56:43,880 --> 00:56:45,280 GENE AND SHOWING CONCORDANCE 1191 00:56:45,280 --> 00:56:46,640 AGAIN THIS MOUSE MODEL AND WHAT 1192 00:56:46,640 --> 00:56:50,800 WE'RE SEEING IN PIEZO2 SYNDROME 1193 00:56:50,800 --> 00:56:51,720 AND I'LL GET INTO THAT MORE 1194 00:56:51,720 --> 00:56:54,000 LATER IN MY TALK. 1195 00:56:54,000 --> 00:56:56,560 HIS FUTURE RESEARCH IS FOCUSSING 1196 00:56:56,560 --> 00:56:57,600 ON IDENTIFYING CHEM MODULATORS 1197 00:56:57,600 --> 00:57:07,920 OF TOUCH AND PAIN. 1198 00:57:10,000 --> 00:57:12,120 AND UNDER COVERING NEURO PEP 1199 00:57:12,120 --> 00:57:16,800 PEPTIDES IN ACUTE AND CHRONIC 1200 00:57:16,800 --> 00:57:17,000 PAIN. 1201 00:57:17,000 --> 00:57:20,680 THERE WAS A PAPER LOOKING AT 1202 00:57:20,680 --> 00:57:25,320 PIEZO 2 IN THE DORSAL ROOT 1203 00:57:25,320 --> 00:57:26,880 GANGLION OF THE SPINAL CORD AN 1204 00:57:26,880 --> 00:57:36,120 IN MICE WITH AUTO SOSOMAL RECES 1205 00:57:36,120 --> 00:57:39,320 AND THE SOMATO SENSORY IN THE 1206 00:57:39,320 --> 00:57:47,680 DORSAL ROOT GANGLIA REGULATE GUT 1207 00:57:47,680 --> 00:57:52,000 BY SENSING PROPER DIGESTION AND 1208 00:57:52,000 --> 00:57:56,160 NUTRIENT ABSORPTION AND WASTE 1209 00:57:56,160 --> 00:58:00,080 REMOVAL AND AUTOSOMAL PIEZO 2 1210 00:58:00,080 --> 00:58:02,560 PATIENTS INHIBIT G.I. 1211 00:58:02,560 --> 00:58:03,760 DYSFUNCTION AND CONCORDANCE 1212 00:58:03,760 --> 00:58:05,320 BETWEEN HIS ANIMAL MODEL WHAT 1213 00:58:05,320 --> 00:58:05,840 HAPPENED WE SEE IN PIEZO 1214 00:58:05,840 --> 00:58:08,600 PATIENTS. 1215 00:58:08,600 --> 00:58:10,000 THE OTHER INTERESTING FINDING 1216 00:58:10,000 --> 00:58:14,920 JUST PUBLISHED I THINK LAST WEEK 1217 00:58:14,920 --> 00:58:25,480 IS SHOWING PIEZO2 IS INVOLVED IN 1218 00:58:31,680 --> 00:58:33,960 PERINEAL TOUCH AND PLAYS A ROLE 1219 00:58:33,960 --> 00:58:40,680 IN REPRODUCTIVE HEALTH AND 1220 00:58:40,680 --> 00:58:47,880 PATIENTS WITH COMPLETE PIEZO 2 1221 00:58:47,880 --> 00:58:51,040 HAVE GENITAL SENSITIVITY AND 1222 00:58:51,040 --> 00:58:54,360 LOOKING AT THE GENE INVOLVED IN 1223 00:58:54,360 --> 00:58:55,480 PHYSIOLOGICAL AND NEURAL LOGICAL 1224 00:58:55,480 --> 00:58:56,440 FUNCTIONING. 1225 00:58:56,440 --> 00:58:58,320 EXCITING WORK FROM HIS LAB. 1226 00:58:58,320 --> 00:59:02,000 FOR OUR FINAL P.I., DR. LAUREN 1227 00:59:02,000 --> 00:59:04,160 ATLAS CONDUCTS CLINICAL RESEARCH 1228 00:59:04,160 --> 00:59:06,280 IN OUR NIH CLINICAL CENTER AND 1229 00:59:06,280 --> 00:59:10,240 HER MAIN GOAL IS TO DISTINGUISH 1230 00:59:10,240 --> 00:59:11,840 PAIN FROM NOCICEPTION AND 1231 00:59:11,840 --> 00:59:13,640 INTERESTED IN THE INTERSECTION 1232 00:59:13,640 --> 00:59:17,160 BETWEEN PSYCHOLOGICAL PAIN 1233 00:59:17,160 --> 00:59:23,000 PERCEPTION AND PHYSIO 1234 00:59:23,000 --> 00:59:25,360 NOCICEPTION FOR PAIN RESPONSES. 1235 00:59:25,360 --> 00:59:30,280 THE LAB ISOLATES MECHANISMS OF 1236 00:59:30,280 --> 00:59:33,440 PAIN MODULATIONS AND LOOKS AT 1237 00:59:33,440 --> 00:59:35,720 PSYCHOSOCIAL FACTORS MODULATE 1238 00:59:35,720 --> 00:59:37,600 PAIN IN THE CLINICAL AND PATIENT 1239 00:59:37,600 --> 00:59:37,920 POPULATION. 1240 00:59:37,920 --> 00:59:39,280 SOME OF HER FUTURE WORK WILL BE 1241 00:59:39,280 --> 00:59:41,440 TO CHARACTERIZE BEHAVIORAL 1242 00:59:41,440 --> 00:59:43,600 FACTORS THAT CONTRIBUTE TO PAIN 1243 00:59:43,600 --> 00:59:44,720 ASSESSMENT, BIASES AND HEALTH 1244 00:59:44,720 --> 00:59:47,000 DISPARITIES IN PAIN AND USING 1245 00:59:47,000 --> 00:59:48,280 COMPUTATIONAL MODELLING, 1246 00:59:48,280 --> 00:59:50,560 INTERCRANIAL REPORTING AND 1247 00:59:50,560 --> 00:59:54,200 PSYCHO PHARMACOLOGY TO ISOLATE 1248 00:59:54,200 --> 00:59:54,720 CIRCUITS UNDERGOING PAIN 1249 00:59:54,720 --> 00:59:57,760 MODULATION AND HER LAB WILL FIND 1250 00:59:57,760 --> 00:59:59,760 LINKS BETWEEN PAIN, MENTAL 1251 00:59:59,760 --> 01:00:01,320 HEALTH INCLUDING SUBSTANCE USE 1252 01:00:01,320 --> 01:00:03,880 DISORDER, PSYCHIATRIC CONDITIONS 1253 01:00:03,880 --> 01:00:05,440 AND CHRONIC PAIN. 1254 01:00:05,440 --> 01:00:06,720 SOME VERY INTERESTING FINDINGS 1255 01:00:06,720 --> 01:00:07,920 FROM HER LAP IN THE LAST YEAR 1256 01:00:07,920 --> 01:00:11,600 THE DISCOVERY OF ACUTE PAIN 1257 01:00:11,600 --> 01:00:12,560 SENSITIVITY IS MORE CONSISTENT 1258 01:00:12,560 --> 01:00:14,560 AMONG FEMALES THAN MALES WHICH 1259 01:00:14,560 --> 01:00:18,200 IS INTERESTING AND NOT EXPECTED. 1260 01:00:18,200 --> 01:00:20,560 SHE'S ALSO FOUND THAT SHE CAN 1261 01:00:20,560 --> 01:00:21,680 DISASSOCIATE NEURAL PATHWAYS IN 1262 01:00:21,680 --> 01:00:26,440 THE BRAIN THAT MODULATE PAIN 1263 01:00:26,440 --> 01:00:27,480 BASED ON INSTRUCTION DIFFERENT 1264 01:00:27,480 --> 01:00:31,440 FROM PAIN ON CLASSICAL 1265 01:00:31,440 --> 01:00:34,480 CONDITIONING WHICH IS 1266 01:00:34,480 --> 01:00:35,600 INTERESTING AND FACIAL 1267 01:00:35,600 --> 01:00:36,760 EXPRESSIONS FROM SUBJECT TO 1268 01:00:36,760 --> 01:00:38,960 GENDER AND RACE-BASED BIASES 1269 01:00:38,960 --> 01:00:39,840 SHE'S EXPLORING IN MORE DETAIL 1270 01:00:39,840 --> 01:00:42,840 IN HER FUTURE WORK. 1271 01:00:42,840 --> 01:00:45,600 A COUPLE INTERESTING FINDINGS 1272 01:00:45,600 --> 01:00:49,440 FROM HER LAB INCLUDE A RECENT 1273 01:00:49,440 --> 01:00:51,880 STUDY LOOKING AT THE VENTRAL 1274 01:00:51,880 --> 01:00:54,840 MEDIAL PREFRONTAL CORTEX AND THE 1275 01:00:54,840 --> 01:00:56,360 EXPECTATION FOR PAIN. 1276 01:00:56,360 --> 01:00:58,440 WHEN YOU DAMAGE THIS AREA IN 1277 01:00:58,440 --> 01:01:01,040 PATIENTS WHO HAVE HAD LESIONS IN 1278 01:01:01,040 --> 01:01:02,720 THESE AREAS HAVE REAL PROBLEMS 1279 01:01:02,720 --> 01:01:07,720 UPDATING EXPECTATIONS ON PAIN 1280 01:01:07,720 --> 01:01:08,040 PROCESSING. 1281 01:01:08,040 --> 01:01:10,600 AND THIS COMPROMISED EXPECTANCY 1282 01:01:10,600 --> 01:01:13,720 IS BY NEW SENSORY FEEDBACK TO 1283 01:01:13,720 --> 01:01:15,480 UPDATE EXPECTATIONS ABOUT PAIN. 1284 01:01:15,480 --> 01:01:17,560 THEY DON'T REALLY TAKE IN THE 1285 01:01:17,560 --> 01:01:18,800 NEW INFORMATION. 1286 01:01:18,800 --> 01:01:22,080 SO IMPORTANTLY, THIS RESULTS 1287 01:01:22,080 --> 01:01:25,600 PROVIDES DATA REGARDING THE 1288 01:01:25,600 --> 01:01:26,960 FUNCTIONAL CONTRIBUTION IN THIS 1289 01:01:26,960 --> 01:01:30,120 AREA IN PAIN MODULATION. 1290 01:01:30,120 --> 01:01:32,640 IN ADDITION, DURING THE COVID 1291 01:01:32,640 --> 01:01:33,840 PANDEMIC WHEN CLINICAL RESEARCH 1292 01:01:33,840 --> 01:01:35,280 WAS BASICALLY SHUT DOWN PIVOTED 1293 01:01:35,280 --> 01:01:40,000 TO CONDUCTED WEB-BASED MENTAL 1294 01:01:40,000 --> 01:01:40,360 HEALTH SURVEYS. 1295 01:01:40,360 --> 01:01:42,720 THIS LOOKED AT THE STRESSORS 1296 01:01:42,720 --> 01:01:43,840 RELATED TO THE COVID PANDEMIC. 1297 01:01:43,840 --> 01:01:45,960 IT ENDED IN A FREE TEXT 1298 01:01:45,960 --> 01:01:47,320 QUESTION, IS THERE ANYTHING ELSE 1299 01:01:47,320 --> 01:01:49,200 YOU'D LIKE TO TELL US THAT MIGHT 1300 01:01:49,200 --> 01:01:51,200 BE IMPORTANT THAT WE DIDN'T NOT 1301 01:01:51,200 --> 01:01:58,800 ASK ABOUT AND GOT RESPONSES AND 1302 01:01:58,800 --> 01:02:00,840 SHE USED A LOT OF TEXT ANALYSIS 1303 01:02:00,840 --> 01:02:06,280 METHODS TO LOOK AT WHAT THIS 1304 01:02:06,280 --> 01:02:10,040 MIGHT MEAN AND THEY FOUND 1305 01:02:10,040 --> 01:02:11,960 INDIVIDUALS WITH MENTAL HEALTH 1306 01:02:11,960 --> 01:02:16,200 TREATMENT HISTORIES HAD MORE 1307 01:02:16,200 --> 01:02:17,720 FIRST-PERSON PRONOUN USE AND 1308 01:02:17,720 --> 01:02:20,920 MORE NEGATIVE EMOTIONAL WORDS 1309 01:02:20,920 --> 01:02:22,400 AND INTERESTING AS WELL THE 1310 01:02:22,400 --> 01:02:24,000 STRESS AND LONELINESS TENDED TO 1311 01:02:24,000 --> 01:02:25,960 INCREASE THE RESPONSE LIKELIHOOD 1312 01:02:25,960 --> 01:02:28,640 AND RESPONSE LENGTH IN THE TEXT 1313 01:02:28,640 --> 01:02:28,800 BOX. 1314 01:02:28,800 --> 01:02:29,560 A LOT OF INFORMATION YOU CAN 1315 01:02:29,560 --> 01:02:31,960 LEARN FROM THE TEXTS. 1316 01:02:31,960 --> 01:02:34,840 AND THEY HYPOTHESIZE THIS MAY BE 1317 01:02:34,840 --> 01:02:36,800 THERAPEUTIC AND MAY BE AN OUTLET 1318 01:02:36,800 --> 01:02:39,960 TO EXPRESS NEGATIVE EMOTIONS OR 1319 01:02:39,960 --> 01:02:42,240 MAY HELP COPE WITH LONELINESS. 1320 01:02:42,240 --> 01:02:44,440 MORE TO COME ON THAT. 1321 01:02:44,440 --> 01:02:48,080 IF YOU'RE INTERESTED ON SOME OF 1322 01:02:48,080 --> 01:02:49,280 THE OTHER RESEARCH THE NCCIH 1323 01:02:49,280 --> 01:02:50,720 RESEARCH SPOTLIGHT ON OUR 1324 01:02:50,720 --> 01:02:51,880 WEBSITE AND THE ADDRESS IS 1325 01:02:51,880 --> 01:02:53,920 BELOW, I ENCOURAGE YOU TO TAKE A 1326 01:02:53,920 --> 01:02:56,840 LOOK AT THE MANY OTHER HIGHLIGHT 1327 01:02:56,840 --> 01:02:57,720 HAVE BEEN HIGHLIGHTED -- 1328 01:02:57,720 --> 01:03:03,040 PRESENTED ON OUR WEBSITE OVER 1329 01:03:03,040 --> 01:03:05,880 THE YEARS. 1330 01:03:05,880 --> 01:03:08,360 SO SO WE ARE EXPANDING THE -- 1331 01:03:08,360 --> 01:03:09,800 WE'RE SMALL BUT WE'RE TRYING TO 1332 01:03:09,800 --> 01:03:11,440 GROW IN AREAS THAT WE THINK MAKE 1333 01:03:11,440 --> 01:03:12,360 SENSE FOR THE INTRAMURAL PROGRAM 1334 01:03:12,360 --> 01:03:14,120 SO WE'RE EXPANDING OUR PROGRAM. 1335 01:03:14,120 --> 01:03:17,800 ONE AREA WE'RE EXPANDING INTO IS 1336 01:03:17,800 --> 01:03:18,520 EPIDEMIOLOGICAL RESEARCH. 1337 01:03:18,520 --> 01:03:24,360 WE HAVE AN OPEN RECRUITMENT FOR 1338 01:03:24,360 --> 01:03:25,280 SENIOR INTRAMURAL EPIDEMIOLOGIST 1339 01:03:25,280 --> 01:03:27,480 THE SOLICITATION CLOSES THIS 1340 01:03:27,480 --> 01:03:30,320 MONTH ON THE 20th. 1341 01:03:30,320 --> 01:03:32,760 THIS IS REALLY NOT NEW TO NCCIH. 1342 01:03:32,760 --> 01:03:39,320 IT CURRENTLY RESIDES UNDER THE 1343 01:03:39,320 --> 01:03:41,760 NCCIH'S DIRECTOR DR. LANGEVIN 1344 01:03:41,760 --> 01:03:44,280 AND THINK IT'S TIME TO MOVE IT 1345 01:03:44,280 --> 01:03:47,520 HENCE THE RECRUITMENT FOR OUR 1346 01:03:47,520 --> 01:03:48,560 SENIOR INTRAMURAL INVESTIGATOR. 1347 01:03:48,560 --> 01:03:49,880 THE PROGRAM WILL CONTINUE TO DO 1348 01:03:49,880 --> 01:03:51,360 THE SAME IT'S DONE FOR MANY 1349 01:03:51,360 --> 01:03:54,080 YEARS UNDER THE OFFICE OF THE 1350 01:03:54,080 --> 01:03:55,240 DIRECTOR OF THE INSTITUTE 1351 01:03:55,240 --> 01:03:59,120 PROVIDE DEFINITIVE NATIONAL 1352 01:03:59,120 --> 01:04:01,000 ESTIMATES OF PAIN IN ADULTS AND 1353 01:04:01,000 --> 01:04:03,280 LOOK AT COMPLEMENTARY HEALTH 1354 01:04:03,280 --> 01:04:05,800 APPROACHES AND THE ADVANTAGES TO 1355 01:04:05,800 --> 01:04:06,480 COMING TO THE INTRAMURAL PROGRAM 1356 01:04:06,480 --> 01:04:08,120 IS WE CAN ALLOW FOR TRAINING OF 1357 01:04:08,120 --> 01:04:13,320 STUDENTS, FELLOWS, RESEARCH 1358 01:04:13,320 --> 01:04:16,800 FELLOWS AND COLLABORATE WITH 1359 01:04:16,800 --> 01:04:18,320 OTHER PROGRAMS ACROSS THE NIH 1360 01:04:18,320 --> 01:04:19,440 INTRAMURAL PROGRAM. 1361 01:04:19,440 --> 01:04:20,440 A LOT OF WAYS THIS MAKES A LOT 1362 01:04:20,440 --> 01:04:21,520 OF SENSE. 1363 01:04:21,520 --> 01:04:25,800 SO THAT WILL BE HAPPENING SOON. 1364 01:04:25,800 --> 01:04:29,920 JUST ONE RECENT STUDY LED BY OUR 1365 01:04:29,920 --> 01:04:33,600 EPIDEMIOLOGY GROUP DR. RICHARD 1366 01:04:33,600 --> 01:04:35,920 NAYHAN AND DR. FINEBERG SHOWS 1367 01:04:35,920 --> 01:04:40,400 THERE'S A PERSISTENCE IN CHRONIC 1368 01:04:40,400 --> 01:04:43,960 PAIN IN ADULTS ACCORDING TO THE 1369 01:04:43,960 --> 01:04:45,320 NATIONAL HEALTH INTERVIEW 1370 01:04:45,320 --> 01:04:45,560 SURVEY. 1371 01:04:45,560 --> 01:04:48,000 61% OF ADULTS WITH CHRONIC PAIN 1372 01:04:48,000 --> 01:04:50,400 IN 2019 CONTINUE TO HAVE CHRONIC 1373 01:04:50,400 --> 01:04:51,120 PAIN IN 2020. 1374 01:04:51,120 --> 01:04:53,040 IN ADDITION THE INCIDENTS OF 1375 01:04:53,040 --> 01:04:54,560 CHRONIC PAIN WAS HIGH COMPARED 1376 01:04:54,560 --> 01:04:56,800 WITH OTHER CHRONIC DISEASES SUCH 1377 01:04:56,800 --> 01:04:58,240 AS DIABETES, DEPRESSION, 1378 01:04:58,240 --> 01:04:58,600 HYPERTENSION. 1379 01:04:58,600 --> 01:05:00,720 JUST TO SAY WE HAVE MORE WORK TO 1380 01:05:00,720 --> 01:05:03,880 DO ON TREATING CHRONIC PAIN AND 1381 01:05:03,880 --> 01:05:05,640 REALLY SHOWS THE PREVALENCE OF 1382 01:05:05,640 --> 01:05:09,040 THIS PROBLEM RELATIVE TO OTHER 1383 01:05:09,040 --> 01:05:10,080 CHRONIC DISEASES. 1384 01:05:10,080 --> 01:05:13,960 IT'S AN INTERESTING PAPER THAT 1385 01:05:13,960 --> 01:05:14,880 JUST CAME OUT. 1386 01:05:14,880 --> 01:05:17,960 IN ADDITION TO EXPANDING 1387 01:05:17,960 --> 01:05:19,240 EPIDEMIOLOGY PROGRAM WE'RE 1388 01:05:19,240 --> 01:05:20,160 EXPANDING OUR PRESENCE IN THE 1389 01:05:20,160 --> 01:05:21,240 CLINICAL CENTER THROUGH THE NIH 1390 01:05:21,240 --> 01:05:22,680 PAIN RESEARCH CENTER. 1391 01:05:22,680 --> 01:05:23,800 MY NEXT TALK WILL GO INTO A LOT 1392 01:05:23,800 --> 01:05:25,200 OF DETAIL, PROBABLY MORE THAN 1393 01:05:25,200 --> 01:05:26,760 YOU EVER WANT TO KNOW ABOUT THE 1394 01:05:26,760 --> 01:05:28,600 PRC BUT WERE AFRAID TO ASK BUT 1395 01:05:28,600 --> 01:05:31,640 I'LL TELL YOU ANYWAY IN MY NEXT 1396 01:05:31,640 --> 01:05:33,280 TALK. 1397 01:05:33,280 --> 01:05:37,120 STAY TUNED FOR THAT. 1398 01:05:37,120 --> 01:05:39,720 OVER ALL, WE WANT TO PROMOTE THE 1399 01:05:39,720 --> 01:05:42,080 BEST SCIENCE POSSIBLE WITHIN OUR 1400 01:05:42,080 --> 01:05:43,120 DIVISION OF INTRAMURAL RESEARCH 1401 01:05:43,120 --> 01:05:44,480 BUT ARE ALSO BUILDING COMMUNITY 1402 01:05:44,480 --> 01:05:46,240 AND WANT TO SHARE KNOWLEDGE, WE 1403 01:05:46,240 --> 01:05:50,240 WANT TO SUPPORT AND HELP OUR 1404 01:05:50,240 --> 01:05:53,320 COLLEAGUES FOSTER COMMUNICATION 1405 01:05:53,320 --> 01:05:54,160 AND COLLABORATION AND PROMOTE 1406 01:05:54,160 --> 01:05:55,480 ACCORD IN OUR PROGRAMMING AND 1407 01:05:55,480 --> 01:05:58,880 CONTINUE TO DO THAT VERY WELL. 1408 01:05:58,880 --> 01:06:01,320 SO I WANTED TO PIVOT TO 1409 01:06:01,320 --> 01:06:02,320 SOMETHING THAT MAY BE OF MORE 1410 01:06:02,320 --> 01:06:05,040 INTEREST TO OUR CBS AND MAYBE 1411 01:06:05,040 --> 01:06:07,480 THE VIEWERSHIP IN THE FACT THE 1412 01:06:07,480 --> 01:06:08,800 NIH DOES OFFER A LOT OF TRAINING 1413 01:06:08,800 --> 01:06:09,760 AND CAREER OPPORTUNITIES TO 1414 01:06:09,760 --> 01:06:10,920 THOSE OUTSIDE OF NIH. 1415 01:06:10,920 --> 01:06:14,440 I JUST WANTED TO MAKE YOU AWARE 1416 01:06:14,440 --> 01:06:15,400 OF THE PROGRAMS BECAUSE YOU ARE 1417 01:06:15,400 --> 01:06:16,520 FACULTY YOURSELVES. 1418 01:06:16,520 --> 01:06:18,560 YOU HAVE STUDENTS WHO MAY BE 1419 01:06:18,560 --> 01:06:20,040 LOOKING FOR CAREER OPPORTUNITIES 1420 01:06:20,040 --> 01:06:22,560 OR TRAINING AND NIH IS A GOOD 1421 01:06:22,560 --> 01:06:28,360 PLACE TO GO AND COME TO. 1422 01:06:28,360 --> 01:06:30,200 WHY NIH AS A PLACE TO COME FOR A 1423 01:06:30,200 --> 01:06:31,200 CAREER OR TRAINING? 1424 01:06:31,200 --> 01:06:34,120 WE HAVE SO MUCH TO OFFER IN 1425 01:06:34,120 --> 01:06:36,160 TERMS OF OUR BIO MEDICAL AND 1426 01:06:36,160 --> 01:06:37,720 SOCIAL SCIENCE RESEARCH. 1427 01:06:37,720 --> 01:06:39,600 WE'RE TRULY TRANSLATIONAL AND 1428 01:06:39,600 --> 01:06:42,360 HAVE A HOSPITAL AND LABS 1429 01:06:42,360 --> 01:06:44,160 LITERALLY PATIENTS AND 1430 01:06:44,160 --> 01:06:45,280 LABORATORIES CO-LOCATED IN THE 1431 01:06:45,280 --> 01:06:46,600 CLINICAL CENTER. 1432 01:06:46,600 --> 01:06:49,880 WE HAVE 26 VIBRANT INTRAMURAL 1433 01:06:49,880 --> 01:06:53,320 PROGRAMS, SCIENCE EDUCATION AND 1434 01:06:53,320 --> 01:06:55,600 TRAINING. 1435 01:06:55,600 --> 01:06:55,960 FR 1436 01:06:55,960 --> 01:07:00,680 INTERESTINGLY, THE CAMPUSES IN 1437 01:07:00,680 --> 01:07:02,760 BETHE 1438 01:07:02,760 --> 01:07:03,360 BETHESDA, NORTH CAROLINA AND 1439 01:07:03,360 --> 01:07:03,600 MONTANA. 1440 01:07:03,600 --> 01:07:05,480 IT'S A PLACE FOR PERSONAL CAREER 1441 01:07:05,480 --> 01:07:06,880 DEVELOPMENT AND LOTS OF 1442 01:07:06,880 --> 01:07:08,520 RESOURCES AND GREAT NEW 1443 01:07:08,520 --> 01:07:10,200 TECHNOLOGIES AND LOTS OF SUPPORT 1444 01:07:10,200 --> 01:07:12,360 FOR EARLY CAREER INVESTIGATORS 1445 01:07:12,360 --> 01:07:15,280 AND FELLOWS. 1446 01:07:15,280 --> 01:07:17,280 SO THIS GIVES YOU A SNAPSHOT OF 1447 01:07:17,280 --> 01:07:18,280 THE TRAINING PROGRAMS AVAILABLE 1448 01:07:18,280 --> 01:07:20,840 FROM SUMMER INTERNSHIPS AND 1449 01:07:20,840 --> 01:07:22,080 UNDERGRADUATE SCHOLAR PROGRAMS 1450 01:07:22,080 --> 01:07:23,080 TO GRADUATE PARTNERSHIP 1451 01:07:23,080 --> 01:07:23,320 PROGRAMS. 1452 01:07:23,320 --> 01:07:25,520 WE DON'T HAVE A GRADUATE SCHOOL 1453 01:07:25,520 --> 01:07:27,960 OURSELVES BUT PARTNER WITH 1454 01:07:27,960 --> 01:07:33,160 SEVERAL UNIVERSITIES IS THE 1455 01:07:33,160 --> 01:07:34,920 RESEARCH CAN BE DONE IN 1456 01:07:34,920 --> 01:07:35,600 CONJUNCTION WITH A UNIVERSITY 1457 01:07:35,600 --> 01:07:37,320 WITH ACADEMIC SUPPORT. 1458 01:07:37,320 --> 01:07:40,240 WE HAVE A STRONG POST-BAC 1459 01:07:40,240 --> 01:07:45,320 PROGRAM WHICH IS UNIQUE. 1460 01:07:45,320 --> 01:07:52,320 MANY COME YEAR OR TWO YEARS AND 1461 01:07:52,320 --> 01:07:56,640 GO ON TO MEDICAL SCHOOL OR OTHER 1462 01:07:56,640 --> 01:07:57,520 BIOMEDICAL PROGRAMS. 1463 01:07:57,520 --> 01:07:58,880 I ENCOURAGE TO THINK ABOUT THE 1464 01:07:58,880 --> 01:08:00,200 PROGRAMS AS YOU THINK OF YOUR 1465 01:08:00,200 --> 01:08:01,360 STUDENTS AND FELLOWS THAT NIH IS 1466 01:08:01,360 --> 01:08:08,600 A PLACE TO COME FOR TRAINING. 1467 01:08:08,600 --> 01:08:11,840 IN ADDITION WE HAVE A LOT OF 1468 01:08:11,840 --> 01:08:17,240 TRAINING FOR CLINICIAN 1469 01:08:17,240 --> 01:08:17,760 SCIENTISTS. 1470 01:08:17,760 --> 01:08:20,520 WE FEEL PEOPLE IN THE CLINICAL 1471 01:08:20,520 --> 01:08:22,480 ARE MOST INFORMED ABOUT THE 1472 01:08:22,480 --> 01:08:23,600 CURRENT PROBLEMS AND IN THE 1473 01:08:23,600 --> 01:08:25,640 POSITION TO DO TRANSLATIONAL 1474 01:08:25,640 --> 01:08:26,000 WORK. 1475 01:08:26,000 --> 01:08:28,040 THERE'S THREE PROGRAMS LISTED ON 1476 01:08:28,040 --> 01:08:29,200 THE SLIDE AVAILABLE TO CLINICIAN 1477 01:08:29,200 --> 01:08:35,520 SCIENTIST TO PURSUE HERE AT THE 1478 01:08:35,520 --> 01:08:35,680 NIH. 1479 01:08:35,680 --> 01:08:37,600 WE'RE INVOLVED FOR THE CLINICAL 1480 01:08:37,600 --> 01:08:42,120 RESEARCH FELLOWSHIP AND 1481 01:08:42,120 --> 01:08:48,400 TRANSLATIONAL PAIN MEDICINE LED 1482 01:08:48,400 --> 01:08:53,200 BY DR. BACKONJONI AND IT'S A 1483 01:08:53,200 --> 01:08:53,880 GREAT OPPORTUNITY FOR CLINICIAN 1484 01:08:53,880 --> 01:08:57,160 SCIENTISTS. 1485 01:08:57,160 --> 01:08:59,320 WE ALSO HAVE A FACULTY LEVEL 1486 01:08:59,320 --> 01:09:00,600 RESEARCH POSITION. 1487 01:09:00,600 --> 01:09:04,120 YOU MAY NOT KNOW BUT NIH HIRES 1488 01:09:04,120 --> 01:09:07,560 ABOUT 30 TENURED TRACK POSITIONS 1489 01:09:07,560 --> 01:09:09,040 A YEAR ACROSS OUR INTRAMURAL AND 1490 01:09:09,040 --> 01:09:11,600 THEY'RE QUITE COVETED POSITIONS. 1491 01:09:11,600 --> 01:09:13,400 THE SCIENTISTS LEAD INDEPENDENT 1492 01:09:13,400 --> 01:09:16,320 RESEARCH LABORATORIES AND THE 1493 01:09:16,320 --> 01:09:17,280 PROJECTS SEEM TO BE MOST 1494 01:09:17,280 --> 01:09:22,760 GENEROUS IN MOST CASES AND THE 1495 01:09:22,760 --> 01:09:24,080 INVESTIGATORS PLAY A ROLE IN 1496 01:09:24,080 --> 01:09:26,000 MENTORING OUR NEXT GENERATION OF 1497 01:09:26,000 --> 01:09:26,320 RESEARCHERS. 1498 01:09:26,320 --> 01:09:28,280 THE LINKS BELOW GIVE ACCESS TO 1499 01:09:28,280 --> 01:09:29,280 THE CURRENT OPPORTUNITIES FOR 1500 01:09:29,280 --> 01:09:36,720 FACULTY LEVEL POSITIONS. 1501 01:09:36,720 --> 01:09:44,560 AND FINALLY WE ALSO HAVE 1502 01:09:44,560 --> 01:09:46,200 OPPORTUNITIES FOR STAFF 1503 01:09:46,200 --> 01:09:47,560 SCIENTISTS AND THEY PLAY A ROLE 1504 01:09:47,560 --> 01:09:50,200 IN HELPING AND SUPPORTING SENIOR 1505 01:09:50,200 --> 01:09:51,920 INVESTIGATORS TO RUN SPECIFIC 1506 01:09:51,920 --> 01:09:54,040 PROJECTS OR IN MANY CASES CAN 1507 01:09:54,040 --> 01:09:56,840 RUN SPECIFIC CORE FACILITIES AND 1508 01:09:56,840 --> 01:10:02,080 ACTUALLY WE'RE TRYING TO RECRUIT 1509 01:10:02,080 --> 01:10:05,240 A SENIOR STAFF SCIENTIST TO RUN 1510 01:10:05,240 --> 01:10:07,280 THE PAIN RESEARCH CENTER. 1511 01:10:07,280 --> 01:10:11,000 THAT WE THINK WILL BE A PERFECT 1512 01:10:11,000 --> 01:10:12,480 OPPORTUNITY FOR AN NIH STAFF 1513 01:10:12,480 --> 01:10:13,520 SCIENTIST. 1514 01:10:13,520 --> 01:10:16,080 THEY HAVE TITLES OF SENIOR 1515 01:10:16,080 --> 01:10:18,360 ASSOCIATE SCIENTISTS DEPENDING 1516 01:10:18,360 --> 01:10:22,280 ON THEIR EXPERIENCE AND TENURE 1517 01:10:22,280 --> 01:10:23,640 AT THE NIH. 1518 01:10:23,640 --> 01:10:24,320 THOSE ARE SOME OPPORTUNITIES I 1519 01:10:24,320 --> 01:10:28,720 THOUGHT YOU'D BE INTERESTED IN. 1520 01:10:28,720 --> 01:10:31,040 DR. LANGEVIN MENTION THE NIH 1521 01:10:31,040 --> 01:10:33,040 VIRTUAL TOUR IN HER TALK. 1522 01:10:33,040 --> 01:10:34,280 THERE'S A LOT OF INFORMATION ON 1523 01:10:34,280 --> 01:10:36,440 THE INTRAMURAL PROGRAM AND ONE 1524 01:10:36,440 --> 01:10:39,240 OF OUR PRINCIPLE INVESTIGATORS, 1525 01:10:39,240 --> 01:10:42,320 DR. ATLAS IS FEATURED AND 1526 01:10:42,320 --> 01:10:43,840 DISCUSSES HER RESEARCH IN THE 1527 01:10:43,840 --> 01:10:46,080 CLINICAL CENTER THAT I THINK 1528 01:10:46,080 --> 01:10:47,360 YOU'D FIND VERY INTERESTING ON 1529 01:10:47,360 --> 01:10:48,760 HER PERSPECTIVE ON HER RESEARCH 1530 01:10:48,760 --> 01:10:52,720 AND HOW IT FITS INTO THE NIH 1531 01:10:52,720 --> 01:10:55,080 MISSION AND NCCIH. 1532 01:10:55,080 --> 01:10:57,320 I ENCOURAGE YOU TO LOOK AT THE 1533 01:10:57,320 --> 01:10:57,840 VIRTUAL TOUR. 1534 01:10:57,840 --> 01:10:59,680 IT'S VERY COOL AND INTERACTIVE 1535 01:10:59,680 --> 01:11:01,720 SO YOU WON'T BE BORED. 1536 01:11:01,720 --> 01:11:05,240 FINALLY, TO REITERATE THERE IS 1537 01:11:05,240 --> 01:11:06,280 THE OPPORTUNITY FOR CLINICAL 1538 01:11:06,280 --> 01:11:08,120 RESEARCH FELLOWSHIP 1539 01:11:08,120 --> 01:11:09,280 TRANSLATIONAL PAIN RESEARCH 1540 01:11:09,280 --> 01:11:10,280 MENTORSHIP PROGRAM IN OUR PAIN 1541 01:11:10,280 --> 01:11:10,840 RESEARCH CENTER. 1542 01:11:10,840 --> 01:11:15,160 THE CONTACT FOR THAT IS 1543 01:11:15,160 --> 01:11:21,320 DR. BACKONNIA AND DR. ATLAS IS 1544 01:11:21,320 --> 01:11:22,440 SEEKING POST-DOCTORAL RESEARCH 1545 01:11:22,440 --> 01:11:24,080 FELLOWS TO JOIN HER LAB AND 1546 01:11:24,080 --> 01:11:25,880 WE'RE ALWAYS SEEKING POSTDOCS, 1547 01:11:25,880 --> 01:11:27,400 POST-BACS FOR ALL THE LABS. 1548 01:11:27,400 --> 01:11:35,240 THIS IS THE CONTACT INFORMATION. 1549 01:11:35,240 --> 01:11:41,560 WE CONTINUE TO SEEK NEW TRAINEES 1550 01:11:41,560 --> 01:11:52,120 AS WE TURN OVER IF KNOW ANYONE 1551 01:11:54,880 --> 01:11:57,520 INTERESTED AND WITH THAT I'LL 1552 01:11:57,520 --> 01:11:59,200 STOP AND IF THERE'S QUESTIONS 1553 01:11:59,200 --> 01:12:01,600 I'LL BE HAPPY TO TAKE THEM NOW. 1554 01:12:01,600 --> 01:12:12,040 ANY QUESTION OR COMMENTS? 1555 01:12:19,520 --> 01:12:21,640 IF NOT, I GUESS I TOLD YOU 1556 01:12:21,640 --> 01:12:22,960 EVERYTHING YOU WOULD WANT TO 1557 01:12:22,960 --> 01:12:24,360 KNOW ABOUT THE PROGRAM OF 1558 01:12:24,360 --> 01:12:24,840 INTRAMURAL RESEARCH. 1559 01:12:24,840 --> 01:12:26,920 I DIDN'T LEAVE ANYTHING OUT. 1560 01:12:26,920 --> 01:12:29,040 THE NEXT PRESENTATION IS 1561 01:12:29,040 --> 01:12:34,600 SOMETHING DR. LANGEVIN ASKED WE 1562 01:12:34,600 --> 01:12:38,520 TALK ABOUT BECAUSE IT TALKS 1563 01:12:38,520 --> 01:12:41,320 ABOUT NCCIH AS A CENTER THAT 1564 01:12:41,320 --> 01:12:43,000 SEEKS COLLABORATION BEYOND OUR 1565 01:12:43,000 --> 01:12:43,320 FOUR WALLS. 1566 01:12:43,320 --> 01:12:45,560 AS A MENTIONED BEFORE, THERE IS 1567 01:12:45,560 --> 01:12:47,400 NO PAIN RESEARCH CENTER. 1568 01:12:47,400 --> 01:12:52,080 NO PAIN RESEARCH INSTITUTE AT 1569 01:12:52,080 --> 01:12:53,120 THE NIH. 1570 01:12:53,120 --> 01:12:56,040 SO THOUGH IT'S CERTAINLY A 1571 01:12:56,040 --> 01:12:57,760 RESEARCH PRIORITY THERE'S NO WAY 1572 01:12:57,760 --> 01:13:00,040 OF EMPHASIZING PAIN RESEARCH. 1573 01:13:00,040 --> 01:13:03,240 SO WE HAVE DECIDED AT NCCIH TO 1574 01:13:03,240 --> 01:13:04,760 TAKE THE RESPONSIBILITY OF 1575 01:13:04,760 --> 01:13:06,200 BRINGING TOGETHER CLINICAL 1576 01:13:06,200 --> 01:13:13,920 RESEARCHERS TO STUDY PAIN. 1577 01:13:13,920 --> 01:13:18,480 I ALWAYS WEEK TO SAY WHEN I TALK 1578 01:13:18,480 --> 01:13:20,080 TO MY INTRAMURAL COLLEAGUES YOU 1579 01:13:20,080 --> 01:13:21,320 MAY BE A PAIN RESEARCHER AND NOT 1580 01:13:21,320 --> 01:13:21,880 KNOW IT. 1581 01:13:21,880 --> 01:13:24,400 WHY IS THAT THE CASE? 1582 01:13:24,400 --> 01:13:25,920 THE CLINICAL RESEARCHERS WHO 1583 01:13:25,920 --> 01:13:27,960 WORK THERE STUDY A DIVERSITY OF 1584 01:13:27,960 --> 01:13:30,800 PATIENTS WITH CONDITIONS RANGE 1585 01:13:30,800 --> 01:13:33,120 FROM CANCER TO SICKLE CELL 1586 01:13:33,120 --> 01:13:34,560 DISEASE TO AUTOIMMUNE AND RARE 1587 01:13:34,560 --> 01:13:36,360 GENETIC CONDITIONS AND 1588 01:13:36,360 --> 01:13:36,960 PSYCHIATRIC DISORDERS. 1589 01:13:36,960 --> 01:13:43,040 MANY ARE COMORBID FOR PAIN. 1590 01:13:43,040 --> 01:13:45,360 RESEARCHERS ARE FOCUSSED AND 1591 01:13:45,360 --> 01:13:49,280 BUSY IN AN ORDER OR DISEASE AND 1592 01:13:49,280 --> 01:13:52,800 NOT NECESSARILY FOCUSSED ON THE 1593 01:13:52,800 --> 01:13:58,440 PAIN CONDITION ASSOCIATED FOR 1594 01:13:58,440 --> 01:14:05,320 OTHER DISEASES AND THE NIH PRC, 1595 01:14:05,320 --> 01:14:06,960 PAIN RESEARCH CENTER, OFFERS THE 1596 01:14:06,960 --> 01:14:08,360 OPPORTUNITY FOR CLINICAL 1597 01:14:08,360 --> 01:14:10,760 RESEARCHERS ACROSS THE NIH 1598 01:14:10,760 --> 01:14:11,800 STUDYING DIVERSE PATIENT 1599 01:14:11,800 --> 01:14:13,480 POPULATIONS I MENTIONED TO COME 1600 01:14:13,480 --> 01:14:15,120 TO THE PAIN RESEARCH CENTER TO 1601 01:14:15,120 --> 01:14:21,320 STUDY THE PAIN ASPECT OF THAT 1602 01:14:21,320 --> 01:14:21,560 DISEASE. 1603 01:14:21,560 --> 01:14:22,840 SOMETHING THEY PROBABLY HADN'T 1604 01:14:22,840 --> 01:14:27,560 THOUGHT OF ABOUT AND SEARCH AS A 1605 01:14:27,560 --> 01:14:29,920 DIAGNOSTIC HUB FOR THE 1606 01:14:29,920 --> 01:14:32,080 INTRAMURAL PROGRAM TO HELP 1607 01:14:32,080 --> 01:14:34,120 BETTER IDENTIFY MECHANISMS OF 1608 01:14:34,120 --> 01:14:38,400 THE DIVERSE PAIN STATES PATIENTS 1609 01:14:38,400 --> 01:14:40,480 PRESENT IN COMORBID HEALTH 1610 01:14:40,480 --> 01:14:42,360 CONDITIONS AND DEVELOP AND TEST 1611 01:14:42,360 --> 01:14:50,000 THERAPIES TO BETTER MANAGE PAIN. 1612 01:14:50,000 --> 01:14:54,120 AND STUDY PATIENTS WITH RARE AND 1613 01:14:54,120 --> 01:14:57,200 UNUSUAL PAIN STATES. 1614 01:14:57,200 --> 01:14:58,360 PATIENTS WHO DON'T UNDERSTAND 1615 01:14:58,360 --> 01:14:59,480 WHY THEY HAVE CERTAIN PAIN 1616 01:14:59,480 --> 01:15:00,720 RELATED CONDITIONS AND WE'RE 1617 01:15:00,720 --> 01:15:05,280 HERE TO HELP FIGURE IT OUT. 1618 01:15:05,280 --> 01:15:10,080 SO NEXT SLIDE. 1619 01:15:10,080 --> 01:15:14,240 THIS IS THE IDEA OF THE FORMER 1620 01:15:14,240 --> 01:15:15,160 SCIENTIFIC DIRECTOR AT NCCIH AND 1621 01:15:15,160 --> 01:15:20,480 THE STAFF HERE LAUNCHED THE 1622 01:15:20,480 --> 01:15:24,160 PROGRAM FOUR OR FIVE YEARS AGO 1623 01:15:24,160 --> 01:15:27,160 AND RECEIVED SEED MONEY FROM THE 1624 01:15:27,160 --> 01:15:32,440 CHALLENGE AWARD TO GET STAFFING 1625 01:15:32,440 --> 01:15:37,040 IN PLACE IT WAS A GRASSROOTS 1626 01:15:37,040 --> 01:15:41,360 EFFORT THAT LED TO WHERE THE PRC 1627 01:15:41,360 --> 01:15:44,840 IS TODAY. 1628 01:15:44,840 --> 01:15:45,880 WE'RE LOOKING FOR A FACILITY 1629 01:15:45,880 --> 01:15:51,280 HEAD TO RUN THE PRC AND TAKE THE 1630 01:15:51,280 --> 01:15:54,160 LEAD SO I DON'T HAVE TO DO IT 1631 01:15:54,160 --> 01:15:55,000 ANYMORE AND HIRING A PATIENT 1632 01:15:55,000 --> 01:16:00,160 COORDINATOR TO HELP WITH 1633 01:16:00,160 --> 01:16:01,160 RECRUITMENT TO HELP WITH 1634 01:16:01,160 --> 01:16:02,240 SPECIFIC PAIN POPULATION. 1635 01:16:02,240 --> 01:16:04,520 WE ALSO RECEIVED GENEROUS 1636 01:16:04,520 --> 01:16:05,240 SUPPORT FROM THE NATIONAL 1637 01:16:05,240 --> 01:16:07,680 INSTITUTE OF NEUROLOGICAL 1638 01:16:07,680 --> 01:16:09,240 DISEASE AND STROKE MONITOR 1639 01:16:09,240 --> 01:16:10,520 PROTOCOLS AND PROTOCOL 1640 01:16:10,520 --> 01:16:12,960 DEVELOPMENT AND IRB OVERSIGHT. 1641 01:16:12,960 --> 01:16:15,400 SO THESE ARE THE CURRENT 1642 01:16:15,400 --> 01:16:18,160 RESOURCES WITHIN THE PRC. 1643 01:16:18,160 --> 01:16:21,320 YOU CAN SEE THEY'RE QUITE 1644 01:16:21,320 --> 01:16:24,200 EXTENSIVE AND SOME INVOLVE 1645 01:16:24,200 --> 01:16:30,000 PUTTING EDGE TECHNOLOGY SICH AS 1646 01:16:30,000 --> 01:16:30,400 MIC 1647 01:16:30,400 --> 01:16:32,280 MICRONEUROGRAPHY AND OTHER WAYS 1648 01:16:32,280 --> 01:16:35,280 TO ASSESS TACTILE SENSATION AND 1649 01:16:35,280 --> 01:16:38,440 PAIN AND MODULATE NEURAL 1650 01:16:38,440 --> 01:16:39,880 CIRCUITRY THROUGH VARIOUS MEANS 1651 01:16:39,880 --> 01:16:42,880 NON INVASIVELY. 1652 01:16:42,880 --> 01:16:46,120 THESE ARE THE CURRENT 1653 01:16:46,120 --> 01:16:52,280 COLLABORATORS WITHIN THE PRC. 1654 01:16:52,280 --> 01:16:53,480 WE'VE BEEN ABLE TO COLLABORATE 1655 01:16:53,480 --> 01:16:55,880 WITH MANY INSTITUTES AND CENTERS 1656 01:16:55,880 --> 01:16:57,320 AND INCLUDING SOME INSTITUTIONS 1657 01:16:57,320 --> 01:17:05,240 OUTSIDE OF NIH LISTED HERE. 1658 01:17:05,240 --> 01:17:08,440 THESE ARE PUBLICATIONS AND 1659 01:17:08,440 --> 01:17:09,280 PRESENTATIONS WE'VE BEEN 1660 01:17:09,280 --> 01:17:11,840 INVOLVED WITH MANY ARE STILL 1661 01:17:11,840 --> 01:17:12,160 EARLY. 1662 01:17:12,160 --> 01:17:14,880 THE PIEZO 2 STORY THERE'S 1663 01:17:14,880 --> 01:17:16,360 SEVERAL PUBLICATIONS WITH 1664 01:17:16,360 --> 01:17:17,080 DR. CHESLER. 1665 01:17:17,080 --> 01:17:23,120 WE'RE DEVELOPING STANDARDS FOR 1666 01:17:23,120 --> 01:17:24,200 TRANSCUTANEOUS VEGAS NERVE 1667 01:17:24,200 --> 01:17:25,440 STIMULATION TO MODULATE PAIN AND 1668 01:17:25,440 --> 01:17:26,320 MOOD STATES. 1669 01:17:26,320 --> 01:17:30,600 WE'RE LOOKING AT MECHANISMS OF 1670 01:17:30,600 --> 01:17:34,000 PERSISTENT PAIN AND CURATIVE 1671 01:17:34,000 --> 01:17:36,400 THERAPY FOR SICKLE CELL AND THIS 1672 01:17:36,400 --> 01:17:38,000 WILL CONTINUE TO GROW AS WE 1673 01:17:38,000 --> 01:17:39,520 CONTINUE TO COMPLETE STUDIES 1674 01:17:39,520 --> 01:17:42,400 UNDER THE PRC. 1675 01:17:42,400 --> 01:17:43,640 THESE ARE THE CURRENT PROJECTS. 1676 01:17:43,640 --> 01:17:45,640 I WON'T GO THROUGH ALL OF THEM. 1677 01:17:45,640 --> 01:17:48,000 YOU CAN SEE PIEZO 2 AGAIN AND 1678 01:17:48,000 --> 01:17:51,000 I'LL GO OVER SOME MORE IN A 1679 01:17:51,000 --> 01:17:51,240 MOMENT. 1680 01:17:51,240 --> 01:17:53,720 CHRONIC PAIN WITH SICKLE CELL 1681 01:17:53,720 --> 01:17:56,080 PATIENTS WHO RECEIVE CURATIVE 1682 01:17:56,080 --> 01:17:56,760 THERAPY, SURPRISINGLY MANY STILL 1683 01:17:56,760 --> 01:17:58,240 HAVE ISSUES WITH PAIN AND GET 1684 01:17:58,240 --> 01:18:00,200 INTO THAT IN MORE DETAIL AND 1685 01:18:00,200 --> 01:18:06,400 STUDIES WITH UNIQUE GENETIC 1686 01:18:06,400 --> 01:18:11,720 MUTATIONS, SCHWANN PATIENTS 1687 01:18:11,720 --> 01:18:16,400 VULNERABLE FOR MALIGNANCIES IN 1688 01:18:16,400 --> 01:18:19,000 CANCER AND SUBJECT TO NOXIOUS 1689 01:18:19,000 --> 01:18:20,480 HEAT PERCEPTION AND CHRONIC 1690 01:18:20,480 --> 01:18:21,000 PAIN. 1691 01:18:21,000 --> 01:18:21,640 FROM THE CANCER PERSPECTIVE 1692 01:18:21,640 --> 01:18:24,760 THEY'RE STUDYING FOR 1693 01:18:24,760 --> 01:18:29,920 CANCER-RELATED VULNERABILITY BUT 1694 01:18:29,920 --> 01:18:34,360 AT THE SAME TIME WE'RE 1695 01:18:34,360 --> 01:18:36,360 INTERESTED IN AS A PAIN RESEARCH 1696 01:18:36,360 --> 01:18:40,280 CENTER. 1697 01:18:40,280 --> 01:18:41,960 THIS CONTINUES THE LIST ONWARD 1698 01:18:41,960 --> 01:18:44,680 TO MANY I'LL GET INTO IN SOME 1699 01:18:44,680 --> 01:18:54,440 DETAIL AS I PRESENT. 1700 01:18:54,440 --> 01:18:55,880 000 ARE THE CURRENT S WE 1701 01:18:55,880 --> 01:18:59,600 CONTINUE TO SEEK NEW PROJECTS 1702 01:18:59,600 --> 01:19:05,320 AND WE'RE GOING TO FORM THE 1703 01:19:05,320 --> 01:19:07,040 COLLABORATIONS AGAIN ACROSS THE 1704 01:19:07,040 --> 01:19:09,640 AND ONE THAT JUST CAME ONLINE 1705 01:19:09,640 --> 01:19:14,400 WE'RE EXCITE ABOUT IS THE TMJ 1706 01:19:14,400 --> 01:19:16,040 TEMPOROMANDIBULAR JOINT SYMPHONY 1707 01:19:16,040 --> 01:19:19,640 AND PATIENT-CENTERED HOLISTIC 1708 01:19:19,640 --> 01:19:23,000 OUTCOMES INVOLVING A NETWORK OF 1709 01:19:23,000 --> 01:19:23,880 NATIONAL AND INTERNATIONAL 1710 01:19:23,880 --> 01:19:24,480 COLLABORATORS AND NATIONAL 1711 01:19:24,480 --> 01:19:25,800 INSTITUTE ON DENTAL AND CRANIAL 1712 01:19:25,800 --> 01:19:28,880 AND FACIAL RESEARCH. 1713 01:19:28,880 --> 01:19:32,120 THAT'S THE LEAD BUT AGAIN AS PRC 1714 01:19:32,120 --> 01:19:35,960 ARE PROVIDING INFORMATION ON 1715 01:19:35,960 --> 01:19:37,440 DEVELOPING STANDARDS FOR TESTING 1716 01:19:37,440 --> 01:19:44,960 AND DIAGNOSING PAIN. 1717 01:19:44,960 --> 01:19:45,800 WE'RE EXCITE ABOUT THE PROJECT 1718 01:19:45,800 --> 01:19:49,400 COMING ONLINE. 1719 01:19:49,400 --> 01:19:54,320 SOME UPCOMING STUDIES. 1720 01:19:54,320 --> 01:20:01,320 I MENTIONED THE PIEZO 2 STORY 1721 01:20:01,320 --> 01:20:03,080 AND INTERESTED IN USING 1722 01:20:03,080 --> 01:20:06,440 MICROGRAPHY MEASURING PERIPHERAL 1723 01:20:06,440 --> 01:20:08,600 NERVE ACTIVITY TO DETERMINE WHAT 1724 01:20:08,600 --> 01:20:11,920 IS HAPPENING IN PATIENTS WITH 1725 01:20:11,920 --> 01:20:13,080 THESE PIEZO 2 GENE ALTERATIONS 1726 01:20:13,080 --> 01:20:15,600 AND WHAT'S GOING ON WITH THE 1727 01:20:15,600 --> 01:20:16,640 TRANSDUCTION OF THESE NERVE 1728 01:20:16,640 --> 01:20:18,440 FIBERS IN THESE PATIENTS. 1729 01:20:18,440 --> 01:20:21,160 BEYOND THAT, ONCE WE HAVE THAT 1730 01:20:21,160 --> 01:20:22,680 TECHNIQUE WELL IN HAND WE'LL BE 1731 01:20:22,680 --> 01:20:24,680 ABLE TO USE THAT MORE BROADLY AS 1732 01:20:24,680 --> 01:20:29,440 PART OF THE PAIN RESEARCH CENTER 1733 01:20:29,440 --> 01:20:30,600 FOR FUTURE RESEARCH. 1734 01:20:30,600 --> 01:20:33,200 ANOTHER AREA WE'RE WORKING ON IS 1735 01:20:33,200 --> 01:20:34,000 WITH THE NATIONAL INSTITUTE ON 1736 01:20:34,000 --> 01:20:34,720 NURSING RESEARCH. 1737 01:20:34,720 --> 01:20:37,040 IT'S NOT A NURSING STUDY BUT 1738 01:20:37,040 --> 01:20:40,120 RIGHT NOW WE'RE SUPPORTING THEIR 1739 01:20:40,120 --> 01:20:42,440 ROLE IN STUDYING CHRONIC FATIGUE 1740 01:20:42,440 --> 01:20:45,120 SYNDROME AND CHARACTERIZING THE 1741 01:20:45,120 --> 01:20:45,760 PHENOTYPE ASSOCIATED WITH 1742 01:20:45,760 --> 01:20:47,240 CHRONIC FATIGUE. 1743 01:20:47,240 --> 01:20:50,000 WE'LL BE PERFORMING STRUCTURAL 1744 01:20:50,000 --> 01:20:53,760 AND FUNCTIONAL NEURAL IMAGING TO 1745 01:20:53,760 --> 01:20:56,040 ASSESS THE NEURAL CORRELATES OF 1746 01:20:56,040 --> 01:20:59,200 DISEASE AND WE'LL PROBABLY SEE 1747 01:20:59,200 --> 01:21:00,280 THIS LEAD TO ADDITIONAL RESEARCH 1748 01:21:00,280 --> 01:21:02,160 AND PAIN AND WHAT IT MEANS WITH 1749 01:21:02,160 --> 01:21:02,800 OUR RESOURCES AVAILABLE TO THE 1750 01:21:02,800 --> 01:21:08,320 PRC. 1751 01:21:08,320 --> 01:21:11,080 THIS IS AN IMPORTANT AREA OF 1752 01:21:11,080 --> 01:21:14,120 STUDY BEING LED BY THE CLINICAL 1753 01:21:14,120 --> 01:21:15,280 CENTER AND INSTITUTE OF CHILD 1754 01:21:15,280 --> 01:21:19,280 HEALTH AND HUMAN DEVELOPMENT. 1755 01:21:19,280 --> 01:21:22,160 CRITICALLY IMPORTANT, MANY 1756 01:21:22,160 --> 01:21:24,880 PEOPLE WITH INTELLECTUALLY 1757 01:21:24,880 --> 01:21:26,200 DISABILITY CAN'T VERBALLY 1758 01:21:26,200 --> 01:21:27,600 EXPRESS THEIR PAIN AND CAN'T 1759 01:21:27,600 --> 01:21:28,480 UNDERSTAND HOW THEY'RE FEELING 1760 01:21:28,480 --> 01:21:33,080 AT LEAST FROM A VERBAL RESPONSE. 1761 01:21:33,080 --> 01:21:34,520 IN CONJUNCTION WITH THE CLINICAL 1762 01:21:34,520 --> 01:21:37,320 CENTER WE'RE LOOKING AT 1763 01:21:37,320 --> 01:21:41,880 NON-VERBAL WAYS TO MEASURE PAIN 1764 01:21:41,880 --> 01:21:46,840 USING OTHER AUTONOMIC 1765 01:21:46,840 --> 01:21:49,680 ASSESSMENT, PUPIL DILATION WITH 1766 01:21:49,680 --> 01:21:55,560 METHODS TO COME UP WITH A 1767 01:21:55,560 --> 01:21:58,120 NON-VERBAL PAIN SIGNATURE. 1768 01:21:58,120 --> 01:21:59,760 THIS IS UNDERSTAND IF PEOPLE 1769 01:21:59,760 --> 01:22:01,160 WITH INTELLECTUAL DISABILITIES 1770 01:22:01,160 --> 01:22:03,840 ARE EXPERIENCING PAIN AND MORE 1771 01:22:03,840 --> 01:22:05,240 IMPORTANTLY IF THE TREATMENTS 1772 01:22:05,240 --> 01:22:07,640 WE'RE PROVIDING ACTUALLY WORK 1773 01:22:07,640 --> 01:22:09,320 AND ALLEVIATE PAIN. 1774 01:22:09,320 --> 01:22:12,440 THAT'S EXCITING WORK HAPPENING 1775 01:22:12,440 --> 01:22:19,720 STOON. 1776 01:22:19,720 --> 01:22:22,760 I WANTED TO HIGHLIGHT THE 1777 01:22:22,760 --> 01:22:27,160 CURATIVE THERAPIES FOR SICKLE 1778 01:22:27,160 --> 01:22:29,560 CELL DISEASE BECAUSE THIS IS A 1779 01:22:29,560 --> 01:22:32,360 TECHNOLOGY DEVELOPED AT NHLBI 1780 01:22:32,360 --> 01:22:34,040 THE STEM CELL TRANSPLANTATION 1781 01:22:34,040 --> 01:22:35,880 THAT REALLY LEADS TO CURES. 1782 01:22:35,880 --> 01:22:40,120 THESE PATIENTS NO LONGER HAVE 1783 01:22:40,120 --> 01:22:40,800 SICKLE CELL. 1784 01:22:40,800 --> 01:22:42,440 A HUGE BREAKTHROUGH AND THE 1785 01:22:42,440 --> 01:22:46,880 FIRST STUDY THE PRC UNDERTOOK 1786 01:22:46,880 --> 01:22:47,920 WHEN THEY SAID SOME PATIENTS ARE 1787 01:22:47,920 --> 01:22:49,160 STILL EXPERIENCING PAIN. 1788 01:22:49,160 --> 01:22:52,360 WE NEED TO GET A BETTER 1789 01:22:52,360 --> 01:22:53,200 UNDERSTANDING WHY THIS IS HAP. 1790 01:22:53,200 --> 01:22:54,520 WE THINK THERE'S RISK FACTORS 1791 01:22:54,520 --> 01:22:56,320 WHY THAT MATE BE THE CASE AND 1792 01:22:56,320 --> 01:22:58,120 THROUGH THE -- MIGHT BE THE CASE 1793 01:22:58,120 --> 01:23:01,320 AND WITH THE PRC YOU MAY DIG 1794 01:23:01,320 --> 01:23:03,160 DEEPLY OUTSIDE OF CURATIVE 1795 01:23:03,160 --> 01:23:03,760 THERAPY SOME PATIENTS STILL 1796 01:23:03,760 --> 01:23:08,920 EXPERIENCE PAIN. 1797 01:23:08,920 --> 01:23:10,160 IT IS TRUE IF YOU LOOK AT THE 1798 01:23:10,160 --> 01:23:13,840 FAR LEFT MOST PATIENTS DO REDUCE 1799 01:23:13,840 --> 01:23:16,480 THEIR PAIN POSTCURATIVE THERAPY 1800 01:23:16,480 --> 01:23:17,560 WHICH IS WONDERFUL NEWS. 1801 01:23:17,560 --> 01:23:20,120 IN FACT SEVERAL TESTS ON THE PRC 1802 01:23:20,120 --> 01:23:23,080 THEY HAVE GREATER TOLERANCE FOR 1803 01:23:23,080 --> 01:23:25,880 PAIN. 1804 01:23:25,880 --> 01:23:28,600 THIS IS SIMILAR FOR COLD AND 1805 01:23:28,600 --> 01:23:29,920 HEAT WHICH IS FASCINATING. 1806 01:23:29,920 --> 01:23:31,480 WE DON'T QUITE UNDERSTAND AND 1807 01:23:31,480 --> 01:23:38,200 NEED TO DIG INTO THAT MORE. 1808 01:23:38,200 --> 01:23:41,320 MANY PATIENTS GOING THROUGH POST 1809 01:23:41,320 --> 01:23:43,480 CURATIVE THERAPY SO WHEN YOU GET 1810 01:23:43,480 --> 01:23:45,240 MULTIPLE PAIN STIMULI THEY TEND 1811 01:23:45,240 --> 01:23:48,680 TO RATE THE PAIN HIGHER RELATIVE 1812 01:23:48,680 --> 01:23:52,480 TO HEALTHY CONTROLS DUE TO 1813 01:23:52,480 --> 01:23:54,480 SENSITIZATION AND THERE MAY BE 1814 01:23:54,480 --> 01:23:55,960 WAYS TO CERTAINLY STUDY THIS 1815 01:23:55,960 --> 01:23:57,440 POPULATION BUT THINK OF WAYS WE 1816 01:23:57,440 --> 01:24:03,960 MAY BE ABLE TO MODULATE THAT 1817 01:24:03,960 --> 01:24:07,560 AFFECT. 1818 01:24:07,560 --> 01:24:08,960 THE PRELIMINARY RESULTS EXHIBIT 1819 01:24:08,960 --> 01:24:11,520 THE THERAPY SIGNIFICANTLY 1820 01:24:11,520 --> 01:24:15,160 REDUCES PAIN AND CURATIVE 1821 01:24:15,160 --> 01:24:17,400 THERAPIES DO REDUCE SENSITIVITY 1822 01:24:17,400 --> 01:24:21,320 TO ACUTE NOXIOUS STIMULI WHICH 1823 01:24:21,320 --> 01:24:25,960 IS ENCOURAGING BUT MOST PATIENTS 1824 01:24:25,960 --> 01:24:27,360 STILL EXPERIENCE SENSITIZATION 1825 01:24:27,360 --> 01:24:29,120 WHICH MAY CONTRIBUTE TO 1826 01:24:29,120 --> 01:24:30,600 PERSISTENT PAIN AFTER CURATIVE 1827 01:24:30,600 --> 01:24:31,480 THERAPY. 1828 01:24:31,480 --> 01:24:34,560 WE'LL CONTINUE THE STUDY OF THE 1829 01:24:34,560 --> 01:24:36,440 PATIENTS AND DEVELOP A PROTOCOL 1830 01:24:36,440 --> 01:24:38,320 TO SEE IF THAT SENSITIZATION 1831 01:24:38,320 --> 01:24:40,640 PERSISTS OVER TIME AND IF 1832 01:24:40,640 --> 01:24:41,800 THERE'S WAYS TO POTENTIALLY 1833 01:24:41,800 --> 01:24:42,200 INTERVENE. 1834 01:24:42,200 --> 01:24:43,400 WE'RE EXCITED ABOUT THIS 1835 01:24:43,400 --> 01:24:44,040 CONTINUED COLLABORATION. 1836 01:24:44,040 --> 01:24:49,080 MORE TO COME ON THIS. 1837 01:24:49,080 --> 01:24:51,960 ANOTHER AREA WE THINK IS 1838 01:24:51,960 --> 01:24:53,080 CRITICALLY IMPORTANT GETTING 1839 01:24:53,080 --> 01:24:57,920 AWAY FROM NON-PHARMACOLOGIC 1840 01:24:57,920 --> 01:25:06,440 APPROACHES WE'RE STUDYING VAGUS 1841 01:25:06,440 --> 01:25:09,320 NERVE STIMULATION AND IMPROVES 1842 01:25:09,320 --> 01:25:14,000 MOOD AND ANXIETY AND MEDIATED 1843 01:25:14,000 --> 01:25:16,680 ANALGESIC AFFECTS AND HOW IT MAY 1844 01:25:16,680 --> 01:25:18,440 AFFECT AUTONOMIC RESPONSES WE 1845 01:25:18,440 --> 01:25:19,600 KNOW ARE CRITICAL IN THE PAIN 1846 01:25:19,600 --> 01:25:20,520 RESPONSE. 1847 01:25:20,520 --> 01:25:23,400 AGAIN THE STUDY IS STILL ONGOING 1848 01:25:23,400 --> 01:25:25,200 AND MORE TO COME. 1849 01:25:25,200 --> 01:25:29,840 MAYBE NEXT YEAR I'LL GIVE YOU 1850 01:25:29,840 --> 01:25:30,280 PRELIMINARY DATA. 1851 01:25:30,280 --> 01:25:31,760 ANOTHER INTERESTING 1852 01:25:31,760 --> 01:25:38,440 COLLABORATION IS WORKING WITH 1853 01:25:38,440 --> 01:25:40,680 NIDCR ON AN UNFORTUNATE 1854 01:25:40,680 --> 01:25:43,800 DISORDER, FIBROSIS DYSPLASIA A 1855 01:25:43,800 --> 01:25:45,760 RARE BONE DISEASE WHERE FIBROTIC 1856 01:25:45,760 --> 01:25:48,320 TISSUE REPLACES BONE. 1857 01:25:48,320 --> 01:25:50,360 IT'S QUITE PAINFUL. 1858 01:25:50,360 --> 01:25:53,320 RESULTS IN SKELETAL DEFORMITIES, 1859 01:25:53,320 --> 01:25:55,200 FRACT 1860 01:25:55,200 --> 01:25:56,480 FRACTURES, WEAKNESS BUT THE PAIN 1861 01:25:56,480 --> 01:25:57,920 MECHANISMS ARE REALLY UNKNOWN. 1862 01:25:57,920 --> 01:26:02,080 THIS IS A COLLABORATION WHERE 1863 01:26:02,080 --> 01:26:02,920 WE'RE TRYING TO CHARACTERIZE 1864 01:26:02,920 --> 01:26:04,120 WHAT PAIN THEY'RE EXPERIENCING 1865 01:26:04,120 --> 01:26:05,320 AND USING A VARIETY OF 1866 01:26:05,320 --> 01:26:05,600 TECHNIQUE. 1867 01:26:05,600 --> 01:26:11,760 WE JUST STARTED TO DO 1868 01:26:11,760 --> 01:26:12,520 OBSERVATIONAL WORK AND MORE TO 1869 01:26:12,520 --> 01:26:21,360 COME ON THE STUDY. 1870 01:26:21,360 --> 01:26:27,160 WE'RE WORKING TO STUDY 1871 01:26:27,160 --> 01:26:28,040 FUNCTIONAL MOVEMENT DISORDER 1872 01:26:28,040 --> 01:26:30,200 THAT CANNOT BE EXPLAINED BY 1873 01:26:30,200 --> 01:26:33,320 OTHER NEUROLOGICAL DISEASES. 1874 01:26:33,320 --> 01:26:35,480 THERE'S A LIMBIC CONNECTION 1875 01:26:35,480 --> 01:26:37,960 SUGGESTING DATA BURST TO THE 1876 01:26:37,960 --> 01:26:39,320 AMYGDALA IMPROVES SYSTEMS IN 1877 01:26:39,320 --> 01:26:41,320 THESE PATIENTS SO WHAT WE ARE 1878 01:26:41,320 --> 01:26:45,120 DOING IS TRYING TO HELP THEM 1879 01:26:45,120 --> 01:26:49,760 FIGURE OUT THE BEST DOSE OF THE 1880 01:26:49,760 --> 01:26:55,600 DATA BURST USING OUR FMRI 1881 01:26:55,600 --> 01:26:57,680 CAPABILITIES IN DETERMINING HOW 1882 01:26:57,680 --> 01:27:00,160 WELL THEY'RE ACTIVATING THE 1883 01:27:00,160 --> 01:27:00,480 AMYGDALA. 1884 01:27:00,480 --> 01:27:02,160 AGAIN, A COLLABORATION WHERE WE 1885 01:27:02,160 --> 01:27:03,160 CAN PROVIDE SOME TECHNOLOGIES 1886 01:27:03,160 --> 01:27:07,400 THAT MAY NOT BE RELATED TO PAIN 1887 01:27:07,400 --> 01:27:08,160 BUT HELPING OUR COLLEAGUES 1888 01:27:08,160 --> 01:27:15,840 OPTIMIZE TREATMENT FOR FMD. 1889 01:27:15,840 --> 01:27:21,320 THIS STUDY INVOLVES A NATURAL 1890 01:27:21,320 --> 01:27:24,520 PRODUCT BUT WE'RE LOOKING AT 1891 01:27:24,520 --> 01:27:26,600 PATIENTS WITH A PAINFUL 1892 01:27:26,600 --> 01:27:33,320 CONDITION OF THE FOOT, MORTON'S 1893 01:27:33,320 --> 01:27:34,920 NEUROMA AND PEOPLE HAVE TROUBLE 1894 01:27:34,920 --> 01:27:35,160 WALKING. 1895 01:27:35,160 --> 01:27:45,680 YOU CAN SEE ON THE FAR RIGHT AND 1896 01:27:51,200 --> 01:27:57,920 LOOKING AT RTX LOOKING AT THIS 1897 01:27:57,920 --> 01:28:00,920 FROM A PLANT THAT GROWS IN 1898 01:28:00,920 --> 01:28:01,160 MOROCCO. 1899 01:28:01,160 --> 01:28:04,560 I DIDN'T KNOW UNTIL WE STARTED 1900 01:28:04,560 --> 01:28:09,320 STUDYING THIS POTENT PRODUCT. 1901 01:28:09,320 --> 01:28:12,280 NOW MA WE CHARACTERIZED THE 1902 01:28:12,280 --> 01:28:15,400 MORTON'S NEURONA WE'LL LOOK TO 1903 01:28:15,400 --> 01:28:16,680 SEE IF IT'S AN EFFECTIVE 1904 01:28:16,680 --> 01:28:17,480 TREATMENT FOR THIS. 1905 01:28:17,480 --> 01:28:24,840 MORE TO COME ON THIS STUDY. 1906 01:28:24,840 --> 01:28:28,240 WE JUST TALKED ABOUT MOST ACUTE 1907 01:28:28,240 --> 01:28:29,320 SEQUELAE FOR SARS COVID-19. 1908 01:28:29,320 --> 01:28:32,360 WE'RE TRYING TO DO OUR PART TO 1909 01:28:32,360 --> 01:28:38,600 WORK WITH NINDS TO BRING IN 1910 01:28:38,600 --> 01:28:42,440 POST-A 1911 01:28:42,440 --> 01:28:47,200 POST-ACUTE SEQUELAE PATIENTS AND 1912 01:28:47,200 --> 01:28:48,560 LOOKING AT NEUROPSYCHOLOGICAL 1913 01:28:48,560 --> 01:28:51,480 TESTS AND QUANTITATIVE SENSORY 1914 01:28:51,480 --> 01:28:52,200 TECHNOLOGY TO BETTER 1915 01:28:52,200 --> 01:28:53,320 CHARACTERIZE THE PATIENTS TO 1916 01:28:53,320 --> 01:28:59,200 LOOK AT HOW THEY RECOVER AND IF 1917 01:28:59,200 --> 01:29:05,040 THEY DON'T, WHY. 1918 01:29:05,040 --> 01:29:09,360 IT'S AN EARLY STAGES AND HOPE TO 1919 01:29:09,360 --> 01:29:13,200 HAVE MORE LATER. 1920 01:29:13,200 --> 01:29:14,600 WE'RE INTERESTED IN BRINGING THE 1921 01:29:14,600 --> 01:29:19,600 BENCH TO THE BEDSIDE AND WE WANT 1922 01:29:19,600 --> 01:29:21,240 TO MAKE SURE OUR CLINICAL 1923 01:29:21,240 --> 01:29:22,920 RESEARCH IS USEFUL AND USED IN 1924 01:29:22,920 --> 01:29:24,680 THE SENSE I GETS THE NEXT LEVEL 1925 01:29:24,680 --> 01:29:31,920 OF CLINIC RESEARCH AND BEYOND. 1926 01:29:31,920 --> 01:29:34,280 THE MAIN AREA WE STARTED WITH 1927 01:29:34,280 --> 01:29:37,120 THE PRC AND CONTINUE TO WORK 1928 01:29:37,120 --> 01:29:38,880 WITH THE PRECLINICAL MODELS ARE 1929 01:29:38,880 --> 01:29:42,440 GIVING US NEW IDEAS ABOUT WHAT 1930 01:29:42,440 --> 01:29:45,920 LOSS OF PIEZO 2 MEANS IN TERMS 1931 01:29:45,920 --> 01:29:55,320 OF THE PHYSIOLOGY AND OTHER 1932 01:29:55,320 --> 01:29:58,400 SYMPTOMS AND LOOK AT PATIENTS 1933 01:29:58,400 --> 01:30:01,320 WITH THE SYNDROME AND LOOK AT 1934 01:30:01,320 --> 01:30:11,840 SOMATO SENSATION, TOUCH, ALOE 1935 01:30:12,480 --> 01:30:20,960 -- ALODYNIA AND IT'S EXCITING 1936 01:30:20,960 --> 01:30:26,120 WORK BEING LED BY NCCIH AND THE 1937 01:30:26,120 --> 01:30:32,880 NINDS WITH SUPPORT. 1938 01:30:32,880 --> 01:30:38,280 WE'RE ALSO LOOKING AT ANOTHER 1939 01:30:38,280 --> 01:30:48,760 POTENTIAL PHARMOCOLOGIC AGENT 1940 01:30:49,400 --> 01:30:49,960 AND YOU SEE THE CONNECTIONS TO 1941 01:30:49,960 --> 01:30:57,240 PAIN. 1942 01:30:57,240 --> 01:31:01,760 AND WE WANT TO TAKE IT TO THE 1943 01:31:01,760 --> 01:31:05,280 ASPECT OF LOOKING AT HNK. 1944 01:31:05,280 --> 01:31:09,920 AND I MENTIONED THE WORK OF 1945 01:31:09,920 --> 01:31:18,440 DR. CARRASQUILLO AND LOOK AT HOW 1946 01:31:18,440 --> 01:31:19,720 IT GOES ON TO MODULATE PAIN 1947 01:31:19,720 --> 01:31:21,200 PERCEPTION. 1948 01:31:21,200 --> 01:31:25,360 AND THE SYMPHONY STUDY WITH 1949 01:31:25,360 --> 01:31:30,920 NIDCR TO EXPLORE WAYS TO ADDRESS 1950 01:31:30,920 --> 01:31:41,120 THE DISEASE. 1951 01:32:06,320 --> 01:32:09,120 AND SOME RUN INTO A BRICK WALL 1952 01:32:09,120 --> 01:32:11,760 WITH THE HEALTH CARE SYSTEM AND 1953 01:32:11,760 --> 01:32:13,240 APPROACHES THEY MIGHT HAVE 1954 01:32:13,240 --> 01:32:15,480 FIGURE OUT WHAT'S HAPPENING. 1955 01:32:15,480 --> 01:32:17,320 ONE CASE STUDY THIS IS ONE OF 1956 01:32:17,320 --> 01:32:19,000 SEVERAL WE'VE BEEN ABLE TO WORK 1957 01:32:19,000 --> 01:32:20,520 PATIENTS WE'VE BEEN WORKING WITH 1958 01:32:20,520 --> 01:32:23,120 OVER THE TWO YEARS WE'VE BEEN IN 1959 01:32:23,120 --> 01:32:23,440 EXISTENCE. 1960 01:32:23,440 --> 01:32:29,160 THIS IS THE PATIENT, A YOUNG 1961 01:32:29,160 --> 01:32:31,160 INDIVIDUAL WHO REPORTS NO PAIN. 1962 01:32:31,160 --> 01:32:33,600 YOU CAN SEE IN THE UPPER RIGHT 1963 01:32:33,600 --> 01:32:36,240 HAND PANEL HERE WHERE THIS 1964 01:32:36,240 --> 01:32:37,000 PERSON'S IN RED. 1965 01:32:37,000 --> 01:32:39,320 IF YOU GIVE THEM LOW OR HIGH 1966 01:32:39,320 --> 01:32:41,240 HEAT THERE'S ACTUALLY NO CHANGE 1967 01:32:41,240 --> 01:32:43,320 IN PAIN INTENSITY COMPARED TO 1968 01:32:43,320 --> 01:32:45,960 HEALTHY CONTROLS. 1969 01:32:45,960 --> 01:32:51,840 THEY DO EXPERIENCE AUTONOMIC 1970 01:32:51,840 --> 01:32:52,080 RESPONSE. 1971 01:32:52,080 --> 01:32:55,120 THERE'S NO APPARENT BRAIN OR 1972 01:32:55,120 --> 01:32:57,240 SPINAL CORD ABNORMALITIES AT 1973 01:32:57,240 --> 01:33:00,440 LEAST WE CAN DETECT 1974 01:33:00,440 --> 01:33:00,760 ANATOMICALLY. 1975 01:33:00,760 --> 01:33:03,840 THEY SHOW A NORMAL FLARE 1976 01:33:03,840 --> 01:33:05,960 RESPONSE AND YOU SEE THE AREA 1977 01:33:05,960 --> 01:33:10,000 FLARES AS WOULD BE EXPECTED AND 1978 01:33:10,000 --> 01:33:14,040 NORMAL NERVE BIOPSIES. 1979 01:33:14,040 --> 01:33:15,640 WHEN WE DID THIS WITH THE 1980 01:33:15,640 --> 01:33:16,720 VOLUNTEER THEY HAD REDUCED 1981 01:33:16,720 --> 01:33:20,480 ACTIVATION IN THE ACC AND SOMATO 1982 01:33:20,480 --> 01:33:25,320 SENSORY CORTEX S1, S2 THALAMUS 1983 01:33:25,320 --> 01:33:26,880 SO SOMETHING IS DIFFERENT IN THE 1984 01:33:26,880 --> 01:33:27,120 BRAIN. 1985 01:33:27,120 --> 01:33:30,440 THE SIGNAL MAY BE GETTING THERE 1986 01:33:30,440 --> 01:33:31,880 BUT IT'S DIFFERENT FOR THE 1987 01:33:31,880 --> 01:33:33,560 HEALTHY CONTROL AND THE BOTTOM 1988 01:33:33,560 --> 01:33:34,560 RELATIVE TO THE PATIENT. 1989 01:33:34,560 --> 01:33:36,320 YOU SEE RELATIVELY LITTLE 1990 01:33:36,320 --> 01:33:39,400 ACTIVITY WHEN GIVEN A PAINFUL 1991 01:33:39,400 --> 01:33:39,680 STIMULUS. 1992 01:33:39,680 --> 01:33:41,880 IT SUGGESTS SOMETHING GOING ON 1993 01:33:41,880 --> 01:33:43,240 BETWEEN THE BRAIN STEM AND 1994 01:33:43,240 --> 01:33:43,880 HIGHER ORDER FUNCTIONING IN THE 1995 01:33:43,880 --> 01:33:45,400 BRAIN. 1996 01:33:45,400 --> 01:33:49,000 IT LIMITS THEIR ABILITY TO 1997 01:33:49,000 --> 01:33:50,200 RECOGNIZE A PAINFUL EVENT. 1998 01:33:50,200 --> 01:33:52,200 VERY FASCINATING AND WE'RE 1999 01:33:52,200 --> 01:33:53,040 CONTINUING TO FOLLOW UP ON THE 2000 01:33:53,040 --> 01:33:55,360 PATIENT AS WELL. 2001 01:33:55,360 --> 01:33:59,160 SO THAT I THINK IS IT. 2002 01:33:59,160 --> 01:34:02,400 JUST IN CONCLUSION, WE HAVE 2003 01:34:02,400 --> 01:34:06,080 ESTABLISHED THE PRC AS A PAIN 2004 01:34:06,080 --> 01:34:07,160 RESEARCH HUB IN THE INTRAMURAL 2005 01:34:07,160 --> 01:34:09,040 RESEARCH PROGRAM FOR CONDUCTING 2006 01:34:09,040 --> 01:34:10,240 PAIN PHENOTYPING IN DIVERSE 2007 01:34:10,240 --> 01:34:11,800 POPULATIONS ACROSS THE NIH. 2008 01:34:11,800 --> 01:34:13,400 SOMETHING I THINK THAT'S 2009 01:34:13,400 --> 01:34:16,200 CRITICALLY NEEDED. 2010 01:34:16,200 --> 01:34:17,960 PAIN IS COMORBID WITH SO MANY 2011 01:34:17,960 --> 01:34:20,600 DISEASES AND PATIENTS COMING TO 2012 01:34:20,600 --> 01:34:24,040 THE CLINICAL CENTER IT'S HELPFUL 2013 01:34:24,040 --> 01:34:24,880 TO HELP THEM WITH THE PAIN 2014 01:34:24,880 --> 01:34:26,040 CONDITIONS AND ADVANCE THE FIELD 2015 01:34:26,040 --> 01:34:26,960 AND UNDERSTANDING THE MECHANISMS 2016 01:34:26,960 --> 01:34:28,000 OF PAIN. 2017 01:34:28,000 --> 01:34:29,240 WE REALLY DO HAVE THE 2018 01:34:29,240 --> 01:34:30,840 OPPORTUNITY TO FACILITATE 2019 01:34:30,840 --> 01:34:32,240 TRANSLATIONAL RESEARCH FROM THE 2020 01:34:32,240 --> 01:34:35,080 LAB TO THE BENCH SIDE WITH THE 2021 01:34:35,080 --> 01:34:35,560 PRC. 2022 01:34:35,560 --> 01:34:38,320 AS I SHOWED YOU WE CAN 2023 01:34:38,320 --> 01:34:39,600 CHARACTERIZE INDIVIDUAL PATIENTS 2024 01:34:39,600 --> 01:34:41,360 WITH RARE PHENOTYPES THROUGH THE 2025 01:34:41,360 --> 01:34:41,560 CENTER. 2026 01:34:41,560 --> 01:34:44,000 WE'RE VERY EXCITED ABOUT THE 2027 01:34:44,000 --> 01:34:44,240 FUTURE. 2028 01:34:44,240 --> 01:34:45,640 IT'S ONLY BEEN ABOUT FOUR YEARS 2029 01:34:45,640 --> 01:34:47,200 AND WE'RE LOOKING TO FURTHER 2030 01:34:47,200 --> 01:34:50,720 GROW AND DEVELOP AND MATURE AS A 2031 01:34:50,720 --> 01:34:52,040 CENTER WITHIN THE NIH CLINICAL 2032 01:34:52,040 --> 01:34:52,320 CENTER. 2033 01:34:52,320 --> 01:34:53,320 WITH THAT I'LL STOP AND TAKE ANY 2034 01:34:53,320 --> 01:34:55,560 QUESTIONS YOU MIGHT HAVE. 2035 01:34:55,560 --> 01:35:00,480 YES. 2036 01:35:00,480 --> 01:35:02,000 >> THANK YOU, THAT WAS A 2037 01:35:02,000 --> 01:35:05,040 WONDERFUL TALK AND NICE TO SEE 2038 01:35:05,040 --> 01:35:09,120 THE BREADTH OF ACTIVITIES AND 2039 01:35:09,120 --> 01:35:11,160 NCCIH TAKING THE LEAD. 2040 01:35:11,160 --> 01:35:15,720 IT'S NICE TO SEE THE CENTER HAS 2041 01:35:15,720 --> 01:35:17,960 THE CAPABILITY TO GO FROM BENCH 2042 01:35:17,960 --> 01:35:19,240 TO CLINIC. 2043 01:35:19,240 --> 01:35:21,800 IS THERE A POSSIBILITY FOR THE 2044 01:35:21,800 --> 01:35:23,840 MECHANISTIC KNOWLEDGE BE 2045 01:35:23,840 --> 01:35:27,160 TRANSLATED TO SCREENS TO SCREEN 2046 01:35:27,160 --> 01:35:29,640 FOR NEW DRUGS LIKE NCI HAS THAT 2047 01:35:29,640 --> 01:35:30,600 CAPACITY? 2048 01:35:30,600 --> 01:35:32,720 >> IT'S GREAT YOU MENTION -- 2049 01:35:32,720 --> 01:35:35,480 THIS IS ONLY THE TIP OF THE 2050 01:35:35,480 --> 01:35:37,320 ICEBERG. 2051 01:35:37,320 --> 01:35:38,520 THAT WAS A GREAT QUESTION. 2052 01:35:38,520 --> 01:35:40,040 I DIDN'T PLANT IT BUT WE'RE 2053 01:35:40,040 --> 01:35:42,400 WORKING FOR THE NATIONAL CENTER 2054 01:35:42,400 --> 01:35:47,480 FOR ACCELERATING TRANSLATIONAL 2055 01:35:47,480 --> 01:35:48,440 CENTER. 2056 01:35:48,440 --> 01:35:53,680 BASED ON OUR KNOWLEDGE OF THE 2057 01:35:53,680 --> 01:35:56,200 PIEZO 2 SYNDROME THEY'RE LOOKING 2058 01:35:56,200 --> 01:36:00,440 THROUGH HIGH THROUGHPUT 2059 01:36:00,440 --> 01:36:02,120 SCREENING DISCOVERY PLATFORM 2060 01:36:02,120 --> 01:36:04,320 THAT THEY'RE FINDING HITS IN THE 2061 01:36:04,320 --> 01:36:07,400 EARLY DISCOVERY PHASE GOING FROM 2062 01:36:07,400 --> 01:36:09,320 DR. CHESSLER'S LAB WITH THE 2063 01:36:09,320 --> 01:36:11,280 MOUSE MODEL AND IF THAT LOOKS 2064 01:36:11,280 --> 01:36:13,600 PROMISING TO THE PRC. 2065 01:36:13,600 --> 01:36:15,960 YES, THERE'S THE CONDUIT 2066 01:36:15,960 --> 01:36:18,200 STARTING WITH THE NCATS THE 2067 01:36:18,200 --> 01:36:20,840 NATIONAL CENTER FOR ACCELERATED 2068 01:36:20,840 --> 01:36:21,760 TRANSLATIONAL SCIENCE AND DO 2069 01:36:21,760 --> 01:36:29,280 THAT WORK AND TAKE IT THROUGH 2070 01:36:29,280 --> 01:36:29,720 CLINIC RESEARCH. 2071 01:36:29,720 --> 01:36:30,000 THANK YOU. 2072 01:36:30,000 --> 01:36:33,320 >> THAT'S GREAT ESPECIALLY FOR 2073 01:36:33,320 --> 01:36:43,640 NATURAL PRODUCTS. 2074 01:36:50,200 --> 01:36:51,840 LET'S SEE IF THERE'S OTHER 2075 01:36:51,840 --> 01:36:52,120 QUESTIONS. 2076 01:36:52,120 --> 01:36:56,920 DR. HANEY. 2077 01:36:56,920 --> 01:37:03,000 >> THANK YOU, MY QUESTION MY OWN 2078 01:37:03,000 --> 01:37:03,280 CURIOSITY. 2079 01:37:03,280 --> 01:37:04,400 THERE WAS AN INTERESTING STUDY 2080 01:37:04,400 --> 01:37:11,040 OF A WOMAN WITH A LOSS OF 2081 01:37:11,040 --> 01:37:13,440 MUTATION DUE TO ENDOCANNAB 2082 01:37:13,440 --> 01:37:13,880 ENDOCANNABINOIDS. 2083 01:37:13,880 --> 01:37:17,840 >> THIS IS THE KIND OF THING WE 2084 01:37:17,840 --> 01:37:20,520 CAN DO. 2085 01:37:20,520 --> 01:37:24,440 WE'VE HAD PATIENTS WITH 2086 01:37:24,440 --> 01:37:26,120 HOMOZYGOUS TRIP D1 THE EARLY 2087 01:37:26,120 --> 01:37:28,720 NEURO SENSORY INVOLVED IN THE 2088 01:37:28,720 --> 01:37:31,000 SENSATION OF COLD AND OTHER 2089 01:37:31,000 --> 01:37:31,360 SENSATIONS. 2090 01:37:31,360 --> 01:37:34,360 THESE ARE THE KINDS OF 2091 01:37:34,360 --> 01:37:35,360 INTERESTING KINDS OF CASES WE 2092 01:37:35,360 --> 01:37:38,200 CAN STUDY IN MORE DETAIL. 2093 01:37:38,200 --> 01:37:41,440 IF YOU KNOW OF PATIENTS OR 2094 01:37:41,440 --> 01:37:42,520 PEOPLE WHO ARE INTERESTED IN 2095 01:37:42,520 --> 01:37:44,280 LEARNING MORE ABOUT THEIR 2096 01:37:44,280 --> 01:37:44,840 CONDITIONS, WE'RE OPEN TO 2097 01:37:44,840 --> 01:37:49,840 CONSIDERING BRINGING THEM HERE. 2098 01:37:49,840 --> 01:37:51,960 HERE AT NIH WE'RE TRYING TO 2099 01:37:51,960 --> 01:37:53,440 FURTHER UNDERSTAND THE MECHANISM 2100 01:37:53,440 --> 01:37:54,360 THEFZ CONDITIONS AND FROM THE 2101 01:37:54,360 --> 01:37:56,240 RARE CONDITIONS THAT WAS A GREAT 2102 01:37:56,240 --> 01:37:58,040 USE FOR DEVELOPING NEW THERAPIES 2103 01:37:58,040 --> 01:38:00,800 AND WAYS OF THINKING ABOUT THE 2104 01:38:00,800 --> 01:38:02,040 MECHANISMS OF PAIN. 2105 01:38:02,040 --> 01:38:02,760 YEAH. 2106 01:38:02,760 --> 01:38:04,240 YEAH. 2107 01:38:04,240 --> 01:38:06,560 THAT'S A GOOD POINT. 2108 01:38:06,560 --> 01:38:09,400 >> AND THE PIEZO 2 STORY, SO IT 2109 01:38:09,400 --> 01:38:11,400 SOUNDS LIKE THERE'S ABT OF A 2110 01:38:11,400 --> 01:38:12,960 LOSS OF FUNCTION AS WELL. 2111 01:38:12,960 --> 01:38:15,200 ARE THEY COMMON GENETIC MUTATION 2112 01:38:15,200 --> 01:38:16,840 FOR PEOPLE? 2113 01:38:16,840 --> 01:38:18,200 >> THEY'RE QUITE RARE. 2114 01:38:18,200 --> 01:38:24,480 I THINK WE'VE IDENTIFIED FOUR OR 2115 01:38:24,480 --> 01:38:30,480 FIVE IN THE WORLD. 2116 01:38:30,480 --> 01:38:40,920 IT'S NOT A RARE CONDITION. 2117 01:38:41,400 --> 01:38:44,520 IT'S NOT A COMMON CONDITION BUT 2118 01:38:44,520 --> 01:38:45,520 IT GAVE PEOPLE A BETTER 2119 01:38:45,520 --> 01:38:47,160 UNDERSTANDING OF WHAT THEY'RE 2120 01:38:47,160 --> 01:38:48,400 EXPERIENCING AND GAVE THEM A 2121 01:38:48,400 --> 01:38:49,760 BETTER SENSE OF WHAT WAS 2122 01:38:49,760 --> 01:38:51,640 HAPPENING TO THEM NOW THAT WE 2123 01:38:51,640 --> 01:38:53,840 UNDERSTAND WHAT THE ROLE OF 2124 01:38:53,840 --> 01:39:01,760 PIEZO 2 AND THE PHYSIOLOGY AND 2125 01:39:01,760 --> 01:39:05,400 NOW LEARNING MORE IN PEOPLE A 2126 01:39:05,400 --> 01:39:06,800 CLASSIC FOUNDATIONAL MODEL FROM 2127 01:39:06,800 --> 01:39:11,360 MICE TO PEOPLE. 2128 01:39:11,360 --> 01:39:12,440 >> HI, DAVID. 2129 01:39:12,440 --> 01:39:14,160 INTERESTING TO HEAR ABOUT ALL 2130 01:39:14,160 --> 01:39:16,320 THAT AND I REALLY APPRECIATE 2131 01:39:16,320 --> 01:39:18,480 YOUR COMMENTS ABOUT HOW THERE'S 2132 01:39:18,480 --> 01:39:19,760 NO OTHER CENTER DEVOTED TO PAIN 2133 01:39:19,760 --> 01:39:21,840 AT NIH AND WHAT AN IMPORTANT 2134 01:39:21,840 --> 01:39:22,640 THING TO BE THINKING ABOUT. 2135 01:39:22,640 --> 01:39:25,880 IT'S JUST REALLY INSPIRING TO 2136 01:39:25,880 --> 01:39:27,560 SEE HOW NCCIH HAS CONTINUED TO 2137 01:39:27,560 --> 01:39:36,520 BE A LEADER IN THIS AREA. 2138 01:39:36,520 --> 01:39:38,920 I LIKE THE EXAMPLE OF THE BENCH 2139 01:39:38,920 --> 01:39:42,640 TO BEDSIDE DEVELOPMENT OF 2140 01:39:42,640 --> 01:39:43,960 TREATMENTS FOR PAIN AND 2141 01:39:43,960 --> 01:39:46,360 CERTAINLY WE HAVE A WONDERFUL 2142 01:39:46,360 --> 01:39:49,320 HISTORY OF NATURAL PRODUCTS 2143 01:39:49,320 --> 01:39:51,000 BEING EFFECTIVE AGAINST PAIN AND 2144 01:39:51,000 --> 01:39:53,320 A LOT OF OUR PAIN TREATMENT 2145 01:39:53,320 --> 01:39:54,800 PHARMACOLOGIC INTERVENTIONS ARE 2146 01:39:54,800 --> 01:39:56,240 FROM NATURAL PRODUCTS. 2147 01:39:56,240 --> 01:39:57,320 I THINK THERE'S SO MANY 2148 01:39:57,320 --> 01:40:01,640 OPPORTUNITIES TO DO MORE OF THAT 2149 01:40:01,640 --> 01:40:05,280 AND WONDER FRIDAY THERE'S PLAN 2150 01:40:05,280 --> 01:40:07,760 TO HAVE MORE OUTWARDLY FACING 2151 01:40:07,760 --> 01:40:09,600 RFAs TO BRING IN INVESTIGATORS 2152 01:40:09,600 --> 01:40:12,200 IN THAT AREA AND CONNECT THEM 2153 01:40:12,200 --> 01:40:17,440 WITH YOUR TEAM THAT ARE DEVELOP 2154 01:40:17,440 --> 01:40:23,800 ING ASSAYS AND DOING NICE WORK. 2155 01:40:23,800 --> 01:40:29,200 >> WE'RE EARLY IN OUR 2156 01:40:29,200 --> 01:40:29,480 DEVELOPMENT. 2157 01:40:29,480 --> 01:40:36,080 WE'RE TRYING TO BRING TOGETHER 2158 01:40:36,080 --> 01:40:40,920 THE INTRAMURAL PROGRAM. 2159 01:40:40,920 --> 01:40:43,360 AND MY FIRST SLIDE YOU MAY BE A 2160 01:40:43,360 --> 01:40:45,320 PAIN RESEARCHER AND WE'RE STILL 2161 01:40:45,320 --> 01:40:49,320 TRYING TO FIND THOSE PEOPLE IN 2162 01:40:49,320 --> 01:40:50,600 THE INTRAMURAL PROGRAM THE GET 2163 01:40:50,600 --> 01:40:52,440 IS TO CONTINUE TO GROW AND 2164 01:40:52,440 --> 01:40:56,360 DEVELOP THE CONNECTIONS TO 2165 01:40:56,360 --> 01:40:56,640 EXTRAMURAL. 2166 01:40:56,640 --> 01:40:59,040 THE ENTITIES I SHOWED ARE 2167 01:40:59,040 --> 01:41:00,560 PRIMARILY VISITING FELLOWS AND 2168 01:41:00,560 --> 01:41:04,200 OTHERS THAT COME THROUGH THE PRC 2169 01:41:04,200 --> 01:41:07,000 OR OTHER INSTITUTES BUT YES, THE 2170 01:41:07,000 --> 01:41:09,000 INTENTION WOULD BE TO CONTINUE 2171 01:41:09,000 --> 01:41:10,720 TO GROW THIS TO THE INTRAMURAL 2172 01:41:10,720 --> 01:41:11,800 ONCE WE CONTINUE TO FIGURE OUT 2173 01:41:11,800 --> 01:41:14,560 HOW TO DO IT INTERNALLY AND THE 2174 01:41:14,560 --> 01:41:15,960 NEXT STEP IS TO GO OUTWARD. 2175 01:41:15,960 --> 01:41:18,360 I THINK THE WORK YOU'RE DOING 2176 01:41:18,360 --> 01:41:19,720 AND OTHERS IN THE NATURAL 2177 01:41:19,720 --> 01:41:24,000 PRODUCT SPACE IS VITALLY 2178 01:41:24,000 --> 01:41:24,360 IMPORTANT. 2179 01:41:24,360 --> 01:41:34,840 ONE AREA WE CAN THINK ABOUT. 2180 01:41:39,760 --> 01:41:46,280 >> WE IT'S A SPECIFIC PAR NUMBER 2181 01:41:46,280 --> 01:41:48,480 AND YOU'LL FIND IT. 2182 01:41:48,480 --> 01:41:50,280 WITHIN THAT PROGRAM WE'RE 2183 01:41:50,280 --> 01:41:53,800 EXPLICITLY ASKING FOR 2184 01:41:53,800 --> 01:41:55,120 INVESTIGATORS TO PROPOSE NOVEL 2185 01:41:55,120 --> 01:41:57,360 ANALGESIC ASSAYS. 2186 01:41:57,360 --> 01:42:02,600 THE R61, R331 AND THEY'RE 2187 01:42:02,600 --> 01:42:04,440 PROPOSING NOVEL ANALGESIC ASSAYS 2188 01:42:04,440 --> 01:42:08,560 AND THEY WOULD BE APPROVED TO 2189 01:42:08,560 --> 01:42:11,640 THE R33 PHASE WHERE THEY'RE 2190 01:42:11,640 --> 01:42:12,720 ENCOURAGED TO SCREEN LARGE 2191 01:42:12,720 --> 01:42:13,000 LIBRARIES. 2192 01:42:13,000 --> 01:42:15,640 WE SPECIFICALLY POINTED OUT IN 2193 01:42:15,640 --> 01:42:20,600 THE PAR THE NCI LIBRARY BUT 2194 01:42:20,600 --> 01:42:23,120 PEOPLE CAN PROPOSE ANY LARGE 2195 01:42:23,120 --> 01:42:24,520 LIBRARY THEY HAVE ACCESS TO IT'S 2196 01:42:24,520 --> 01:42:31,800 ALL ABOUT NATIONAL PRODUCTS AND 2197 01:42:31,800 --> 01:42:32,000 PAIN. 2198 01:42:32,000 --> 01:42:36,200 >> THAT'S USING THE NCATS 2199 01:42:36,200 --> 01:42:36,440 PLATFORM? 2200 01:42:36,440 --> 01:42:37,840 >> IT'S NOT. 2201 01:42:37,840 --> 01:42:39,560 IT'S INVESTIGATOR INITIATED. 2202 01:42:39,560 --> 01:42:41,720 IT DOESN'T INTERSECT OR LEVERAGE 2203 01:42:41,720 --> 01:42:46,320 WITH THE PRC OR OTHER ACTIVITIES 2204 01:42:46,320 --> 01:42:49,320 WITH PIEZO 2 OR NCATS AND WE'RE 2205 01:42:49,320 --> 01:42:53,160 DOING OTHER THINGS BUT THAT'S 2206 01:42:53,160 --> 01:42:55,920 ANOTHER STORY THE EXTRAMURAL 2207 01:42:55,920 --> 01:42:57,400 COMMUNITY IS ONE THEY CAN 2208 01:42:57,400 --> 01:42:58,320 LEVERAGE RIGHT NOW. 2209 01:42:58,320 --> 01:42:59,880 >> THE POINT IS THERE'S MANY 2210 01:42:59,880 --> 01:43:02,160 AVENUES TO GET THAT KIND OF 2211 01:43:02,160 --> 01:43:02,440 WORK. 2212 01:43:02,440 --> 01:43:03,720 THE EARLY DISCOVERY I THINK WAS 2213 01:43:03,720 --> 01:43:06,880 BROUGHT UP BEFORE AND GET THAT 2214 01:43:06,880 --> 01:43:08,800 DONE TO MOVE WHETHER THROUGH PRC 2215 01:43:08,800 --> 01:43:13,360 OR OTHER MECHANISM TO DO THE 2216 01:43:13,360 --> 01:43:23,880 CLINICAL AND TRANSLATIONAL WORK. 2217 01:43:29,640 --> 01:43:31,360 >> WELL, THANK YOU FOR LETTING 2218 01:43:31,360 --> 01:43:35,120 ME SHARE SOME OF THE BEST KEPT 2219 01:43:35,120 --> 01:43:36,920 SECRETS AT NIH. 2220 01:43:36,920 --> 01:43:37,840 >> OUR GUEST SPEAKER HAS 2221 01:43:37,840 --> 01:43:41,320 ARRIVED. 2222 01:43:41,320 --> 01:43:42,280 WELCOME. 2223 01:43:42,280 --> 01:43:46,000 DR. BYRNES, IT'S MY GREAT 2224 01:43:46,000 --> 01:43:49,840 PLEASURE TO INTRODUCE DR. NONI 2225 01:43:49,840 --> 01:43:52,440 BYRNES TO GIVE OUR FEATURED 2226 01:43:52,440 --> 01:43:53,240 PRESENTATION. 2227 01:43:53,240 --> 01:43:53,440 TODAY. 2228 01:43:53,440 --> 01:43:55,000 SHE'S THE DIRECTOR OF THE CENTER 2229 01:43:55,000 --> 01:44:01,120 FOR SCIENTIFIC REVIEW OR CSR 2230 01:44:01,120 --> 01:44:03,840 WHERE SHE LEADS A STAFF OF 2231 01:44:03,840 --> 01:44:05,280 SCIENTISTS AND CONTRACT 2232 01:44:05,280 --> 01:44:07,560 PERSONNEL AND RESPONSIBLE FOR 2233 01:44:07,560 --> 01:44:13,360 OVERSEEING THE PROCESS. 2234 01:44:13,360 --> 01:44:17,000 SHE HAS A Ph.D. PERFECT EMORY 2235 01:44:17,000 --> 01:44:19,840 AND AFTER TIME IN THE 2236 01:44:19,840 --> 01:44:21,200 PHARMACEUTICAL INDUSTRY SHE 2237 01:44:21,200 --> 01:44:23,480 BECAME A SCIENTIFIC REVIEW 2238 01:44:23,480 --> 01:44:27,480 OFFICER IN 2000 IN THE 2239 01:44:27,480 --> 01:44:28,520 BIOLOGICAL, CHEMISTRY AND 2240 01:44:28,520 --> 01:44:30,480 INTEGRATIVE REVIEW GROUP. 2241 01:44:30,480 --> 01:44:32,440 THEN SHE HELD VARIOUS POSITIONS 2242 01:44:32,440 --> 01:44:39,160 AT C.R.S INCLUDING THE DIRECTOR 2243 01:44:39,160 --> 01:44:41,720 OF THE DIVISION OF OVERSEEING 60 2244 01:44:41,720 --> 01:44:43,480 STUDY SECTIONS AND BECAME THE 2245 01:44:43,480 --> 01:44:49,880 DIRECTOR OF CSR IN 2019. 2246 01:44:49,880 --> 01:44:53,320 SHE HAS PROVIDED OUTSTANDING 2247 01:44:53,320 --> 01:44:56,400 LEADERSHIP AND OVERSIGHT OF THE 2248 01:44:56,400 --> 01:44:57,800 INITIATIVES AND UNDER HER 2249 01:44:57,800 --> 01:45:00,440 LEADERSHIP, CSR LAUNCHED A NEW 2250 01:45:00,440 --> 01:45:02,040 DATA-DRIVEN FRAMEWORK FOR THE 2251 01:45:02,040 --> 01:45:03,480 CONTINUOUS EVALUATION OF THE 2252 01:45:03,480 --> 01:45:06,040 MORE THAN 170 STUDY SECTIONS 2253 01:45:06,040 --> 01:45:08,800 USING QUANTITATIVE MEASURES AND 2254 01:45:08,800 --> 01:45:11,440 INPUT FROM STAKEHOLDERS FROM THE 2255 01:45:11,440 --> 01:45:12,000 SCIENTIFIC COMMUNITY. 2256 01:45:12,000 --> 01:45:14,200 I CAN SAY PERSONALLY, DR. BYRNES 2257 01:45:14,200 --> 01:45:15,600 IS ALWAYS SO WELL INFORMED AND 2258 01:45:15,600 --> 01:45:18,440 GIVES SUCH INSIGHTS TO ALL OF 2259 01:45:18,440 --> 01:45:20,280 NIH ABOUT THE REVIEW PROCESS. 2260 01:45:20,280 --> 01:45:22,600 SO WE'RE SO HAPPY SHE'S BEEN 2261 01:45:22,600 --> 01:45:26,640 ABLE TO COME HERE AND SPEAK TO 2262 01:45:26,640 --> 01:45:28,480 US ABOUT VARIOUS TOPICS 2263 01:45:28,480 --> 01:45:29,240 INCLUDING INITIATIVE TO 2264 01:45:29,240 --> 01:45:30,240 STRENGTHEN PEER REVIEW. 2265 01:45:30,240 --> 01:45:32,000 THANK YOU AND WELCOME. 2266 01:45:32,000 --> 01:45:36,200 >> THANK YOU VERY MUCH FOR THAT 2267 01:45:36,200 --> 01:45:37,320 REALLY KIND INTRODUCTION AND 2268 01:45:37,320 --> 01:45:38,160 DAVID AND MARTINA FOR THE 2269 01:45:38,160 --> 01:45:42,040 INSIGHT. 2270 01:45:42,040 --> 01:45:43,520 IT'S A PLEASURE TO COME HERE AND 2271 01:45:43,520 --> 01:45:45,320 TALK ABOUT WHAT WE'RE DOING AT 2272 01:45:45,320 --> 01:45:48,960 CSR TO STRENGTHEN PEER REVIEW. 2273 01:45:48,960 --> 01:45:51,600 LET'S START OFF WITH BACKGROUND 2274 01:45:51,600 --> 01:45:52,560 ON CSR. 2275 01:45:52,560 --> 01:45:55,400 SO CSR'S MISSION THE BROADER 2276 01:45:55,400 --> 01:45:58,520 MISSION IS TO HELP IDENTIFY THE 2277 01:45:58,520 --> 01:46:00,200 STRONGEST, HIGHEST IMPACT 2278 01:46:00,200 --> 01:46:02,200 SCIENCE FOR NIH FUNDING 2279 01:46:02,200 --> 01:46:02,520 INSTITUTES. 2280 01:46:02,520 --> 01:46:05,040 WE DO THAT THROUGH ENSURING THE 2281 01:46:05,040 --> 01:46:08,480 PROCESS OF PEER REVIEW IS FAIR, 2282 01:46:08,480 --> 01:46:10,280 INDEPENDENT, EXPERT, TIMELY AND 2283 01:46:10,280 --> 01:46:10,760 FREE FROM INAPPROPRIATE 2284 01:46:10,760 --> 01:46:17,160 INFLUENCES. 2285 01:46:17,160 --> 01:46:20,720 IN PHYSICAL 2023 -- IT'S A LARGE 2286 01:46:20,720 --> 01:46:23,680 OPERATION, SO IN FISCAL 2023, 2287 01:46:23,680 --> 01:46:24,960 CSR REVIEWED MORE THAN 60,000 2288 01:46:24,960 --> 01:46:25,960 APPLICATIONS MORE THAN 2289 01:46:25,960 --> 01:46:27,760 THREE-QUARTERS OF ALL THE 2290 01:46:27,760 --> 01:46:28,360 APPLICATIONS SUBMITTED TO THE 2291 01:46:28,360 --> 01:46:31,640 NIH. 2292 01:46:31,640 --> 01:46:40,720 A VAST MAJORITY OF THE RO1s ARE 2293 01:46:40,720 --> 01:46:43,560 REVIEWED WE HAVE A LARGE STAFF, 2294 01:46:43,560 --> 01:46:43,720 275. 2295 01:46:43,720 --> 01:46:46,240 EVERY YEAR WE ENGAGE WITH OVER 2296 01:46:46,240 --> 01:46:48,560 19,000 INDIVIDUAL PEER 2297 01:46:48,560 --> 01:46:58,760 REVIEWERS. 2298 01:47:05,840 --> 01:47:07,560 MORE EMPHASIS PANELS THAN 2299 01:47:07,560 --> 01:47:09,760 CHARTERED STUDY SECTIONS. 2300 01:47:09,760 --> 01:47:12,440 BECAUSE WE HANDLE A LARGE NUMBER 2301 01:47:12,440 --> 01:47:14,320 OF SPECIAL INITIATIVES AND 2302 01:47:14,320 --> 01:47:17,320 INVOLVE MORE THAN ONE INSTITUTE 2303 01:47:17,320 --> 01:47:21,280 OR CENTER. 2304 01:47:21,280 --> 01:47:23,040 LAST YEAR WAS 161 SPECIAL 2305 01:47:23,040 --> 01:47:27,360 INITIATIVES FOR CSR REVIEW. 2306 01:47:27,360 --> 01:47:30,480 SO SINCE 2019, WE'VE HAD THIS 2307 01:47:30,480 --> 01:47:32,760 SORT OF GROUNDING STRATEGIC 2308 01:47:32,760 --> 01:47:34,440 FRAMEWORK THAT WE BUILD ALL OF 2309 01:47:34,440 --> 01:47:35,200 OUR ACTIVITIES ON. 2310 01:47:35,200 --> 01:47:40,800 AND ALL OF IT IS BASED ON THE 2311 01:47:40,800 --> 01:47:42,840 OUTCOMES OF PEER REVIEW AND 2312 01:47:42,840 --> 01:47:44,640 OPTIMIZING THE QUALITY OF PEER 2313 01:47:44,640 --> 01:47:44,880 REVIEW. 2314 01:47:44,880 --> 01:47:46,800 AND IT'S IN THREE DOMAINS. 2315 01:47:46,800 --> 01:47:49,280 ONE IS ON THE TOP RIGHT THE 2316 01:47:49,280 --> 01:47:49,920 STUDY SECTION. 2317 01:47:49,920 --> 01:47:52,280 SO THE SCOPE OF THE STUDY 2318 01:47:52,280 --> 01:47:53,640 SECTION VERY MUCH DEFINES THE 2319 01:47:53,640 --> 01:47:54,640 OUTPUT OF PEER REVIEW. 2320 01:47:54,640 --> 01:47:57,960 YOU CAN HAVE A STUDY SECTION 2321 01:47:57,960 --> 01:47:59,240 REVIEWING SCIENCE FIELD THAT IS 2322 01:47:59,240 --> 01:48:00,760 DYING AND 10% OF THAT IS GOING 2323 01:48:00,760 --> 01:48:04,960 TO GET GOOD SCORES. 2324 01:48:04,960 --> 01:48:07,200 SIMILARLY YOU CAN HAVE HIGH 2325 01:48:07,200 --> 01:48:09,040 IMPACT SCIENCE BEING REVIEWED IN 2326 01:48:09,040 --> 01:48:10,240 ONE STUDY SECTION COMPETING WITH 2327 01:48:10,240 --> 01:48:11,080 EACH OTHER. 2328 01:48:11,080 --> 01:48:13,680 I THINK THE RELEVANCE TO THE 2329 01:48:13,680 --> 01:48:16,640 EMERGING AREAS AND ENSURING OUR 2330 01:48:16,640 --> 01:48:18,440 STUDY SECTION MAPS ON TO THE 2331 01:48:18,440 --> 01:48:20,920 CURRENT STATE OF THE SCIENCE IS 2332 01:48:20,920 --> 01:48:22,160 VERY MUCH RELEVANT TO THE 2333 01:48:22,160 --> 01:48:24,080 QUALITY OF REVIEW. 2334 01:48:24,080 --> 01:48:25,280 ALSO THE SIZE IS APPROPRIATE FOR 2335 01:48:25,280 --> 01:48:26,960 COMPETITION. 2336 01:48:26,960 --> 01:48:29,720 BUT EVEN IF THE STUDY SECTIONS 2337 01:48:29,720 --> 01:48:31,600 ARE WELL STRUCTURED AND ADAPTED 2338 01:48:31,600 --> 01:48:34,320 TO EMERGING AREAS, THE QUALITY 2339 01:48:34,320 --> 01:48:35,840 AND SELECTION OF REVIEWERS AS 2340 01:48:35,840 --> 01:48:38,960 YOU ALL KNOW WOULD HAVE A 2341 01:48:38,960 --> 01:48:41,280 TREMENDOUS YIMENT PACT ON THE 2342 01:48:41,280 --> 01:48:42,480 OUTPUT. 2343 01:48:42,480 --> 01:48:45,680 THAT'S THE -- IMPACT ON THE 2344 01:48:45,680 --> 01:48:47,200 OUTPUT AND YOU'RE LOOKING AT 2345 01:48:47,200 --> 01:48:49,600 DIVERSITY AND BREADTH AND OTHER 2346 01:48:49,600 --> 01:48:50,440 FACTORS IN THERE. 2347 01:48:50,440 --> 01:48:52,440 AND THEN IF YOU HAVE GREAT 2348 01:48:52,440 --> 01:48:54,240 REVIEWERS AND A WONDERFUL STUDY 2349 01:48:54,240 --> 01:48:57,920 SECTION STRUCTURE, MORE ASPECTS 2350 01:48:57,920 --> 01:48:59,680 OF THE PROCESS THAT CAN IMPACT 2351 01:48:59,680 --> 01:49:01,920 THE OUTPUT AND THAT IS WHETHER 2352 01:49:01,920 --> 01:49:03,920 THE PROCESS IS CONFIDENTIAL. 2353 01:49:03,920 --> 01:49:05,240 THAT'S WHAT WE NEED FOR CANDID 2354 01:49:05,240 --> 01:49:05,520 DISCUSSION. 2355 01:49:05,520 --> 01:49:08,080 WHETHER IT'S GETTING AN UNFAIR 2356 01:49:08,080 --> 01:49:11,160 INFLUENCE FROM SOMEONE WHO IS 2357 01:49:11,160 --> 01:49:13,080 INTERFERING IN THE PROCESS 2358 01:49:13,080 --> 01:49:13,960 INAPPROPRIATELY AND THAT AFFECTS 2359 01:49:13,960 --> 01:49:15,040 OUR APPLICATION AND THE OTHERS 2360 01:49:15,040 --> 01:49:17,320 AND THE WAY THE RANKING WORKS IN 2361 01:49:17,320 --> 01:49:17,960 STUDY SECTIONS. 2362 01:49:17,960 --> 01:49:23,680 FAIRNESS AND BIAS MITIGATION, 2363 01:49:23,680 --> 01:49:24,960 HOW STUDY SECTIONS RECEIVE 2364 01:49:24,960 --> 01:49:27,240 APPLICATIONS AND HOW SCIENCE IS 2365 01:49:27,240 --> 01:49:28,560 ASSIGNED AND REVIEW CRITERIA AND 2366 01:49:28,560 --> 01:49:31,640 SCORING SYSTEM. 2367 01:49:31,640 --> 01:49:34,840 SO THESE ARE THE THREE DOMAINS 2368 01:49:34,840 --> 01:49:38,200 AND WE DO THIS ON A FOUNDATION 2369 01:49:38,200 --> 01:49:40,160 OF THESE PRINCIPLES STATED BELOW 2370 01:49:40,160 --> 01:49:42,440 AS A PUBLIC AGENCY WE MUST BE 2371 01:49:42,440 --> 01:49:43,960 TRANSPARENT AND PROMOTE 2372 01:49:43,960 --> 01:49:47,440 TRANSPARENCY IN ALL THESE DOUMAN 2373 01:49:47,440 --> 01:49:52,600 DOMAINS AND APPLYING DATA TO THE 2374 01:49:52,600 --> 01:49:53,680 DECISION MAKE. 2375 01:49:53,680 --> 01:49:57,560 WE HAVE EXTERNAL ENGAGEMENT IN 2376 01:49:57,560 --> 01:49:58,360 OUR INITIATIVE. 2377 01:49:58,360 --> 01:50:00,520 OUR COUNCIL VERY ACTIVE AND 2378 01:50:00,520 --> 01:50:02,120 WORKING GROUPS AND THEY ADVISE 2379 01:50:02,120 --> 01:50:02,800 US AND A LOT OF THEIR 2380 01:50:02,800 --> 01:50:04,320 INITIATIVES HAVE MOVED FORWARD. 2381 01:50:04,320 --> 01:50:08,800 NOTHING CAN BE DONE WITHOUT OUR 2382 01:50:08,800 --> 01:50:10,680 STAFF AND WE'VE INVESTED A LOT 2383 01:50:10,680 --> 01:50:12,920 OF IN TRAINING AND DEVELOPING 2384 01:50:12,920 --> 01:50:15,640 OUR STAFF THAT ARE CENTRAL TO 2385 01:50:15,640 --> 01:50:17,160 EVERYTHING WE DO. 2386 01:50:17,160 --> 01:50:18,920 TODAY'S TOPICS, YOU'RE WELCOME 2387 01:50:18,920 --> 01:50:21,320 TO EXPLORE OUR WEBSITE AND I'LL 2388 01:50:21,320 --> 01:50:22,960 TOUCH UPON INQUIRE OUR STUDY 2389 01:50:22,960 --> 01:50:28,920 SECTION RESTRUCTURING PROCESS. 2390 01:50:28,920 --> 01:50:30,160 TWO ONGOING INITIATIVES YOU'LL 2391 01:50:30,160 --> 01:50:32,200 SEE COME OUT SOON, ONE IS 2392 01:50:32,200 --> 01:50:33,440 SIMPLIFYING THE REVIEW OF 2393 01:50:33,440 --> 01:50:35,240 RESEARCH PROJECT GRANTS AND THE 2394 01:50:35,240 --> 01:50:39,600 OTHER IS IMPROVING THE REVIEW OF 2395 01:50:39,600 --> 01:50:41,080 NRSA FELLOWSHIP. 2396 01:50:41,080 --> 01:50:43,960 AND IN SOME ASPECTS TO PROMOTING 2397 01:50:43,960 --> 01:50:45,320 FAIRNESS AND DIVERSIFYING OUR 2398 01:50:45,320 --> 01:50:49,600 COMMITTEES. 2399 01:50:49,600 --> 01:51:00,160 LET'S START WITH IN -- ENQUIRE. 2400 01:51:04,640 --> 01:51:07,680 IT WAS LAUNCH IN 2019 AND IS A 2401 01:51:07,680 --> 01:51:09,680 SYSTEMATIC DATA-DRIVEN 2402 01:51:09,680 --> 01:51:11,680 CONTINUOUS PROCESS THAT LOOKS AT 2403 01:51:11,680 --> 01:51:13,400 STUDY SECTIONS AND SEES HOW WELL 2404 01:51:13,400 --> 01:51:14,560 THEY MAP ON TO THE CURRENT STATE 2405 01:51:14,560 --> 01:51:15,720 OF THE SCIENCE. 2406 01:51:15,720 --> 01:51:21,520 THE GOAL WAS AND MET ALMOST 200 2407 01:51:21,520 --> 01:51:23,560 STUDY SECTIONS EACH YEAR AND 2408 01:51:23,560 --> 01:51:24,600 THAT PUTS THE STUDY SECTIONS ON 2409 01:51:24,600 --> 01:51:26,840 A FIVE-YEAR CYCLE. 2410 01:51:26,840 --> 01:51:28,800 SO IT ALLOWS STUDY SECTIONS TO 2411 01:51:28,800 --> 01:51:29,400 GET ANOTHER LOOK EVERY FIVE 2412 01:51:29,400 --> 01:51:32,680 YEARS. 2413 01:51:32,680 --> 01:51:35,040 IT'S A VERY THOROUGH PROCESS. 2414 01:51:35,040 --> 01:51:37,640 THE FIRST STAGE INVOLVED 2415 01:51:37,640 --> 01:51:39,720 SCIENTIFIC EVALUATION AND THAT 2416 01:51:39,720 --> 01:51:40,640 INVOLVES THE SCIENTIFIC 2417 01:51:40,640 --> 01:51:44,280 COMMUNITY AND BRING IN EXPERTS 2418 01:51:44,280 --> 01:51:46,080 IN THE AREAS OF CLUSTERS OF 2419 01:51:46,080 --> 01:51:47,240 STUDY SECTIONS AND SHOW EXAMPLES 2420 01:51:47,240 --> 01:51:47,960 OF THE CLUSTERS. 2421 01:51:47,960 --> 01:51:53,040 WE'RE NOT LOOKING FOR PEOPLE WHO 2422 01:51:53,040 --> 01:51:54,640 ARE VESTED IN THE EXISTENCE OF A 2423 01:51:54,640 --> 01:51:57,360 SINGLE STUDY SECTION THEN WE GET 2424 01:51:57,360 --> 01:51:57,600 EFFICACY. 2425 01:51:57,600 --> 01:51:59,280 WE'RE LOOKING AT PEOPLE WHO CAN 2426 01:51:59,280 --> 01:52:04,280 LOOK BROADER AND TALK TO US 2427 01:52:04,280 --> 01:52:09,960 ABOUT EMERGING AREAS AND IT'S 2428 01:52:09,960 --> 01:52:11,640 WORKING WELL THEY IDENTIFY 2429 01:52:11,640 --> 01:52:13,240 EMERGING AND DECLINING AREAS. 2430 01:52:13,240 --> 01:52:15,080 THEY CAN MERGE STUDY SECTIONS, 2431 01:52:15,080 --> 01:52:16,680 ELIMINATE STUDY SECTIONS AND CAN 2432 01:52:16,680 --> 01:52:18,360 CREATE STUDY SECTIONS. 2433 01:52:18,360 --> 01:52:19,600 WE GIVE THEM A LOT OF DATA. 2434 01:52:19,600 --> 01:52:20,880 THIS IS JUST SOME OF IT. 2435 01:52:20,880 --> 01:52:22,600 WE LOOK AT PUBLICATIONS THAT 2436 01:52:22,600 --> 01:52:26,400 CAME OUT FROM PREVIOUSLY FUNDED 2437 01:52:26,400 --> 01:52:28,120 APPLICATIONS, HOW ESI, EARLY 2438 01:52:28,120 --> 01:52:28,760 STAGE INVESTIGATORS ARE DOING, 2439 01:52:28,760 --> 01:52:38,960 ETCETERA. 2440 01:52:41,440 --> 01:52:44,440 THEN THEY GO TO PROCESS 2441 01:52:44,440 --> 01:52:45,520 EVALUATION AND WHETHER WE'RE 2442 01:52:45,520 --> 01:52:47,600 CHOOSING THE RIGHT REVIEWERS AND 2443 01:52:47,600 --> 01:52:51,480 THE SCORE DISTRIBUTIONS, 2444 01:52:51,480 --> 01:52:52,880 EXPERTISE, ALSO THE MEETING 2445 01:52:52,880 --> 01:52:55,040 DYNAMICS AND THIS EVALUATION WE 2446 01:52:55,040 --> 01:52:56,400 HAVE AN NIH PROCESS PANEL. 2447 01:52:56,400 --> 01:52:59,400 IT'S NOT CSR. 2448 01:52:59,400 --> 01:53:01,280 IT INVOLVES MEMBERS OF NIH 2449 01:53:01,280 --> 01:53:02,560 INSTITUTES NOT SINGLE PROGRAM 2450 01:53:02,560 --> 01:53:04,520 OFFICERS WHO MAY HAVE A VESTED 2451 01:53:04,520 --> 01:53:06,000 INTERESTED IN ONE STUDY SECTION 2452 01:53:06,000 --> 01:53:07,000 BUT FOR A LEVEL HIGHER AND 2453 01:53:07,000 --> 01:53:11,400 BRANCH CHIEF. 2454 01:53:11,400 --> 01:53:13,000 THEY GET THE RESULTS OF INPUT 2455 01:53:13,000 --> 01:53:15,960 AND SCORE DISTRIBUTIONS AND 2456 01:53:15,960 --> 01:53:16,720 ROSTER EXPERTISE AND WE HAVE 2457 01:53:16,720 --> 01:53:18,360 SITE VISITS TO STUDY SECTIONS. 2458 01:53:18,360 --> 01:53:19,880 A LOT HAPPENS AT THE MEETING AND 2459 01:53:19,880 --> 01:53:21,440 THE MEETING DYNAMIC AND 2460 01:53:21,440 --> 01:53:24,240 INFLUENCE OUTCOME. 2461 01:53:24,240 --> 01:53:26,080 THOSE REPORTS FEEDBACK OR 2462 01:53:26,080 --> 01:53:28,640 SURVEYED RESULTS FROM INDIVIDUAL 2463 01:53:28,640 --> 01:53:30,320 PROGRAM OFFICERS FOR THE STUDY 2464 01:53:30,320 --> 01:53:31,720 SECTION GOES BACK TO THE SECOND 2465 01:53:31,720 --> 01:53:32,720 PANEL EVALUATION. 2466 01:53:32,720 --> 01:53:33,320 THEN THERE'S A REPORT OF 2467 01:53:33,320 --> 01:53:37,040 RECOMMENDATIONS THERE. 2468 01:53:37,040 --> 01:53:37,720 THAT GOES TO OUR ADVISORY 2469 01:53:37,720 --> 01:53:40,480 COUNCIL FOR APPROVAL. 2470 01:53:40,480 --> 01:53:43,640 THE ENTIRE PROCESS IS OVERSEEN 2471 01:53:43,640 --> 01:53:45,320 BY OUR SCIENTIFIC DIVISION 2472 01:53:45,320 --> 01:53:48,000 DIRECTORS. 2473 01:53:48,000 --> 01:53:50,480 SO AFTER ADVISORY COUNCIL 2474 01:53:50,480 --> 01:53:51,040 APPROVAL THERE'S ACTUALLY 2475 01:53:51,040 --> 01:53:52,440 SEVERAL STEPS THAT NEED TO TAKE 2476 01:53:52,440 --> 01:53:53,680 PLACE BEFORE WE CAN HOLD STUDY 2477 01:53:53,680 --> 01:53:55,880 SECTION MEETINGS OF THE NEW 2478 01:53:55,880 --> 01:53:57,880 STUDY SECTIONS AND THAT IS A LOT 2479 01:53:57,880 --> 01:54:00,120 OF REFINEMENT OF THE GUIDELINE, 2480 01:54:00,120 --> 01:54:01,440 DEVELOPMENT OF HOW SCIENTIFIC 2481 01:54:01,440 --> 01:54:03,880 OVERLAP WORKS BETWEEN STUDY 2482 01:54:03,880 --> 01:54:05,240 SECTIONS AND MOVING EXISTING 2483 01:54:05,240 --> 01:54:08,080 STUDY SECTION MEMBERS TO NEW 2484 01:54:08,080 --> 01:54:11,400 PANELS BASED ON WHERE THEIR 2485 01:54:11,400 --> 01:54:13,200 EXPERTISE IS NEEDED. 2486 01:54:13,200 --> 01:54:16,040 THE ENTIRE THING TAKES 12 TO 18 2487 01:54:16,040 --> 01:54:17,880 MONTHS TO FIRST PANEL MEETING TO 2488 01:54:17,880 --> 01:54:19,880 WHERE THE RESTUDY SECTIONS HAVE 2489 01:54:19,880 --> 01:54:21,120 THEIR FIRST MEETINGS. 2490 01:54:21,120 --> 01:54:22,960 THUS FAR WE'VE DONE 13 2491 01:54:22,960 --> 01:54:24,680 SCIENTIFIC CLUSTERS. 2492 01:54:24,680 --> 01:54:30,200 THEY HAVE 8 TO 15 OR 16 STUDY 2493 01:54:30,200 --> 01:54:31,560 SECTIONS PER STUDY CLUSTER. 2494 01:54:31,560 --> 01:54:34,960 THESE ARE THE AREAS OF SCIENCE 2495 01:54:34,960 --> 01:54:36,520 THAT HAVE BEEN OR ARE IN THE 2496 01:54:36,520 --> 01:54:36,840 PROCESS. 2497 01:54:36,840 --> 01:54:41,320 THE ONES SHADED ARE THE ONES 2498 01:54:41,320 --> 01:54:42,880 THAT ARE STILL IN PROCESS. 2499 01:54:42,880 --> 01:54:44,880 WE FOUND BECAUSE WE GIVE A FAIR 2500 01:54:44,880 --> 01:54:47,760 AMOUNT OF FREEDOM TO THE 2501 01:54:47,760 --> 01:54:50,800 EXTERNAL COMMITTEES, IT'S 2502 01:54:50,800 --> 01:54:53,080 ACTUALLY THE INQUIRY HAS 2503 01:54:53,080 --> 01:54:54,520 RESULTED IN SUBSTANTIVE CHANGES 2504 01:54:54,520 --> 01:55:00,520 TO STUDY SECTIONS. 2505 01:55:00,520 --> 01:55:02,640 THE ELIMINATION OF SMALLER 2506 01:55:02,640 --> 01:55:04,960 BOUTIQUE PANELS AND FORMING 2507 01:55:04,960 --> 01:55:09,080 STUDY SECTIONS IN AREAS. 2508 01:55:09,080 --> 01:55:10,120 LATE STAGE PRECLINIC DRUG 2509 01:55:10,120 --> 01:55:11,520 DISCOVERY WAS SEEN AS A GAP AREA 2510 01:55:11,520 --> 01:55:15,760 AND WE FORMED THIS BASED ON 2511 01:55:15,760 --> 01:55:15,960 INQUIRE. 2512 01:55:15,960 --> 01:55:16,560 THERE WAS A REAL NEED IN THE 2513 01:55:16,560 --> 01:55:26,760 COMMUNITY. 2514 01:56:15,600 --> 01:56:26,080 THE MAIN GOAL OF THE FIRST LEVEL 2515 01:56:33,800 --> 01:56:35,080 WE BRING EXPERTS IN AND WANT 2516 01:56:35,080 --> 01:56:36,520 THEM TO TELL US THE RELATIVE 2517 01:56:36,520 --> 01:56:41,480 MERIT AND IMPACT. 2518 01:56:41,480 --> 01:56:48,520 OVER THE YEARS A LOT OF AND 2519 01:56:48,520 --> 01:56:49,840 THERE'S REVIEWERS AND STAFF AND 2520 01:56:49,840 --> 01:56:51,560 ONE OF THE MAIN GOALS IN THE 2521 01:56:51,560 --> 01:56:53,320 BEGIN WAS TO REFOCUS PEER REVIEW 2522 01:56:53,320 --> 01:57:03,800 ON THE SCIENTIFIC EVALUATION. 2523 01:57:06,400 --> 01:57:09,000 AND THEY THE REPUTATIONAL BIAS 2524 01:57:09,000 --> 01:57:14,360 PLAYS A BIG ROLE AND PEER REVIEW 2525 01:57:14,360 --> 01:57:15,920 IS A MICROCOSM OF THE COMMUNITY. 2526 01:57:15,920 --> 01:57:21,120 WE GET PEOPLE FROM THE 2527 01:57:21,120 --> 01:57:31,320 COMMUNITY. 2528 01:57:35,160 --> 01:57:36,600 HARVARD GETS A SCORE OF ONE FOR 2529 01:57:36,600 --> 01:57:37,480 THE ENVIRONMENT AND ANOTHER MAY 2530 01:57:37,480 --> 01:57:38,800 GET A SCORE OF THREE. 2531 01:57:38,800 --> 01:57:39,200 THAT'S STILL OKAY. 2532 01:57:39,200 --> 01:57:44,440 IT'S NOT A ONE. 2533 01:57:44,440 --> 01:57:46,720 THE GOAL WAS SO REFOCUS THE 2534 01:57:46,720 --> 01:57:48,520 EVALUATION OF PLACE WHERE'S 2535 01:57:48,520 --> 01:57:55,400 REPUTATIONAL BIAS COMES IN 2536 01:57:55,400 --> 01:57:56,080 BECAUSE WE'RE ASKING THE EXPERTS 2537 01:57:56,080 --> 01:58:01,720 TO EVALUATE THE PROJECT. 2538 01:58:01,720 --> 01:58:05,320 AND IDENTIFIES THE STRONGEST 2539 01:58:05,320 --> 01:58:09,160 SCIENCE. 2540 01:58:09,160 --> 01:58:13,120 WE'VE HAD A LONG CAREFUL PROCESS 2541 01:58:13,120 --> 01:58:15,400 WE CONVENED TWO CSR COUNCIL 2542 01:58:15,400 --> 01:58:17,440 WORKING GROUPS THAT LOOKED AT 2543 01:58:17,440 --> 01:58:20,400 NON-CLINICAL TRIALS WHICH IS A 2544 01:58:20,400 --> 01:58:24,520 VAST MAJORITY OF NIH 2545 01:58:24,520 --> 01:58:26,160 APPLICATIONS AND CLINICAL TRIALS 2546 01:58:26,160 --> 01:58:27,840 AND THE CODE OF REGULATIONS 2547 01:58:27,840 --> 01:58:29,160 REQUIRES WE MUST USE THE FIVE 2548 01:58:29,160 --> 01:58:32,800 REVIEW CRITERIA THAT EXISTS NOW, 2549 01:58:32,800 --> 01:58:35,400 SIGNIFICANCE, INVESTIGATORS, 2550 01:58:35,400 --> 01:58:36,000 INNOVATION, APPROACH AND 2551 01:58:36,000 --> 01:58:36,560 VARIETY. 2552 01:58:36,560 --> 01:58:37,920 BUT THERE ARE NO RULES ABOUT HOW 2553 01:58:37,920 --> 01:58:39,440 TO GROUP THEM AND HOW TO 2554 01:58:39,440 --> 01:58:41,560 INTERPRET THEM AND SCORE THEM. 2555 01:58:41,560 --> 01:58:43,320 THEY KNEW WHAT THEY HAD TO DO 2556 01:58:43,320 --> 01:58:50,720 AND WHAT FLEXIBILITY THEY HAD. 2557 01:58:50,720 --> 01:58:52,280 AND WITH THE PANDEMIC HITTING IN 2558 01:58:52,280 --> 01:58:56,080 THE MIDDLE AND THERE WAS INPUT 2559 01:58:56,080 --> 01:58:57,560 GATHERING THROUGH BLOG POSTS 2560 01:58:57,560 --> 01:59:01,280 WITH THE OER AND OPEN MIC REVIEW 2561 01:59:01,280 --> 01:59:03,640 MATTERS WHICH IS A CSR BLOG AND 2562 01:59:03,640 --> 01:59:06,320 CONTENT ANALYSES ON THE COMMENTS 2563 01:59:06,320 --> 01:59:08,560 RECEIVED AND PROVIDE HAD TO THE 2564 01:59:08,560 --> 01:59:11,160 WORKING GROUP WHICH HELD A 2565 01:59:11,160 --> 01:59:12,320 VIRTUAL MEETING DURING THE 14 2566 01:59:12,320 --> 01:59:13,200 MONTH PERIOD AND MADE A 2567 01:59:13,200 --> 01:59:14,480 RECOMMENDATION THAT WAS THEN 2568 01:59:14,480 --> 01:59:17,320 APPROVED BY THE FULL ADVISORY 2569 01:59:17,320 --> 01:59:18,960 COUNCIL PUBLISHED THE REPORT AND 2570 01:59:18,960 --> 01:59:22,480 THEN WENT INTERNAL TO NIH WHERE 2571 01:59:22,480 --> 01:59:24,160 A HIGHER LEVEL OF NIH POLICY 2572 01:59:24,160 --> 01:59:25,200 GROUP WORKED ON THE 2573 01:59:25,200 --> 01:59:26,560 RECOMMENDATIONS, MODIFIED SOME 2574 01:59:26,560 --> 01:59:31,480 OF THEM AND THEN THAT GOT 2575 01:59:31,480 --> 01:59:33,280 APPRO 2576 01:59:33,280 --> 01:59:34,520 APPRO 2577 01:59:34,520 --> 01:59:36,960 APPROVAL AT NICHD DIRECTORS AND 2578 01:59:36,960 --> 01:59:37,320 LEADERSHIP. 2579 01:59:37,320 --> 01:59:39,760 AFTER WE HAD A MORE FORMED OF 2580 01:59:39,760 --> 01:59:40,800 CRITERIA WE PUT OUT A REQUEST 2581 01:59:40,800 --> 01:59:51,480 FOR INFORMATION FROM THE PUBLIC. 2582 01:59:51,480 --> 01:59:52,800 THEY'RE GROUPED INTO THREE 2583 01:59:52,800 --> 01:59:53,080 FACTORS. 2584 01:59:53,080 --> 01:59:55,640 ONE IS THE FIRST ONE IS 2585 01:59:55,640 --> 01:59:58,240 IMPORTANCE OF THE RESEARCH WHICH 2586 01:59:58,240 --> 02:00:00,480 INCLUDES SIGNIFICANCE AND 2587 02:00:00,480 --> 02:00:03,880 INNOVATION WHICH IS KIND OF 2588 02:00:03,880 --> 02:00:04,480 PROBLEMATIC BECAUSE WE HEARD 2589 02:00:04,480 --> 02:00:06,240 FROM REVIEWERS AND THE COMMUNITY 2590 02:00:06,240 --> 02:00:09,280 THEY DON'T KNOW HOW TO INTERPRET 2591 02:00:09,280 --> 02:00:09,600 INNOVATION. 2592 02:00:09,600 --> 02:00:12,120 TECHNICAL AND CONCEPTUAL, DOES 2593 02:00:12,120 --> 02:00:14,960 EVERYTHING HAVE TO BE 2594 02:00:14,960 --> 02:00:15,520 INNOVATIVE? 2595 02:00:15,520 --> 02:00:16,960 NO, SOME THINGS CAN BE AN 2596 02:00:16,960 --> 02:00:18,440 OUTREACH THAT'S IMPORTANT TO A 2597 02:00:18,440 --> 02:00:21,880 COMMUNITY BUT IT'S NOT INHER 2598 02:00:21,880 --> 02:00:22,960 INHEREINHER 2599 02:00:22,960 --> 02:00:25,320 INHERENTLY INNOVATIVELY AND 2600 02:00:25,320 --> 02:00:27,400 ALLOWS THEM TO WEIGHT WHAT IS 2601 02:00:27,400 --> 02:00:28,600 MOST IMPORTANT FOR THE SCIENCE 2602 02:00:28,600 --> 02:00:29,400 BEING PROPOSED. 2603 02:00:29,400 --> 02:00:31,440 FACTOR ONE IS INDIVIDUALLY 2604 02:00:31,440 --> 02:00:32,720 SCORED ONE TO NINE. 2605 02:00:32,720 --> 02:00:35,960 FACTOR TWO, IS RIGOR AND 2606 02:00:35,960 --> 02:00:36,280 FEASIBILITY. 2607 02:00:36,280 --> 02:00:37,960 THAT INCLUDES APPROACH. 2608 02:00:37,960 --> 02:00:39,440 FACTOR THREE WAS NAMED EXPERTISE 2609 02:00:39,440 --> 02:00:42,120 AND RESOURCES AND UNDER THAT 2610 02:00:42,120 --> 02:00:50,000 INVESTIGATORS AND ENVIRONMENT. 2611 02:00:50,000 --> 02:00:52,840 WE HAVE TO ASSESS WHETHER THE 2612 02:00:52,840 --> 02:00:53,600 INVESTIGATOR HAS THE EXPERTISE 2613 02:00:53,600 --> 02:00:55,840 OR WHETHER THE RESOURCES EXIST 2614 02:00:55,840 --> 02:00:57,320 TO COMPLETE THE PROJECT. 2615 02:00:57,320 --> 02:00:58,920 WE'RE NOT ASKING FOR PERSONAL 2616 02:00:58,920 --> 02:00:59,800 OPINIONS HOW GREAT THE 2617 02:00:59,800 --> 02:01:00,640 INVESTIGATOR IS OR HOW WONDERFUL 2618 02:01:00,640 --> 02:01:01,360 THE UNIVERSITY IS. 2619 02:01:01,360 --> 02:01:03,800 THAT WAS NEVER THE INTENT. 2620 02:01:03,800 --> 02:01:06,360 THIS CLARIFIES THAT. 2621 02:01:06,360 --> 02:01:08,720 THE OTHER THING WE'VE DONE IS 2622 02:01:08,720 --> 02:01:12,520 TAKE ENAWAY THE SCORES OF ONE TO 2623 02:01:12,520 --> 02:01:14,760 NINE. 2624 02:01:14,760 --> 02:01:17,200 AND THERE'S A HIGHER POSSIBILITY 2625 02:01:17,200 --> 02:01:23,960 OF BIAS CREEPING IN AS HAS BEEN 2626 02:01:23,960 --> 02:01:24,640 THE EXAMPLE BEFORE. 2627 02:01:24,640 --> 02:01:27,960 THE PROPOSAL WAS TO HAVE A 2628 02:01:27,960 --> 02:01:33,040 BINARY CHOICE EITHER IT'S FINE, 2629 02:01:33,040 --> 02:01:34,720 THAT'S EXPERTISE OR THERE'S A 2630 02:01:34,720 --> 02:01:36,400 GAP AND SELECT GAPS IDENTIFIED 2631 02:01:36,400 --> 02:01:46,920 AND MUST WRITE WHAT THE GAP IS. 2632 02:02:18,240 --> 02:02:19,560 ADDITIONALLY CONSIDERATIONS WERE 2633 02:02:19,560 --> 02:02:21,160 MOSTLY ADMINISTRATIVE. 2634 02:02:21,160 --> 02:02:23,120 THEY NEVER DID ANY BEARING ON 2635 02:02:23,120 --> 02:02:24,600 THE IMPACT SCORE AND THOSE HAVE 2636 02:02:24,600 --> 02:02:27,040 BEEN REMOVED FROM FIRST-LEVEL 2637 02:02:27,040 --> 02:02:27,320 PEER REVIEW. 2638 02:02:27,320 --> 02:02:30,040 THIS IS THE OVERVIEW OF THE 2639 02:02:30,040 --> 02:02:30,560 CHANGES. 2640 02:02:30,560 --> 02:02:32,560 AGAIN, FACTOR ONE SCORED, FACTOR 2641 02:02:32,560 --> 02:02:35,240 TWO, SCORED AND WE HAVE 2642 02:02:35,240 --> 02:02:37,400 INCORPORATED -- WE'VE TAKEN THE 2643 02:02:37,400 --> 02:02:39,080 INCLUSION OF WOMEN, MINORITIES 2644 02:02:39,080 --> 02:02:41,080 AND CHILDREN FOR HUMAN SUBJECTS 2645 02:02:41,080 --> 02:02:44,680 IN CLINICAL TRIALS AND 2646 02:02:44,680 --> 02:02:46,360 INCORPORATE HAD TO RIGOR AND 2647 02:02:46,360 --> 02:02:48,360 FEASIBILITY A STUDY NOT 2648 02:02:48,360 --> 02:02:49,080 INCLUSIVE OF THE BROADER 2649 02:02:49,080 --> 02:02:53,280 POPULATION IS NOT RIGOROUS AND 2650 02:02:53,280 --> 02:02:53,680 SHOULD COUNT. 2651 02:02:53,680 --> 02:02:54,800 INDIVIDUAL CRITERIA ARE NOT 2652 02:02:54,800 --> 02:02:56,240 SCORED BUT THEY COUNT FOR OVER 2653 02:02:56,240 --> 02:02:58,120 ALL IMPACT AND THE WAY REVIEWERS 2654 02:02:58,120 --> 02:02:59,440 THINK, ONCE THEY'RE DONE ONE THE 2655 02:02:59,440 --> 02:03:01,120 MAIN CRITERIA THE REST LOOKS 2656 02:03:01,120 --> 02:03:03,560 LIKE IT'S SORT OF ADDITIONAL. 2657 02:03:03,560 --> 02:03:05,320 SO IT WAS IMPORTANT TO MOVE 2658 02:03:05,320 --> 02:03:06,840 INCLUSIONS TO THE MAIN REVIEW 2659 02:03:06,840 --> 02:03:08,600 CRITERIA TO HAVE THEM THINKING 2660 02:03:08,600 --> 02:03:09,320 ABOUT IT WHEN ASSESSING FACTOR 2661 02:03:09,320 --> 02:03:15,280 TWO. 2662 02:03:15,280 --> 02:03:18,720 AND IN MARP WE HAD A LOT OF 2663 02:03:18,720 --> 02:03:20,240 RESPONSES. 2664 02:03:20,240 --> 02:03:22,480 A VAST MAJORITY WERE SUPPORTIVE. 2665 02:03:22,480 --> 02:03:24,520 THE REPORT WAS PUBLISHED. 2666 02:03:24,520 --> 02:03:26,600 IT'S NOT SURPRISING BECAUSE AS I 2667 02:03:26,600 --> 02:03:27,680 SHOWED YOU WE GOT A LOT OF 2668 02:03:27,680 --> 02:03:29,520 PUBLIC INPUT ON THE FRONT END 2669 02:03:29,520 --> 02:03:33,360 AND COUNCIL IS VERY INVOLVED IN 2670 02:03:33,360 --> 02:03:34,320 CREATING THIS. 2671 02:03:34,320 --> 02:03:34,880 MINORITY FACTOR 3 SHOULD BE 2672 02:03:34,880 --> 02:03:37,080 SCORED. 2673 02:03:37,080 --> 02:03:38,320 MOST RECOMMENDED AND WE 2674 02:03:38,320 --> 02:03:40,080 COMPLETELY AGREE WE NEED TO MAKE 2675 02:03:40,080 --> 02:03:41,160 SURE WE SOCIALIZE THE CHANGE 2676 02:03:41,160 --> 02:03:42,960 WELL FOR REVIEWERS AND FOR 2677 02:03:42,960 --> 02:03:45,680 CHAIRS AND FOR SROs BY 2678 02:03:45,680 --> 02:03:48,560 DEVELOPING STRONG TRAINING 2679 02:03:48,560 --> 02:03:49,920 RESOURCES. 2680 02:03:49,920 --> 02:03:51,800 CSR HAS INVESTED A LOT IN 2681 02:03:51,800 --> 02:03:53,040 TRAINING AND DEVELOPMENT OF 2682 02:03:53,040 --> 02:03:53,600 REVIEWERS AND STAFF. 2683 02:03:53,600 --> 02:03:56,680 WE HAVE A NEW OFFICE THAT HAS A 2684 02:03:56,680 --> 02:03:58,240 LOT OF EXPERTISE THERE. 2685 02:03:58,240 --> 02:03:59,080 THEY'RE INVOLVED IN THE TRANS 2686 02:03:59,080 --> 02:04:01,000 NIH IMPLEMENTATION COMMITTEE FOR 2687 02:04:01,000 --> 02:04:03,240 THE NEW REVIEW CRITERIA WITH 2688 02:04:03,240 --> 02:04:04,680 DOMAIN EXPERTISE IN DIFFERENT 2689 02:04:04,680 --> 02:04:05,440 AREAS OF POLICY AND SYSTEMS AND 2690 02:04:05,440 --> 02:04:07,840 TRAINING. 2691 02:04:07,840 --> 02:04:09,320 SO THEY'LL BE INVOLVED. 2692 02:04:09,320 --> 02:04:11,360 THE PLAN FOR IMPLEMENTATION IS 2693 02:04:11,360 --> 02:04:14,160 WITH THE JANUARY 2025 RECEIPT 2694 02:04:14,160 --> 02:04:17,040 STATES WHICH MEANS SUMMER 2025 2695 02:04:17,040 --> 02:04:19,360 WOULD BE THE FIRST REVIEWS OF 2696 02:04:19,360 --> 02:04:20,640 THESE CRITERIA. 2697 02:04:20,640 --> 02:04:23,400 AND I HAVE TO ACKNOWLEDGE OUR 2698 02:04:23,400 --> 02:04:24,240 WONDERFUL ADVISORY COUNCIL AND 2699 02:04:24,240 --> 02:04:25,720 THEIR WORKING GROUP WHICH WORKED 2700 02:04:25,720 --> 02:04:27,240 VERY HARD ON THIS ESPECIALLY AS 2701 02:04:27,240 --> 02:04:28,440 THE PANDEMIC HIT AND THEY 2702 02:04:28,440 --> 02:04:30,080 CONTINUED THEIR HARD WORK SO 2703 02:04:30,080 --> 02:04:32,000 THIS IS A BIG ACKNOWLEDGEMENT TO 2704 02:04:32,000 --> 02:04:35,920 THE HEAVY LIFT THEY DID. 2705 02:04:35,920 --> 02:04:36,160 OKAY. 2706 02:04:36,160 --> 02:04:40,520 LET'S TALK ABOUT FELLOWSHIP 2707 02:04:40,520 --> 02:04:40,880 APPLICATIONS. 2708 02:04:40,880 --> 02:04:42,880 SO NOT QUITE CONCURRENTLY BUT A 2709 02:04:42,880 --> 02:04:47,280 LITTLE BIT STAGGERED STARTING IN 2710 02:04:47,280 --> 02:04:50,400 2022, THERE WERE CONCERNS 2711 02:04:50,400 --> 02:04:52,520 RELATED TO NRSA FELLOWSHIP 2712 02:04:52,520 --> 02:04:54,560 REVIEWS WE HEARD ABOUT FOR YEARS 2713 02:04:54,560 --> 02:05:03,240 AND IN 2022 WE CONVENED AN 2714 02:05:03,240 --> 02:05:05,280 ADVISORY COUNCIL WORKING GROUP 2715 02:05:05,280 --> 02:05:06,960 AND CONTINUOUSLY ASKED FOR MORE 2716 02:05:06,960 --> 02:05:09,680 AND MORE DATA WE PROVIDED ON 2717 02:05:09,680 --> 02:05:10,440 FELLOWSHIPS. 2718 02:05:10,440 --> 02:05:12,320 WE HAD A BLOG POST AND GATHERED 2719 02:05:12,320 --> 02:05:12,520 INPUT. 2720 02:05:12,520 --> 02:05:14,360 THE INPUT FROM THE WORKING GROUP 2721 02:05:14,360 --> 02:05:18,160 AND COMMUNITY FEEDBACK WAS THAT 2722 02:05:18,160 --> 02:05:19,800 NIH IS LEAVING OUT REALLY 2723 02:05:19,800 --> 02:05:21,040 PROMISING YOUNG FUTURE 2724 02:05:21,040 --> 02:05:23,680 SCIENTISTS BECAUSE WE HAVE A 2725 02:05:23,680 --> 02:05:25,040 PROCESS THAT JUST LIKE 2726 02:05:25,040 --> 02:05:27,040 EVERYTHING ELSE IN BIOMEDICAL 2727 02:05:27,040 --> 02:05:28,400 AND BEHAVIORAL SCIENCE FAVORS 2728 02:05:28,400 --> 02:05:29,960 THE LEAD INSTITUTIONS AND SENIOR 2729 02:05:29,960 --> 02:05:31,640 INVESTIGATORS AND HAS A NARROW 2730 02:05:31,640 --> 02:05:32,240 INFORMATION ON TRADITIONAL 2731 02:05:32,240 --> 02:05:36,040 MARKERS OF SUCCESS. 2732 02:05:36,040 --> 02:05:38,240 SO THAT WAS THEIR OPINION. 2733 02:05:38,240 --> 02:05:40,680 ONCE WE LOOKED AT THE DATA, 2734 02:05:40,680 --> 02:05:41,640 6,000 APPLICATIONS OVER THE 2735 02:05:41,640 --> 02:05:43,160 COURSE OF 2021 THAT WERE 2736 02:05:43,160 --> 02:05:43,680 SUBMITTED SUPPORT THESE 2737 02:05:43,680 --> 02:05:46,920 CONCERNS. 2738 02:05:46,920 --> 02:05:50,720 AND THAT IS THAT A SMALL NUMBER 2739 02:05:50,720 --> 02:05:51,760 OF INSTITUTIONS SUBMIT A 2740 02:05:51,760 --> 02:05:52,240 MAJORITY OF FELLOWSHIP 2741 02:05:52,240 --> 02:06:00,320 APPLICATIONS. 2742 02:06:00,320 --> 02:06:05,680 THIGH KNOW -- THOSE THAT SUBMIT 2743 02:06:05,680 --> 02:06:08,240 A LARGE NUMBER DO BETTER AND THE 2744 02:06:08,240 --> 02:06:10,720 REVIEW OUTCOMES ARE PROPORTIONAL 2745 02:06:10,720 --> 02:06:12,720 TO THE SENIORITY OF THE SPONSOR. 2746 02:06:12,720 --> 02:06:13,600 I'LL SHOW THE DATA. 2747 02:06:13,600 --> 02:06:15,800 THIS IS ABOUT THE NUMBER OF 2748 02:06:15,800 --> 02:06:16,120 INSTITUTIONS. 2749 02:06:16,120 --> 02:06:18,200 WHAT YOU'RE LOOKING AT HERE, 2750 02:06:18,200 --> 02:06:20,200 BECAUSE IF YOU LOOK AT THE VERY 2751 02:06:20,200 --> 02:06:21,320 RIGHT, WE LOOKED AT ONE YEAR'S 2752 02:06:21,320 --> 02:06:22,960 WORTH OF APPLICATIONS JUST OVER 2753 02:06:22,960 --> 02:06:27,160 6,000 APPLICATIONS. 2754 02:06:27,160 --> 02:06:29,880 15 INSTITUTIONS OVER THE COURSE 2755 02:06:29,880 --> 02:06:31,800 OF THE YEAR WHO SUBMITTED 100 2756 02:06:31,800 --> 02:06:32,280 APPLICATIONS PLUS PER 2757 02:06:32,280 --> 02:06:36,160 INSTITUTION. 2758 02:06:36,160 --> 02:06:40,120 THEN YOU LOOK ON THE LEFT, 106 2759 02:06:40,120 --> 02:06:41,120 INSTITUTIONS SUBMITTED JUST ONE 2760 02:06:41,120 --> 02:06:42,560 TO TWO APPLICATIONS AND 2761 02:06:42,560 --> 02:06:46,960 EVERYTHING IN BETWEEN. 2762 02:06:46,960 --> 02:06:48,920 IT'S REALLY WHO WE'RE GETTING 2763 02:06:48,920 --> 02:06:50,360 APPLICATIONS FROM IS REALLY 2764 02:06:50,360 --> 02:06:50,800 SKEWED. 2765 02:06:50,800 --> 02:06:52,360 LOOKING AT THE REVIEW OUTCOMES. 2766 02:06:52,360 --> 02:06:57,120 THE TOP ONE IS THE INSTITUTIONS 2767 02:06:57,120 --> 02:06:59,200 THAT SUBMITTED ONE TO 25 2768 02:06:59,200 --> 02:07:00,200 APPLICATIONS DURING THAT PERIOD 2769 02:07:00,200 --> 02:07:02,320 AND 53% WERE NOT DISCUSSED AND 2770 02:07:02,320 --> 02:07:04,400 29% WERE HIGH IMPACT. 2771 02:07:04,400 --> 02:07:06,440 WE LOOK AT THE ONE AT THE VERY 2772 02:07:06,440 --> 02:07:09,960 BOTTOM WHICH IS THE INSTITUTIONS 2773 02:07:09,960 --> 02:07:12,400 SUBMITTED A HUNDRED PLUS 2774 02:07:12,400 --> 02:07:13,840 APPLICATIONS MUCH LOWER AND MANY 2775 02:07:13,840 --> 02:07:16,880 MORE IN THE HIGH IMPACT AREA. 2776 02:07:16,880 --> 02:07:18,560 AND IT'S UNDERSTANDABLE. 2777 02:07:18,560 --> 02:07:19,600 THEY'RE REALLY GOOD AT WRITING 2778 02:07:19,600 --> 02:07:24,600 THESE AND WE SEE THAT. 2779 02:07:24,600 --> 02:07:27,680 SO WE LOOKED AT THE ACADEMIC 2780 02:07:27,680 --> 02:07:29,320 RANK OF THE SPONSOR AND THEY 2781 02:07:29,320 --> 02:07:31,480 LOOK AT THE TOP FOUR THERE. 2782 02:07:31,480 --> 02:07:33,880 SO FIRST OF ALL ASSISTANT 2783 02:07:33,880 --> 02:07:35,160 PROFESSORS AS SPONSORS ARE KIND 2784 02:07:35,160 --> 02:07:35,800 OF RARE. 2785 02:07:35,800 --> 02:07:40,200 THAT'S BECAUSE THEY DON'T DO SO 2786 02:07:40,200 --> 02:07:41,520 WELL AND WE HEARD THIS FROM OUR 2787 02:07:41,520 --> 02:07:43,480 COMMENTS AND FEEDBACK THAT 2788 02:07:43,480 --> 02:07:45,280 ASSISTANT PROFESSORS CAN'T SEEM 2789 02:07:45,280 --> 02:07:48,240 TO GET AN NSRA FELLOWSHIP FUNDED 2790 02:07:48,240 --> 02:07:49,160 WHICH IS UNFORTUNATE BECAUSE 2791 02:07:49,160 --> 02:07:50,960 THEY COULD BE GOOD MENTORS, 2792 02:07:50,960 --> 02:07:53,280 SOMETIMES BETTER THAN SOME OF 2793 02:07:53,280 --> 02:07:56,360 THE SENIOR INVESTIGATORS. 2794 02:07:56,360 --> 02:07:58,840 SO WE LOOK AT ASSISTANT 2795 02:07:58,840 --> 02:08:02,120 PROFESSORS AND 45% GET NOT 2796 02:08:02,120 --> 02:08:04,800 DISCUSSED AND AROUND 26% GET 2797 02:08:04,800 --> 02:08:06,360 HIGH IMPACT AND THE MAJORITY OF 2798 02:08:06,360 --> 02:08:10,640 WHAT WE GET FOR FELLOWSHIPS IT'S 2799 02:08:10,640 --> 02:08:13,320 A LOWER NOT DISCUSSED RATE AND 2800 02:08:13,320 --> 02:08:14,480 HIGHER HIGH IMPACT RATE. 2801 02:08:14,480 --> 02:08:16,160 THE OTHER CATEGORY IS EVEN 2802 02:08:16,160 --> 02:08:17,320 BETTER THAN PROFESSOR. 2803 02:08:17,320 --> 02:08:19,400 WE DUG INTO THAT TO SEE WHAT'S 2804 02:08:19,400 --> 02:08:21,200 DOING BETTER THAN PROFESSORS. 2805 02:08:21,200 --> 02:08:22,640 THEY'RE NOT OFFICIALLY CALLED 2806 02:08:22,640 --> 02:08:23,920 PROFESSORS BECAUSE THEY'RE DEANS 2807 02:08:23,920 --> 02:08:26,600 AND PROVOSTS. 2808 02:08:26,600 --> 02:08:27,880 THAT'S THEIR OFFICIAL TITLE 2809 02:08:27,880 --> 02:08:28,840 CAPTURED BY THE SYSTEM AND SO 2810 02:08:28,840 --> 02:08:39,160 THAT EXPLAINS IT. 2811 02:09:03,400 --> 02:09:05,440 AND LOOKING AT WHAT THE 2812 02:09:05,440 --> 02:09:06,640 CANDIDATE'S SPECIFIC NEEDS ARE. 2813 02:09:06,640 --> 02:09:08,720 IN ADDITION, THE SECOND 2814 02:09:08,720 --> 02:09:10,720 RECOMMENDATION IS TO REVISE THE 2815 02:09:10,720 --> 02:09:11,960 REVIEW CRITERIA AGAIN TO MATCH 2816 02:09:11,960 --> 02:09:13,960 WITH THE FELLOWSHIP APPLICATION 2817 02:09:13,960 --> 02:09:16,080 TO MAKE SURE THAT THE STRENGTH 2818 02:09:16,080 --> 02:09:18,000 OF THE SCIENCE IS CONSIDERED AND 2819 02:09:18,000 --> 02:09:19,880 THE QUALITY AND TARGETING OF THE 2820 02:09:19,880 --> 02:09:24,360 TRAINING PLAN IS TAKEN INTO 2821 02:09:24,360 --> 02:09:25,520 CONSIDERATION WITHOUT THE 2822 02:09:25,520 --> 02:09:26,640 INAPPROPRIATE INFLUENCE OF WHERE 2823 02:09:26,640 --> 02:09:28,600 THE SPONSOR IS OR WHERE THE 2824 02:09:28,600 --> 02:09:29,040 INSTITUTION IS. 2825 02:09:29,040 --> 02:09:29,600 VERY MUCH FOCUSSED ON THE 2826 02:09:29,600 --> 02:09:32,680 CANDIDATE. 2827 02:09:32,680 --> 02:09:34,720 AND AGAIN THIS FACILITATES THE 2828 02:09:34,720 --> 02:09:37,840 BROADER GOAL OF NSRA FELLOWSHIP 2829 02:09:37,840 --> 02:09:39,320 TO LOOK AT THE NEXT GENERATION 2830 02:09:39,320 --> 02:09:41,880 OF FELLOWSHIP AND RESEARCHERS. 2831 02:09:41,880 --> 02:09:43,080 HERE'S SOME OF THE SPECIFIC 2832 02:09:43,080 --> 02:09:43,440 RECOMMENDATIONS. 2833 02:09:43,440 --> 02:09:45,960 ONE IS TO ELIMINATE GRADES. 2834 02:09:45,960 --> 02:09:50,600 THIS WAS THE MOST POPULAR 2835 02:09:50,600 --> 02:09:52,720 BECAUSE UNDERGRADUATE RATES ARE 2836 02:09:52,720 --> 02:09:55,440 NOT PREDICTIVE OF SUCCESS AS A 2837 02:09:55,440 --> 02:09:56,480 POST-DOCTORAL FELLOW AND THE 2838 02:09:56,480 --> 02:10:00,080 MINUTE YOU PUT THAT IN FRONT OF 2839 02:10:00,080 --> 02:10:01,640 REVIEWERS THEY'RE COMPARING B 2840 02:10:01,640 --> 02:10:03,520 PLUS IN ORGANIC CHEMISTRY IN 2841 02:10:03,520 --> 02:10:09,280 SOME MORE -- SOPHOMORE YEAR TO 2842 02:10:09,280 --> 02:10:12,520 AN A-MUNICIPAL AND THAT WAS 2843 02:10:12,520 --> 02:10:17,920 AGREED UPON TO EVERYONE LONG THE 2844 02:10:17,920 --> 02:10:19,280 WAY. 2845 02:10:19,280 --> 02:10:21,280 THE REST MAKES IT MORE TARGETED 2846 02:10:21,280 --> 02:10:23,400 TO REMOVE THE BIAS THAT COMES 2847 02:10:23,400 --> 02:10:25,200 INTO JUST TALKING ABOUT HOW 2848 02:10:25,200 --> 02:10:26,800 GREAT THE SPONSOR IS MAKING IT 2849 02:10:26,800 --> 02:10:29,000 MUCH MORE FOCUSSED ON THE 2850 02:10:29,000 --> 02:10:29,640 SPONSOR'S TRAINING APPROACH FOR 2851 02:10:29,640 --> 02:10:39,920 THIS CANDIDATE. 2852 02:10:44,640 --> 02:10:45,880 THERE'S BOILER PLATE LANGUAGE 2853 02:10:45,880 --> 02:10:47,880 USED IN INSTITUTIONS. 2854 02:10:47,880 --> 02:10:49,280 THERE'S NO CHANGE TO THE SCIENCE 2855 02:10:49,280 --> 02:10:59,760 PART THAT REMAINS IMPORTANT. 2856 02:11:08,680 --> 02:11:09,880 AND IF SOMEONE IS GUESSING 2857 02:11:09,880 --> 02:11:11,880 HARRIED IN A LAB HOW DOES THAT 2858 02:11:11,880 --> 02:11:14,360 AFFECT THEIR TRAJECTORY AND IT'S 2859 02:11:14,360 --> 02:11:18,320 OPTIONAL WITH COVID-19 AND THE 2860 02:11:18,320 --> 02:11:18,680 CIRCUMSTANCES. 2861 02:11:18,680 --> 02:11:25,320 IN THE YELLOW YOU SEE THE OLD 2862 02:11:25,320 --> 02:11:25,560 CRITERIA. 2863 02:11:25,560 --> 02:11:27,360 SPONSORS ARE VERY IMPORTANT TO 2864 02:11:27,360 --> 02:11:28,360 THE SUCCESS OF THE CANDIDATE. 2865 02:11:28,360 --> 02:11:31,200 I THINK THAT WAS VERY WELL 2866 02:11:31,200 --> 02:11:31,520 RECOGNIZED. 2867 02:11:31,520 --> 02:11:33,600 WHEN HAVE YOU A STAND ALONE 2868 02:11:33,600 --> 02:11:36,040 CATEGORY SPONSOR THAT LEADS TO 2869 02:11:36,040 --> 02:11:37,840 BIAS AND REPUTATIONAL BIAS. 2870 02:11:37,840 --> 02:11:39,560 THE EVALUATION OF THE SPONSOR 2871 02:11:39,560 --> 02:11:42,480 HAS BEEN INTEGRATED INTO THE 2872 02:11:42,480 --> 02:11:44,280 SCIENCE AND SCIENTIFIC RESOURCES 2873 02:11:44,280 --> 02:11:46,240 TRAINING PLAN AND TRAINING 2874 02:11:46,240 --> 02:11:46,560 RESOURCES. 2875 02:11:46,560 --> 02:11:48,080 WHAT HAS THE SPONSOR DONE AND 2876 02:11:48,080 --> 02:11:50,000 WHAT'S THE PLAN FOR TRAINING? 2877 02:11:50,000 --> 02:11:52,360 THE NEW CRITERIA ARE MUCH MORE 2878 02:11:52,360 --> 02:11:53,320 FOCUSSED ON A TARGETED TRAINING 2879 02:11:53,320 --> 02:12:00,760 PLAN. 2880 02:12:00,760 --> 02:12:05,400 AT THE END OF 2022 THEY WERE 2881 02:12:05,400 --> 02:12:07,520 APPROVED AND WENT TO THE HIRN 2882 02:12:07,520 --> 02:12:10,280 LEADERSHIP WHICH ALSO APPROVED 2883 02:12:10,280 --> 02:12:15,840 THEM WITHOUT CHANGES. 2884 02:12:15,840 --> 02:12:19,080 WE RELEASED AN RFI FOR PUBLIC 2885 02:12:19,080 --> 02:12:21,120 INPUT. 2886 02:12:21,120 --> 02:12:25,480 IT'S BEEN GATHERED AND MOST PLY 2887 02:12:25,480 --> 02:12:27,040 SUPPORTIVE AND REFLECTS WHAT WE 2888 02:12:27,040 --> 02:12:29,320 GOT FOR THE RPGs. 2889 02:12:29,320 --> 02:12:32,040 SUPPORTIVE OF THE CHANGES 2890 02:12:32,040 --> 02:12:33,320 ELIMINATING GRADES AND STILL 2891 02:12:33,320 --> 02:12:35,360 THINK THERE NEEDS TO BE A LOT OF 2892 02:12:35,360 --> 02:12:37,400 TRAINING RESOURCES DEVOTED. 2893 02:12:37,400 --> 02:12:41,280 WE WILL PUBLISH THE RFI ANALYSIS 2894 02:12:41,280 --> 02:12:43,960 AND IMPLEMENTATION PLANNING 2895 02:12:43,960 --> 02:12:44,640 TAKING INTO ACCOUNT THE COMMENTS 2896 02:12:44,640 --> 02:12:49,280 FROM THE PUBLIC NOW UNDERWAY. 2897 02:12:49,280 --> 02:12:53,280 AGAIN, I WANT TO ACKNOWLEDGE OUR 2898 02:12:53,280 --> 02:12:55,120 NRSA CRITERIA WORKING GROUP 2899 02:12:55,120 --> 02:12:56,640 INCLUDING NIH STAFF AS WELL AS A 2900 02:12:56,640 --> 02:13:05,280 NUMBER OF EXTERNAL MEMBERS AND A 2901 02:13:05,280 --> 02:13:09,120 BIG THANKS TO THE GROUP LEADER 2902 02:13:09,120 --> 02:13:10,400 AND IT WENT VERY WELL. 2903 02:13:10,400 --> 02:13:16,160 JUST CHANGING AND JUGGLING ASH 2904 02:13:16,160 --> 02:13:17,040 REVIEW CRITERIA ISN'T GOING TO 2905 02:13:17,040 --> 02:13:18,200 BE THE ONLY THING WE'RE GOING 2906 02:13:18,200 --> 02:13:19,600 AND THERE'S MORE TO MAKE SURE 2907 02:13:19,600 --> 02:13:21,440 THERE'S FAIRNESS IN THE REVIEW 2908 02:13:21,440 --> 02:13:24,400 PROPOSE. 2909 02:13:24,400 --> 02:13:25,320 -- PROCESS. 2910 02:13:25,320 --> 02:13:27,480 CSR CONDUCTS ANNUAL CHAIR 2911 02:13:27,480 --> 02:13:28,760 RECOMMENDATIONS FOR STUDY 2912 02:13:28,760 --> 02:13:29,480 SECTION MEMBERS EVERY YEAR IN 2913 02:13:29,480 --> 02:13:33,520 THE SUMMER. 2914 02:13:33,520 --> 02:13:37,360 IT'S A LIVE SESSION HOLDING 2915 02:13:37,360 --> 02:13:40,000 VIRTUALLY, NINE TO 10 CHAIRS AND 2916 02:13:40,000 --> 02:13:43,800 THERE'S 90 INCOMING CHAIRS EVERY 2917 02:13:43,800 --> 02:13:46,200 YEAR AND HALF CYCLE OFF EVERY 2918 02:13:46,200 --> 02:13:46,600 YEAR. 2919 02:13:46,600 --> 02:13:47,480 IT'S AN OVERVIEW. 2920 02:13:47,480 --> 02:13:52,640 WE TALK ABOUT THE ROLE OF THE 2921 02:13:52,640 --> 02:13:55,560 CHAIR AND PROMOTING A STUDY 2922 02:13:55,560 --> 02:13:57,840 SECTION THAT'S FAIR AND 2923 02:13:57,840 --> 02:13:58,080 INCLUSIVE. 2924 02:13:58,080 --> 02:14:00,880 THERE'S SAMPLES OF THE CHAIR 2925 02:14:00,880 --> 02:14:01,520 ORIENTATIONS AVAILABLE TO VIEW 2926 02:14:01,520 --> 02:14:11,800 ON OUR WEBSITE. 2927 02:14:24,640 --> 02:14:26,480 THIS NOT IMPLICIT BIAS TRAINING 2928 02:14:26,480 --> 02:14:28,040 AND SAYING WE WERE NOT GOING 2929 02:14:28,040 --> 02:14:30,640 CHANGE SOMEONE'S HEART AND MIND 2930 02:14:30,640 --> 02:14:32,600 IN A 30 MINUTE SEGMENT IN THE 2931 02:14:32,600 --> 02:14:33,720 SMALL AMOUNT OF TIME THEY'RE 2932 02:14:33,720 --> 02:14:35,200 HERE DOING PEER REVIEW. 2933 02:14:35,200 --> 02:14:36,040 THAT'S UP TO THE INSTITUTION 2934 02:14:36,040 --> 02:14:41,840 WHERE'S THEY WORK AND LIVE. 2935 02:14:41,840 --> 02:14:45,320 FOR US WE ACCEPT THE FACT 2936 02:14:45,320 --> 02:14:46,960 THERE'S BIAS OUT THERE IN THE 2937 02:14:46,960 --> 02:14:48,960 BIOMEDICAL COMMUNITY AND HOW DO 2938 02:14:48,960 --> 02:14:52,880 WE PREVENT THOSE BIASES FROM 2939 02:14:52,880 --> 02:14:54,600 CREEPING IN THE PEER-REVIEW 2940 02:14:54,600 --> 02:14:58,640 PROCESS AND THERE'S TARGETED 2941 02:14:58,640 --> 02:14:58,880 TRAINING. 2942 02:14:58,880 --> 02:15:00,640 IT INCLUDES INTERACTIVE 2943 02:15:00,640 --> 02:15:03,200 NARRATIVES AND MOCK STUDY 2944 02:15:03,200 --> 02:15:05,120 SECTIONS AND WE DEVELOPED THIS 2945 02:15:05,120 --> 02:15:05,800 WITH ANOTHER ADVISORY COUNCIL 2946 02:15:05,800 --> 02:15:07,280 WORKING GROUP THAT TOLD US WHAT 2947 02:15:07,280 --> 02:15:08,840 WERE THE MOST EFFECTIVE AND 2948 02:15:08,840 --> 02:15:13,400 WOULD RESONATE WITH REVIEWERS. 2949 02:15:13,400 --> 02:15:18,080 IT'S TAKEN FOUR WEEKS AND SO FAR 2950 02:15:18,080 --> 02:15:20,160 22,000 CSR REVIEWERS AND 2951 02:15:20,160 --> 02:15:21,440 TRAINERS HAVE TAKEN THE 2952 02:15:21,440 --> 02:15:21,720 TRAINING. 2953 02:15:21,720 --> 02:15:24,160 IT'S BEEN WELL RECEIVED BY THE 2954 02:15:24,160 --> 02:15:26,520 SCIENTIFIC COMMUNITY. 2955 02:15:26,520 --> 02:15:27,640 THERE'S A FEW THAT DIDN'T MAKE 2956 02:15:27,640 --> 02:15:32,200 IT ON HERE THAT TALKS ABOUT THIS 2957 02:15:32,200 --> 02:15:33,240 BEING GOOD FOR GOVERNMENT 2958 02:15:33,240 --> 02:15:33,480 TRAINING. 2959 02:15:33,480 --> 02:15:36,640 I'LL TAKE THAT. 2960 02:15:36,640 --> 02:15:42,240 I'M OKAY WITH IT. 2961 02:15:42,240 --> 02:15:43,400 WE SEE MORE COMFORT IN TRAINING 2962 02:15:43,400 --> 02:15:45,120 AND THIS IS POST IMPLEMENTATION 2963 02:15:45,120 --> 02:15:46,120 OF TRAINING AND WE'RE SEEING 2964 02:15:46,120 --> 02:15:50,520 THIS IN OUR STUDY SECTIONS. 2965 02:15:50,520 --> 02:15:52,160 PEOPLE INTERVENING AND SAYING 2966 02:15:52,160 --> 02:15:54,120 THIS DOESN'T HAVE ANYTHING TO DO 2967 02:15:54,120 --> 02:15:55,960 WITH THE SCIENCE OR SCIENCE BUT 2968 02:15:55,960 --> 02:15:56,960 INTERVENING AS PEOPLE SPEAK UP. 2969 02:15:56,960 --> 02:15:58,800 I THINK IT'S STARTING TO CHANGE 2970 02:15:58,800 --> 02:16:06,520 FROM SOME OF THE CULTURE OF THE 2971 02:16:06,520 --> 02:16:06,840 DISCUSSION. 2972 02:16:06,840 --> 02:16:09,280 IT WILL BE REQUIRED FOR ALL NIH 2973 02:16:09,280 --> 02:16:09,880 ARE REVIEWERS. 2974 02:16:09,880 --> 02:16:12,800 THEY WANT ALL NIH REVIEW NOT 2975 02:16:12,800 --> 02:16:15,480 JUST CSR TO TAKE TRAININGS AND 2976 02:16:15,480 --> 02:16:17,840 IT WILL BE IMPLEMENTED IN THE 2977 02:16:17,840 --> 02:16:18,520 2024 COUNCIL ROUND. 2978 02:16:18,520 --> 02:16:19,920 YOU CAN LOOK AT THE FULL SURVEY 2979 02:16:19,920 --> 02:16:25,960 ANALYSIS ON OUR WEBSITE. 2980 02:16:25,960 --> 02:16:28,400 AND WE HAD A FIRST VERSION THAT 2981 02:16:28,400 --> 02:16:29,360 WAS RUDIMENTARY A FEW YEARS AGO. 2982 02:16:29,360 --> 02:16:31,800 WE UPDATED THAT AND LEARNED TO 2983 02:16:31,800 --> 02:16:34,080 PRODUCE BETTER VIDEOS AND HAVE 2984 02:16:34,080 --> 02:16:35,800 BETTER RESOURCES NOW AND WITH 2985 02:16:35,800 --> 02:16:38,400 DID THIS WITH THE HELP OF OUR 2986 02:16:38,400 --> 02:16:39,440 ADVISORY COUNCIL WORKING GROUP 2987 02:16:39,440 --> 02:16:41,840 THAT TOLD US WHERE THEY SEE 2988 02:16:41,840 --> 02:16:43,160 ISSUES COMING UP. 2989 02:16:43,160 --> 02:16:44,680 PEOPLE ARE GOING TO CONFERENCES 2990 02:16:44,680 --> 02:16:46,760 AND APPLICANT COMING UP SAYING 2991 02:16:46,760 --> 02:16:48,240 HEY, I THINK YOU WERE ON THE 2992 02:16:48,240 --> 02:16:49,280 STUDY SECTION THAT REVIEWED MY 2993 02:16:49,280 --> 02:16:49,520 GRANT. 2994 02:16:49,520 --> 02:16:51,640 THEY WANTED TO KNOW HOW DO WE 2995 02:16:51,640 --> 02:16:53,200 NAVIGATE THOSE KINDS OF 2996 02:16:53,200 --> 02:16:53,880 INTERACTIONS IN THE SCIENTIFIC 2997 02:16:53,880 --> 02:16:54,560 COMMUNITY OUT THERE. 2998 02:16:54,560 --> 02:16:57,360 THIS IS ALSO VERY TARGETED. 2999 02:16:57,360 --> 02:17:00,240 IT'S ALSO ABOUT 30 MINUTES LONG 3000 02:17:00,240 --> 02:17:03,080 AND IT'S FOCUSSED ON PROTECTING 3001 02:17:03,080 --> 02:17:04,800 THE CONFIDENTIALITY AND 3002 02:17:04,800 --> 02:17:07,560 INTEGRITY OF THE PROCESS. 3003 02:17:07,560 --> 02:17:10,040 IF YOU TAKE THIS TRAINING IF YOU 3004 02:17:10,040 --> 02:17:11,560 HAVEN'T ALREADY TAKEN IT KNOW 3005 02:17:11,560 --> 02:17:14,840 ALL THE SCENARIOS ARE BIFFED ON 3006 02:17:14,840 --> 02:17:15,760 ACTUAL CASES. 3007 02:17:15,760 --> 02:17:18,240 SOMETIMES I HOPE YOU'RE 3008 02:17:18,240 --> 02:17:22,640 FORTUNATE ENOUGH TO NEVER HAVE 3009 02:17:22,640 --> 02:17:24,320 ENCOUNTERED IT AND WONDER DID 3010 02:17:24,320 --> 02:17:26,320 THIS HAPPEN, YES IT DID AND 3011 02:17:26,320 --> 02:17:28,880 THAT'S WHY IT'S HERE. 3012 02:17:28,880 --> 02:17:30,800 MORE THAN 16,000 REVIEWERS HAVE 3013 02:17:30,800 --> 02:17:34,320 DONE THE TRAINING AND IT WILL BE 3014 02:17:34,320 --> 02:17:36,600 REQUIRED FOR ALL REVIEWERS NOT 3015 02:17:36,600 --> 02:17:37,280 JUST CSR BEGINNING WITH THE MAY 3016 02:17:37,280 --> 02:17:42,080 COUNCIL. 3017 02:17:42,080 --> 02:17:44,520 AND LITTLE DO WE KNOW WITH 3018 02:17:44,520 --> 02:17:48,840 19,000 HUMAN BEINGS WE ENGAGE IN 3019 02:17:48,840 --> 02:17:52,480 AS SCIENTIFIC EXPERTS BIAS WILL 3020 02:17:52,480 --> 02:17:53,120 COME IN. 3021 02:17:53,120 --> 02:17:55,960 PEOPLE BRING THEIR BIASES IN AND 3022 02:17:55,960 --> 02:18:00,880 IF WE KNOW ABOUT IT WE CAN DO 3023 02:18:00,880 --> 02:18:02,040 SOMETHING ABOUT IT. 3024 02:18:02,040 --> 02:18:04,400 WE ESTABLISHED THE DIRECT 3025 02:18:04,400 --> 02:18:06,400 REPORTING MEC NIF FOR C.R.S OPEN 3026 02:18:06,400 --> 02:18:09,240 TO APPLICANTS AND REVIEWERS IF 3027 02:18:09,240 --> 02:18:11,200 THEY FEEL THERE WAS DISRESPECT 3028 02:18:11,200 --> 02:18:12,720 OR BIAS DURING THE STUDY SECTION 3029 02:18:12,720 --> 02:18:13,080 MEETING. 3030 02:18:13,080 --> 02:18:16,360 SOMETIMES WE HEAR THAT AND TO 3031 02:18:16,360 --> 02:18:16,760 PROGRAM STAFF. 3032 02:18:16,760 --> 02:18:17,840 THEY'RE THE ONES OBSERVING 3033 02:18:17,840 --> 02:18:19,280 MEETINGS AND IF THEY SEE 3034 02:18:19,280 --> 02:18:24,440 SOMETHING THEY CAN REPORT 3035 02:18:24,440 --> 02:18:24,880 DIRECTLY. 3036 02:18:24,880 --> 02:18:27,640 OUR CHIEF DIVERSITY OFFICER HIS 3037 02:18:27,640 --> 02:18:29,800 E-MAIL IS IN ALL SIGNATURES FOR 3038 02:18:29,800 --> 02:18:30,840 ALL STAFF AT CSR. 3039 02:18:30,840 --> 02:18:33,280 SO IT'S AVAILABLE REPEATEDLY TO 3040 02:18:33,280 --> 02:18:41,280 PEOPLE WHO ENGAGE WITH US. 3041 02:18:41,280 --> 02:18:44,080 WE INVESTIGATE EVERY ALLEGATION 3042 02:18:44,080 --> 02:18:48,760 THAT COMES IN TWOFOLD BY 3043 02:18:48,760 --> 02:18:49,360 DR. FAUSO AND THE SPECIFIC 3044 02:18:49,360 --> 02:18:51,840 DIRECTOR IF WE AGREE IT WAS A 3045 02:18:51,840 --> 02:18:52,720 BIASSED STATEMENT OR FLAWED 3046 02:18:52,720 --> 02:18:54,960 REVIEW, I WOULD SAY ABOUT A 3047 02:18:54,960 --> 02:18:59,000 THIRD TO HALF THE TIME WE AGREE 3048 02:18:59,000 --> 02:19:01,640 OR CONFIRM AND IF WE THINK THERE 3049 02:19:01,640 --> 02:19:04,160 WAS A PROBLEM WITH THE REVIEW WE 3050 02:19:04,160 --> 02:19:05,880 REVIEW IN THE SAME COUNCIL ROUND 3051 02:19:05,880 --> 02:19:07,320 BECAUSE WE DON'T WANT TO 3052 02:19:07,320 --> 02:19:08,280 DISADVANTAGE THE APPLICANT AND 3053 02:19:08,280 --> 02:19:09,360 THEIR FUNDING TIME LINE AND WE 3054 02:19:09,360 --> 02:19:11,360 INFORM THE APPLICANT. 3055 02:19:11,360 --> 02:19:13,360 IF WE DON'T AGREE, WE ALSO 3056 02:19:13,360 --> 02:19:17,320 INFORM THE APPLICANT AND TELL 3057 02:19:17,320 --> 02:19:19,200 THEM THEIR NORMAL REVIEWER 3058 02:19:19,200 --> 02:19:21,400 PROCESS REMAINS AVAILABLE AND 3059 02:19:21,400 --> 02:19:22,760 GUIDE THEM TO THE PROGRAM 3060 02:19:22,760 --> 02:19:23,000 OFFICER. 3061 02:19:23,000 --> 02:19:25,080 THE LAST THING WAS ADDED LAST 3062 02:19:25,080 --> 02:19:26,640 YEAR AND THAT'S BECAUSE I FELT 3063 02:19:26,640 --> 02:19:29,320 IT WAS REALLY IMPORTANT FOR 3064 02:19:29,320 --> 02:19:31,560 REVIEWERS TO HEAR WHEN THEY HAVE 3065 02:19:31,560 --> 02:19:35,400 MADE BIAS STATEMENTS THAT LED TO 3066 02:19:35,400 --> 02:19:36,960 A REREVIEW. 3067 02:19:36,960 --> 02:19:39,520 IT'S IMPORTANT TO HEAR THAT. 3068 02:19:39,520 --> 02:19:42,520 OUR DIVISION DIRECTOR NOW CALL 3069 02:19:42,520 --> 02:19:44,200 REVIEWERS AND SAY YOU SAID THIS 3070 02:19:44,200 --> 02:19:47,160 AND WE HAD TO DO IT AGAIN. 3071 02:19:47,160 --> 02:19:49,480 A VAST MAJORITY OF THE TIME 3072 02:19:49,480 --> 02:19:51,920 PEOPLE ARE VERY CONTRITE AND 3073 02:19:51,920 --> 02:19:52,520 THINK I SHOULDN'T HAVE DONE 3074 02:19:52,520 --> 02:19:52,920 THAT. 3075 02:19:52,920 --> 02:19:55,400 I'M SORRY, I WON'T DO IT AGAIN. 3076 02:19:55,400 --> 02:19:56,000 THAT'S CULTURE CHANGE. 3077 02:19:56,000 --> 02:19:57,400 PEOPLE HEAR ABOUT IT AND FEEL 3078 02:19:57,400 --> 02:19:59,360 IT'S NOT ACCEPTABLE. 3079 02:19:59,360 --> 02:20:01,040 THERE'S A SMALL MINORITY THAT 3080 02:20:01,040 --> 02:20:02,520 ARGUES WITH US AND THAT GIVES US 3081 02:20:02,520 --> 02:20:04,040 MORE INFORMATION ON THAT 3082 02:20:04,040 --> 02:20:07,680 REVIEWER AND AS ALWAYS WE 3083 02:20:07,680 --> 02:20:09,320 MAINTAIN DISCRETION ABOUT WHO WE 3084 02:20:09,320 --> 02:20:16,400 INVITE AND DON'T INVITE. 3085 02:20:16,400 --> 02:20:17,960 AND DIVERSIFYING OUR REVIEW 3086 02:20:17,960 --> 02:20:18,160 PANEL. 3087 02:20:18,160 --> 02:20:19,360 WE'LL START OFF TALKING ABOUT 3088 02:20:19,360 --> 02:20:20,960 THE TOOL WE HAVE AND THE GOAL 3089 02:20:20,960 --> 02:20:25,000 WAS TO HELP OUR SCIENTIFIC 3090 02:20:25,000 --> 02:20:26,160 REVIEW OFFICERS FIND PEOPLE 3091 02:20:26,160 --> 02:20:28,480 LESSER KNOWN. 3092 02:20:28,480 --> 02:20:30,160 WE HAVE VERY NICE NIH DATABASES 3093 02:20:30,160 --> 02:20:33,600 BUT THAT'S LIMITED TO PEOPLE WHO 3094 02:20:33,600 --> 02:20:37,640 APPLY TO NIH AND SOMETIMES SROs 3095 02:20:37,640 --> 02:20:43,160 THINK OF THOSE FUNDED BY NIH BUT 3096 02:20:43,160 --> 02:20:45,400 WE HAVE CAREER REVIEWERS AND 3097 02:20:45,400 --> 02:20:49,040 MULT PALT SOURCES AND NSF, DOE, 3098 02:20:49,040 --> 02:20:49,640 ALL THE FUNDED DATA GOES IN 3099 02:20:49,640 --> 02:20:54,960 THERE. 3100 02:20:54,960 --> 02:20:56,120 WE ENCOURAGE SOCIETY TO 3101 02:20:56,120 --> 02:21:00,720 RECOMMEND NAMES AND IT'S A NICE 3102 02:21:00,720 --> 02:21:03,880 EASY INTERFACE FOR SROs TO 3103 02:21:03,880 --> 02:21:04,640 SEARCH AND WE'RE HOPING ONE 3104 02:21:04,640 --> 02:21:07,560 THING IT WILL DO IS BROADEN WHO 3105 02:21:07,560 --> 02:21:09,320 THEY'RE TAPPING TO SERVE ON 3106 02:21:09,320 --> 02:21:13,760 COMMITTEES. 3107 02:21:13,760 --> 02:21:16,080 JUST A TOOL WILL NOT CHANGE THE 3108 02:21:16,080 --> 02:21:16,320 CULTURE. 3109 02:21:16,320 --> 02:21:17,720 WE SPENT A GOOD AMOUNT OF TIME 3110 02:21:17,720 --> 02:21:22,720 WORKING WITH STAFF ON RETHINKING 3111 02:21:22,720 --> 02:21:24,280 WHAT IT MEANS AND WHY WE MUST 3112 02:21:24,280 --> 02:21:25,480 HAVE DIVERSE PANELS. 3113 02:21:25,480 --> 02:21:28,160 IT'S NOT A CHECK BOX. 3114 02:21:28,160 --> 02:21:31,080 WE WANT TO MAKE SURE OUR STAFF 3115 02:21:31,080 --> 02:21:32,960 UNDERSTOOD THAT AND THEY DO AND 3116 02:21:32,960 --> 02:21:33,840 NIH NEEDS TO HEAR DIVERSE 3117 02:21:33,840 --> 02:21:35,400 PERSPECTIVES TO CARRY OUT THE 3118 02:21:35,400 --> 02:21:37,040 PEER REVIEW MISSION OF 3119 02:21:37,040 --> 02:21:37,640 IDENTIFYING THE BEST AND MOST 3120 02:21:37,640 --> 02:21:41,800 DISRUPTIVE SCIENCE. 3121 02:21:41,800 --> 02:21:45,720 AND BY DIVERSITY IT'S NOT JUST 3122 02:21:45,720 --> 02:21:46,320 DEMOGRAPHIC AND GEOGRAPHIC 3123 02:21:46,320 --> 02:21:48,440 THOUGH IT'S PART OF IT. 3124 02:21:48,440 --> 02:21:49,520 IT'S SCIENTIFIC BACKGROUND AND 3125 02:21:49,520 --> 02:21:49,840 PERSPECTIVE. 3126 02:21:49,840 --> 02:21:52,000 HAVE YOU FOUR PEOPLE WITH THE 3127 02:21:52,000 --> 02:21:54,680 SAME LINEAGE YOU'LL GET 3128 02:21:54,680 --> 02:21:55,720 DERIVATIVE HIGH IMPACT QUOTES 3129 02:21:55,720 --> 02:22:03,600 OUT OF THAT STUDY SECTION. 3130 02:22:03,600 --> 02:22:04,320 DEMOGRAPHIC AND GEOGRAPHIC AND 3131 02:22:04,320 --> 02:22:05,000 CAREER STAGE. 3132 02:22:05,000 --> 02:22:06,440 WE WANT PEOPLE AT DIFFERENT 3133 02:22:06,440 --> 02:22:07,400 CAREER STAGES AND DIFFERENT 3134 02:22:07,400 --> 02:22:12,640 LEVELS OF PEER REVIEW 3135 02:22:12,640 --> 02:22:12,960 EXPERIENCE. 3136 02:22:12,960 --> 02:22:14,440 WE WANT EXPERIENCED REVIEWERS 3137 02:22:14,440 --> 02:22:15,720 AND PEOPLE WE HAVEN'T TRIED OUT 3138 02:22:15,720 --> 02:22:15,960 BEFORE. 3139 02:22:15,960 --> 02:22:19,040 OUR STANDING STUDY SECTION 3140 02:22:19,040 --> 02:22:20,240 MEMBERSHIP HAS MULTIPLE LEVELS 3141 02:22:20,240 --> 02:22:20,840 OF OVERSIGHT. 3142 02:22:20,840 --> 02:22:26,120 I APPROVE EVERY MEMBER AND IT'S 3143 02:22:26,120 --> 02:22:28,120 APPROVED AND BEEN ENRICHED IN 3144 02:22:28,120 --> 02:22:29,240 DIVERSITY. 3145 02:22:29,240 --> 02:22:30,520 WE'RE FOCUSSING ON OUR SPECIAL 3146 02:22:30,520 --> 02:22:31,360 EMPHASIS PANEL WHICH A MATH 3147 02:22:31,360 --> 02:22:34,440 OUTER OF OUR MEETINGS AND IT'S 3148 02:22:34,440 --> 02:22:36,640 UNDERSTANDABLE THEY WERE LOWER 3149 02:22:36,640 --> 02:22:41,800 IN DIVERSITY BECAUSE THOSE ARE 3150 02:22:41,800 --> 02:22:46,960 AD HOC AND SROs NEED TO FIND 3151 02:22:46,960 --> 02:22:48,640 PEOPLE QUICKLY AND SO YOU GO TO 3152 02:22:48,640 --> 02:22:50,240 YOUR COMFORT ZONE AND WHERE THE 3153 02:22:50,240 --> 02:22:52,680 REVIEWER FINDER COMES IN TO HELP 3154 02:22:52,680 --> 02:22:52,880 THEM. 3155 02:22:52,880 --> 02:22:54,040 WE'VE BEEN RAISING COLLECTIVE 3156 02:22:54,040 --> 02:22:57,920 AWARENESS OF OUR STAFF, SETTING 3157 02:22:57,920 --> 02:22:58,880 EXPECTATIONS, DATA SHARING HAS 3158 02:22:58,880 --> 02:23:00,720 BEEN IMPORTANT AND THE TOOLS I 3159 02:23:00,720 --> 02:23:03,640 MENTIONED BEFORE. 3160 02:23:03,640 --> 02:23:05,800 THE MOST IMPORTANT ASPECT HAS 3161 02:23:05,800 --> 02:23:07,640 BEEN PEER-TO-PEER SHARING BY 3162 02:23:07,640 --> 02:23:08,160 SROs. 3163 02:23:08,160 --> 02:23:09,480 WE HAVE 275. 3164 02:23:09,480 --> 02:23:12,760 MANY ARE REALLY SKILLED AT 3165 02:23:12,760 --> 02:23:15,600 IDENTIFYING STRONG EXPERTS FROM 3166 02:23:15,600 --> 02:23:16,560 A DIVERSE POOL AND THEY'RE 3167 02:23:16,560 --> 02:23:20,640 SHARING WITH EACH OTHER. 3168 02:23:20,640 --> 02:23:22,360 HERE'S OUR DATA. 3169 02:23:22,360 --> 02:23:24,680 IF YOU LOOK AT THE TOP PLOT AND 3170 02:23:24,680 --> 02:23:27,000 IT STARTS IT'S EVERY ROUND 3171 02:23:27,000 --> 02:23:31,160 STARTING FROM OCTOBER 2019 TO 3172 02:23:31,160 --> 02:23:33,240 MAY 2023. 3173 02:23:33,240 --> 02:23:35,440 THE DARK BROWN LINE AT THE TOP 3174 02:23:35,440 --> 02:23:41,320 WITH WOMEN SHOWS YOU THE 3175 02:23:41,320 --> 02:23:43,280 PERCENTAGE OF WOMEN WHO ARE PIs 3176 02:23:43,280 --> 02:23:47,200 IN APPLICATIONS SUBMITTED TO 3177 02:23:47,200 --> 02:23:48,080 CSR. 3178 02:23:48,080 --> 02:23:50,440 IT MATCHES UP WITH NIH WIDE 3179 02:23:50,440 --> 02:23:53,320 BECAUSE WE'RE THE OVERWHELMING 3180 02:23:53,320 --> 02:23:53,600 MAJORITY. 3181 02:23:53,600 --> 02:24:02,720 IT'S AROUND 36% AND HADN'T 3182 02:24:02,720 --> 02:24:02,960 CHANGE. 3183 02:24:02,960 --> 02:24:08,920 THE RED LINE IS THE STANDING 3184 02:24:08,920 --> 02:24:10,440 MEMBERSHIP AND WE'RE NOW AT 3185 02:24:10,440 --> 02:24:12,920 ABOUT 45% OF OUR MEMBERS ARE 3186 02:24:12,920 --> 02:24:18,240 WOMEN. 3187 02:24:18,240 --> 02:24:19,880 SHE SPECIAL EMPHASIS PANEL YOU 3188 02:24:19,880 --> 02:24:24,680 CAN SEE STARTING AROUND OCTOBER 3189 02:24:24,680 --> 02:24:26,000 2020 THERE'S BEEN AN UPTAKE IN 3190 02:24:26,000 --> 02:24:33,320 THE NUMBER OF WOMEN SERVING. 3191 02:24:33,320 --> 02:24:36,640 THAT'S A RESULT OF OUR SROs 3192 02:24:36,640 --> 02:24:38,160 HAVING MORE RESOURCE TO TAP. 3193 02:24:38,160 --> 02:24:45,320 UNDER REPRESENTED MINORITIES. 3194 02:24:45,320 --> 02:24:48,960 AND CONTENT P.I. ARE UNDER 3195 02:24:48,960 --> 02:24:50,880 REPRESENTED MINORITIES MATCHING 3196 02:24:50,880 --> 02:24:51,960 NIH WIDE METRICS. 3197 02:24:51,960 --> 02:24:53,480 THE DARK BLUE LINE ARE MEMBERS 3198 02:24:53,480 --> 02:24:57,000 AND WE'RE UP TO ALMOST 18% UNDER 3199 02:24:57,000 --> 02:24:59,000 REPRESENTED MINORITIES IN STUDY 3200 02:24:59,000 --> 02:25:03,920 SECTION MEMBER. 3201 02:25:03,920 --> 02:25:08,440 THIS WAS EVEN LOWER OF THE BFG 3202 02:25:08,440 --> 02:25:10,320 BASELINE OF THE APPLICANT POOL 3203 02:25:10,320 --> 02:25:12,720 AND THEN THINGS STARTED CHANGING 3204 02:25:12,720 --> 02:25:15,160 AND WE'RE UP TO ABOUT 13% SEP 3205 02:25:15,160 --> 02:25:15,440 REVIEWERS. 3206 02:25:15,440 --> 02:25:17,320 ONE THING TO NOTE IS THAT WHEN 3207 02:25:17,320 --> 02:25:19,960 WE HAVE MORE SEP REVIEWERS WHO 3208 02:25:19,960 --> 02:25:22,080 ARE TRIED OUT AND THEY DO A GOOD 3209 02:25:22,080 --> 02:25:24,560 JOB THEY'RE MORE LIKELY TO MAKE 3210 02:25:24,560 --> 02:25:27,360 IT TO MEMBERSHIP. 3211 02:25:27,360 --> 02:25:32,440 THEY'RE ALL LINKED. 3212 02:25:32,440 --> 02:25:36,240 WE HAVE A COMPREHENSIVE WEBSITE 3213 02:25:36,240 --> 02:25:38,920 AND YOU CAN READ AT YOUR 3214 02:25:38,920 --> 02:25:39,160 LEISURE. 3215 02:25:39,160 --> 02:25:49,600 HAPPY TO ANSWER QUESTIONS. 3216 02:25:55,120 --> 02:25:57,320 >> HOW DO YOU FEEL WITH LESS 3217 02:25:57,320 --> 02:25:59,200 EXPERIENCED REVIEWERS? 3218 02:25:59,200 --> 02:26:00,720 IN MY EXPERIENCE THERE'S A 3219 02:26:00,720 --> 02:26:10,880 HARSHNESS. 3220 02:26:11,680 --> 02:26:17,960 WE ARE -- WE HAVE AN OFFICE 3221 02:26:17,960 --> 02:26:19,520 DEVOTED TO TRAINING. 3222 02:26:19,520 --> 02:26:20,920 WE HAVE A STRONG REVIEWER 3223 02:26:20,920 --> 02:26:22,320 TRAINING RESOURCES THAT ARE 3224 02:26:22,320 --> 02:26:22,680 CENTRALIZED. 3225 02:26:22,680 --> 02:26:24,640 PART OF REVIEWER TRAINING IS 3226 02:26:24,640 --> 02:26:26,840 ALSO SRO TRAINING. 3227 02:26:26,840 --> 02:26:30,600 THE OFFICE ALSO HAS A STRONG SRO 3228 02:26:30,600 --> 02:26:32,360 TRAINING COMPONENT FOR NEW AS 3229 02:26:32,360 --> 02:26:36,920 WELL AS CONTINUING SROs. 3230 02:26:36,920 --> 02:26:39,760 I AGREE IN TERMS OF HARSH. 3231 02:26:39,760 --> 02:26:42,440 I'VE HAD A LOT OF EXPERIENCE 3232 02:26:42,440 --> 02:26:43,760 THAT INCLUDES STUDY SECTIONS 3233 02:26:43,760 --> 02:26:45,440 OVER THE YEARS, I'M NOT SURE THE 3234 02:26:45,440 --> 02:26:52,120 SENIOR PEOPLE ARE ALL THAT MUCH 3235 02:26:52,120 --> 02:27:02,320 BETTER AND WE'RE TRAINING OUR 3236 02:27:02,320 --> 02:27:06,320 VOs TO READ THE CRITIQUE WHEN 3237 02:27:06,320 --> 02:27:09,840 THEY OFFER FEEDBACK. 3238 02:27:09,840 --> 02:27:11,280 WE HAVE JUNIOR REVIEWERS THAT 3239 02:27:11,280 --> 02:27:12,960 ARE NOT THAT GOOD AND SAME COULD 3240 02:27:12,960 --> 02:27:23,480 BE SAID FOR SENIOR REVIEWERS. 3241 02:27:27,920 --> 02:27:28,000 3242 02:27:28,000 --> 02:27:28,840 >> ARE YOU GOING TO BE DOING 3243 02:27:28,840 --> 02:27:30,720 OUTREACH TO THE INSTITUTIONS BUT 3244 02:27:30,720 --> 02:27:31,760 IT SEEMS PART OF THE PROBLEM THE 3245 02:27:31,760 --> 02:27:33,360 CULTURE AT SOME INSTITUTIONS 3246 02:27:33,360 --> 02:27:37,200 THEY KNOW ABOUT THESE AND THEY 3247 02:27:37,200 --> 02:27:40,160 ENCOURAGE THEM AND OTHERS DON'T 3248 02:27:40,160 --> 02:27:43,200 KNOW ABOUT THEM OR BY CHANCE. 3249 02:27:43,200 --> 02:27:44,640 IT SEEMS THEY HAVE TO START AT 3250 02:27:44,640 --> 02:27:45,240 THE INSTITUTION TO HAVE A 3251 02:27:45,240 --> 02:27:54,480 CULTURE SHIFT. 3252 02:27:54,480 --> 02:28:01,320 AND THIS IS BY THE DIVISION OF 3253 02:28:01,320 --> 02:28:02,280 WORKFORCE DEVELOPMENT AND 3254 02:28:02,280 --> 02:28:03,360 THERE'S A MULTIPRONGED EFFORT 3255 02:28:03,360 --> 02:28:05,680 ONE TO LOOK AT REVIEW BUT IT'S 3256 02:28:05,680 --> 02:28:06,960 NOT GOING TO SOLVE EVERYTHING. 3257 02:28:06,960 --> 02:28:08,160 THAT OUTREACH AND INCREASING THE 3258 02:28:08,160 --> 02:28:09,560 NUMBER OF APPLICANTS FROM THE 3259 02:28:09,560 --> 02:28:10,520 INSTITUTIONS IS A BIG PRIORITY. 3260 02:28:10,520 --> 02:28:19,680 YES. 3261 02:28:19,680 --> 02:28:21,360 >> THANKS TO AN INTERESTING TALK 3262 02:28:21,360 --> 02:28:27,040 I HAD A QUESTION ABOUT THE 3263 02:28:27,040 --> 02:28:37,360 ADDITIONAL CRITERIA. 3264 02:28:42,480 --> 02:28:45,560 >> IT'S AN ADDITIONAL REVIEW 3265 02:28:45,560 --> 02:28:54,360 CRITERION THAT REMAINS. 3266 02:28:54,360 --> 02:28:55,880 >> DR. DICKERSON. 3267 02:28:55,880 --> 02:29:06,160 >> YOU'RE MUTED. 3268 02:29:22,200 --> 02:29:24,720 >> THANK YOU, FOR AN AMAZING 3269 02:29:24,720 --> 02:29:25,040 PRESENTATION. 3270 02:29:25,040 --> 02:29:26,280 I HAVE GENERAL COMMENTS. 3271 02:29:26,280 --> 02:29:28,120 I REALLY -- 3272 02:29:28,120 --> 02:29:29,480 >> I CAN'T HEAR -- YOU'RE STILL 3273 02:29:29,480 --> 02:29:29,680 MUTED. 3274 02:29:29,680 --> 02:29:37,640 SORRY. 3275 02:29:37,640 --> 02:29:38,440 >> SOME CAN CAN HEAR, OTHERS 3276 02:29:38,440 --> 02:29:41,120 CANNOT. 3277 02:29:41,120 --> 02:29:51,600 EVERYONE ON VIDEO IS MUTED. 3278 02:29:55,520 --> 02:29:57,720 >> YOU CAN COME BACK TO ME. 3279 02:29:57,720 --> 02:30:04,880 MAYBE IT WILL COME BACK ON. 3280 02:30:04,880 --> 02:30:05,840 >> WE HAVE ONE QUESTION IN THE 3281 02:30:05,840 --> 02:30:13,720 CHAT. 3282 02:30:13,720 --> 02:30:21,320 >> ARE YOU CONCERNED THAT ONLY 3283 02:30:21,320 --> 02:30:23,760 2021 MAY HAVE SLIGHTLY 3284 02:30:23,760 --> 02:30:24,880 EXACERBATED THE TREND WITH 3285 02:30:24,880 --> 02:30:26,680 INSTITUTIONS AND P.I.s MAY HAVE 3286 02:30:26,680 --> 02:30:28,880 BEEN ABLE TO BETTER WEATHER THE 3287 02:30:28,880 --> 02:30:30,760 UNCERTAINTY DURING THAT TIME 3288 02:30:30,760 --> 02:30:30,960 FRAME. 3289 02:30:30,960 --> 02:30:33,320 I TRUST THE RESULTS BUT I WONDER 3290 02:30:33,320 --> 02:30:36,760 HOW THE APPLICATIONS LOOK IN 3291 02:30:36,760 --> 02:30:37,040 2019. 3292 02:30:37,040 --> 02:30:37,960 I ASSUME THIS ALL RELATES TO THE 3293 02:30:37,960 --> 02:30:42,280 PANDEMIC. 3294 02:30:42,280 --> 02:30:42,440 >> 3295 02:30:42,440 --> 02:30:43,520 >> THAT'S AN INTERESTING POINT. 3296 02:30:43,520 --> 02:30:48,320 WE GENERATE THE DATA BECAUSE THE 3297 02:30:48,320 --> 02:30:49,520 WORKING GROUP WAS MEETING AND 3298 02:30:49,520 --> 02:30:50,520 PRESSURED OUT TO PROVIDE THE 3299 02:30:50,520 --> 02:30:50,920 DATA. 3300 02:30:50,920 --> 02:30:52,160 WE LOOKED AT THE YEAR WE HAD. 3301 02:30:52,160 --> 02:30:53,960 IT WOULD BE INTERESTING TO SEE 3302 02:30:53,960 --> 02:30:56,040 HOW THINGS CHANGE BUT THE TREND 3303 02:30:56,040 --> 02:30:57,160 IS SO STARK I CAN'T IMAGINE 3304 02:30:57,160 --> 02:30:59,480 WE'LL SEE A COMPLETE HISTORY OR 3305 02:30:59,480 --> 02:31:00,600 TURNAROUND BUT THAT'S A REALLY 3306 02:31:00,600 --> 02:31:05,320 GOOD POINT AND WE SHOULD LOOK AT 3307 02:31:05,320 --> 02:31:15,680 A BROADER SET OF DATA. 3308 02:31:16,440 --> 02:31:19,480 >> IS THERE ANY SPECIAL TRAINING 3309 02:31:19,480 --> 02:31:21,320 IN THE EFFORT TO REDUCE BIAS? 3310 02:31:21,320 --> 02:31:26,960 >> YES, FIRST OF ALL WE REQUIRED 3311 02:31:26,960 --> 02:31:28,800 BIAS TRAINING FOR CHAIRS. 3312 02:31:28,800 --> 02:31:29,840 WE REQUIRED ALL OF OUR CHAIRS TO 3313 02:31:29,840 --> 02:31:32,400 TAKE THE TRAINING FOR REVIEWERS 3314 02:31:32,400 --> 02:31:33,600 IT WAS ONLY RECOMMENDED THOUGH 3315 02:31:33,600 --> 02:31:35,240 WE STRONGLY ENCOURAGED AND MOST 3316 02:31:35,240 --> 02:31:37,800 OF THEM DID COMPLETE IT. 3317 02:31:37,800 --> 02:31:39,640 FOR CHAIRS IT WAS REQUIRED AND 3318 02:31:39,640 --> 02:31:41,360 DURING OUR ORIENTATION SESSIONS 3319 02:31:41,360 --> 02:31:43,400 THERE'S A SPECIAL SESSION WHERE 3320 02:31:43,400 --> 02:31:46,440 WE TALK ABOUT BIAS AND HOW TO 3321 02:31:46,440 --> 02:31:47,920 MANAGE WHEN IT'S HAPPENING IN 3322 02:31:47,920 --> 02:31:50,520 REAL TIME IN THE STUDY SECTION. 3323 02:31:50,520 --> 02:31:53,200 HOW TO ENSURE INCLUSIVE VOICES 3324 02:31:53,200 --> 02:31:55,480 ARE BEING HEARD AND CALLED ON 3325 02:31:55,480 --> 02:31:57,160 FOR QUIETER PEOPLE ARE SOMETIMES 3326 02:31:57,160 --> 02:31:58,640 MORE INSIGHTFUL. 3327 02:31:58,640 --> 02:31:59,720 SO WE SPEND A FAIR AMOUNT OF 3328 02:31:59,720 --> 02:32:10,160 TIME TRAINING OUR CHAIRS. 3329 02:32:14,800 --> 02:32:17,280 >> THOSE ON ZOOM CAN HEAR EACH 3330 02:32:17,280 --> 02:32:19,200 OTHER BUT THERE'S A PROBLEM WITH 3331 02:32:19,200 --> 02:32:20,480 AUDIO IN THE ROOM WHICH IS WHY 3332 02:32:20,480 --> 02:32:22,520 WE CANNOT HEAR YOU IN THE ROOM. 3333 02:32:22,520 --> 02:32:24,240 BECAUSE OF THIS FOR RIGHT NOW IF 3334 02:32:24,240 --> 02:32:25,360 YOU CAN PUT YOUR QUESTIONS IN 3335 02:32:25,360 --> 02:32:28,000 THE CHAT, I CAN SEE THEM AND 3336 02:32:28,000 --> 02:32:38,280 I'LL READ THEM. 3337 02:32:57,280 --> 02:32:59,560 >> THIS HAS BEEN A GREAT 3338 02:32:59,560 --> 02:33:00,320 REPRESENTATION AND AN APPRECIATE 3339 02:33:00,320 --> 02:33:02,120 YOUR DEEP DIVE TOO THE PANELS 3340 02:33:02,120 --> 02:33:09,760 AND HOW IT'S SKEWED THE ABILITY 3341 02:33:10,040 --> 02:33:11,680 TO BE PART OF THE PROCESS. 3342 02:33:11,680 --> 02:33:13,720 REALLY EXCELLENT THE CHANGES AND 3343 02:33:13,720 --> 02:33:15,400 SUGGESTIONS AND I APPLAUD YOU. 3344 02:33:15,400 --> 02:33:18,200 I'LL TRY TO CATCH YOU AFTER THE 3345 02:33:18,200 --> 02:33:21,640 MEETING TO DISCUSS A FEW OTHER 3346 02:33:21,640 --> 02:33:22,440 THOUGHTS I HAVE. 3347 02:33:22,440 --> 02:33:22,880 GREAT PRESENTATION. 3348 02:33:22,880 --> 02:33:24,000 THANK YOU FOR SHARING THE DATA 3349 02:33:24,000 --> 02:33:25,680 AND I LOOK FORWARD TO THE 3350 02:33:25,680 --> 02:33:31,160 PROCESS GOING FORWARD. 3351 02:33:31,160 --> 02:33:33,720 >> THANK YOU, AND I WOULD 3352 02:33:33,720 --> 02:33:35,600 ENCOURAGE ALL OF TO YOU SHARE 3353 02:33:35,600 --> 02:33:38,120 WITH YOUR COMMUNITIES IF YOU 3354 02:33:38,120 --> 02:33:39,560 WANT US TO TALK TO YOU THERE'S 3355 02:33:39,560 --> 02:33:42,720 PEOPLE HAPPY TO ENGAGE WITH YOUR 3356 02:33:42,720 --> 02:33:53,240 INSTITUTIONS AND COMMUNITIES. 3357 02:34:18,080 --> 02:34:20,920 >> ALL RIGHT, WE NEED TO KEEP 3358 02:34:20,920 --> 02:34:21,200 THE CHAT. 3359 02:34:21,200 --> 02:34:24,720 IT'S NOT FIXABLE. 3360 02:34:24,720 --> 02:34:35,040 SORRY ABOUT THAT. 3361 02:34:37,640 --> 02:34:38,960 EVERYBODY IN THE ZOOM, DID YOU 3362 02:34:38,960 --> 02:34:39,520 HAVE A CHANCE TO ASK YOUR 3363 02:34:39,520 --> 02:34:49,680 QUESTIONS? 3364 02:34:53,960 --> 02:34:54,920 >> I WANT TO APPLAUD YOU FOR 3365 02:34:54,920 --> 02:35:00,680 TAKING THIS ON. 3366 02:35:00,680 --> 02:35:11,240 TO DO IT IN SUCH A SYSTEMATIC, 3367 02:35:14,240 --> 02:35:17,400 STEP BY STEP PROCESS IN A 3368 02:35:17,400 --> 02:35:18,680 THOUGHTFUL AND PROVIDING 3369 02:35:18,680 --> 02:35:21,720 CONFIDENCE IN THE OVER ALL 3370 02:35:21,720 --> 02:35:22,000 ENTERPRISE. 3371 02:35:22,000 --> 02:35:27,200 THAT'S KIND OF WHAT I WOULD 3372 02:35:27,200 --> 02:35:33,920 ASSUME WILL BE THE OVER ALL 3373 02:35:33,920 --> 02:35:35,720 OUTCOME ONCE IT'S DONE. 3374 02:35:35,720 --> 02:35:37,120 DO YOU HAVE A SENSE GENERAL 3375 02:35:37,120 --> 02:35:39,280 SKEPTICISM ABOUT REVIEW HAS 3376 02:35:39,280 --> 02:35:40,040 STARTED TO CHANGE OR IS 3377 02:35:40,040 --> 02:35:42,960 SOMETHING THAT IS GOING TO TAKE 3378 02:35:42,960 --> 02:35:49,600 MORE TIME AND WHEN DO YOU THINK 3379 02:35:49,600 --> 02:35:53,960 IN YOUR WILDEST DREAMS THAT 3380 02:35:53,960 --> 02:35:54,880 WOULD HAPPEN? 3381 02:35:54,880 --> 02:35:56,480 >> I'VE BEEN WITH REVIEW FOR A 3382 02:35:56,480 --> 02:36:01,640 LONG TIME AND THE MORE WE DO IN 3383 02:36:01,640 --> 02:36:03,800 BEING TRANSPARENT AND 3384 02:36:03,800 --> 02:36:04,320 COMMUNICATING. 3385 02:36:04,320 --> 02:36:06,480 ONE THING WE DID WAS SET UP AN 3386 02:36:06,480 --> 02:36:11,320 OFFICE OF COMMUNICATION AND 3387 02:36:11,320 --> 02:36:13,400 OUTREACH AND ENGAGING A LOT WITH 3388 02:36:13,400 --> 02:36:14,560 THE EXTERNAL COMMUNITY AND 3389 02:36:14,560 --> 02:36:15,600 TALKING DIRECTLY TO THE 3390 02:36:15,600 --> 02:36:21,320 COMMUNITY SO WE HAVE PEOPLE WHO 3391 02:36:21,320 --> 02:36:24,840 CAN CORRECT MISIMPRESSIONS. 3392 02:36:24,840 --> 02:36:26,360 THERE'S REAL ISSUES. 3393 02:36:26,360 --> 02:36:27,720 ANY TIME HAVE YOU 19,000 HUMAN 3394 02:36:27,720 --> 02:36:33,320 BEINGS YOU WON'T BE ISSUE FREE. 3395 02:36:33,320 --> 02:36:35,400 IT'S WHEN PEOPLE BRING UP STUFF 3396 02:36:35,400 --> 02:36:38,160 FROM 1982 AND ASK ME ABOUT THAT 3397 02:36:38,160 --> 02:36:39,520 TELLS ME WE'RE NOT COMMUNICATING 3398 02:36:39,520 --> 02:36:45,840 AND ENGAGING ENOUGH. 3399 02:36:45,840 --> 02:36:48,680 I DON'T HAVE AN ANSWER TO YOUR 3400 02:36:48,680 --> 02:36:58,880 QUESTION. 3401 02:37:40,200 --> 02:37:42,440 WE SHOWED THE CSR DATA AND MAPS 3402 02:37:42,440 --> 02:37:44,240 ON TO THE NIH-WIDE DATA. 3403 02:37:44,240 --> 02:37:47,840 I THINK WE'RE TALKING ABOUT 3404 02:37:47,840 --> 02:37:50,280 BREAKDOWN AS IN BLACK AFRICAN 3405 02:37:50,280 --> 02:37:52,120 AMERICANS OR HISPANIC. 3406 02:37:52,120 --> 02:37:55,120 IT'S PRETTY LOW AND A FLAT LINE. 3407 02:37:55,120 --> 02:37:56,080 SO ON OUR WEBSITE WE HAVE THE 3408 02:37:56,080 --> 02:38:06,160 DATA. 3409 02:38:15,400 --> 02:38:19,360 I THINK IT'S 1 1/2 BUT POSTED ON 3410 02:38:19,360 --> 02:38:21,320 OUR WEBSITE AND WELL UNDER 5% 3411 02:38:21,320 --> 02:38:23,000 AND HASN'T MOVED. 3412 02:38:23,000 --> 02:38:26,680 I THINK OUR BIG ISSUE IS NOT AS 3413 02:38:26,680 --> 02:38:28,080 MUCH THE PEER REVIEW COMMITTEES 3414 02:38:28,080 --> 02:38:30,240 WHICH WE'RE GETTING TO A POINT 3415 02:38:30,240 --> 02:38:32,520 OF SATURATION IS GETTING MORE 3416 02:38:32,520 --> 02:38:33,320 APPLICANTS IN FROM THOSE 3417 02:38:33,320 --> 02:38:43,520 COMMUNITIES. 3418 02:39:04,440 --> 02:39:06,240 >> THANK YOU FOR YOUR 3419 02:39:06,240 --> 02:39:06,560 PRESENTATION. 3420 02:39:06,560 --> 02:39:08,320 I KNOW IT WILL PROMPT US TO KEEP 3421 02:39:08,320 --> 02:39:11,680 TRACK OF WHAT YOU'RE DOING AT 3422 02:39:11,680 --> 02:39:13,720 CSR AND WHAT YOU'RE DOING AND OF 3423 02:39:13,720 --> 02:39:16,080 COURSE WHAT'S GOING TO HAPPEN 3424 02:39:16,080 --> 02:39:22,880 WITH THESE REVIEW CRITERIA. 3425 02:39:22,880 --> 02:39:30,320 I'M SURE THESE ARE AN 3426 02:39:30,320 --> 02:39:30,760 EXPERIMENT. 3427 02:39:30,760 --> 02:39:34,440 >> WE'LL DO AN EVALUATION. 3428 02:39:34,440 --> 02:39:35,920 WE HAVE TO EVALUATE HOW WELL 3429 02:39:35,920 --> 02:39:38,760 THEY'RE WORKING. 3430 02:39:38,760 --> 02:39:41,320 >> TO BE CONTINUED. 3431 02:39:41,320 --> 02:39:50,320 THANK YOU VERY MUCH. 3432 02:39:50,320 --> 02:39:52,400 >> THEY'RE COMBINING THE REVIEW 3433 02:39:52,400 --> 02:39:52,640 CRITERIA. 3434 02:39:52,640 --> 02:39:54,560 I WAS FASCINATED SEEING THIS 3435 02:39:54,560 --> 02:39:57,760 BECAUSE THIS IS HOW WE WRITE OUR 3436 02:39:57,760 --> 02:39:58,000 RESUME. 3437 02:39:58,000 --> 02:40:02,960 HOW WE COMBINE IT. 3438 02:40:02,960 --> 02:40:05,840 IT MAKES PERFECT SENSE HOW YOU 3439 02:40:05,840 --> 02:40:16,320 GROUP THEM AND CHANGE THEM. 3440 02:40:18,240 --> 02:40:22,080 NOW WE HAVE A FIVE-MINUTE BREAK 3441 02:40:22,080 --> 02:40:24,520 >> WE'RE PLEASED TO 3442 02:40:24,520 --> 02:40:26,560 PRESENT CONCEPT FOR THE NEXT 3443 02:40:26,560 --> 02:40:29,880 ITERATION OF THE CARBON PROGRAM 3444 02:40:29,880 --> 02:40:32,360 AND BARBARA WILL START AND I'LL 3445 02:40:32,360 --> 02:40:33,720 PICK UP IN A FEW MINUTES. 3446 02:40:33,720 --> 02:40:35,920 GO AHEAD AND GET STARTED. 3447 02:40:35,920 --> 02:40:38,320 >> I WANT TO START BY THANKING 3448 02:40:38,320 --> 02:40:40,720 THE COUNCIL MEMBERS FOR THEIR 3449 02:40:40,720 --> 02:40:43,000 INPUT ON THE CAN CONCEPT AND 3450 02:40:43,000 --> 02:40:45,320 POINTING OUT I'M AT THE OFFICE 3451 02:40:45,320 --> 02:40:47,280 OF DIETARY SUPPLEMENTS. 3452 02:40:47,280 --> 02:40:49,440 THIS IS ONE OF NIH'S RESEARCH 3453 02:40:49,440 --> 02:40:49,880 COORDINATING OFFICES. 3454 02:40:49,880 --> 02:40:56,960 I'M GRATEFUL NOT ONLY TO MY ODS 3455 02:40:56,960 --> 02:40:58,160 COLLEAGUES AND NCCIH WHICH HAS 3456 02:40:58,160 --> 02:41:00,560 BEEN OUR PRIMARY COLLABORATOR ON 3457 02:41:00,560 --> 02:41:01,760 THIS INITIATIVE SINCE THE 3458 02:41:01,760 --> 02:41:03,080 BEGINNING AS WELL AS COLLEAGUES 3459 02:41:03,080 --> 02:41:06,080 AT NATIONAL CANCER CENTER, NIEHS 3460 02:41:06,080 --> 02:41:14,320 AND NIA AND THE EXPERT PANELS 3461 02:41:14,320 --> 02:41:17,600 AND INVESTIGATORS WHO MAKE THE 3462 02:41:17,600 --> 02:41:24,680 PROGRAM AS STRONGZ AS THE MOST 3463 02:41:24,680 --> 02:41:26,200 EXPERT PANEL AND I'LL GIVE 3464 02:41:26,200 --> 02:41:27,080 BACKGROUND FOR THE PRESENTATION. 3465 02:41:27,080 --> 02:41:28,400 SINCE THE BEGINNING IN ADDITION 3466 02:41:28,400 --> 02:41:32,320 TO BEING A COLLABORATION AS WE 3467 02:41:32,320 --> 02:41:36,920 HAVE A COORDINATING OFFICE, THE 3468 02:41:36,920 --> 02:41:39,560 OVER ARCHING FOCUS HAS BEEN -- 3469 02:41:39,560 --> 02:41:42,160 >> BARBARA, I'M SORRY FOR SOME 3470 02:41:42,160 --> 02:41:44,360 REASON IT'S DEAFENING. 3471 02:41:44,360 --> 02:41:46,000 CAN YOU SPEAK A LITTLE SOFTER 3472 02:41:46,000 --> 02:41:48,120 BECAUSE WE CAN'T CONTROL THE 3473 02:41:48,120 --> 02:41:49,080 VOLUME IN THE ROOM. 3474 02:41:49,080 --> 02:41:51,600 >> IS THAT BETTER? 3475 02:41:51,600 --> 02:41:53,840 I'M USED TO HAVING TROUBLE BEING 3476 02:41:53,840 --> 02:41:54,640 HEARD. 3477 02:41:54,640 --> 02:41:54,920 HOW'S THAT? 3478 02:41:54,920 --> 02:41:55,200 >> BETTER. 3479 02:41:55,200 --> 02:41:57,480 THANK YOU. 3480 02:41:57,480 --> 02:41:59,720 >> SINCE THE BEGINNING OF THE 3481 02:41:59,720 --> 02:42:01,280 PROGRAM THE OVER ARCHING FOLKS 3482 02:42:01,280 --> 02:42:02,880 HAS BEEN ON TRANS DISCIPLINARY 3483 02:42:02,880 --> 02:42:06,000 RESEARCH TO UNDERSTAND THE 3484 02:42:06,000 --> 02:42:12,200 EFFECTS ON INGESTED CHEMICALLY 3485 02:42:12,200 --> 02:42:15,320 DIGESTED PRODUCTS IN FOODS AND 3486 02:42:15,320 --> 02:42:16,960 IN THE LEGAL DEFINITION OF 3487 02:42:16,960 --> 02:42:17,960 DIETARY SUPPLEMENTS IN THE 3488 02:42:17,960 --> 02:42:19,640 U.S. AS IS THE FOCUS ON HEALTH 3489 02:42:19,640 --> 02:42:25,280 AND RESILIENCE OUTCOMES AND THE 3490 02:42:25,280 --> 02:42:26,880 LATTER ALIGNED WITH THE NICHD 3491 02:42:26,880 --> 02:42:28,560 RESEARCH PRIORITIES. 3492 02:42:28,560 --> 02:42:29,480 APPROXIMATELY EVERY DECADE WE 3493 02:42:29,480 --> 02:42:31,040 BROUGHT IN A PANEL OF OUTSIDE 3494 02:42:31,040 --> 02:42:34,280 EXPERTS TO ADVISE US ON THE 3495 02:42:34,280 --> 02:42:35,760 STRENGTHS, WEAKNESSES AND 3496 02:42:35,760 --> 02:42:40,880 PROMISING FUTURE RESEARCH 3497 02:42:40,880 --> 02:42:41,640 DIRECTIONS. 3498 02:42:41,640 --> 02:42:43,520 THE SPECIFIC APPROACH HAVE 3499 02:42:43,520 --> 02:42:45,480 EVOLVED OVER TIME IN RESPONSE TO 3500 02:42:45,480 --> 02:42:48,920 THE EXPERT PANELS AND THE NEW 3501 02:42:48,920 --> 02:42:49,880 TECHNOLOGICAL OPPORTUNITIES AND 3502 02:42:49,880 --> 02:42:51,160 THE SHIFTING NEEDS OF THE 3503 02:42:51,160 --> 02:42:52,120 RESEARCH FIELD. 3504 02:42:52,120 --> 02:42:54,720 WHILE THE PROGRAM HAS ALSO 3505 02:42:54,720 --> 02:42:56,080 ALWAYS HAD A FOCUS ON MECHANISMS 3506 02:42:56,080 --> 02:43:02,320 OF ACTIONS OF THESE PRODUCTS THE 3507 02:43:02,320 --> 02:43:05,800 SPECIFIC APPROACHES TAKEN HAVE 3508 02:43:05,800 --> 02:43:07,160 EVOLVED IN PARTICULAR THE EARLY 3509 02:43:07,160 --> 02:43:09,000 YEARS OF THE PROGRAM THE CARBON 3510 02:43:09,000 --> 02:43:13,200 AND OTHERS AT NIH FOCUSSED ON 3511 02:43:13,200 --> 02:43:16,520 PHASE 3 EFFICACY TRIALS OF 3512 02:43:16,520 --> 02:43:16,800 BOTANICALS. 3513 02:43:16,800 --> 02:43:21,360 MOST WERE NOT PART OF LOW CARBON 3514 02:43:21,360 --> 02:43:22,400 PROGRAM BUT 50 SUCH TRIALS. 3515 02:43:22,400 --> 02:43:24,640 WHAT WE LEARNED IS NOT WHETHER 3516 02:43:24,640 --> 02:43:32,000 THEY WORKED OUT OR NOT BUT AND 3517 02:43:32,000 --> 02:43:33,360 OTHER MECHANISMS OF ACTION AND 3518 02:43:33,360 --> 02:43:37,320 THE DATA WE DID HAVE WERE NOT 3519 02:43:37,320 --> 02:43:40,800 RIGOROUS ENOUGH TO TO SUPPORT 3520 02:43:40,800 --> 02:43:42,120 THE CLINICAL TRIALS AND MOST DID 3521 02:43:42,120 --> 02:43:44,160 NOT SHARE THE EXPECTED BENEFIT. 3522 02:43:44,160 --> 02:43:45,280 WE DIDN'T HAVE ENOUGH 3523 02:43:45,280 --> 02:43:45,880 INFORMATION TO UNDERSTAND WHY 3524 02:43:45,880 --> 02:43:51,560 NOT. 3525 02:43:51,560 --> 02:43:54,240 AND WE MOVED TO THE FOCUS OF THE 3526 02:43:54,240 --> 02:43:56,320 PROGRAM ON FILLING IN THE GAPS 3527 02:43:56,320 --> 02:43:58,200 AND UNDERSTANDING THE MECHANISMS 3528 02:43:58,200 --> 02:44:00,680 MOST CRITICAL TO DESIGNING AND 3529 02:44:00,680 --> 02:44:02,200 INTERPRETING A CLINICAL TRIAL SO 3530 02:44:02,200 --> 02:44:06,560 AN INCREASED FOCUS ON ELUCID 3531 02:44:06,560 --> 02:44:09,960 ELUCIDATING CHEMISTRY AND WHAT 3532 02:44:09,960 --> 02:44:12,880 CHEMISTRY WAS NEEDED TO 3533 02:44:12,880 --> 02:44:15,800 MANIPULATE AND UNDERSTAND 3534 02:44:15,800 --> 02:44:18,840 EXACTLY WHAT CLINICALLY 3535 02:44:18,840 --> 02:44:19,920 ACCESSIBLE OUTCOMES THOSE 3536 02:44:19,920 --> 02:44:21,400 AFFECTED TO FACILITATE THIS WE 3537 02:44:21,400 --> 02:44:23,000 ADDED ON THE RIGHT OF THE SLIDE 3538 02:44:23,000 --> 02:44:25,040 TO THE BOTANICAL DIETARY 3539 02:44:25,040 --> 02:44:27,600 SUPPLEMENT RESEARCH CENTERS THAT 3540 02:44:27,600 --> 02:44:28,560 FORMED A PART OF THE PROGRAM 3541 02:44:28,560 --> 02:44:33,040 FROM THE BEGINNING, CENTERS 3542 02:44:33,040 --> 02:44:33,440 FOR 3543 02:44:33,440 --> 02:44:35,320 FOCUSSED ON DEVELOPING RESOURCES 3544 02:44:35,320 --> 02:44:38,840 AND METHODS FOR ELUCIDATION OF 3545 02:44:38,840 --> 02:44:40,680 THE CHEMISTRY AND WHICH 3546 02:44:40,680 --> 02:44:44,320 CHEMISTRY WAS NEEDED TO ACT ON 3547 02:44:44,320 --> 02:44:47,800 WHICH BIOLOGICAL SYSTEMS. 3548 02:44:47,800 --> 02:44:49,160 THE SEPARATELY COMPETING 3549 02:44:49,160 --> 02:44:50,200 PROJECTS DIVERSIFIED THE BIOLOGY 3550 02:44:50,200 --> 02:44:52,240 TO BE STUDIED IN THE PROGRAM AS 3551 02:44:52,240 --> 02:44:53,480 WELL AS THE INSTITUTIONS AND 3552 02:44:53,480 --> 02:44:54,920 INVESTIGATORS PARTICIPATING IN 3553 02:44:54,920 --> 02:44:55,720 THE PROGRAM AND CRAIG WILL TAKE 3554 02:44:55,720 --> 02:45:06,080 THE BALL FROM HERE. 3555 02:45:09,400 --> 02:45:13,040 >> THERE'S BEEN A DUAL FOCUS 3556 02:45:13,040 --> 02:45:15,000 CONDUCTING TRANSLATIONALLY 3557 02:45:15,000 --> 02:45:17,560 RELEVANT RESEARCH ON BOTANICALS 3558 02:45:17,560 --> 02:45:19,920 AN COMPLEX PLANT MIXTURES. 3559 02:45:19,920 --> 02:45:22,280 ALSO, THERE'S BEEN A HEAVY 3560 02:45:22,280 --> 02:45:23,240 COMPONENT ON DEVELOPING NOVEL 3561 02:45:23,240 --> 02:45:30,320 METHODOLOGIES AND TECHNOLOGIES. 3562 02:45:30,320 --> 02:45:32,440 WITH RECENT EXPERT PANELS WERE 3563 02:45:32,440 --> 02:45:33,280 LARGELY SUPPORTIVE OF CONTINUING 3564 02:45:33,280 --> 02:45:35,320 THE DUAL APPROACH FOR THE 3565 02:45:35,320 --> 02:45:38,160 PROGRAM BUT THEY DID HAVE A 3566 02:45:38,160 --> 02:45:39,800 NUMBER OF SUGGESTION AND IDEAS 3567 02:45:39,800 --> 02:45:42,240 FOR HOW WE COULD STRENGTHEN THE 3568 02:45:42,240 --> 02:45:43,800 PROGRAM AND WE CERTAINLY GAVE 3569 02:45:43,800 --> 02:45:45,040 THOSE A LOT OF WEIGHT IN COMING 3570 02:45:45,040 --> 02:45:46,280 UP WITH THE CONCEPT. 3571 02:45:46,280 --> 02:45:48,400 WE ALSO HAD OUR EYES FIRMLY ON 3572 02:45:48,400 --> 02:45:50,800 OUR STRATEGIC PLAN AT ODS AND 3573 02:45:50,800 --> 02:45:55,480 NICHD AND WITH THAT WE HAVE 3574 02:45:55,480 --> 02:45:58,080 SUGGESTED A NUMBER OF SHIFTS IN 3575 02:45:58,080 --> 02:46:00,400 EMPHASIS WHILE MAINTAINING THE 3576 02:46:00,400 --> 02:46:02,280 DUAL FOCUS ON TRANSLATIONALLY 3577 02:46:02,280 --> 02:46:03,320 RELEVANT RESEARCH AND 3578 02:46:03,320 --> 02:46:03,640 METHODOLOGY. 3579 02:46:03,640 --> 02:46:06,800 THE SHIFT S ARE AS FOLLOWS. 3580 02:46:06,800 --> 02:46:11,560 THE PANEL IS LARGELY SUPPORTIVE 3581 02:46:11,560 --> 02:46:15,000 OF THE MECHANISTIC BOTANICAL 3582 02:46:15,000 --> 02:46:16,400 RESEARCH AND WE INCREASED THE 3583 02:46:16,400 --> 02:46:18,720 FOCUS ON THE TRANSLATIONAL 3584 02:46:18,720 --> 02:46:20,480 RELEVANCE OF THE RESEARCH. 3585 02:46:20,480 --> 02:46:22,240 SO A HEAVIER EMPHASIS ON 3586 02:46:22,240 --> 02:46:23,280 CLINICAL RESEARCH WE WERE 3587 02:46:23,280 --> 02:46:24,560 PROPOSING THOR THE NEXT 3588 02:46:24,560 --> 02:46:27,920 ITERATION OF IT. 3589 02:46:27,920 --> 02:46:30,840 ALSO, WITH THE METHODOLOGICAL 3590 02:46:30,840 --> 02:46:32,000 AND TECHNOLOGY LOGICAL 3591 02:46:32,000 --> 02:46:33,800 COMPONENT, THERE WAS A 3592 02:46:33,800 --> 02:46:35,320 SUGGESTION TO INCREASE THE 3593 02:46:35,320 --> 02:46:37,320 UTILIZATION AND LEVERAGING OF 3594 02:46:37,320 --> 02:46:40,320 BIG DATA. 3595 02:46:40,320 --> 02:46:42,960 A.I. AND M.L. WAS SO MUCH APART 3596 02:46:42,960 --> 02:46:44,040 OF WHAT WE'RE HEARING IN SCIENCE 3597 02:46:44,040 --> 02:46:45,560 TODAY AND THERE WAS A SUGGESTION 3598 02:46:45,560 --> 02:46:47,880 TO INCREASE THE FOCUS ON 3599 02:46:47,880 --> 02:46:49,560 COMPUTATIONAL METHODS THAT WOULD 3600 02:46:49,560 --> 02:46:52,760 HELP TO UNDERSTAND SOME OF THE 3601 02:46:52,760 --> 02:46:54,560 COMPLEX MECHANISMS BY WHICH 3602 02:46:54,560 --> 02:46:55,040 NATURAL PRODUCTS WORK. 3603 02:46:55,040 --> 02:46:57,360 THERE'S ALSO CURRENTLY A DATA 3604 02:46:57,360 --> 02:46:57,760 REPOSITORY. 3605 02:46:57,760 --> 02:47:02,120 THIS IS THE NEWEST MEMBER OF THE 3606 02:47:02,120 --> 02:47:05,960 CARBON CONSORTIUM BUT DOING A 3607 02:47:05,960 --> 02:47:06,840 LOT OF THE THINGS WE HOPED IT 3608 02:47:06,840 --> 02:47:09,840 WOULD DO AND A DESIRE TO KEEP IT 3609 02:47:09,840 --> 02:47:11,080 PART OF THE PROGRAM WHILE 3610 02:47:11,080 --> 02:47:12,760 RECOGNIZING WITH ANY DATA 3611 02:47:12,760 --> 02:47:15,440 REPOSITORY THERE'S A DESIRE 3612 02:47:15,440 --> 02:47:17,920 ULTIMATELY TO HAVE THIS TO STAND 3613 02:47:17,920 --> 02:47:20,120 ON ITS OWN TWO FEET, IF YOU 3614 02:47:20,120 --> 02:47:20,320 WILL. 3615 02:47:20,320 --> 02:47:21,200 WE'D LIKE TO SEE THIS TRANSITION 3616 02:47:21,200 --> 02:47:28,960 TO A MODEL WHERE THEY CAN 3617 02:47:28,960 --> 02:47:30,800 SUSTAIN THEMSELVES WITHOUT NIH 3618 02:47:30,800 --> 02:47:32,440 CONTINUOUS SUPPORT. 3619 02:47:32,440 --> 02:47:34,880 AND SOMETHING WE HEARD IN THE 3620 02:47:34,880 --> 02:47:37,040 LAST PRESENTATION AND HEARD 3621 02:47:37,040 --> 02:47:39,440 ACROSS NIH IS HOW TO INCREASE 3622 02:47:39,440 --> 02:47:41,200 THE DIVERSITY OF THE TEAMS WE 3623 02:47:41,200 --> 02:47:41,480 SUPPORT. 3624 02:47:41,480 --> 02:47:43,800 THAT'S SOMETHING WE AGREED WITH 3625 02:47:43,800 --> 02:47:48,920 AND WE'LL BE TAKING EFFORT TO 3626 02:47:48,920 --> 02:47:51,760 MAKE THAT PART OF THE PROGRAM 3627 02:47:51,760 --> 02:47:52,040 EXPLICITLY. 3628 02:47:52,040 --> 02:47:54,320 WE'RE PROPOSING TO MAINTAIN THE 3629 02:47:54,320 --> 02:47:56,600 THREE COMPONENTS CURRENTLY PART 3630 02:47:56,600 --> 02:47:59,320 OF THE CARBON PROGRAM WHILE 3631 02:47:59,320 --> 02:48:01,760 INCORPORATING THE CHANGES I HAD 3632 02:48:01,760 --> 02:48:02,640 LAID OUT. 3633 02:48:02,640 --> 02:48:05,480 THERE'LL CONTINUE TO BE A 3634 02:48:05,480 --> 02:48:06,120 TRANSLATION BOTANICAL RESEARCH 3635 02:48:06,120 --> 02:48:07,480 COMPONENT AND RESOURCE COMPONENT 3636 02:48:07,480 --> 02:48:12,280 AND TECHNOLOGY AND METHODOLOGY 3637 02:48:12,280 --> 02:48:12,680 COMPONENT. 3638 02:48:12,680 --> 02:48:13,640 THE SUGGESTIONS HERE ARE 3639 02:48:13,640 --> 02:48:14,760 EXAMPLES OF THE TYPES OF 3640 02:48:14,760 --> 02:48:16,200 RESEARCH THAT MIGHT BE 3641 02:48:16,200 --> 02:48:17,200 INCORPORATED IN THESE. 3642 02:48:17,200 --> 02:48:18,840 THESE ARE NOT MEANT TO BE THE 3643 02:48:18,840 --> 02:48:21,240 ONLY THINGS THAT COULD POSSIBLY 3644 02:48:21,240 --> 02:48:21,760 COME IN. 3645 02:48:21,760 --> 02:48:23,320 WITHIN THE BOTANICAL RESEARCH 3646 02:48:23,320 --> 02:48:25,200 COMPONENT FOR THINGS THAT HAVE 3647 02:48:25,200 --> 02:48:28,320 VERY STRONG PRELIMINARY DATA 3648 02:48:28,320 --> 02:48:30,280 CONDUCTING PRE-CLINICAL RESEARCH 3649 02:48:30,280 --> 02:48:32,520 TO UNDERSTAND THE MECHANISMS BY 3650 02:48:32,520 --> 02:48:35,760 WHICH THEY ACT COUPLES WITH 3651 02:48:35,760 --> 02:48:36,520 IMPORTANTLY MECHANISTIC CLINICAL 3652 02:48:36,520 --> 02:48:38,880 TRIALS FOR OPTIMAL DOSING, 3653 02:48:38,880 --> 02:48:41,920 SAFETY AND RELEVANCE ON NOT 3654 02:48:41,920 --> 02:48:43,080 EXPLICITLY EFFICACY. 3655 02:48:43,080 --> 02:48:47,520 ON THE RESEARCH DEVELOPMENT SIZE 3656 02:48:47,520 --> 02:48:51,480 HOW CAN WE SHIFT THIS TO A MODEL 3657 02:48:51,480 --> 02:48:55,160 OF SELF-SUSTAINABILITY WHILE 3658 02:48:55,160 --> 02:49:02,640 MAINTAIN THE OPEN ACCESS? 3659 02:49:02,640 --> 02:49:04,400 UTILIZATION OF COMPUTATIONAL 3660 02:49:04,400 --> 02:49:06,080 METHODS TO DISCOVER ACROSS THE 3661 02:49:06,080 --> 02:49:08,640 MULTIPLE LEVELS OF HUMAN HEALTH 3662 02:49:08,640 --> 02:49:12,880 WITHIN THE COMPLEX NATURE OF 3663 02:49:12,880 --> 02:49:14,680 MIXTURES, CAN WE FISH OUT 3664 02:49:14,680 --> 02:49:17,200 HYPOTHESES THAT COULD BE TESTED 3665 02:49:17,200 --> 02:49:19,520 FURTHER THAT EXPLAIN HOW SOME OF 3666 02:49:19,520 --> 02:49:23,520 THE COMPLEX PRODUCTS MAY WORK TO 3667 02:49:23,520 --> 02:49:24,120 MODULATE HEALTH IN THE WHOLE 3668 02:49:24,120 --> 02:49:26,040 PERSON CONTEXT. 3669 02:49:26,040 --> 02:49:28,520 SO WITH THAT, I WOULD BE 3670 02:49:28,520 --> 02:49:30,560 THRILLED TO HEAR ANY QUESTIONS 3671 02:49:30,560 --> 02:49:41,040 OR COMMENTS FROM COUNCIL. 3672 02:49:46,960 --> 02:49:50,680 >> SO THE INNOVATIVE 3673 02:49:50,680 --> 02:49:53,760 COMPUTATIONAL METHODS IS 3674 02:49:53,760 --> 02:49:55,520 SEPARATE OR WILL YOU SEE 3675 02:49:55,520 --> 02:49:59,240 COMPUTATIONAL RESEARCH? 3676 02:49:59,240 --> 02:50:01,600 >> THERE'S A COMPONENT FOCUSSED 3677 02:50:01,600 --> 02:50:06,200 ON COMPUTATION AND METHODOLOGY 3678 02:50:06,200 --> 02:50:08,720 NOT TO SAY YOU COULDN'T DO IT 3679 02:50:08,720 --> 02:50:14,360 THROUGH ANOTHER TRANSLATIONAL 3680 02:50:14,360 --> 02:50:15,440 COMPONENT. 3681 02:50:15,440 --> 02:50:15,640 BARBARA? 3682 02:50:15,640 --> 02:50:18,880 >> AGREED. 3683 02:50:18,880 --> 02:50:24,520 >> GOOD. 3684 02:50:24,520 --> 02:50:25,920 >> THANK YOU FOR PRESENTING THIS 3685 02:50:25,920 --> 02:50:27,280 AND IT'S AN EXCITING VISION FOR 3686 02:50:27,280 --> 02:50:34,920 THE FUTURE FOR A PROGRAM THAT IN 3687 02:50:34,920 --> 02:50:39,360 MY BIASSED OPINION HAS POTENTIAL 3688 02:50:39,360 --> 02:50:40,800 FOR NICHD AND BROUGHT TOGETHER 3689 02:50:40,800 --> 02:50:43,000 GREAT TEAMS. 3690 02:50:43,000 --> 02:50:44,840 I WAS CURIOUS ABOUT YOUR 3691 02:50:44,840 --> 02:50:49,120 COMPUTATIONAL -- YOUR FOCUS ON 3692 02:50:49,120 --> 02:50:50,120 THE COMPUTATIONAL WHICH BIG DATA 3693 02:50:50,120 --> 02:50:50,880 CONTINUES TO BE A TOPIC THAT'S 3694 02:50:50,880 --> 02:51:01,160 IMPORTANT TO US. 3695 02:51:05,000 --> 02:51:08,800 IS THIS CONSIDERED TO BE AN 3696 02:51:08,800 --> 02:51:10,120 IMPORTANT ASPECT. 3697 02:51:10,120 --> 02:51:11,560 >> TO BE DETERMINED. 3698 02:51:11,560 --> 02:51:14,840 COMPUTATIONAL TOOLS WILL BE AT 3699 02:51:14,840 --> 02:51:20,240 THE FOREFRONT. 3700 02:51:20,240 --> 02:51:22,360 THIS IS ABOUT THE 3701 02:51:22,360 --> 02:51:26,680 COMPUTATIONALLY DRIVE N BUT THEE 3702 02:51:26,680 --> 02:51:29,080 COULD BE OTHER THINGS. 3703 02:51:29,080 --> 02:51:30,880 COMPUTATIONAL IS WHERE WE'RE 3704 02:51:30,880 --> 02:51:38,640 TRYING TO FOCUS. 3705 02:51:38,640 --> 02:51:41,320 >> IN TERMS OF THE LONG TERM 3706 02:51:41,320 --> 02:51:42,520 SUSTAINABILITY IT SEEMS LIKE TAT 3707 02:51:42,520 --> 02:51:44,040 AN IMPORTANT TOPIC TO THINK 3708 02:51:44,040 --> 02:51:44,440 ABOUT. 3709 02:51:44,440 --> 02:51:47,080 YOU DON'T WANT TO JUST DEVELOP 3710 02:51:47,080 --> 02:51:49,200 TOOL THAT END WHEN THE GRANT 3711 02:51:49,200 --> 02:51:50,400 FUNDING ENDS BUT CURIOUS WHAT 3712 02:51:50,400 --> 02:51:51,040 THAT LOOKS LIKE. 3713 02:51:51,040 --> 02:51:55,240 IS IS THERE PLAN FOR THE NIH TO 3714 02:51:55,240 --> 02:51:56,440 HELP THE PROGRAMS TO BE 3715 02:51:56,440 --> 02:51:57,160 SUSTAINABLE IN THE FUTURE BEYOND 3716 02:51:57,160 --> 02:52:07,520 THE LEVEL OF FUNDING? 3717 02:52:11,320 --> 02:52:15,400 >> WE'LL BE DOING EVERYTHING WE 3718 02:52:15,400 --> 02:52:20,160 CAN TO HELP THE PROJECT MAKE THE 3719 02:52:20,160 --> 02:52:20,560 TRANSITION. 3720 02:52:20,560 --> 02:52:22,400 THERE'S A VARIETY OF MODELS YOU 3721 02:52:22,400 --> 02:52:24,360 CAN ENVISION FOR HOW THAT MIGHT 3722 02:52:24,360 --> 02:52:24,600 HAPPEN. 3723 02:52:24,600 --> 02:52:27,360 THERE COULD BE A SMALL AMOUNT OF 3724 02:52:27,360 --> 02:52:29,480 SUPPORT HYPOTHETICALLY SPEAKING 3725 02:52:29,480 --> 02:52:31,080 BUT LARGELY WE'D HOPE THEY'D BE 3726 02:52:31,080 --> 02:52:33,680 ABLE TO COLLABORATE WITH OTHER 3727 02:52:33,680 --> 02:52:35,280 SPONSORS, INDUSTRY THAT MIGHT 3728 02:52:35,280 --> 02:52:36,320 HAVE AN INTEREST IN SUPPORTING 3729 02:52:36,320 --> 02:52:46,080 THIS AS WELL. 3730 02:52:46,080 --> 02:52:47,560 >> WILL A LOT OF TIMES INDUSTRY 3731 02:52:47,560 --> 02:52:53,000 HAS A DIFFERENT GOAL IN MIND 3732 02:52:53,000 --> 02:52:54,480 THAN WE DO AND WE LIKE 3733 02:52:54,480 --> 02:52:56,000 EVERYTHING OPEN ACCESS AND THEY 3734 02:52:56,000 --> 02:53:04,720 LIKE TO MAKE MONEY. 3735 02:53:04,720 --> 02:53:06,040 >> IT'S SOMETHING I'M SENSITIVE 3736 02:53:06,040 --> 02:53:08,200 TO BUT WHEN YOU SAY WE'LL 3737 02:53:08,200 --> 02:53:12,000 DEVELOP A SUBSCRIPTION MODEL -- 3738 02:53:12,000 --> 02:53:14,920 I THINK YOU CAN HAVE YOUR CAKE 3739 02:53:14,920 --> 02:53:16,960 AND EAT IT TOO. 3740 02:53:16,960 --> 02:53:19,120 CONTINUE TO HAVE IT OPEN ACCESS 3741 02:53:19,120 --> 02:53:23,160 BUT HAVE MODELS OF SUPPORT THAT 3742 02:53:23,160 --> 02:53:24,720 DOESN'T IMPINGE UPON THAT OPEN 3743 02:53:24,720 --> 02:53:25,080 ACCESS. 3744 02:53:25,080 --> 02:53:28,080 >> THAT MAKES SENSE AND PART IS 3745 02:53:28,080 --> 02:53:29,080 LEVERAGING EXISTING DATABASES 3746 02:53:29,080 --> 02:53:30,720 THAT ALREADY HAVE AN 3747 02:53:30,720 --> 02:53:31,280 INFRASTRUCTURE AND ADDING 3748 02:53:31,280 --> 02:53:32,920 NATURAL PRODUCT ELEMENTS TO 3749 02:53:32,920 --> 02:53:39,360 THEM. 3750 02:53:39,360 --> 02:53:42,280 >> IT'S UP TO INVESTIGATORS TO 3751 02:53:42,280 --> 02:53:48,320 BE CREATIVE IN THAT ASPECT AND 3752 02:53:48,320 --> 02:53:52,760 PROPOSE MODELS THAT WILL LEAD TO 3753 02:53:52,760 --> 02:53:53,160 SUSTAINABILITY. 3754 02:53:53,160 --> 02:53:54,920 THAT WILL PLAY INTO HOW THE 3755 02:53:54,920 --> 02:54:05,360 APPLICATIONS WILL BE USED. 3756 02:54:07,360 --> 02:54:12,760 >> I DIDN'T KNOW WE SAID WE WANT 3757 02:54:12,760 --> 02:54:16,080 TO MAINTAIN THESE FAIR FOR 3758 02:54:16,080 --> 02:54:19,120 EVERYONE AND ACCESSIBLE TO ALL. 3759 02:54:19,120 --> 02:54:21,440 >> IT SEEMS LIKE AN EXCITING 3760 02:54:21,440 --> 02:54:26,880 OPPORTUNITY TO STUDY COMPLEX 3761 02:54:26,880 --> 02:54:28,080 HEALING SYSTEMS. 3762 02:54:28,080 --> 02:54:29,440 I STUDIED CHANCE MEDICINE WHERE 3763 02:54:29,440 --> 02:54:39,840 NOTHING IS USED IN ISOLATION. 3764 02:54:39,840 --> 02:54:45,240 ASHWAGANDA IS ALMOST NEVER USED 3765 02:54:45,240 --> 02:54:48,920 ALONE. 3766 02:54:48,920 --> 02:54:51,840 >> WITHIN THE BOTANICAL 3767 02:54:51,840 --> 02:54:53,520 COMPONENT AND THE METHODOLOGICAL 3768 02:54:53,520 --> 02:55:00,160 AND TECHNICAL COMPONENT, I THINK 3769 02:55:00,160 --> 02:55:01,360 AYURVEDA AND OTHER SYSTEMS ARE 3770 02:55:01,360 --> 02:55:03,560 ALWAYS ENCOURAGED AS PART OF THE 3771 02:55:03,560 --> 02:55:03,800 SYSTEM. 3772 02:55:03,800 --> 02:55:06,800 WE DON'T ALWAYS GET APPLICATIONS 3773 02:55:06,800 --> 02:55:08,040 ON THOSE SYSTEMS BUT IT'S 3774 02:55:08,040 --> 02:55:12,240 FOREMOST IN OUR MIND OF THINGS 3775 02:55:12,240 --> 02:55:14,960 THAT WOULD BE IDEAL TYPES OF 3776 02:55:14,960 --> 02:55:25,200 APPLICATIONS. 3777 02:55:27,320 --> 02:55:30,960 >> AND I WANT TO TALK ABOUT THE 3778 02:55:30,960 --> 02:55:31,840 VALUE OF THE PROGRAM INCLUDING 3779 02:55:31,840 --> 02:55:34,920 TRAINING TO GENERATIONS AS WELL. 3780 02:55:34,920 --> 02:55:35,760 AGAIN, I'M BIASSED PART OF THE 3781 02:55:35,760 --> 02:55:46,040 CURRENT PROGRAM. 3782 02:55:48,560 --> 02:55:51,040 DO YOU HAVE TRANSLATIONAL 3783 02:55:51,040 --> 02:55:51,520 PROJECTS? 3784 02:55:51,520 --> 02:55:52,120 >> THAT'S ABOUT THE RESOURCE 3785 02:55:52,120 --> 02:56:02,320 COMPONENT. 3786 02:56:05,720 --> 02:56:06,680 >> ANY OTHER QUESTIONS? 3787 02:56:06,680 --> 02:56:08,960 I GUESS WE NEED A VOTE? 3788 02:56:08,960 --> 02:56:10,880 >> DO WE HAVE A MOTION TO 3789 02:56:10,880 --> 02:56:11,800 APPROVE THE CONCEPT FOR THE CAR 3790 02:56:11,800 --> 02:56:13,600 BRAN PROGRAM? 3791 02:56:13,600 --> 02:56:15,560 -- CARBON PROGRAM? 3792 02:56:15,560 --> 02:56:24,280 DO WE HAVE A SECOND? 3793 02:56:24,280 --> 02:56:27,200 EVERYBODY IN FAVOR FOR THE 3794 02:56:27,200 --> 02:56:28,560 MOTION PLEASE RAISE YOUR HAND ON 3795 02:56:28,560 --> 02:56:30,880 ZOOM AS WELL AS HERE IN THE 3796 02:56:30,880 --> 02:56:41,000 ROOM. 3797 02:56:43,360 --> 02:56:45,000 THANK YOU. 3798 02:56:45,000 --> 02:56:45,880 WE ARE MOVING TO THE SECOND 3799 02:56:45,880 --> 02:56:56,200 CONCEPT CLEARANCE. 3800 02:57:05,120 --> 02:57:05,600 >> ALL RIGHT. 3801 02:57:05,600 --> 02:57:07,520 GOOD AFTERNOON. 3802 02:57:07,520 --> 02:57:08,960 I'M WEN CHEN. 3803 02:57:08,960 --> 02:57:10,440 I'M A CHIEF OF THE BASIC 3804 02:57:10,440 --> 02:57:15,000 MECHANISTIC RESEARCH BRANCH 3805 02:57:15,000 --> 02:57:16,360 WITHIN THE DIVISION OF 3806 02:57:16,360 --> 02:57:16,920 EXTRAMURAL RESEARCH. 3807 02:57:16,920 --> 02:57:22,920 I'D LIKE TO PRESENT A CONCEPT 3808 02:57:22,920 --> 02:57:27,360 CLEARANCE ON NCCIH MERIT AWARDS 3809 02:57:27,360 --> 02:57:30,000 THE METHOD TO EXTEND RESEARCH IN 3810 02:57:30,000 --> 02:57:33,640 TIME TO PROMOTE INNOVATION IN 3811 02:57:33,640 --> 02:57:34,680 DIVERSITY IN COMPLEMENTARY AND 3812 02:57:34,680 --> 02:57:37,160 INTEGRATIVE HEALTH APPROACH. 3813 02:57:37,160 --> 02:57:40,040 THERE'S TWO. 3814 02:57:40,040 --> 02:57:41,520 WITHIN THE NIH COMMON FUND 3815 02:57:41,520 --> 02:57:46,960 PROGRAM THERE'S TWO PROMINENT 3816 02:57:46,960 --> 02:57:57,200 AWARD PROGRAM. 3817 02:57:58,960 --> 02:58:02,000 THE FIRST IS THE NIH DIRECTOR'S 3818 02:58:02,000 --> 02:58:04,120 PIONEER AWARD WHICH SUPPORTS 3819 02:58:04,120 --> 02:58:08,960 INDIVIDUAL SCIENTISTS WHO APPLY 3820 02:58:08,960 --> 02:58:16,320 PIONEERING APPROACHES TO STUDY 3821 02:58:16,320 --> 02:58:18,600 NEW RESEARCH WITH A 3822 02:58:18,600 --> 02:58:20,480 TRANSFORMATIVE EFFECT AND THE 3823 02:58:20,480 --> 02:58:22,520 SECOND ONE IS THE NIH DIRECTOR'S 3824 02:58:22,520 --> 02:58:25,720 TRANSFORMATIVE RESEARCH AWARDS 3825 02:58:25,720 --> 02:58:27,400 WHICH AIMS TO SUPPORT INDIVIDUAL 3826 02:58:27,400 --> 02:58:32,640 SCIENTISTS OR TEAM SCIENTISTS 3827 02:58:32,640 --> 02:58:37,280 WHO WILL BE LOOKING TO UNDERTAKE 3828 02:58:37,280 --> 02:58:38,720 TRANSFORMATIVE RESEARCH THAT 3829 02:58:38,720 --> 02:58:39,240 WILL RESHAPE SCIENTIFIC 3830 02:58:39,240 --> 02:58:47,120 PARADIGMS. 3831 02:58:47,120 --> 02:58:50,080 NCCIH HAS BEEN INVOLVED IN THE 3832 02:58:50,080 --> 02:58:51,480 TWO PROGRAMS. 3833 02:58:51,480 --> 02:58:57,120 IN THE PAST 10 YEARS WE HAVE 3834 02:58:57,120 --> 02:58:57,720 VACCIN 3835 02:58:57,720 --> 02:58:58,640 ATTRACTED A TOTAL OF 13 3836 02:58:58,640 --> 02:59:00,800 TRANSFORMATIVE RESEARCH AWARDS. 3837 02:59:00,800 --> 02:59:03,200 THOSE APPLICATIONS AND THEY'RE 3838 02:59:03,200 --> 02:59:04,920 PREDOMINANTLY FUNDED BY THE NIH 3839 02:59:04,920 --> 02:59:07,520 COMMON FUND AND ASSIGNED TO 3840 02:59:07,520 --> 02:59:10,760 BECAUSE OF THEIR ALIGNMENT TO 3841 02:59:10,760 --> 02:59:13,880 OUR RESEARCH AREA SUCH ADDS 3842 02:59:13,880 --> 02:59:17,080 INTERO CEPTION, MICROBIOME AND 3843 02:59:17,080 --> 02:59:21,640 FUNCTIONAL GENOMICS AND BRAIN. 3844 02:59:21,640 --> 02:59:25,960 WHILE WE HAVE BEEN SUCCESSFUL OR 3845 02:59:25,960 --> 02:59:29,560 MAKE PROGRESS IN ATTRACTING THE 3846 02:59:29,560 --> 02:59:32,600 PIONEER AND TRANSFORMATIVE 3847 02:59:32,600 --> 02:59:35,000 RESEARCHERS TO OUR PORTFOLIO WE 3848 02:59:35,000 --> 02:59:38,120 ALSO ENCOUNTERED CHALLENGES. 3849 02:59:38,120 --> 02:59:43,160 THE SECOND IS ON THE ISSUE OF 3850 02:59:43,160 --> 02:59:43,440 RETENTION. 3851 02:59:43,440 --> 02:59:48,600 MANY FEW OF THE PIONEER AWARDEES 3852 02:59:48,600 --> 02:59:52,680 THE TRANSFORMATIVE RESEARCH 3853 02:59:52,680 --> 02:59:54,240 AWARDEES CONTINUED TO BEAR THEIR 3854 02:59:54,240 --> 02:59:55,840 HIGHLY INNOVATIVE PROGRAMS IN 3855 02:59:55,840 --> 02:59:57,680 THE DIRECTION OF COMPLEMENTARY 3856 02:59:57,680 --> 03:00:05,120 AND INTEGRATIVE HEALTH 3857 03:00:05,120 --> 03:00:09,000 APPROACHES THAT COULD BE FUNDED 3858 03:00:09,000 --> 03:00:10,320 BY NCCIH. 3859 03:00:10,320 --> 03:00:11,240 SEVERAL HAVE REACHED THE 3860 03:00:11,240 --> 03:00:14,160 DIRECTION TO BE MORE ALIGNED 3861 03:00:14,160 --> 03:00:15,760 WITH OTHER NIH INSTITUTES 3862 03:00:15,760 --> 03:00:19,840 BECAUSE OF THE ABILITY TO OBTAIN 3863 03:00:19,840 --> 03:00:24,960 LONG-TERM FUNDING COMMITMENT 3864 03:00:24,960 --> 03:00:30,080 FROM NIH INSTITUTES. 3865 03:00:30,080 --> 03:00:35,880 AND PIONEER AWARDEES, SEVERAL 3866 03:00:35,880 --> 03:00:37,800 OPTED TO HAVE THEIR POTENTIAL 3867 03:00:37,800 --> 03:00:41,080 AWARDS ASSIGNED OR MANAGED BY 3868 03:00:41,080 --> 03:00:42,280 OTHER NIH INSTITUTES BECAUSE OF 3869 03:00:42,280 --> 03:00:47,880 THE POTENTIAL FOR THEM TO OBTAIN 3870 03:00:47,880 --> 03:00:52,240 LONG TERM FUNDING COMMITMENT 3871 03:00:52,240 --> 03:00:52,800 THERE THE INSTITUTE. 3872 03:00:52,800 --> 03:00:54,880 THE PROJECT HIGHLY ALIGNED WITH 3873 03:00:54,880 --> 03:00:58,480 THE MISSION. 3874 03:00:58,480 --> 03:00:59,920 THE THIRD CHALLENGE FOR THIS 3875 03:00:59,920 --> 03:01:01,920 PROGRAM FOR WHAT WE HAVE IS ON 3876 03:01:01,920 --> 03:01:05,360 THE ISSUE OF LACK OF DIVERSITY 3877 03:01:05,360 --> 03:01:07,520 WHICH IS ACTUALLY QUITE COMMON 3878 03:01:07,520 --> 03:01:10,000 IN HIGH IMPACT RESEARCH PROGRAMS 3879 03:01:10,000 --> 03:01:12,600 THOUGH WE ALL KNOW OVER AND OVER 3880 03:01:12,600 --> 03:01:16,280 AGAIN EVEN TODAY THE IMPORTANCE 3881 03:01:16,280 --> 03:01:19,400 OF A DIVERSE AND INCLUSIVE 3882 03:01:19,400 --> 03:01:20,480 RESEARCH ENVIRONMENT FOR 3883 03:01:20,480 --> 03:01:21,880 SCIENTIFIC SUCCESS. 3884 03:01:21,880 --> 03:01:23,120 HOW SHOULD WE ADDRESS THE 3885 03:01:23,120 --> 03:01:25,480 CHALLENGES AT NICHD? 3886 03:01:25,480 --> 03:01:35,960 ONE POSSIBILITY IS FOR US TO 3887 03:01:36,520 --> 03:01:37,760 PROVIDE LONG-TERM FUNDING 3888 03:01:37,760 --> 03:01:41,120 OPPORTUNITIES TO TRANSFORM 3889 03:01:41,120 --> 03:01:43,760 RESEARCH AWARDEES AND COMPETE 3890 03:01:43,760 --> 03:01:48,840 WITH OTHER NIH INSTITUTES BUT 3891 03:01:48,840 --> 03:01:59,360 ALSO BUT IF DESIGNED PROPERLY 3892 03:02:06,200 --> 03:02:09,200 FROM THE LONG-TERM COMMITMENT 3893 03:02:09,200 --> 03:02:13,800 FUNDING OPPORTUNITY MIGHT ALSO 3894 03:02:13,800 --> 03:02:18,840 ENCOURAGE THE INVESTIGATORS TO 3895 03:02:18,840 --> 03:02:19,720 EXTEND THEIR TRAINING AND 3896 03:02:19,720 --> 03:02:21,400 DIVERSE INCLUSION EFFORTS THAT 3897 03:02:21,400 --> 03:02:24,160 WILL BE HELPFUL TO ENRICH THE 3898 03:02:24,160 --> 03:02:24,680 DIVERSITY OF THE RESEARCH 3899 03:02:24,680 --> 03:02:32,800 PROGRAMS. 3900 03:02:32,800 --> 03:02:33,720 IN FACT THERE'S A LOT OF 3901 03:02:33,720 --> 03:02:37,120 POTENTIAL BENEFITS IF WE WERE 3902 03:02:37,120 --> 03:02:38,720 ABLE TO OFFER A LONG-TERM 3903 03:02:38,720 --> 03:02:41,600 FUNDING OPPORTUNITY THIS IN 3904 03:02:41,600 --> 03:02:42,920 ITSELF MAY ALSO ATTRACT THE 3905 03:02:42,920 --> 03:02:47,960 CURRENT NCCIH GRANTEES AND 3906 03:02:47,960 --> 03:02:49,520 INVESTIGATORS TO CONSIDER OR 3907 03:02:49,520 --> 03:02:53,000 PURSUE INNOVATIVE AWARDS FOR THE 3908 03:02:53,000 --> 03:02:54,880 NIH TRANSFORMATIVE RESEARCH 3909 03:02:54,880 --> 03:02:59,680 PROGRAM TO BEGIN WITH. 3910 03:02:59,680 --> 03:03:02,880 YOU MIGHT WONDER WHAT ARE 3911 03:03:02,880 --> 03:03:05,720 OPTIONS OF SUPPORTING SUCH A 3912 03:03:05,720 --> 03:03:07,840 LONG-TERM FUNDING OPPORTUNITY. 3913 03:03:07,840 --> 03:03:11,880 ONE WAY WHICH NIH HAS USED BY 3914 03:03:11,880 --> 03:03:13,800 MANY DIFFERENT INSTITUTES IS 3915 03:03:13,800 --> 03:03:16,320 CALLED THE MERIT AWARD THE 3916 03:03:16,320 --> 03:03:18,920 METHOD TO EXTEND RESEARCH IN 3917 03:03:18,920 --> 03:03:20,960 TIME. 3918 03:03:20,960 --> 03:03:23,800 HOW DOES IS WORK? 3919 03:03:23,800 --> 03:03:26,960 IT STARS WITH INVESTIGATORS 3920 03:03:26,960 --> 03:03:35,840 INITIATING RO1 APPLICATIONS AND 3921 03:03:35,840 --> 03:03:46,400 THEY'LL GET FUNDING SCORES AND 3922 03:03:46,720 --> 03:03:50,320 THEN THEN THE POOL OF RO1 3923 03:03:50,320 --> 03:03:52,440 APPLICATIONS PROGRAM STAFF WILL 3924 03:03:52,440 --> 03:03:57,560 NOMINATE POTENTIAL MERIT 3925 03:03:57,560 --> 03:04:01,680 AWARDEES BASED ON SPECIAL 3926 03:04:01,680 --> 03:04:02,960 SELECTION CRITERIA BY THE 3927 03:04:02,960 --> 03:04:03,640 INDIVIDUAL INSTITUTE. 3928 03:04:03,640 --> 03:04:05,720 THEN THE INSTITUTE'S LEADERSHIP 3929 03:04:05,720 --> 03:04:08,720 WITH THE ADVISORY COUNCIL WILL 3930 03:04:08,720 --> 03:04:12,240 REVIEW, PRIORITIZE AND IMPROVE 3931 03:04:12,240 --> 03:04:16,080 OR DISAPPROVE THOSE MERIT AWARDS 3932 03:04:16,080 --> 03:04:17,040 NOMINATIONS. 3933 03:04:17,040 --> 03:04:20,200 IF THE NOMINATIONS ARE APPROVED 3934 03:04:20,200 --> 03:04:21,880 FOR THE PROCESS THEN THEY WILL 3935 03:04:21,880 --> 03:04:25,920 BE CONVERTED TO AN R37 MERIT 3936 03:04:25,920 --> 03:04:26,120 AWARD. 3937 03:04:26,120 --> 03:04:27,640 SO IT'S A FUNDING MECHANISM, 3938 03:04:27,640 --> 03:04:37,800 BASICALLY. 3939 03:04:44,040 --> 03:04:46,320 THE R37 PRINCIPAL INVESTIGATORS 3940 03:04:46,320 --> 03:04:48,600 WILL HAVE TO SUBMIT AN EXTENSION 3941 03:04:48,600 --> 03:04:49,640 APPLICATION TO THE INSTITUTE 3942 03:04:49,640 --> 03:04:52,720 SIMILAR TO WHAT THEY'D NORMALLY 3943 03:04:52,720 --> 03:04:54,280 SUBMIT TO AN RO1 COMPETITIVE 3944 03:04:54,280 --> 03:04:54,560 APPLICATION. 3945 03:04:54,560 --> 03:04:58,120 IN THIS CASE THE PROGRAM STAFF 3946 03:04:58,120 --> 03:05:01,680 FOR NIH LEADERSHIP AND ADVISORY 3947 03:05:01,680 --> 03:05:04,040 COUNCIL WILL REVIEW THE 3948 03:05:04,040 --> 03:05:08,400 PROGRESS, THE SCIENTIFIC MERIT 3949 03:05:08,400 --> 03:05:09,200 OF THE RESEARCH AS WELL AS 3950 03:05:09,200 --> 03:05:13,520 WHETHER THE PROGRAM THE R37 3951 03:05:13,520 --> 03:05:19,440 AWARDS HAVE MET OTHER EXTENSION 3952 03:05:19,440 --> 03:05:28,840 CRITERIA TO DETERMINE THE 3953 03:05:28,840 --> 03:05:31,400 SUITABILITY AND THE EXTENSION 3954 03:05:31,400 --> 03:05:33,720 WILL NOT INVOLVE A PEER-REVIEW 3955 03:05:33,720 --> 03:05:34,240 PROCESS. 3956 03:05:34,240 --> 03:05:39,400 SO THE INITIATIVE FOR US TO 3957 03:05:39,400 --> 03:05:41,320 ADDRESS THE CHALLENGES AND 3958 03:05:41,320 --> 03:05:42,880 OPPORTUNITIES IS FOR NICHD TO 3959 03:05:42,880 --> 03:05:45,840 ESTABLISH A NEW FUNDING 3960 03:05:45,840 --> 03:05:48,400 MECHANISM THE NICHD MERIT AWARD 3961 03:05:48,400 --> 03:05:52,120 OR METHOD TO EXTENSION IN TIME 3962 03:05:52,120 --> 03:05:53,320 AND THE INITIATIVE WILL PROVIDE 3963 03:05:53,320 --> 03:05:57,600 PAYER FUNDING TO CURRENT AND 3964 03:05:57,600 --> 03:06:00,960 PAST AWARDEES SO THEY WILL HAVE 3965 03:06:00,960 --> 03:06:03,280 AMPLE TIME TO DEVELOP HIGHLY 3966 03:06:03,280 --> 03:06:07,400 INNOVATIVE AND TRANSFORMATIVE 3967 03:06:07,400 --> 03:06:09,960 WORK SPECIFICALLY AIMED AT 3968 03:06:09,960 --> 03:06:12,200 STUDYING THE COMPLEMENTARY 3969 03:06:12,200 --> 03:06:13,640 HEALTH APPROACHES. 3970 03:06:13,640 --> 03:06:17,280 IN ADDITION, WE'LL REQUIRE THOSE 3971 03:06:17,280 --> 03:06:19,560 AWARDEES TO DEVELOP A PLAN THAT 3972 03:06:19,560 --> 03:06:22,640 WILL RECRUIT AND TRAIN DIVERSE 3973 03:06:22,640 --> 03:06:24,040 LABORATORY TRAINEES IN THE 3974 03:06:24,040 --> 03:06:28,240 EFFORT OF PROMOTING DIVERSITY. 3975 03:06:28,240 --> 03:06:30,480 TO ENSURE THE EXCELLENCE AND 3976 03:06:30,480 --> 03:06:33,120 HIGH QUALITY OF RESEARCH IN THE 3977 03:06:33,120 --> 03:06:35,800 EXTENDED RESEARCH FOR TIME THE 3978 03:06:35,800 --> 03:06:36,360 SCIENTIFIC ACHIEVEMENT AND 3979 03:06:36,360 --> 03:06:41,920 SUCCESS IN PROMOTING DIVERSITY 3980 03:06:41,920 --> 03:06:45,280 WILL BE REVIEWED BY THE ADVISORY 3981 03:06:45,280 --> 03:06:47,440 COUNCIL AND BASICALLY YOU TO 3982 03:06:47,440 --> 03:06:52,440 DETERMINE WHETHER THE EXTENSION 3983 03:06:52,440 --> 03:06:53,720 TO THE SECOND FIVE-YEAR CYCLE 3984 03:06:53,720 --> 03:06:55,000 WILL BE WARRANTED. 3985 03:06:55,000 --> 03:06:56,720 WE HOPE IN ESTABLISHING THE 3986 03:06:56,720 --> 03:06:59,520 MERIT AWARDS WE'LL BE ABLE TO 3987 03:06:59,520 --> 03:07:01,480 ADDRESS THE CHALLENGE AND 3988 03:07:01,480 --> 03:07:04,000 RETENTION AND RECRUITMENT 3989 03:07:04,000 --> 03:07:08,840 CHALLENGES FOR A PIONEER AWARDEE 3990 03:07:08,840 --> 03:07:12,360 FOR AN RO1 AWARDEE TO STUDY 3991 03:07:12,360 --> 03:07:13,760 COMPLIMENTARY, INTEGRATIVE 3992 03:07:13,760 --> 03:07:16,520 HEALTH APPROACHES AND APPLYING 3993 03:07:16,520 --> 03:07:18,320 THE MOST CUTTING-EDGE 3994 03:07:18,320 --> 03:07:20,400 METHODOLOGY AND SCIENTIFIC 3995 03:07:20,400 --> 03:07:25,560 THINKING TO THEM AS WELL AS TO 3996 03:07:25,560 --> 03:07:26,840 PROMOTE AND STRENGTHEN THE 3997 03:07:26,840 --> 03:07:28,920 SCIENTIFIC COMMUNITY THAT WILL 3998 03:07:28,920 --> 03:07:33,880 HELP PROMOTE DIVERSITY AS WELL. 3999 03:07:33,880 --> 03:07:39,400 WITH THE LAST SLIDE I'LL END MY 4000 03:07:39,400 --> 03:07:45,880 PRESENTATION AND SEEK THE 4001 03:07:45,880 --> 03:07:51,160 ADVISORY COUNCIL'S SUPPORT AND 4002 03:07:51,160 --> 03:07:52,080 APPROVAL. 4003 03:07:52,080 --> 03:07:52,360 YES. 4004 03:07:52,360 --> 03:07:53,480 >> 4005 03:07:53,480 --> 03:07:55,560 >> I THINK THIS IS NOT ONLY A 4006 03:07:55,560 --> 03:07:56,960 NICE THING TO DO BUT NECESSARY 4007 03:07:56,960 --> 03:07:58,200 THING TO DO. 4008 03:07:58,200 --> 03:08:00,040 IT'S CLEAR IT WILL DIRECTLY 4009 03:08:00,040 --> 03:08:01,440 ADDRESS EXACTLY WHAT THE PROBLEM 4010 03:08:01,440 --> 03:08:11,760 YOU'VE BROUGHT UP. 4011 03:08:13,000 --> 03:08:15,040 >> SO, I'M INTERESTED AND 4012 03:08:15,040 --> 03:08:16,000 CONFUSED ABOUT THE POOL. 4013 03:08:16,000 --> 03:08:20,080 THE POOL IS ONLY THE CURRENT AND 4014 03:08:20,080 --> 03:08:23,560 FORMER TRANSFORMATIVE AND 4015 03:08:23,560 --> 03:08:25,600 PIONEER AWARDS FOR LIKE 13 4016 03:08:25,600 --> 03:08:26,360 PEOPLE. 4017 03:08:26,360 --> 03:08:28,120 >> WE'RE HOPING WITH THIS AWARD 4018 03:08:28,120 --> 03:08:29,680 MORE PEOPLE WILL APPLY FOR THEM 4019 03:08:29,680 --> 03:08:32,200 AND GET REWARDED AS WELL SO THE 4020 03:08:32,200 --> 03:08:37,840 POOL COULD BE BIGGER. 4021 03:08:37,840 --> 03:08:41,120 >> SO IT'S NOT FOR DIFFERENT 4022 03:08:41,120 --> 03:08:43,840 AWARDEES -- 4023 03:08:43,840 --> 03:08:44,800 >> EACH INSTITUTE ESTABLISHES 4024 03:08:44,800 --> 03:08:46,680 ITS OWN CRITERIA FOR NOMINATION. 4025 03:08:46,680 --> 03:08:48,720 SOME INSTITUTES, FOR INSTANCE, 4026 03:08:48,720 --> 03:08:52,280 WHEN I WAS WORKING AT NIA THEY 4027 03:08:52,280 --> 03:09:02,680 HAVE TEN PERCENTILE OF 4028 03:09:02,960 --> 03:09:05,840 SUCCESSFUL FUNDING AND DIFFERENT 4029 03:09:05,840 --> 03:09:06,640 INSTITUTES USE DIFFERENT 4030 03:09:06,640 --> 03:09:07,800 CRITERIA TO ACHIEVE THE GOAL FOR 4031 03:09:07,800 --> 03:09:10,480 THE MERIT AWARD BUT THE CONCEPT 4032 03:09:10,480 --> 03:09:14,120 IS THE SAME AS YOU EXTEND THE 4033 03:09:14,120 --> 03:09:19,600 RESEARCH IN TIME FOR 10 YEARS. 4034 03:09:19,600 --> 03:09:25,320 >> SAY YOU GOT A PIONEER AWARD 4035 03:09:25,320 --> 03:09:28,480 DO YOU SUBMIT A SEPARATE 4036 03:09:28,480 --> 03:09:28,760 APPLICATION? 4037 03:09:28,760 --> 03:09:31,360 >> A SEPARATE RO1 AS YOU 4038 03:09:31,360 --> 03:09:33,160 NORMALLY DO AND IF IT NEEDS TO 4039 03:09:33,160 --> 03:09:35,840 BE PEER REVIEWED AND A FUNDABLE 4040 03:09:35,840 --> 03:09:36,040 SCORE. 4041 03:09:36,040 --> 03:09:38,680 >> BUT IF YOU'RE IN A PIONEER 4042 03:09:38,680 --> 03:09:41,600 AWARD THERE'S A RESTRICTION 4043 03:09:41,600 --> 03:09:42,480 BECAUSE IT'S SUPPOSED TO COVER 4044 03:09:42,480 --> 03:09:44,840 MOST YOUR SALARY. 4045 03:09:44,840 --> 03:09:47,360 >> ONLY 51%. 4046 03:09:47,360 --> 03:09:49,040 >> I'D BE SURPRISED IF SOMEONE 4047 03:09:49,040 --> 03:09:51,720 GOT A PIONEER AND NOW AN RO1 TO 4048 03:09:51,720 --> 03:09:52,600 GET AN MERIT. 4049 03:09:52,600 --> 03:09:57,080 >> THERE'S MANY EXAMPLES OF 4050 03:09:57,080 --> 03:09:57,280 THOSE. 4051 03:09:57,280 --> 03:10:00,280 SEVERAL OF OUR PIONEER AWARDEES 4052 03:10:00,280 --> 03:10:01,840 GOT MERIT AWARDS IN OTHER 4053 03:10:01,840 --> 03:10:02,920 INSTITUTES. 4054 03:10:02,920 --> 03:10:08,080 >> OKAY. 4055 03:10:08,080 --> 03:10:08,240 >> 4056 03:10:08,240 --> 03:10:10,080 >> UNDERSTAND THIS IS A SMALL 4057 03:10:10,080 --> 03:10:14,000 POOL OF PEOPLE ELIGIBLE BUT 4058 03:10:14,000 --> 03:10:16,240 WE'RE ALSO NOT PLANNING ON 4059 03:10:16,240 --> 03:10:17,600 FUNDING DOZENS OF THESE. 4060 03:10:17,600 --> 03:10:20,840 IT WOULD BE SMALL NUMBERS FIRST 4061 03:10:20,840 --> 03:10:27,840 AND AS WEN SUGGESTS THIS ACHIEVE 4062 03:10:27,840 --> 03:10:28,760 WHAT WE HOPE WHICH WOULD 4063 03:10:28,760 --> 03:10:33,000 INCREASE THE NUMBER OF ELIGIBLE 4064 03:10:33,000 --> 03:10:34,240 PEOPLE THAT BACK 4065 03:10:34,240 --> 03:10:35,560 TRANSFORMATIONAL AWARDS AND WE 4066 03:10:35,560 --> 03:10:37,360 COULD HAVE MORE PEOPLE ELIGIBLE 4067 03:10:37,360 --> 03:10:37,840 FOR THIS. 4068 03:10:37,840 --> 03:10:42,480 >> WHY NOT MAKE IT SO IF YOU ARE 4069 03:10:42,480 --> 03:10:45,960 A PIONEER AWARDEE YOU COULD BE 4070 03:10:45,960 --> 03:10:49,080 GIVEN THE MERIT TO EXTEND THAT. 4071 03:10:49,080 --> 03:10:51,640 >> I CAN ANSWER THAT QUESTION. 4072 03:10:51,640 --> 03:10:54,400 A PIONEER AWARD TYPICALLY THEY 4073 03:10:54,400 --> 03:10:55,080 HAVE THEIR CRITERIA. 4074 03:10:55,080 --> 03:10:57,680 THEY TYPICALLY DON'T STUDY 4075 03:10:57,680 --> 03:11:03,720 EXACTLY WHAT WE'RE LOOKING FOR 4076 03:11:03,720 --> 03:11:08,720 NCCIH THEY'RE NOT 4077 03:11:08,720 --> 03:11:10,760 INSTITUTE-MISSION SPECIFIC. 4078 03:11:10,760 --> 03:11:12,800 WHEREAS THEY DO VERY INNOVATIVE 4079 03:11:12,800 --> 03:11:14,800 WORK AND THE INVESTIGATORS ARE 4080 03:11:14,800 --> 03:11:15,840 VERY ATTRACTIVE. 4081 03:11:15,840 --> 03:11:18,560 FOR US WE ARE HOPING TO ATTRACT 4082 03:11:18,560 --> 03:11:23,240 THEM TO PURSUE THE RESEARCH 4083 03:11:23,240 --> 03:11:28,680 WE'RE HOPING THEY COULD TO MAKE 4084 03:11:28,680 --> 03:11:30,240 OUR RESEARCH MORE CUTTING EDGE 4085 03:11:30,240 --> 03:11:31,280 AND TRANSFORMING. 4086 03:11:31,280 --> 03:11:41,720 THAT'S THE CONCEPT HERE. 4087 03:11:47,200 --> 03:11:51,320 >> SO IT SEEMS IT WOULD BE A 4088 03:11:51,320 --> 03:11:51,960 TEAM AWARD. 4089 03:11:51,960 --> 03:11:56,320 LIKE INNOVATIVE AWARD BUT IT'S 4090 03:11:56,320 --> 03:11:59,480 AN RO1. 4091 03:11:59,480 --> 03:12:02,920 >> BASICALLY YOU HAVE IT AS AN 4092 03:12:02,920 --> 03:12:05,240 RO1 BUT IF YOU HAPPEN WHERE YOU 4093 03:12:05,240 --> 03:12:09,160 HAVE ABE A PIONEER IN THE PAST 4094 03:12:09,160 --> 03:12:12,840 FROM NCCIH WHERE HAVE YOU 4095 03:12:12,840 --> 03:12:16,280 TRANSFORMATIVE RO1 THAT WOULD 4096 03:12:16,280 --> 03:12:18,800 MAKE YOU ELIGIBLE BECAUSE 4097 03:12:18,800 --> 03:12:22,960 THERE'S A STRONG RECORD YOU'RE A 4098 03:12:22,960 --> 03:12:25,880 SUPER PRODUCTIVE INVESTIGATOR 4099 03:12:25,880 --> 03:12:27,440 AND ELIGIBLE TO BE CONSIDERED 4100 03:12:27,440 --> 03:12:30,560 FOR TO MAKE YOUR 4011 FROM A 4101 03:12:30,560 --> 03:12:33,040 FIVE-YEAR AWARD TO POTENTIALLY A 4102 03:12:33,040 --> 03:12:38,200 10-YEAR AWARD. 4103 03:12:38,200 --> 03:12:45,960 ANY OTHER QUESTIONS? 4104 03:12:45,960 --> 03:12:47,400 >> THERE ARE NO MORE COMMENTS. 4105 03:12:47,400 --> 03:12:51,360 DO WE HAVE A PROVE THE CONCEPT 4106 03:12:51,360 --> 03:12:52,040 FOR THE MERIT AWARD? 4107 03:12:52,040 --> 03:12:57,800 >> SO MOVED. 4108 03:12:57,800 --> 03:12:58,880 >> THIRD? 4109 03:12:58,880 --> 03:13:00,640 >> ALL WHO APPROVE, PLEASE RAISE 4110 03:13:00,640 --> 03:13:05,040 YOUR HAND. 4111 03:13:05,040 --> 03:13:05,640 THE MOTION HAS PASSED. 4112 03:13:05,640 --> 03:13:06,120 >> THANK YOU VERY MUCH. 4113 03:13:06,120 --> 03:13:16,360 >> THANK YOU. 4114 03:13:18,920 --> 03:13:20,000 WE'RE GETTING CLOSER TO THE END 4115 03:13:20,000 --> 03:13:21,800 OF THE MEETING AND I WOULD LIKE 4116 03:13:21,800 --> 03:13:24,760 TO REITERATE WHAT DR. LANGEVIN 4117 03:13:24,760 --> 03:13:26,600 SAID, THE NEXT MEETING WE'LL 4118 03:13:26,600 --> 03:13:30,280 HAVE IS JANUARY 19, 2024 AND 4119 03:13:30,280 --> 03:13:31,160 THIS MEETING WILL BE HELD 4120 03:13:31,160 --> 03:13:33,720 VIRTUALLY. 4121 03:13:33,720 --> 03:13:38,520 THE LAST AGENDA ITEM FOR THE 4122 03:13:38,520 --> 03:13:39,560 OPEN SESSION IS THE PUBLIC 4123 03:13:39,560 --> 03:13:40,480 COMMENT SESSION. 4124 03:13:40,480 --> 03:13:43,040 SINCE MEMBERS OF THE PUBLIC ARE 4125 03:13:43,040 --> 03:13:44,440 ATTENDING VIRTUALLY IT'S NOT 4126 03:13:44,440 --> 03:13:47,720 POSSIBLE TO MAKE IN-PERSON 4127 03:13:47,720 --> 03:13:48,280 COMMENTS. 4128 03:13:48,280 --> 03:13:50,160 THEREFORE ANY MEMBER OF THE 4129 03:13:50,160 --> 03:13:51,600 PUBLIC WHO WISHES TO MAKE A 4130 03:13:51,600 --> 03:13:53,880 PUBLIC COMMENT MAY DO SO BY 4131 03:13:53,880 --> 03:13:57,040 SENDING ME YOUR WRITTEN COMMENT 4132 03:13:57,040 --> 03:13:59,680 AND WE CHANGED IT FOR THIS ROUND 4133 03:13:59,680 --> 03:14:02,200 WITHIN 15 DAYS BEFORE THE ACTUAL 4134 03:14:02,200 --> 03:14:03,320 COUNCIL MEETING. 4135 03:14:03,320 --> 03:14:06,640 CAN DO THIS BY EITHER SENDING 4136 03:14:06,640 --> 03:14:09,280 THIS TO THE E-MAIL OR HARD COPY 4137 03:14:09,280 --> 03:14:09,520 LETTER. 4138 03:14:09,520 --> 03:14:10,920 YOUR WRITTEN COMMENTS SHOULD BE 4139 03:14:10,920 --> 03:14:12,560 LESS THAN 700 WORDS IN LENGTH 4140 03:14:12,560 --> 03:14:15,280 CONSISTENT WITH THE FIVE-MINUTE 4141 03:14:15,280 --> 03:14:17,320 ORAL PRESENTATION. 4142 03:14:17,320 --> 03:14:19,480 YOUR WRITTEN COMMENT WILL THEN 4143 03:14:19,480 --> 03:14:23,520 BE PROVIDED TO COUNCIL VIA THE 4144 03:14:23,520 --> 03:14:25,320 ELECTRONIC COUNCIL BOOK IN 4145 03:14:25,320 --> 03:14:26,480 ADVANCE OF THE COUNCIL MEETING 4146 03:14:26,480 --> 03:14:29,160 AND I WILL ACKNOWLEDGE THE 4147 03:14:29,160 --> 03:14:29,360 RECEIPT. 4148 03:14:29,360 --> 03:14:32,800 WE RECEIVED SOME DURING THE OPEN 4149 03:14:32,800 --> 03:14:33,600 SESSION. 4150 03:14:33,600 --> 03:14:36,000 SO FOR THIS ROUND WE DID NOT 4151 03:14:36,000 --> 03:14:37,160 RECEIVE ANY COMMENTS THIS TIME 4152 03:14:37,160 --> 03:14:39,040 AROUND BUT IF YOU WOULD LIKE TO 4153 03:14:39,040 --> 03:14:40,160 MAKE ANY COMMENTS NEXT TIME 4154 03:14:40,160 --> 03:14:41,480 WOULD THEN BE FOR THE GENERAL 4155 03:14:41,480 --> 03:14:47,160 COUNCIL MEETING. 4156 03:14:47,160 --> 03:14:53,000 AND WITH THIS, WE HAVE A LITTLE 4157 03:14:53,000 --> 03:14:54,520 BIT OF TIME. 4158 03:14:54,520 --> 03:14:57,040 I REALIZE PEOPLE WANT TO GO AND 4159 03:14:57,040 --> 03:14:57,640 CATCH THEIR FLIGHTS. 4160 03:14:57,640 --> 03:15:02,000 >> I THINK I WANT TO TAKE A 4161 03:15:02,000 --> 03:15:06,120 MINUTE TO ASK IF ANY OF YOU HAVE 4162 03:15:06,120 --> 03:15:08,240 ANY ISSUES YOU'D LIKE TO BRING 4163 03:15:08,240 --> 03:15:10,240 UP AND WE ALWAYS LIKE IT HEAR 4164 03:15:10,240 --> 03:15:12,600 FROM YOU WHAT WOULD YOU LIKE TO 4165 03:15:12,600 --> 03:15:17,960 DISCUSS THE NEXT MEETING OR AT A 4166 03:15:17,960 --> 03:15:20,960 FUTURE MEETING? 4167 03:15:20,960 --> 03:15:23,080 WHAT ARE THE TYPES OF 4168 03:15:23,080 --> 03:15:26,080 DISCUSSIONS YOU'D BE INTERESTED 4169 03:15:26,080 --> 03:15:28,760 IN ENGAGING IN WITH US AND WE'D 4170 03:15:28,760 --> 03:15:30,160 LIKE TO HEAR FROM YOU ON THAT OR 4171 03:15:30,160 --> 03:15:35,000 ANY OTHER THOUGHTS. 4172 03:15:35,000 --> 03:15:39,840 >> IT SEEMS LIKE THE DISCUSSION 4173 03:15:39,840 --> 03:15:41,200 OF VIRTUALALITY NEEDS TO BE ON 4174 03:15:41,200 --> 03:15:42,200 THE AGENDA. 4175 03:15:42,200 --> 03:15:47,440 >> THE OTHER THING THERE WAS A 4176 03:15:47,440 --> 03:15:54,920 COMMENT THAT WAS MADE AFTER MY 4177 03:15:54,920 --> 03:15:57,920 PRESENTATION, ARE WE DOING TOO 4178 03:15:57,920 --> 03:15:58,120 MUCH? 4179 03:15:58,120 --> 03:16:02,920 THERE WAS A SENSE I GOT AS I WAS 4180 03:16:02,920 --> 03:16:06,160 GIVING IT THAT SOME OF YOU MIGHT 4181 03:16:06,160 --> 03:16:09,680 PERCEIVE THAT WE ARE PERHAPS 4182 03:16:09,680 --> 03:16:12,080 SPREADING OURSELVES TOO THIN IN 4183 03:16:12,080 --> 03:16:12,720 MANY DIRECTIONS. 4184 03:16:12,720 --> 03:16:14,040 I DON'T FEEL THAT WAY PERSONALLY 4185 03:16:14,040 --> 03:16:20,000 BUT I WANT TO PERHAPS TAKE A FEW 4186 03:16:20,000 --> 03:16:24,640 MINUTES TO EXPLAIN PERHAPS HOW 4187 03:16:24,640 --> 03:16:25,840 I'M TRUEING VIS AND WONDERING IF 4188 03:16:25,840 --> 03:16:34,760 YOU HAVE THOUGHTS ON THIS? 4189 03:16:34,760 --> 03:16:38,920 WHAT HAPPENS IS WHEN WE CHANGED 4190 03:16:38,920 --> 03:16:41,360 THE PLAN FIVE YEARS AGO AFTER I 4191 03:16:41,360 --> 03:16:46,200 BECAME DIRECTOR, WE WANTED TO 4192 03:16:46,200 --> 03:16:48,600 REALLY CHANGE MAKE A PRETTY 4193 03:16:48,600 --> 03:16:49,680 SIGNIFICANT CHANGE IN THE OVER 4194 03:16:49,680 --> 03:16:54,920 ALL FOCUS OF THE RESEARCH 4195 03:16:54,920 --> 03:16:55,880 TOWARDS THE COUNCIL. 4196 03:16:55,880 --> 03:17:00,840 THAT DID NOT MEAN WE WANTED TO 4197 03:17:00,840 --> 03:17:03,480 ABANDON SOME OF THE RESEARCH 4198 03:17:03,480 --> 03:17:04,080 BEFORE. 4199 03:17:04,080 --> 03:17:05,880 SUCH AS RESEARCH ON MIND AND 4200 03:17:05,880 --> 03:17:07,040 BODY PRACTICES, NATURAL 4201 03:17:07,040 --> 03:17:07,480 PRODUCTS. 4202 03:17:07,480 --> 03:17:09,520 WE WANTED THAT TO CONTINUE AND 4203 03:17:09,520 --> 03:17:11,320 BE SUCCESSFUL AND RESEARCH ON 4204 03:17:11,320 --> 03:17:12,560 PAIN. 4205 03:17:12,560 --> 03:17:13,640 WE HAVE CONTINUED TO DO THAT YOU 4206 03:17:13,640 --> 03:17:18,800 CAN SEE WE CONTINUE TO FUND 4207 03:17:18,800 --> 03:17:20,280 ROBUST PORTFOLIO. 4208 03:17:20,280 --> 03:17:22,200 IN ADDITION, WE WANTED TO 4209 03:17:22,200 --> 03:17:23,360 INCORPORATE NEW ELEMENTS TO THE 4210 03:17:23,360 --> 03:17:27,080 RESEARCH THAT I WOULD SAY ARE 4211 03:17:27,080 --> 03:17:34,800 MORE COMPLEX. 4212 03:17:34,800 --> 03:17:38,720 WE ARE LOOKING AT PROTOCOLS AND 4213 03:17:38,720 --> 03:17:39,360 CONNECTIONS ACROSS SYSTEMS OF 4214 03:17:39,360 --> 03:17:44,560 THE BODY AND LOOKING AT METHODS 4215 03:17:44,560 --> 03:17:47,040 USING BIG DATA, ARTIFICIAL 4216 03:17:47,040 --> 03:17:48,320 INTELLIGENCE TO EXAMINE PUBLIC 4217 03:17:48,320 --> 03:17:50,760 SYSTEMS. 4218 03:17:50,760 --> 03:17:53,600 WE TALKED ABOUT IT IN PRODUCTS 4219 03:17:53,600 --> 03:17:55,200 AND USING NEW COMPUTATIONAL 4220 03:17:55,200 --> 03:17:57,440 METHODS AND IN AREAS OF BEHAVIOR 4221 03:17:57,440 --> 03:18:03,000 AND NOW WE'RE TALKING ABOUT 4222 03:18:03,000 --> 03:18:06,240 DROUGHT AND GOING ANOTHER 4223 03:18:06,240 --> 03:18:06,640 DOMAIN. 4224 03:18:06,640 --> 03:18:09,800 I THINK THE WAY WE HAVE DONE 4225 03:18:09,800 --> 03:18:12,040 THAT IS BY CASTING NETS IN 4226 03:18:12,040 --> 03:18:16,480 DIFFERENT DIRECTIONS. 4227 03:18:16,480 --> 03:18:21,640 WE DON'T ANTICIPATE A LOT OF THE 4228 03:18:21,640 --> 03:18:22,720 INITIATIVES WOULD GIVE US 4229 03:18:22,720 --> 03:18:24,320 TORRENTS OF NEW APPLICATIONS IN 4230 03:18:24,320 --> 03:18:25,600 NEW DIRECTION AND I THINK THERE 4231 03:18:25,600 --> 03:18:27,960 WAS A CONCERN IF WE TRIED TO DO 4232 03:18:27,960 --> 03:18:30,200 TOO MANY THINGS IN TOO MANY 4233 03:18:30,200 --> 03:18:34,080 DIRECTIONS, HOW WILL WE SPEND 4234 03:18:34,080 --> 03:18:39,640 OUR BUDGET WHICH IS QUITE 4235 03:18:39,640 --> 03:18:41,560 MODEST. 4236 03:18:41,560 --> 03:18:43,880 AT THE SAME TIME WE'RE GOING 4237 03:18:43,880 --> 03:18:45,320 THIS WE'RE LOOKING FOR 4238 03:18:45,320 --> 03:18:47,960 COLLABORATIONS AT OTHER 4239 03:18:47,960 --> 03:18:53,160 INSTITUTES AND FUND FROM OTHER 4240 03:18:53,160 --> 03:18:55,040 INSTITUTES AND FROM TRANS-COMMON 4241 03:18:55,040 --> 03:18:56,280 FUND, ETCETERA. 4242 03:18:56,280 --> 03:18:58,440 THERE'S ANOTHER COMPONENT OF 4243 03:18:58,440 --> 03:19:04,360 THIS WHICH I THINK IS IMPORTANT. 4244 03:19:04,360 --> 03:19:10,600 PART IS AN EFFORT ON OUR PART TO 4245 03:19:10,600 --> 03:19:12,360 CAREFULLY AND THOUGHTFULLY 4246 03:19:12,360 --> 03:19:14,200 REDIRECT OUR PORTFOLIO TOWARDS 4247 03:19:14,200 --> 03:19:15,920 THE INITIATIVES WITHOUT BEING 4248 03:19:15,920 --> 03:19:16,240 DISRUPTIVE. 4249 03:19:16,240 --> 03:19:18,080 I'M CURIOUS FROM ALL OF YOU, DO 4250 03:19:18,080 --> 03:19:28,600 YOU FEEL THAT WE ARE DOING THAT? 4251 03:19:33,920 --> 03:19:35,800 ARE YOU MOVING TOWARDS THAT OR 4252 03:19:35,800 --> 03:19:36,440 DO YOU HAVE ANY CONCERNS ABOUT 4253 03:19:36,440 --> 03:19:46,560 THIS? 4254 03:19:48,400 --> 03:19:52,600 ARE WE CASTING TOO MANY NETS? 4255 03:19:52,600 --> 03:19:58,320 >> MY THOUGHT IS NO. 4256 03:19:58,320 --> 03:20:01,880 I THINK OVER TIME YOU'RE ALL 4257 03:20:01,880 --> 03:20:05,120 LOOKING FOR THE LATEST TREND AND 4258 03:20:05,120 --> 03:20:06,720 THINKING ABOUT AND 40 YEARS IN 4259 03:20:06,720 --> 03:20:07,600 CLINICAL PRACTICE AND SOME 4260 03:20:07,600 --> 03:20:09,600 THINGS I WAS DOING IN MY FIRST 4261 03:20:09,600 --> 03:20:10,680 FIVE YEARS OF PRACTICE I WAS 4262 03:20:10,680 --> 03:20:13,080 THINKING WHAT AN IDIOT. 4263 03:20:13,080 --> 03:20:14,600 I THINK THINGS HAVE TO EVOLVE. 4264 03:20:14,600 --> 03:20:19,120 I THINK WE ALSO DO NEED TO PAY 4265 03:20:19,120 --> 03:20:21,920 ATTENTION TO SOME OF THE LESSER 4266 03:20:21,920 --> 03:20:24,440 KNOWN TYPES OF APPROACHES AND BE 4267 03:20:24,440 --> 03:20:25,080 ABLE TO FUND THOSE AND FIND OUT 4268 03:20:25,080 --> 03:20:29,960 WHAT'S GOING ON. 4269 03:20:29,960 --> 03:20:33,120 I DON'T THINK WE'RE CASTING THAT 4270 03:20:33,120 --> 03:20:34,960 WIDE A NET. 4271 03:20:34,960 --> 03:20:43,840 WITH DISCUSS TO SPIRITUALITY AND 4272 03:20:43,840 --> 03:20:45,880 MANY TIMES I'VE HAD PATIENTS SAY 4273 03:20:45,880 --> 03:20:47,320 WILL YOU PRAY WITH ME. 4274 03:20:47,320 --> 03:20:49,240 I WILL SAY YES. 4275 03:20:49,240 --> 03:20:52,240 I DON'T KNOW THE RELIGIOUS 4276 03:20:52,240 --> 03:20:53,560 BACKGROUND OF THE PATIENT SO I 4277 03:20:53,560 --> 03:20:54,720 TELL THEM TO LEAD THE PRAYER BUT 4278 03:20:54,720 --> 03:20:57,120 WE HAVE TO THINK ABOUT THE 4279 03:20:57,120 --> 03:20:59,440 INTERACTION BETWEEN THE PROVIDER 4280 03:20:59,440 --> 03:21:02,920 AND PATIENT IN TERMS OF 4281 03:21:02,920 --> 03:21:03,280 SPIRITUALITY. 4282 03:21:03,280 --> 03:21:04,520 I THINK IT'S WHAT IT OUGHT TO BE 4283 03:21:04,520 --> 03:21:04,760 CALLED. 4284 03:21:04,760 --> 03:21:06,560 I DON'T THINK WE NEED TO COME UP 4285 03:21:06,560 --> 03:21:08,360 WITH SOMETHING ELSE BECAUSE 4286 03:21:08,360 --> 03:21:11,840 PEOPLE KNOW ABOUT MIND, BODY, 4287 03:21:11,840 --> 03:21:12,200 SPIRIT. 4288 03:21:12,200 --> 03:21:14,840 WHAT'S THE FIRST HEAR YOU HEAR 4289 03:21:14,840 --> 03:21:17,200 FROM SOMEBODY WHEN SOMEONE IS 4290 03:21:17,200 --> 03:21:17,400 SICK? 4291 03:21:17,400 --> 03:21:18,720 THOUGHTS AND PRAYERS ARE WITH 4292 03:21:18,720 --> 03:21:18,960 YOU. 4293 03:21:18,960 --> 03:21:24,800 THAT'S HOW THE GENERAL PUBLIC I 4294 03:21:24,800 --> 03:21:26,320 THINK THINKS OF SPIRITUALITY. 4295 03:21:26,320 --> 03:21:29,480 THERE'S A LOT OF LAND MINES. 4296 03:21:29,480 --> 03:21:31,000 WE HAVE TO BE CAREFUL HOW WE 4297 03:21:31,000 --> 03:21:33,040 DEFINE IT BUT I DON'T THINK WE 4298 03:21:33,040 --> 03:21:34,440 CALL IT SOMETHING DIFFERENT THAT 4299 03:21:34,440 --> 03:21:34,760 SPIRITUALITY. 4300 03:21:34,760 --> 03:21:38,960 THAT'S WHAT THE GENERAL PUBLIC 4301 03:21:38,960 --> 03:21:42,000 THINKS OF IT AS. 4302 03:21:42,000 --> 03:21:43,760 AGAIN, WE HAVE TO BE CAREFUL 4303 03:21:43,760 --> 03:21:46,920 DEFINING IT AND HAVE TO BE 4304 03:21:46,920 --> 03:21:53,480 CAREFUL -- AS A SPORTS GUY, WE 4305 03:21:53,480 --> 03:22:03,920 HAVE ON CAMPUS FELLOWSHIP 4306 03:22:04,880 --> 03:22:08,320 CHRISTIAN AND WE PRAY FOR GAMES 4307 03:22:08,320 --> 03:22:14,600 AND MEALS AND IF AN ATHLETE IS 4308 03:22:14,600 --> 03:22:17,000 INJURED, COACH MIGHT BE HANGING 4309 03:22:17,000 --> 03:22:19,400 AROUND BUT OUR CHAPLAIN IS ALSO 4310 03:22:19,400 --> 03:22:22,360 HANGING AROUND AND SPEAKING WITH 4311 03:22:22,360 --> 03:22:24,680 THE ATHLETE AT THE SORT OF SAME 4312 03:22:24,680 --> 03:22:26,000 TIME CONTEMPORANEOUSLY IT'S ALL 4313 03:22:26,000 --> 03:22:36,160 GOING ON. 4314 03:22:59,600 --> 03:23:02,440 AND I THINK WE HAVE TO IT'S 4315 03:23:02,440 --> 03:23:02,920 COMPLICATED. 4316 03:23:02,920 --> 03:23:05,600 IT'S GOING TO BE REALLY HARD BUT 4317 03:23:05,600 --> 03:23:06,920 I THINK WE NEED TO DO IT. 4318 03:23:06,920 --> 03:23:17,160 >> THANK YOU. 4319 03:23:18,800 --> 03:23:19,720 VERY HELPFUL. 4320 03:23:19,720 --> 03:23:21,360 ANY OTHER COMMENTS. 4321 03:23:21,360 --> 03:23:23,800 >> WITH SPREADING TOO THIN, THE 4322 03:23:23,800 --> 03:23:25,960 WHOLE NATURE OF INTEGRATIVE 4323 03:23:25,960 --> 03:23:30,600 HEALTH INVOLVES SO MANY DOUGH 4324 03:23:30,600 --> 03:23:30,920 DA 4325 03:23:30,920 --> 03:23:33,480 -- MODALITIES YOU CAN'T BE VERY 4326 03:23:33,480 --> 03:23:33,760 FOCUSSED. 4327 03:23:33,760 --> 03:23:35,000 YOU NEED A WIDE PORTFOLIO YOU 4328 03:23:35,000 --> 03:23:36,840 ALSO NEED TO MOVE WITH THE TIMES 4329 03:23:36,840 --> 03:23:38,960 AND ADD NEW THINGS AS THEY COME 4330 03:23:38,960 --> 03:23:41,080 UP. 4331 03:23:41,080 --> 03:23:43,400 YOU NEED TIME FOR PEOPLE TO 4332 03:23:43,400 --> 03:23:45,080 DEVELOP THE EXPERTS TO ADDRESS 4333 03:23:45,080 --> 03:23:45,560 THAT. 4334 03:23:45,560 --> 03:23:46,920 IT MAKES SENSE TO DO WHAT YOU'RE 4335 03:23:46,920 --> 03:23:57,280 DOING IN MY OPINION. 4336 03:24:01,720 --> 03:24:05,440 >> I AGREE WITH THIS BEING AN 4337 03:24:05,440 --> 03:24:07,000 IMPORTANT PRIORITY. 4338 03:24:07,000 --> 03:24:11,680 AS ERICA GOES, I THINK IT LIES 4339 03:24:11,680 --> 03:24:16,560 WITHIN THE PHILOSOPHY OF THIS 4340 03:24:16,560 --> 03:24:25,000 COUNCIL OR THIS IT WOULD BE A 4341 03:24:25,000 --> 03:24:30,440 SAME THIS COUNCIL IS THE ONLY 4342 03:24:30,440 --> 03:24:34,200 COUNCIL PERHAPS FOR INTEGRATING 4343 03:24:34,200 --> 03:24:36,080 ALL DIMENSIONS OF HEALTH. 4344 03:24:36,080 --> 03:24:37,360 THERE'S EVEN WAYS TO COLLABORATE 4345 03:24:37,360 --> 03:24:38,520 WITH OTHER INSTITUTES I THINK 4346 03:24:38,520 --> 03:24:48,880 WOULD BE BETTER YET. 4347 03:24:49,920 --> 03:24:52,280 >> WE HAVE A TRANS NIH WORKING 4348 03:24:52,280 --> 03:24:54,360 GROUP ON WHOLE PERSON RESEARCH 4349 03:24:54,360 --> 03:24:57,320 THAT'S ALIVE AND WELL. 4350 03:24:57,320 --> 03:24:58,920 THEY'LL BE TELLING YOU MORE IN 4351 03:24:58,920 --> 03:25:02,000 SUBSEQUENT COUNCILS ABOUT THIS. 4352 03:25:02,000 --> 03:25:04,480 BUT THERE IS A LOT OF INTEREST 4353 03:25:04,480 --> 03:25:05,560 THROUGHOUT NIH IN WHAT WE'RE 4354 03:25:05,560 --> 03:25:15,920 DOING IN THIS AREA. 4355 03:25:24,520 --> 03:25:27,480 >> AS WE THINK OF 4356 03:25:27,480 --> 03:25:30,720 PATIENT-CENTERED OUTCOMES IT'S 4357 03:25:30,720 --> 03:25:32,440 IMPOSSIBLE NOT TO DEAL WITH THE 4358 03:25:32,440 --> 03:25:42,840 PATIENT'S SPIRITUALITY. 4359 03:25:45,840 --> 03:25:46,800 IT'S FINE. 4360 03:25:46,800 --> 03:25:47,480 THAT'S WHAT IT IS. 4361 03:25:47,480 --> 03:25:49,600 IF YOU THINK OF MENTAL IN 4362 03:25:49,600 --> 03:25:52,760 PARTICULAR, MOST PARTICIPANTS I 4363 03:25:52,760 --> 03:25:59,160 KNOW ABOUT DON'T EVEN GO TO 4364 03:25:59,160 --> 03:25:59,440 PROVIDERS. 4365 03:25:59,440 --> 03:26:00,560 THEY BELIEVE SPIRITUALITY IS THE 4366 03:26:00,560 --> 03:26:02,440 ESSENCE OF WHAT CAN CURE THEM 4367 03:26:02,440 --> 03:26:05,400 AND MAKE THEIR PROBLEMS GO AWAY. 4368 03:26:05,400 --> 03:26:07,560 WE HAVE TO FOCUS ON THAT BUT 4369 03:26:07,560 --> 03:26:12,960 MAKE SHURZ IT'S NOT TOO MUCH. 4370 03:26:12,960 --> 03:26:23,520 -- MAKE SURE IT'S NOT TOO MUCH. 4371 03:26:32,120 --> 03:26:33,760 >> ANY OTHER THOUGHTS OR 4372 03:26:33,760 --> 03:26:38,960 COMMENTS OR EVEN ON SOMETHING 4373 03:26:38,960 --> 03:26:40,040 ELSE OTHER TOPICS? 4374 03:26:40,040 --> 03:26:42,080 ANY THOUGHTS ABOUT WHAT TOPICS 4375 03:26:42,080 --> 03:26:43,840 YOU'D LIKE DISCUSSED NEXT TIME 4376 03:26:43,840 --> 03:26:54,240 OR CONTINUE THIS DISCUSSION? 4377 03:26:54,240 --> 03:26:58,720 I DO LOOK FORWARD TO SEEING WHAT 4378 03:26:58,720 --> 03:27:00,880 THE PUBLIC COMMENTS ON THE 4379 03:27:00,880 --> 03:27:01,640 SPIRITUALITY ISSUE WHEN HAVE YOU 4380 03:27:01,640 --> 03:27:04,520 A CHANCE TO COMPILE DHEM. 4381 03:27:04,520 --> 03:27:05,960 -- THEM I THINK IT WILL BE 4382 03:27:05,960 --> 03:27:10,920 FASHION -- FASCINATING AND 4383 03:27:10,920 --> 03:27:13,120 REALLY INSTRUCTIVE. 4384 03:27:13,120 --> 03:27:15,200 >> I WANT TO THANK YOU FOR YOUR 4385 03:27:15,200 --> 03:27:18,960 SUPPORT ON THIS AREA IF YOU 4386 03:27:18,960 --> 03:27:21,920 RECALL, THE WHOLE DISCUSSION WAS 4387 03:27:21,920 --> 03:27:24,800 STARTED FROM INPUT FROM YOU AND 4388 03:27:24,800 --> 03:27:27,440 ALSO FROM A MEMBER OF THE 4389 03:27:27,440 --> 03:27:29,840 COMMUNITY WHO WROTE US A COMMENT 4390 03:27:29,840 --> 03:27:33,200 AND I MEAN, WE THINK THAT THIS 4391 03:27:33,200 --> 03:27:38,800 IS IMPORTANT THAT WE LISTEN TO 4392 03:27:38,800 --> 03:27:45,400 THESE COMMENTS AND IT'S 4393 03:27:45,400 --> 03:27:46,520 IMPORTANT THE TOPICS GET 4394 03:27:46,520 --> 03:27:47,320 ADDRESSED AT THE TIME WHEN 4395 03:27:47,320 --> 03:27:55,720 YOU'RE READY TO ADDRESS THEM. 4396 03:27:55,720 --> 03:27:58,080 THERE'S AN EVOLUTION AND I THINK 4397 03:27:58,080 --> 03:27:59,400 THAT WAS VERY MUCH ILLUSTRATED 4398 03:27:59,400 --> 03:28:03,320 BY THE CARBON PROGRAM. 4399 03:28:03,320 --> 03:28:05,640 THE TYPES OF STUDIES THAT CAN BE 4400 03:28:05,640 --> 03:28:06,240 CONDUCTED WELL AT ANY GIVEN 4401 03:28:06,240 --> 03:28:15,120 POINT IN TIME. 4402 03:28:15,120 --> 03:28:17,160 YOU MAY BE READY TO DO SOMETHING 4403 03:28:17,160 --> 03:28:18,520 AT ONE PERIOD BUT NOT ANOTHER. 4404 03:28:18,520 --> 03:28:20,160 WE HAVE TO ASK OURSELVES IS 4405 03:28:20,160 --> 03:28:21,200 SOMETHING LIKE SPIRITUALITY 4406 03:28:21,200 --> 03:28:22,760 SOMETHING THAT A, IS IMPORTANT. 4407 03:28:22,760 --> 03:28:26,320 I THINK WE'RE ALL IN AGREEMENT 4408 03:28:26,320 --> 03:28:26,600 ON THAT. 4409 03:28:26,600 --> 03:28:27,840 IS IT SOMETHING WHERE WE'RE AT A 4410 03:28:27,840 --> 03:28:32,960 POINT OF MATURITY TO BE ABLE TO 4411 03:28:32,960 --> 03:28:34,160 ADDRESS AND TACKLE AND I GUESS 4412 03:28:34,160 --> 03:28:38,960 WE ARE IN THE MIDDLE OF 4413 03:28:38,960 --> 03:28:39,560 ANSWERING THAT QUESTION MAYBE. 4414 03:28:39,560 --> 03:28:42,400 BUT METHODOLOGY AND SOMEBODY HAD 4415 03:28:42,400 --> 03:28:45,000 MENTIONED ALSO THESE COMPLEX 4416 03:28:45,000 --> 03:28:47,840 SYSTEMS LIKE TRADITIONAL CHINESE 4417 03:28:47,840 --> 03:28:50,680 MEDICINE, AYURVEDA, ARE WE READY 4418 03:28:50,680 --> 03:28:53,680 TO TACKLE THESE. 4419 03:28:53,680 --> 03:28:57,200 IF YOU RECALL WHEN WE WROTE THE 4420 03:28:57,200 --> 03:28:59,320 STRATEGIC PLAN THE FIRST 4421 03:28:59,320 --> 03:29:03,040 STRATEGY GOAL WAS, IS TO DEVELOP 4422 03:29:03,040 --> 03:29:06,840 BETTER METHODOLOGIES TO STUDY 4423 03:29:06,840 --> 03:29:08,640 THESE INTERVENTIONS TO STUDY 4424 03:29:08,640 --> 03:29:11,400 THEIR FIDELITY AND HOW CAN WE 4425 03:29:11,400 --> 03:29:17,000 EVEN STUDY THESE INTERVENTIONS 4426 03:29:17,000 --> 03:29:22,640 BEFORE WE CAN ACTUAL LY COME UP 4427 03:29:22,640 --> 03:29:23,920 WITH THE SPECIFIC DIAGNOSIS OR 4428 03:29:23,920 --> 03:29:24,600 PRESCRIPTION OR ACCORDING TO THE 4429 03:29:24,600 --> 03:29:29,000 SYSTEMS. 4430 03:29:29,000 --> 03:29:32,840 WE HAVE NOT SEEN TOO MANY 4431 03:29:32,840 --> 03:29:33,600 INVESTIGATOR-INITIATED 4432 03:29:33,600 --> 03:29:35,560 APPLICATIONS IN THIS AREA THOUGH 4433 03:29:35,560 --> 03:29:38,400 THE STRATEGIC PLAN HAD BEEN 4434 03:29:38,400 --> 03:29:39,200 AROUND A WHILE. 4435 03:29:39,200 --> 03:29:42,040 WE WERE HOPING TO SEE MORE AND 4436 03:29:42,040 --> 03:29:42,960 PERHAPS WILL NEED TO PROVIDE 4437 03:29:42,960 --> 03:29:46,000 MORE SPECIFIC FUNDING 4438 03:29:46,000 --> 03:29:47,920 OPPORTUNITIES FOR THAT. 4439 03:29:47,920 --> 03:29:48,120 NADJA. 4440 03:29:48,120 --> 03:29:50,440 >> YOU JUST SAID THE THING I WAS 4441 03:29:50,440 --> 03:29:51,720 GOING TO SAY. 4442 03:29:51,720 --> 03:29:52,840 I'M TO HEAR YOU MENTION THIS AS 4443 03:29:52,840 --> 03:30:03,040 A PRIORITY. 4444 03:30:06,720 --> 03:30:08,760 THOSE FOCUSSED ON METHODOLOGY IN 4445 03:30:08,760 --> 03:30:14,520 RO1s IN GENERAL AND THE IDEAS OF 4446 03:30:14,520 --> 03:30:17,560 AYURVEDA ARE PUZZLING FOR THOSE 4447 03:30:17,560 --> 03:30:23,800 ON THE STUDY SY SECTIONS AT CSR. 4448 03:30:23,800 --> 03:30:25,600 IF THEY WANT TO SEE A SERIOUS 4449 03:30:25,600 --> 03:30:28,040 SET OF APPLICATIONS THERE NEEDS 4450 03:30:28,040 --> 03:30:30,120 TO BE SPECIAL EMPHASIS PANELS 4451 03:30:30,120 --> 03:30:31,360 AND SPECIAL CALLS FOR THE 4452 03:30:31,360 --> 03:30:33,000 GRANTS. 4453 03:30:33,000 --> 03:30:35,960 WE KNOW NOT TO EVEN TRY IT 4454 03:30:35,960 --> 03:30:39,680 UNLESS THAT EXISTS. 4455 03:30:39,680 --> 03:30:45,040 >> YOU COULD STUDY A NATURAL 4456 03:30:45,040 --> 03:30:47,440 PRODUCT IN AYURVEDA, SOME ARE 4457 03:30:47,440 --> 03:30:50,680 BEING STUDIED NOW, BUT THAT'S 4458 03:30:50,680 --> 03:30:52,280 DIFFERENT STUDYING ONE COMPONENT 4459 03:30:52,280 --> 03:30:56,120 IN ISOLATION FROM THE PRACTICE 4460 03:30:56,120 --> 03:30:57,400 WHERE THAT PARTICULAR HERB WOULD 4461 03:30:57,400 --> 03:31:01,680 BE PRESCRIBED IN THE CONTEXT OF 4462 03:31:01,680 --> 03:31:03,320 DIAGNOSING A SPECIFIC CONDITION 4463 03:31:03,320 --> 03:31:07,480 WHICH IS FOREIGN TO ANY WESTERN 4464 03:31:07,480 --> 03:31:09,200 CONDITION WE STUDY IN WESTERN 4465 03:31:09,200 --> 03:31:19,400 MEDICINE. 4466 03:31:35,600 --> 03:31:37,200 >> WHAT'S THE VALUE OF 4467 03:31:37,200 --> 03:31:38,600 QUALITATIVE RESEARCH? 4468 03:31:38,600 --> 03:31:40,760 >> WE WOULD LOVE TO HEAR MORE 4469 03:31:40,760 --> 03:31:42,240 AND DISCUSS MORE ABOUT THAT 4470 03:31:42,240 --> 03:31:43,920 BECAUSE, WELL, QUANTITATIVE 4471 03:31:43,920 --> 03:31:46,920 RESEARCH, WE HEARD SOME OF IT 4472 03:31:46,920 --> 03:31:57,320 MENTIONED TODAY ALREADY. 4473 03:31:59,200 --> 03:32:03,040 WE ANALYZED THE CONTENT OF DROP 4474 03:32:03,040 --> 03:32:05,880 DOWN MENUS. 4475 03:32:05,880 --> 03:32:08,520 SO THERE'S A LOT WE CAN DERIVE 4476 03:32:08,520 --> 03:32:14,560 NOW FROM GUESS, WHAT, FREE TEXT. 4477 03:32:14,560 --> 03:32:15,600 WHEN YOU ADMINISTER A 4478 03:32:15,600 --> 03:32:18,040 QUESTIONNAIRE AND HAVE OPTIONS 4479 03:32:18,040 --> 03:32:20,000 FOR PEOPLE TO ANSWER AND HAVE AN 4480 03:32:20,000 --> 03:32:21,600 OPTION TO PUT DOWN THROUGH TEXT. 4481 03:32:21,600 --> 03:32:25,640 WE'RE COMING ALONG SO QUICKLY IN 4482 03:32:25,640 --> 03:32:27,800 OUR ABILITY TO ANALYZE IT EVEN 4483 03:32:27,800 --> 03:32:38,000 GENERATE IT. 4484 03:32:41,800 --> 03:32:52,280 I THINK WE'RE READY TO DO THAT. 4485 03:32:55,280 --> 03:32:58,000 >> I IMAGINED PEOPLE COMING FROM 4486 03:32:58,000 --> 03:33:01,000 NORTH COLORADO WHO ARE 4487 03:33:01,000 --> 03:33:02,640 FUNDAMENTALLY CHRISTIAN TALKING 4488 03:33:02,640 --> 03:33:05,040 WITH ON SPIRITUALITY WITH 4489 03:33:05,040 --> 03:33:15,600 BUDDHISTS -- HOW DO YOU DO THIS? 4490 03:33:25,640 --> 03:33:26,800 >> WHAT DO THESE DIFFERENT 4491 03:33:26,800 --> 03:33:29,280 PRACTICES HAVE IN COMMON? 4492 03:33:29,280 --> 03:33:31,080 WE TALKED ABOUT ALREADY TODAY 4493 03:33:31,080 --> 03:33:41,200 ARE CONNECTIONS. 4494 03:33:41,200 --> 03:33:43,680 THAT'S IN COMMON WITH RELIGIONS 4495 03:33:43,680 --> 03:33:44,880 AND PRACTICES. 4496 03:33:44,880 --> 03:33:55,440 THAT MAY BE A GOOD WAY TO START. 4497 03:33:58,600 --> 03:34:01,840 >> THERE'S A DEARTH OF 4498 03:34:01,840 --> 03:34:03,000 INFORMATION AROUND HOW DIFFERENT 4499 03:34:03,000 --> 03:34:08,560 HEALING CONTRIBUTIONS MIGHT VIEW 4500 03:34:08,560 --> 03:34:12,840 THE SAME PATIENT OR DESCRIBE A 4501 03:34:12,840 --> 03:34:14,240 PATIENT FROM A DIAGNOSTIC 4502 03:34:14,240 --> 03:34:19,360 STANDPOINT AND WONDER IF THERE'S 4503 03:34:19,360 --> 03:34:27,640 OPPORTUNITIES IN PARTICULAR 4504 03:34:27,640 --> 03:34:38,200 ESPECIALLY WITH A -- AYURVEDIC 4505 03:34:38,800 --> 03:34:41,440 PRACTITIONER AND COLLECT 4506 03:34:41,440 --> 03:34:42,600 INFORMATION ASH THE DIAGNOSTIC 4507 03:34:42,600 --> 03:34:44,240 DESCRIPTION OF THOSE PATIENTS AS 4508 03:34:44,240 --> 03:34:45,160 HYPOTHESES GENERATING. 4509 03:34:45,160 --> 03:34:51,000 >> I WOULD NOT AGREE MORE. 4510 03:34:51,000 --> 03:34:54,920 >> THE IDEA OF DIFFERENT 4511 03:34:54,920 --> 03:34:57,960 DIAGNOSTIC FILTERS HAS BEEN 4512 03:34:57,960 --> 03:35:01,360 AROUND AND YOU HAVE ONE PATIENT 4513 03:35:01,360 --> 03:35:03,880 AND USE DIFFERENT FILTERS AND HU 4514 03:35:03,880 --> 03:35:05,480 DO YOU PARS OUT THE PERSON'S 4515 03:35:05,480 --> 03:35:11,880 SIGNS AND SYMPTOMS AND OBJECTIVE 4516 03:35:11,880 --> 03:35:17,200 FINDINGS, WHATEVER IT IS, HOW DO 4517 03:35:17,200 --> 03:35:19,120 YOU ORGANIZE THAT INTO A 4518 03:35:19,120 --> 03:35:19,880 DIAGNOSIS? 4519 03:35:19,880 --> 03:35:21,360 THAT CAN BE STUDIED AND DESCRIBE 4520 03:35:21,360 --> 03:35:26,840 IT FIRST AND COME UP WITH WAYS 4521 03:35:26,840 --> 03:35:33,480 TO -- AND IF YOU HAD DIFFERENT 4522 03:35:33,480 --> 03:35:37,080 PRACTITIONERS OF A GIVEN 4523 03:35:37,080 --> 03:35:38,800 TRANSITION WITH ANOTHER GROUP OF 4524 03:35:38,800 --> 03:35:41,000 A DIFFERENT TRADITION WOULD 4525 03:35:41,000 --> 03:35:44,320 THERE BE MORE AGREEMENT AMONG 4526 03:35:44,320 --> 03:35:46,920 PRACTITIONERS OF EACH TRADITION 4527 03:35:46,920 --> 03:35:49,360 AMONG THEMSELVES COMPARED TO 4528 03:35:49,360 --> 03:35:49,600 ACROSS? 4529 03:35:49,600 --> 03:35:52,080 THAT'S THE FIRST BASIC QUESTION. 4530 03:35:52,080 --> 03:35:55,480 I DON'T -- I'M NOT SURE 4531 03:35:55,480 --> 03:35:56,680 ANYBODY'S EVER DONE THIS. 4532 03:35:56,680 --> 03:35:57,640 IT'S NOT THAT COMPLICATED OF A 4533 03:35:57,640 --> 03:36:07,840 STUDY TO DO. 4534 03:36:10,560 --> 03:36:12,720 WELL, I GUESS WE'RE ALMOST AT 4535 03:36:12,720 --> 03:36:12,920 4:00. 4536 03:36:12,920 --> 03:36:14,360 >> THERE'S ONE COMMENT IN THE 4537 03:36:14,360 --> 03:36:20,840 CHAT FROM DR. HANEY FOR 4538 03:36:20,840 --> 03:36:22,920 EFFICIENT MEETINGS I LOVE 4539 03:36:22,920 --> 03:36:30,880 HEARING FROM NCCIH FUNDED 4540 03:36:30,880 --> 03:36:37,360 SCIENTISTS. 4541 03:36:37,360 --> 03:36:39,600 AND WE WANTED TO PUT IT OFF THIS 4542 03:36:39,600 --> 03:36:41,320 TIME BECAUSE WE THOUGHT IT WAS 4543 03:36:41,320 --> 03:36:46,760 TIMELY SO WE'RE PLANNING AND I'M 4544 03:36:46,760 --> 03:36:54,320 LOOKING AT MY COLLEAGUES I'M 4545 03:36:54,320 --> 03:36:55,920 GLAD, THANK YOU, DR. HANEY. 4546 03:36:55,920 --> 03:36:56,440 I'M GLAD YOU'RE HEAR FOR 4547 03:36:56,440 --> 03:36:58,920 INTEREST. 4548 03:36:58,920 --> 03:37:04,640 >> THANK YOU. 4549 03:37:04,640 --> 03:37:06,120 WE MADE IT TO THE END. 4550 03:37:06,120 --> 03:37:07,200 >> THANK YOU FOR THE DISCUSSION, 4551 03:37:07,200 --> 03:37:10,200 BY THE WAY. 4552 03:37:10,200 --> 03:37:12,840 >> GOOD. 4553 03:37:12,840 --> 03:37:14,960 SO AGAIN, I WOULD LIKE IT SAY 4554 03:37:14,960 --> 03:37:16,920 IT'S BEEN A REAL PLEASURE TO 4555 03:37:16,920 --> 03:37:18,400 MEET ALL OF YOU IN PERSON HERE 4556 03:37:18,400 --> 03:37:22,600 AND HAVE YOU WITH ME IN THE ROOM 4557 03:37:22,600 --> 03:37:27,960 TODAY AS WELL AS THOSE 4558 03:37:27,960 --> 03:37:28,320 VIRTUALLY. 4559 03:37:28,320 --> 03:37:31,560 I KNOW I AM SAYING IT FOR THE 4560 03:37:31,560 --> 03:37:34,040 SECOND TIME NOW, NCCIH WOULD NOT 4561 03:37:34,040 --> 03:37:38,360 BE ABLE TO FULFILL ITS MISSION 4562 03:37:38,360 --> 03:37:45,200 WITHOUT YOUR EXPERTISE AND 4563 03:37:45,200 --> 03:37:46,200 GUIDANCE AND YOUR INPUT IS 4564 03:37:46,200 --> 03:37:46,800 VALUABLE. 4565 03:37:46,800 --> 03:37:50,560 THANK YOU SO MUCH FOR JOINING US 4566 03:37:50,560 --> 03:37:53,080 TODAY AND I ALSO WOULD LIKE TO 4567 03:37:53,080 --> 03:37:55,640 OFFER MY SINCEREST THANKS TO ALL 4568 03:37:55,640 --> 03:38:01,840 OF NCCIH STAFF. 4569 03:38:01,840 --> 03:38:04,640 WE'RE NOT ONLY LOOKING AHEAD FOR 4570 03:38:04,640 --> 03:38:08,480 FISCAL YEAR 2024 BUT STILL IN 4571 03:38:08,480 --> 03:38:10,560 THE MIDDLE OF 2023. 4572 03:38:10,560 --> 03:38:11,920 AND THE OFFICE OF SCIENTIFIC 4573 03:38:11,920 --> 03:38:14,840 REVIEW WAS REALLY HARD TO GET 4574 03:38:14,840 --> 03:38:17,400 OUT ALL THE APPLICATIONS 4575 03:38:17,400 --> 03:38:19,760 REVIEWED, GRANT MANAGEMENT WITH 4576 03:38:19,760 --> 03:38:21,720 OUR PROGRAM OFFICE WHICH HAS 4577 03:38:21,720 --> 03:38:23,840 BEEN WORKING TIRELESSLY TO GET 4578 03:38:23,840 --> 03:38:26,960 ALL THE GRANTS REPAIRED SO THEY 4579 03:38:26,960 --> 03:38:27,240 GET FUNDED. 4580 03:38:27,240 --> 03:38:30,160 ALSO, I HAVE TO TELL YOU IT'S 4581 03:38:30,160 --> 03:38:34,040 NOT THE SECOND TIME WE'RE DOING 4582 03:38:34,040 --> 03:38:35,920 THE HYBRID MEETING AND I'M 4583 03:38:35,920 --> 03:38:38,320 SURPRISED HOW MUCH WORK GOES 4584 03:38:38,320 --> 03:38:40,960 INTO ORGANIZING THE HYBRID 4585 03:38:40,960 --> 03:38:41,240 MEETING. 4586 03:38:41,240 --> 03:38:43,080 IF IT WORKS WELL IT LOOKS EASY 4587 03:38:43,080 --> 03:38:44,600 BUT IT'S ACTUALLY NOT. 4588 03:38:44,600 --> 03:38:47,080 I'M GRATEFUL FOR OUR 4589 03:38:47,080 --> 03:38:48,880 ADMINISTRATIVE, I.T. AND SUPPORT 4590 03:38:48,880 --> 03:38:52,080 STAFF AND OUR OFFICE OF 4591 03:38:52,080 --> 03:38:53,200 COMMUNICATION WITHOUT 4592 03:38:53,200 --> 03:38:53,960 EVERYBODY'S HELP AND DEDICATION 4593 03:38:53,960 --> 03:38:56,280 WE WOULD NOT HAVE BEEN ABLE TO 4594 03:38:56,280 --> 03:38:58,560 HAVE THE MEETING HERE TODAY IN 4595 03:38:58,560 --> 03:38:59,360 THE WAY WE HAD IT. 4596 03:38:59,360 --> 03:39:09,760 THANK YOU TO EVERYBODY. 4597 03:39:10,200 --> 03:39:12,840 >> THANK YOU MARTINA FOR LEADING 4598 03:39:12,840 --> 03:39:14,400 US ALONG ALL DAY AND THANK YOU 4599 03:39:14,400 --> 03:39:14,560 ALL. 4600 03:39:14,560 --> 03:39:17,160 WE LOOK FORWARD TO SEEING YOU 4601 03:39:17,160 --> 00:00:00,000 VIRTUALLY IN JANUARY.